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Summary 
 Medfly (Ceratitis capitata) is an invasive Tephritid fruit fly that severely 
disrupts global agricultural productivity. Pesticides are the primary control method 
despite genetic resistance, questionable efficacy, and negative effects upon the 
environment. The sterile insect technique (SIT) is an ecofriendly alternative, that 
suppresses the reproduction of wild Medfly by the mass release of sterilised males. 
Currently, males are sterilised by irradiation, which frequently reduces the ability of 
males to court females and thereby suppress reproduction.  
 To address these undesirable effects, we developed a novel sterilisation strategy, 
based on the tetracycline-repressible expression of a nuclease effector in the male 
germline. Strains expressing these effectors were 99-100% sterile in the absence of 
tetracycline, but fertile in the presence of tetracycline. Male mating competitiveness was 
not detectably reduced in one strain expressing the effector, indicating that these 
expression systems are suitable for field use. Subsequently, a fluorescent marking 
system to label sperm was developed, which provided a useful tool to assess the mating 
competitiveness of sterile males: it was possible to accurately differentiate whether 
females had mated wild or transgenic males, under field-simulated conditions.  
  These components may be merged with a tetracycline-repressible genetic switch 
to remove females from the rearing population, to improve the efficacy of the strategy 
by releasing sterile males alone. Thereafter, a full assessment of the life history traits of 
the strain and its mating competitiveness under field-like conditions will be performed, 
to confirm that the release of these sterile males is capable of suppressing wild 
populations of Medfly.  
 
 Finally, an efficient expression system for CRISPR effectors in the germline was 
developed. This will facilitate the characterisation of novel transgenic systems for the 
reproductive control of Medfly, and expedite the development of commercial products, 
by the targeted integration of transgenic effectors.  
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Chapter 1 – Introduction 
 
1.1 Pest insects can damage crops and spread disease 
 The insect class is diverse, comprising over half of all described animal species 
(Mayhew, 2007). The majority of species (> 99%) do not negatively impact humanity, 
and perform important roles such as nutrient cycling, pollination, and the production of 
useful compounds including silk (Sallam, 2013). However, pest species are associated 
with crop destruction (Bardner and Fletcher, 1974), disease transmission (Lounibos, 
2002), and architectural damage (Su, 2002). It is estimated that 14% of food production 
is lost to insect pests (Strickland, 1969), (Pimentel, 2007). Furthermore, seven neglected 
tropical diseases transmitted by insects (malaria, trypanosomiasis, lymphatic filiarisis, 
dengue fever, leishmaniasis, Chagas disease and onchocerciasis) were responsible for 
1.23 million deaths, in 2001 alone (World Health Organisation, 2002). Consequently, an 
effective strategy to selectively limit the populations of pest insect species would 
improve quality of life, by reducing the incidence of illness and improving the 
efficiency of food production. This study concerns the development of a novel control 
strategy for Medfly, based upon the mass-release of males sterilised by the targeted 
localisation of protamine-FokI nuclease in the male germline. However, several aspects 
of the methodology and genetic engineering practices could be readily adapted to other 
pest species, such as disease vectors (Alphey et al., 2010). 
 
 Most insect pests are Dipterans (true flies), a diverse order of insects with more 
than 124000 species described (Merritt et al., 2009). The order includes a variety of 
important species such as the model organism D. melanogaster, the dengue vector 
Aedes aegypti (yellow fever mosquito) and the agricultural pest Ceratitis capitata 
(Medfly). The primary characteristics of this order are a single pair of wings with 
balancing organs (halteres), compound eyes, well-developed antennae, and a 
holometabolic life cycle (complete metamorphosis). Two suborders of Diptera are 
recognised, Nematocera and Brachycera, which are primarily differentiated by the size 
of the antennae and the body plan (Yeates and Wiegmann, 1999). Nematoceran insects 
(such as gnats, mosquitoes and midges) are more delicate, with multisegmented 
antennae. Brachyceran insects, such as Medfly, are smaller, thicker and possess 
antennae that are comparatively less segmented (Cranston and Gullan, 2009).  
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1.2 Medfly is a pest of economically important crops  
 
1.2.1 Taxonomy, economic impact and global distribution 
Medfly (Ceratitis capitata) is a pest fruit fly of the Tephritid family (true fruit 
flies). This group includes about 4200 species, of which 1400 species lay eggs in fruit 
(Gesmallah and Abdellah, 2011). Females puncture the skin of the fruit during egg-
laying (oviposition), damaging it and increasing susceptibility to infection (Harris et al., 
1980),. Thereafter, hatching larvae consume the fruit (Wimmer, 2005). Medfly is a 
globally established pest with the ability to severely reduce agricultural productivity. 
The species is strongly invasive due to high fecundity, a short life cycle, and the ability 
to store sperm (Sakai et al., 2001). Furthermore, it tolerates a variety of climates and can 
oviposit in more than 250 species of fruit (Centers for Disease Control and Prevention, 
1999), (Malacrida et al., 2006). This high degree of adaptability and invasiveness makes 
it one of the most serious Tephritid pests (De Meyer et al., 2007). Medfly continues to 
impose severe economic consequences, despite successful control programmes in some 
regions (La Brecque, 1982), (Ehler et al., 1984), (De Longo et al., 2000). The species 
originated in sub-Saharan Africa, but as a consequence of trade, has spread to have 
established populations in a variety of equatorial climates in Central America, South 
America, Europe, Asia, Africa and Australia (Steck et al., 1996), (Centre for 
Agriculture and Bioscience International, 2015). A map of its current distribution is 
provided in Figure 1.1-D.  
 
1.2.2 Life history 
Medfly is a holometabolous insect, progressing through four life stages: egg, 
larva, pupa and adult (Figure 1.1-B). As with most arthropods, development is 
temperature sensitive, proceeding more slowly at lower temperatures (Briere et al., 
1999), (Duyck and Quilici, 2002). Under optimal conditions (28° C), the entire life 
cycle is approximately 25 days (APHIS, 2015). However, at the lowest permissive 
temperature for growth and development (about 15° C), the life cycle may take more 
than 100 days to complete (Department of Agriculture and Food, Western Australia, 
2015). Embryos hatch 3-4 days after oviposition. The highly motile larvae burrow 
through the fruit, and complete three moults (instars), each lasting 3-4 days. Third instar 
larvae evacuate the fruit, and pupate on the soil surface or slightly beneath the surface. 
Approximately ten days later, adults eclose and disperse. 
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1.2.3 Sexual dimorphism 
  Males and females are highly dimorphic (Saul, 1982b). Males possess an extra 
pair of antennae; a white frons (grey in females); black setae; lighter femoral bristles; 
lighter labial palp bristles; and iridescent eyes. Furthermore, females possess a large 
ovipositor, absent from males. Males and females begin to accept mates after about 
three days (Papadopoulos et al., 1998). In terms of sexual anatomy (Figure 1.2), males 
possess a large pair of testes, long tubular accessory glands, short accessory glands, and 
an ejaculatory duct (Marchini et al., 2003). The male medfly has an intromittent organ 
with three ejaculatory tracts, which transfer sperm into both spermathecae and the 
fertilisation chamber of females (Marchini et al., 2001). Large ovaries, accessory 
glands, a fertilisation chamber and spermathecae comprise the female reproductive tract 
(Marchini et al., 2001). The long-term storage of sperm in the spermathecae allows the 
utilisation of sperm from multiple partners (Bertin et al., 2010). These reproductive 
adaptations make it a highly fecund species; under ideal conditions, a single female can 
produce hundreds of progeny in her lifetime (Novoseltsev et al., 2004). 
CONFIDENTIAL Chapter 1 - Introduction  
 
10 
 
CONFIDENTIAL Chapter 1 - Introduction  
 
11 
1.2.4 Mating behaviour 
The mating behaviour of Medfly is highly complex and involves a strong 
element of female selection (Kraaijeveld et al., 2005). It is a polygamous species: males 
and females can mate several times (Miyatake et al., 1999), (Bonizzoni et al., 2002), 
(Kraaijeveld and Chapman, 2004). Females are more likely to re-mate when transferred 
insufficient sperm or seminal fluid (Mossinson and Yuval, 2003), (Kraaijeveld and 
Chapman, 2004). Re-mated females store sperm from both males (Bertin et al., 2010). 
However, a last-mate precedence is observed for several days after re-mating: a greater 
proportion of progeny are sired from the most recent mate (Scolari et al., 2014). In 
Drosophila, sperm may incapacitate one another (Price et al., 1999) and females are 
able to dump sperm (Snook and Hosken, 2004). However, these mechanisms do not 
seem to be present in Medfly (Bertin et al., 2010).  
 
Females respond to cues of male fitness at several stages. Prior to mating, 
females respond positively to large symmetrical males that are well-fed (Orozco and 
Lopez, 1993), (Taylor and Yuval, 1999), (Hunt et al., 2004). Furthermore, males engage 
in the courtship behavior of lekking. This is a competitive display that establishes 
dominance within a group, and involves physical, pheromonal and acoustical 
presentation to females (Field et al., 2002). In this process, the male emits pheromone, 
bends the abdomen and vibrates his wings in repetitive bursts. Subsequently, the 
pheromone pouch is closed and a pattern of wing movement initiated. The head is 
rapidly revolved in patterned movements, prior to attempted copulation. Finally, the 
male leaps atop the female, repeatedly rubbing with the hind legs and nipping at the 
ovipositor (Arita and Kaneshiro, 1985). Ultimately, the female commands reproduction, 
and frequently dislodges males attempting copulation (Briceño and Eberhard, 1998). 
The process is energetically expensive, and only a minority of lekking Medfly males are 
able to secure the majority of females for reproduction (Arita and Kaneshiro, 1985). 
Therefore, it appears that the behaviour is an adaptive mechanism, applying sexual 
conflict to allow the selection of well-adapted males (Kaspi et al., 2000). After mating, 
females shift behaviour from mate-seeking to oviposition, in a process thought to be 
mediated by chemicals in seminal fluid (Jang, 1995), (Gomulski et al., 2012).  
 
Mating behaviour has been observed in the laboratory and in the wild. It is 
apparent that colonisation and mass-rearing negatively affect the ability of Medfly to 
engage in wild-type mating behaviour. Several aspects of mating behaviour are reduced 
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in duration, or removed completely, in colonised Medfly (Liimatainen et al., 1997), 
(Briceño and Eberhard, 1998). Therefore, it appears that the artificial conditions of 
rearing limit the highly selective process of mate selection observed in the wild. This is 
thought to alter the facultative polyandry of wild Medfly (females are highly sexually 
selective, but occasionally remate) to a condition of scramble polygyny, where males 
able to quickly secure females are rewarded (Mossinson and Yuval, 2003). As the pest 
control mechanism described in this thesis applies sterile males to reduce the 
reproductive capacity of wild populations, the effects of sterilisation and mass-rearing 
on mating behaviours is of paramount importance.   
 
1.2.5 Spermatogenesis  
 Spermatogenesis describes the differentiation of primordial germ cells into 
mature sperm: highly elongated, motile cells capable of fertilisation (Fuller, 1993). To 
achieve this, tightly regulated and highly specific patterns of gene expression are 
required in the male germline (Perezgasga et al, 2004). This is relevant to the work 
performed in this thesis, because we attempted to engineer the expression of effectors 
for male sterility and fluorescent marking of sperm nuclei, in the male germline. 
Therefore, the patterns of gene expression in these cells must be considered. The 
process is well-understood in the model organism D. melanogaster (Fuller, 1993), 
(White-Cooper, Doggett & Ellis, 2008), (White-Cooper, 2009), (Fabian and Brill, 
2012). Spermatogenesis in Medfly has been studied, but to a lesser extent (Shahjahan et 
al., 2006), (Scolari et al., 2008), (Intra et al., 2011), (Papanastasiou et al., 2011), 
(IAEA/FAO, 2016). To the author’s knowledge, there is no single publication that 
directly compares spermatogenesis in the two organisms. Therefore, the current 
knowledge of spermatogenesis in D. melanogaster and Medfly are compared (Figure 
1.3). 
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 In D. melanogaster, a niche of hub cells mediates the cellular signalling required 
to renew two populations of stem cell essential for spermatogenesis: cyst stem cells 
(CySC) and germline stem cells (GSCs) (White-Cooper, 2009), (Yamashita, 2010). 
When CPCs divide, they regenerate and also produce a cyst cell. GSC division 
regenerates a GSC, but also yields a spermatogonium, which is enveloped by a pair of 
cyst cells (Leatherman and DiNardo, 2008). The spermatogonium undergoes four 
mitotic divisions to produce 16 primary spermatocytes (Fuller, 1993). These cells are 
highly transcriptionally active, in contrast to post-meiotic cells, which demonstrate 
highly reduced transcription (Chen, 2005), (Vibranovski et al., 2010). The importance 
of the meiotic transcriptional arrest is discussed in the context of this study (Section 
1.4.2.3), when the functional components of the male sterility expression system 
applied in this thesis are considered. Thereafter, two meiotic divisions yield 64 
spermatids, which do not immediately separate but remain interconnected via 
cytoplasmic bridges (Fabian and Brill, 2012). Finally, the spermatid tails elongate, fully 
differentiated spermatids individualise, and mature sperm migrate to the seminal vesicle 
(White-Cooper, 2009). 
 
 The high degree of differentiation observed in spermatogenesis is reflected by 
complex patterns of gene expression. At least 1317 genes are uniquely expressed, and at 
least 2079 are predominantly expressed, in D. melanogaster testes (Chintapalli et al., 
2007). Transcription of testis-specific genes occurs mostly in primary spermatocytes 
(Chen, 2005), (Vibranovski et al., 2010). Many transcripts are directly translated in 
spermatocytes, for example, β2-tubulin (Michiels et al., 1989) and aly (White-Cooper et 
al., 2000). Interestingly, the translation of many genes is repressed until the spermatid 
stage, for example the sperm tail protein Don juan and the protamine-like genes 
Mst35Ba and Mst35Bb (Santel et al., 1997), (Jayaramaiah Raja and Renkawitz-Pohl, 
2005), (White-Cooper, 2009).   
 Testis-specific transcription in D. melanogaster is frequently, but not always, 
regulated by the meiotic arrest genes. Males with homozygous loss of function 
mutations for the meiotic arrest genes are not fertile, and accumulate primary 
spermatocytes, with no subsequent differentiation into spermatids or mature 
spermatozoa (Lin et al., 1996). The first class of mutants are genes whose protein 
products are associated with the testis-specific meiotic arrest complex (tMAC). The 
protein products of aly, comr, mip40, tomb and topi are subunits of tMAC, whereas 
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those of achi/vis and wuc associate with tMAC subunits (Perezgasga et al, 2004), (Beall 
et al., 2007), (Jiang et al., 2007), (Doggett et al., 2011). In the testes of aly mutants, 
1000 genes are underexpressed by a factor of 16 or more, relative to wild type (Doggett 
et al., 2011). Therefore, tMAC is a master regulator of transcription in the male 
germline. 
 
 The second class of mutants are genes paralogous to TATA-binding protein 
associated factors (TAFs): can, mia, nht, rye and sa. It is hypothesised that these 
comprise testis-specific versions of the basal transcription factor TFIID, termed tTAFs 
(Hiller et al., 2001), (Hiller et al., 2004). Like tMAC mutant testes, tTAF mutants 
demonstrate a reduction in the expression of testis-specifically transcribed genes, but 
the effect is less pronounced (White-Cooper, Schafer et al. 1998), (Doggett et al., 2011). 
From a comparison of the genes underexpressed in tMAC or tTAF mutants, two 
observations followed. First, tTAF-dependent genes are a subset of tMAC-dependent 
genes. Secondly, the loss of tMAC subunits or their associated factors almost 
completely removes transcription of the dependent genes; the loss of tTAFs is less 
severe, reducing expression of dependent genes to basal levels.  
 
 It is not yet understood how tMAC and tTAFs activate the transcription of target 
genes. DNA-binding domains are present in several tMAC subunits or their associated 
proteins, including Achi/vis, comr, tomb and topi (Attrill, Falls et al. 2016). 
Furthermore, tMAC subunits and tTAFs are enriched on chromatin (Chen, 2005), (Jiang 
et al., 2007), (Metcalf and Wassarman, 2007). A variety of testis-specific promoters are 
known in D. melanogaster, and in several instances, the elements responsible for testis-
specific expression have been characterised by reporter study. Motifs that are well-
characterised include the 14 bp region upstream of β2-tubulin (β2UE1), essential for 
testis-specific expression and conferring tTAF-sensitivity (Michiels et al., 1989), (Hiller 
et al., 2001). Two additional elements, one within the promoter (β2UE2) and one within 
the 5’UTR (β2DE1), enhance expression (Michiels et al., 1993), (Santel, 2000). 
Homologues of these elements exist in the Medfly β2-tubulin homologue (Scolari et al., 
2008), though their ability to confer testis-specific transcription has not been confirmed 
directly. Similarly, a 10 bp translational control sequence (TCE) is present in certain 
testis-specifically expressed genes, and responds to tTAF (Kempe, Muhs et al. 1993), 
(Katzenberger et al., 2012). Interestingly, replacement of the β2UE1 sequence with a 
TCE retains the testis-specific transcription of β2-tubulin (Kempe, Muhs et al. 1993). 
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Therefore, although the elements are regulated at the transcriptional level in a similar 
manner, the underlying sequence motifs that mediate this are not easily defined, despite 
the evidence that tMAC and tTAF associate with them. Indeed, efforts to determine a 
consensus sequence for male-germline specific transcription have been relatively 
inconclusive (Honeycutt and Gibson, 2004).  
 
 Comparatively little is understood regarding Medfly spermatogenesis; 
essentially none of the key genetic regulators have been experimentally confirmed. 
However, the overall process appears to be relatively similar, at least in terms of cellular 
organisation and the progression of divisions (Intra et al., 2011), (IAEA/FAO, 2016), 
despite the striking contrast in the morphology of the testes (Marchini et al., 2003). As 
in D. melanogaster, spermatogonia are associated with cysts and mitotically divide to 
form primary spermatocytes; there are two subsequent meiotic divisions without full 
individualisation of the spermatids; and finally the tails of spermatids elongate prior to 
individualisation and migration to the deferent duct (Shahjahan et al., 2006), (Scolari et 
al., 2008), (Intra et al., 2011). However, relative to D. melanogaster, there is one 
additional mitotic division that occurs prior to spermatid formation. 32 primary 
spermatocytes divide twice to form 128 spermatids (Intra et al., 2011). Homologues of 
β2-tubulin, the protamine-like genes Mst35Ba and Mst35Bb, and the majority of tMAC 
and tTAF genes are present (NCBI, 2016). The Medfly β2-tubulin and protamine-like 
homologues were used as regulators of transgenic effectors, and are discussed routinely 
throughout this study (Chapters 3-5). Alignments of the tMAC and tTAF homologues 
are provided in the Appendix (Figure 8.1). Although these genes were not investigated 
in this study, it would be interesting to generate mutant strains for these genes with 
CRISPR (clustered regularly interspersed palindromic repeats) technology (Chapter 6). 
In terms of reproductive biology, it would be interesting to experimentally confirm their 
role in regulating spermatogenesis. In practical terms, their regulatory elements might 
be useful for the targeted localisation of transgenic sterilants. Alternatively, some may 
provide useful targets for the development of Medfly population control strategies, for 
by blocking their expression by RNA interference or synthetic repressors. For instance, 
targeted repression of the misfire gene could theoretically be applied to prevent fusion 
of the sperm and egg, without an effect on the quantity or morphology of sperm 
transferred to females upon mating (Ohsako et al., 2003). 
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1.2.6 Genetic engineering 
 Expression constructs with genetically engineered effectors can be readily 
integrated into the Medfly genome by transposition (Gong et al., 2005). Medfly has 
been transformed with several transposons, including piggyBac (Handler et al., 1998), 
minos (Loukeris et al., 1995), and hermes (Michel et al., 2001). piggyBac vectors are 
easy to generate, efficiently transformed, and effective in a variety of insect species 
(Handler, 2002). Therefore, all transformation experiments in this thesis have utilised 
piggyBac. The native piggyBac sequence is an autonomous 2475 bp element that 
encodes the transposase required for mobilisation, within the transposon itself (Li et al., 
2001a). The transposon terminates in palindromic inverted terminal repeats (ITRs), 
which are essential for transposition (Elick et al., 1997). The transposon can integrate 
via a cut-and-paste mechanism at any TTAA sequence (Li et al., 2001b). However, 
integration is heavily biased to particular chromosomal regions, and frequently occurs 
within or nearby transcribed sequences (the first intron and first exon, especially the 
5’UTR, were particularly favoured) in several organisms, including human T-cells, D. 
melanogaster and P. falciparum (Thibault et al., 2004), (Balu et al., 2009), (Galvan et 
al., 2009). Furthermore, there is a significant preference for TTAA rich sequences (Balu 
et al., 2009), (Galvan et al., 2009). Therefore, it appears that insertion is most likely to 
occur in TTAA-rich, transcriptionally open chromatin. In most genetic engineering 
systems, the piggyBac transposase is removed from the native transposon and regulated 
by appropriate sequences for the target species in a helper plasmid (Handler and Ii, 
1999). For instance, the Medfly helper plasmid applies Cchsp70-regulated piggyBac 
transposase. Thereafter, a transposable piggyBac vector is generated by cloning a 
sequence of interest between the ITRs required for transposition. Microinjection of this 
vector with the helper plasmid facilitates germline transformation of Medfly (Gong et 
al., 2005). 
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 A typical piggyBac vector includes a screenable transformation marker, often a 
fluorescent protein, which allows transformants to be efficiently selected (Figure 1.4). 
In Medfly, the baculovirus-derived HR5IE1 promoter-enhancer or a fragment from the 
Mexfly muscle actin gene (comprising the promoter, 5’UTR and 3’UTR) mediate 
efficient fluorescent marker expression in transgenic individuals (Fu et al., 2007), 
(Koukidou et al., 2016). After microinjection of the piggyBac vector and a helper 
plasmid into pre-blastodermal embryos, a minority of germline cells are transformed. 
Subsequent backcrossing to wild-type allows the selection of stable transgenic 
individuals, which have the piggyBac integration in all cells.  
 
 An additional system for the targeted engineering of Medfly is CRISPR (Figure 
1.4). This system was originally adapted from S. pyogenes, where it functions as an 
adaptive immune system that specifically cleaves target DNA (Brouns et al., 2008). 
However, a variety of CRISPR systems with alternate specificity and modes of action 
are known (Fonfara et al., 2014). A simplified version of the Class II CRISPR system 
was applied, which uses a single targeting guide RNA (sgRNA) to direct the Cas9 
nuclease to a target sequence (Jinek et al., 2012), ,(Bassett et al., 2013). This facilitates 
the engineered cleavage of target sequences immediately upstream of the protospacer 
adjacent motif (PAM), to a variety of ends (Wiedenheft et al., 2012)., For instance, 
genes can be mutagenised to study function (Shalem et al., 2014). Alternatively, Cas9-
induced double-stranded breaks can be introduced, to then facilitate targeted 
recombination, for efficient sequence replacement or deletion (Saintigny, 2001). 
Therefore, previous transgenic lines could be engineered to express novel features, or a 
transgenic insertion could be directly targeted to a genomic site with a desirable 
expression profile. A full introduction of CRISPR systems and their functional 
applications is provided in Chapter 6, where the platform was validated in Medfly. 
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1.3 Methods for the control of pest insects 
 
1.3.1 Preventing the introduction of pest species 
 The costs associated with crop loss and the control of accidentally introduced 
insect species are estimated at $14.4 billion, in the United States alone (Pimentel et al., 
2002). The broad host range and climate tolerance of Medfly allows it to invade novel 
habitats, with devastating consequences (Myers et al., 2000). Therefore, vigilant 
monitoring is required to prevent establishment in new territories. The import of fresh 
fruit from infested zones to non-infested zones is carefully regulated. Several nations 
will not import fruit from infested areas unless processed (Jackson, 1971), (Hallman, 
2000), (Mansour and Mohamad, 2004). For instance, fruit exported from Hawaii to the 
mainland United States is routinely irradiated, to destroy viable embryos and larvae 
(Follett and Lower, 2000), (Moy and Wong, 2002). Other potential treatments include 
heating, chilling, and fumigation (Lurie, 1998). Furthermore, routine physical and X-ray 
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screening checks are made in susceptible areas, to detect the presence of potentially 
infested fruit in passenger luggage (Liebhold et al., 2006). Further effective measures 
include the release of sterile male flies as a cautionary measure, to prevent the 
establishment of an invasive species if accidentally imported (Kuba et al., 1996). The 
use of sterile males to control insect populations is the central objective of this thesis, 
and is discussed later (Sections 1.3.7 and 1.4). Prophylactic measures to prevent the 
establishment of Medfly are of paramount importance, because in the absence of an 
established population, active forms of population control are not required. 
 
1.3.2 Chemical insecticides 
 Chemical insecticides are substances that are toxic to any insect life stage. They 
can be differentiated by chemical structure, mode of action, environmental persistence, 
off-target toxicity and origin (natural or synthetic). Chemical control of pest insect 
populations emerged in the 1940s as the most common control method, following the 
practical success of dichlorodiphenyltrichloroethane (DDT) in controlling vectors of 
malaria (Casida and Quistad, 1998). Most insecticides interfere with neurotransmission 
(Vontas et al., 2011). The most common types are carbamates, organophosphates, 
organochlorines, and pyrethroids. However, an emerging class of insecticides have 
hormonal effects that inhibit juvenile development (Dhadialla et al., 1998), (Wu et al., 
2006), (Mains et al., 2015). Naturally-derived insecticides, for instance spinosad, are 
promising in terms of limiting side-effects to non-target species, but they have not been 
widely applied (Salgado, 1998), (Isman, 2006). From each class of insecticide, the 
chemical structure and mode of action of a representative member is presented (Figure 
1.5).  
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 Though effective, the widespread application of insecticides is controversial. 
Many insecticidal compounds are directly toxic to non-target insect species, and may 
impact ecology or remove natural enemies that control pest populations (Shetty, 2004). 
Furthermore, they may be toxic to mammals and birds (Fukuto, 1990), (Mineau et al., 
2001), (Mineau and Whiteside, 2013). They can also accumulate in the food chain 
(Walker, 1990), a particularly severe problem for compounds with off-target toxicity 
and ability to persist in the environment or biological tissue, such as dieldrin and DDT 
(Beyer and Krynitsky, 1989). Modern insecticides, such as neonicotionoids, are often 
selectively toxic to insects (Casida and Quistad, 1998), (Tomizawa and Casida, 2003). 
However, they rarely discriminate between pests and ecologically important insects.  
 
Insecticide misuse selects for genetic resistance, for which three primary 
mechanisms are known: reduced uptake of the compound, enhanced detoxification, and 
mutation of the binding site (Soderlund and Bloomquist, 1990). Insecticides remain 
largely effective for Medfly, with the exception of malathion, for which field resistance 
is known (Magaña et al., 2008). However, resistance to organophosphate, dieldrin and 
DDT have been induced in laboratory populations of Medfly, indicating that such 
resistance is possible, and thus may occur in the field (Georghiou, 1986). Cross-
resistance may present a further issue, because many insecticides have similar effects 
(Casida and Quistad, 1998), (Vontas et al., 2011). Furthermore, spraying does not 
effectively eradicate pests capable of long-range dispersal, like Medfly (Meats and 
Smallridge, 2007). Therefore it appears that insecticides are not adequate as a single 
solution to control Medfly, without the application of further control strategies. 
 
1.3.3 Predator introduction 
 Pests are frequently controlled by competition with other insect species, or direct 
predation. Natural parasite wasps suppress wild populations (Yokoyama et al., 2008), 
(Wang et al., 2010). Carabids, P. rufipes and H. distinguendus prey upon Spanish 
populations of Medfly pupae (Urbaneja et al., 2006). In the Argan forest (Morocco), 
four species of ants were associated with about half of larval mortality under favourable 
temperature conditions (El Keroumi et al., 2010). In Regio Calabria (Italy), about 27% 
of larvae were preyed upon by ants (Campolo et al., 2015). Further studies have 
demonstrated that spider and ant species can effectively limit wild populations of fruit 
flies (Monzó et al., 2009), (Fernandes et al., 2012). It has been suggested that 
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intentionally introduced competitors could suppress pest species (Myers et al., 2000). 
However, these predators are not always species specific, and may therefore affect the 
population of other insects or crops (Piñol et al., 2012). Therefore, their introduction 
must be carefully considered to avoid disrupting the ecosystem. 
 
1.3.4 Pheromone spraying, oviposition deterrence and trapping 
 Medfly respond to a variety of chemicals which alter behaviour, and therefore 
could potentially be used as a means of pest control (Jang et al., 1989), (Papadopoulos 
et al., 1998). Medfly faeces contain pheromones which discourage further oviposition to 
fruit; these could be applied to discourage egg-laying (Arredondo and Díaz-Fleischer, 
2006). Alternatively, a pheromone deposited during oviposition is known to discourage 
further egg laying (Prokopy et al., 1978), (Papaj et al., 1992). Foreign chemicals, such 
as neem extracts, are known to possess the same oviposition deterring effect (Silva et 
al., 2012). Disrupting the reproductive capacity of a wild population by applying 
volatile compounds to discourage oviposition, would be expected to reduce the 
population. Despite validation of this strategy in small-scale field studies (Arredondo 
and Díaz-Fleischer, 2006), to our knowledge, it has not been applied on an area-wide 
scale to control wild Medfly populations.  
 
 A related strategy applies pheromones to disrupt the incidence of mating, which 
has been successful in reducing crop damage associated with the moth species P. 
gossypiella and G. molesta (Minks and Cardé, 1995). In Medfly, males are known to 
produce at least 56 volatile compounds (Jang et al., 1989). A synthetic blend of five of 
these compounds was effective at attracting females within a flight tunnel, though to a 
lesser extent than the natural emissions of live males (Jang et al., 1994). This indicates 
that wide dispersion of these compounds could potentially disrupt mating in wild 
populations of Medfly. To date, this has not been evaluated as an area-wide control 
strategy for Medfly, probably for practical reasons. The ability of male-derived 
pheromones to lure females in the field was frequently unimpressive, though it is 
possible that an effective formulation has yet to be described (Tan et al., 2014). 
Furthermore, a wide variety of plant compounds highly attractive to Medfly exist, 
which lack the chemical complexity of the male pheromone blend (Light et al., 1988), 
(Witzgall et al., 2010). Interestingly, some of these compounds (parapheromones) elicit 
responses similar to pheromones (Navarro-Llopis et al., 2011), and can be applied to 
effectively trap and kill adult populations of Medfly. Sticky traps baited with the 
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parapheromone Trimedlure are effective at capturing adults (Harris et al., 1971), as are 
protein-baited traps with pheromones (Katsoyannos, 1994). Therefore, baited traps 
would prove useful in an integrated pest management strategy, though further measures 
would be necessary to achieve full suppression. 
 
1.3.5 Agricultural practices and engineered crops repellant to insect pests  
 Agricultural practices can reduce crop susceptibility. The push-pull strategy 
applies factors that push insects away from the target crop and pull them towards an 
alternative factor. Push factors include visual cues, repellant chemicals, alarm 
pheromones, and oviposition deterrents. Pull factors include visual cues, attractive 
chemicals or pheromones, and taste stimulants (Cook et al., 2007). A push-pull strategy 
suitable for Medfly would, for instance, involve discouraging oviposition with 
pheromones and thereafter attracting adults to traps. However, these strategies are less 
effective for species with a high population growth rate and wide dispersal (Cook et al., 
2007), (Meats and Smallridge, 2007). Therefore, they may not be optimal to control 
Medfly. 
 
An alternative strategy involves the genetic engineering of commercially 
important crops for pest tolerance. For instance, Roundup-Ready® soybeans express a 
transgene from A. tumefaciens conferring tolerance to glyphosphate, a common 
herbicide used in agriculture (Qaim and Traxler, 2005). Bacillus species produce a 
variety of crystalline toxins, some of which are highly species specific (de Maagd et al., 
2003). This faciliates the development of transgenic crops that will demonstrate 
minimal or no toxicity to other insect species. Commercial crop strains have been 
developed to express a variety of these toxins, including Cry1Ab, Cry3B, Cry1F and 
Cry9C (Arpaia et al., 2000), (Reed and Halliday, 2001), (Nguyen and Jehle, 2007), 
(Buntin, 2008). Transgenic maize and cotton strains expressing these Cry proteins 
effectively control pests, and can improve yields and reduce costs associated with 
insecticide spraying (James, 2003), (Wu et al., 2008). Certain strains of B. thuringiensis 
(eg. Bt 13.4) are toxic to Medfly larvae and adults, though the majority are not highly 
effective (Vidal-Quist et al., 2009), (Aboussaid, 2010). Toxins active against Medfly 
have been identified from other species, for instance from Bacillus pumilus strain 15.1 
(Molina et al., 2010). However, an engineered crop expressing an insecticide active 
against Medfly remains to be developed. This does not, however, preclude the direct 
spraying of Bacillus-derived insecticidal residues on crops. In some respects, direct 
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application would be politically favourable, as it circumvents the controversies 
associated with traditional insecticides and genetic engineering. 
 
Although GM crops have been widely grown in certain countries (eg. 
Argentina), they remain highly controversial, particularly evidenced by protests, low 
approval in opinion polls, and sabotage of GM trials (Gaskell, 1999), (Rowe, 2004), 
(Qaim and Traxler, 2005), (Kuntz, 2012), (Mielby et al., 2013), (Hilbeck et al., 2015). 
The arguments against GM crops include moral concerns about interfering with nature, 
unanticipated effects on the ecosystem, potential risks to humans and other animals, 
escape of the engineered genes into the wild, lack of transparency in labelling GM 
foods, and the ethical tenability of patenting food (Ferber, 1999), (Gaskell, 1999), 
(Shaw, 2002), (Gaskell et al., 2004). A further issue is the potential for evolved 
resistance to GM crops, which has been observed in the field for Bt-expressing cultivars 
(Heckel et al., 2007), (Fabrick et al., 2014), (Gassmann et al., 2014). However, the 
application of GM crops is frequently associated with greater yields (Carpenter, 2010) 
and reduced pesticide input (James, 2003), (Finger et al., 2011). Furthermore, a lack of 
appreciable risk has been demonstrated for many common concerns cited against GM 
crops, including allergenicity to humans (Beachy et al., 2002), the risk of horizontal 
gene transfer (Keese, 2008), and toxicity to butterflies (Sears et al., 2001). However, 
approval of the platform remains low in Europe (TNS Opinion & Social, 2010). 
Therefore, substantial increases in public approval are required to facilitate their 
adoption in all regions affected by Medfly. 
 
1.3.6 Wolbachia   
 Over half of insect species are estimated to be infected with Wolbachia, a group 
of maternally-transmitted intracellular bacteria (Hilgenboecker et al., 2008). The type 
species is W. pipientis, first isolated from the mosquito C. pipiens (Hertig, 1936). Four 
main effects are attributed to Wolbachia species: male-killing, feminisation, 
parthenogenesis and cytoplasmic incompatibility (Hurst et al., 1999). The latter is most 
relevant to the control of insect pests. Cytoplasmic incompatibility is a phenomenon in 
which the viability of a mating event is directly attributed to the infection status of the 
parents (Werren et al., 2008). Mating events between infected males and uninfected 
females lead to zygotic arrest, because chromosomes fail to partition appropriately 
during cellular division (Tram et al., 2006). All other combinations of mating are fertile. 
This enhances the transmissibility of Wolbachia, by increasing the rate of female 
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infection and therefore the rate of vertical transmission to progeny. This effect may be 
unidirectional or bidirectional: requiring infection of males and females with one or two 
strains, respectively (Blagrove et al., 2012). 
 
Virulent infections of Wolbachia can reduce the ability of insect pests to survive, 
indicating that they can be applied to weaken wild populations (Teixeira et al., 2008), 
(Moreira et al., 2009), (Kambris et al., 2010). A second potential application of 
Wolbachia is for the direct reproductive control of pest insects (the incompatible insect 
technique). In this method, the cytoplasmic incompatibility of mating between infected 
males and uninfected females is applied to reduce field populations (Bourtzis, 2008), 
(Saridaki and Bourtzis, 2010). For particular strains of Wolbachia, the progeny of these 
mating events are completely or almost completely inviable (Blagrove et al., 2012). 
Therefore, the mass-release of males infected with a strain of Wolbachia absent in the 
wild, would be expected to severely reduce the reproductive capacity of wild insects. 
Strains of Medfly with Wolbachia-induced cytoplasmic incompatibility have been 
generated (Zabalou et al., 2004), (Zabalou et al., 2009). This strategy has also been 
applied in the field for mosquito control (O’Connor et al., 2012), though concerns about 
its biosafety and efficacy are recognised (Popovici et al., 2010). 
 
 Notably, the success of this strategy is contingent upon a male-only release and 
complete absence of natural infection with the Wolbachia strain. If naturally infected 
females were present, the technique would be substantially less effective, because 
crosses of infected males and infected females are fertile. Similarly, the release of a 
single Wolbachia infected female from rearing facilities would allow the infection to 
potentially sweep through the population (by vertical transmission) and would therefore 
block cytoplasmic incompatibility. The sex-separation strategies employed in prior wild 
releases of Wolbachia-infected males were imperfect, and it has been conceded that 
release of infected females would be expected at low frequency with current non-
genetic separation techniques (Balestrino et al., 2014), (Calvitti et al., 2015). This could 
be avoided by the application of highly effective genetic sex-separating strains to yield 
male only populations, but such strains would need to be 100% effective (Zabalou et al., 
2009). 
Another concern associated with Wolbachia technologies is lateral gene transfer, 
which can occur between the host and the introduced Wolbachia species. This has 
resulted in the transfer of fragments ranging from gene-sized cassettes to nearly-
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complete Wolbachia genomes (Kondo et al., 2002), (Hotopp et al., 2007), (Hou et al., 
2014). This could potentially permanently alter the genetic composition of wild species 
with unknown effects, posing a substantial ethical concern. A further issue concerns the 
wild release of Wolbachia into the environment, which is not easily recalled; novel 
infections can sweep through the wild population in less than a decade (Kriesner et al., 
2013). Therefore, the strategy may prove effective in future application, if several 
conditions are met: releases of infected insects are exclusively male; the effect of 
Wolbachia infection on vectorial capacity is fully understood; and the penetrance of 
cytoplasmic compatibility is complete. However, as cytoplasmic incompatibility is 
rarely entirely penetrant, the strategy must be approached with utmost caution (Zabalou 
et al., 2004) . 
 
1.3.7 The sterile insect technique (SIT)  
The SIT (Figure 1.6) is a strategy for the chemical-free reproductive control of 
pest insect species (Knipling, 1955). The population control strategy devised in this 
thesis is a modification of SIT, to engineer improved male competitiveness and 
enhanced field traceability. In the SIT, reproduction of wild pests is inhibited by the 
mass release of sterilised males, which dilutes the reproductive ability of the population 
(Baumhover et al., 1959), (Takken, 1987), (Alphey, 2006). Prolonged release of sterile 
males in sufficient number has substantially reduced or eradicated wild populations. 
Successful programmes have been applied for several species and several are ongoing 
(Table 1.1). The success of the strategy is dependent upon several factors: reliable male 
sterilisation that minimally affects competitiveness, reliable sex separation to yield 
male-only release populations, appropriate scale of release, and diligent monitoring in 
the field (Alphey, 2002), (Rendón et al., 2004), (Black et al., 2011).   
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Figure 1.6. The sterile insect technique (continued on next page). (A) Irradiation sterilises males 
by introducing dominant lethal mutations into sperm. This leads to chromosomal aberrations, 
preventing the formation of viable zygotes when mated to wild females. (B) The temperature-sensitive 
lethal (tsl) VIENNA-8 genetic sexing strain, commonly applied in SIT programmes. Left: A 
translocation provides male-speciﬁc linkage of the selectable tsl trait and a visual marker. Right: Male 
(brown) and female (white) pupae. 
A  
B  
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Table 1.1: Partial list of previous and ongoing SIT programmes  
Species Region Date Outcome Notes Ref 
C. 
hominivorax 
USA & 
Mexico 
1956-
1991 
Eradication  (Wyss, 2006) 
Guatemala 
& Belize 
1986-
1994 
Eradication  (Wyss and Galvin, 
1996) 
Libya 1990-
1991 
Eradication  (Lindquist et al., 
1993) 
El Salvador 1991-
1995 
Eradication  (Galvin and Wyss, 
1996) 
G. austeni Unguja, 
Zanzibar 
1994-
1997 
Eradication  (Vreysen et al., 
2000) 
G. p. palpalis Central 
Nigeria 
1986 Eradication  (Takken et al., 
1986) 
Medfly  Western 
Australia 
1978-
present 
Suppression Eradication not 
achieved, sterile 
releases continue as a 
preventative measure 
(Department of 
Agriculture and 
Food, Western 
Australia, 2015) 
California, 
USA 
1980s-
present 
Suppression Routine outbreaks 
since 1980s, 
preventative releases 
of sterile males 
continued 
(Jackson and Lee, 
1985), (Headrick 
and Goeden, 1996) 
Guatemala 1983-
present 
Suppression Suppression achieved, 
preventative releases 
continued 
(Linares and 
Valenzuela, 1993), 
(Moscamed, 2016) 
Chile 1988-
1995 
Eradication  (Lobos and 
Machuca, 1998) 
Argentina 1996-
present 
Suppression Preventative releases 
to reduce population 
(De Longo et al., 
2000) 
Israel 1997-
present 
Suppression  (Rossler et al., 
2000), (IAEA, 
2016) 
South 
Africa 
1997 - 
present 
 No literature available 
regarding efficacy 
(IAEA, 2016) 
Melon Fly Okinawa, 
Japan 
1972-
1993 
Eradication Preventative sterile 
releases continue  
(Kuba et al., 1996) 
Sweet potato 
weevil 
Japan 1999-
2002 
Suppressed  (Kohama et al., 
2003) 
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 Mass-released sterile males must remain competitive and able to engage in the 
normal mating behavior of the target species, because they must displace the mating 
attempts of fertile, wild males (Alphey, 2006). The mode of sterility is ideally paternal 
effect embryo lethal, because Medfly primarily damage crops in the larval stage 
(Wimmer, 2005). Currently, almost all mass-release programmes sterilise males by 
irradiation (IAEA, 2016). This reliably introduces dominant lethal mutations into sperm 
(Bakri et al., 2005), but undesirably reduces male performance in the field (Shelly et al., 
1994), (Alphey, 2006). For instance, ability to produce sperm is reduced after 
irradiation (IAEA/FAO, 2016). Furthermore, the mating competitiveness of males is 
reduced by mass-rearing and sterilisation, which reduces their ability to court females 
and thereby reduce the population (Shelly et al., 1994), (Shelly and Whittier, 1996), 
(Lance et al., 2000), (McInnis et al., 2002). Poor competitiveness has been implicated in 
the failure of certain SIT programmes, including attempts to control A. gambiae in 
Burkina Faso and C. tritaeniorhynchus in Pakistan (Benedict, 2003). This can be 
attenuated by releasing more males, though this incurs a greater economic cost (Barry et 
al., 2003), and it is expected that severe deficits in male competitiveness would require 
an unfeasible scale of release. However, it should be noted that if the wild population is 
suppressed, even at sub-optimal levels, then the scale of release required to achieve 
suppression will be gradually reduced, as the wild population declines. 
 
 To further complicate matters, female fruit flies have complex behavioural 
responses to mating. Males must be appropriately sized and nourished to optimally 
attract females (Taylor and Yuval, 1999). Furthermore, males must successfully engage 
in leks; this ability is reduced in mass-reared males (Liimatainen et al., 1997), (Briceño 
and Eberhard, 1998), (Lance et al., 2000). Females also respond to cues in seminal fluid 
and to the presence of sperm in the spermathecae (Mossinson and Yuval, 2003), 
(Gomulski et al., 2012). It has been demonstrated that sterilisation by irradiation reduces 
the ability of Medfly males to induce female refractoriness to re-mating (Kraaijeveld 
and Chapman, 2004). Irradiation can reduce sperm count (Seo et al., 1990), which is 
concerning because females that receive less sperm have been shown to re-mate at a 
higher frequency (Mossinson and Yuval, 2003). Therefore, to effectively mediate the 
desired population suppression, the sperm of sterile males should be incapable of 
allowing development of the zygote, but otherwise equivalent to wild-type. 
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 The requirement for male-only releases is multifactorial. Sterile females can still 
sting fruit, reducing its value. Mating behaviour is also a primary consideration. Males 
mate as often as possible; females frequently mate more than once, but are more 
conservative in their choice of mate (Bonizzoni et al., 2002). Consequently, releasing 
exclusively sterile males achieves greater suppression, as they will attempt to mate with 
several wild females. Field studies demonstrated that mixed sex sterile releases are less 
effective than male-only releases (Rendón et al., 2004). This is because mating events 
between sterile males and sterile females would not reduce the wild population, and 
would expend resources of sterile males that could be used to court wild females. To 
achieve a male-only population, several sex-separation strategies exist. Manual or 
mechanical separation is possible, but error-prone and expensive (Klassen and Curtis, 
2005). For this reason, genetic strategies developed to select against females, have 
vastly improved the practicality of SIT. For instance, male-linked translocations of an 
insecticide resistance allele have been applied (Lines and Curtis, 1985). However, the 
application of insecticide could potentially introduce fitness penalties even at sub-lethal 
doses; it is also difficult to justify the release of genes conferring insecticide resistance 
into the field. 
 
 The VIENNA-8 temperature sensitive lethal (tsl) genetic sexing strain (GSS) 
was a major innovation. In this line, a translocation between the Y and fifth 
chromosomes provides male-specific linkage of the wild-type alleles for a selectable 
trait (temperature specific lethality) and a visual marker (white pupae; males have the 
normal brown colour). Females are homozygous for the recessive loss-of-function 
alleles. Therefore, they can be removed by heat treatment at the restrictive temperature 
and are visually distinguishable from males by white colour; a male-only population is 
derived with 99.9% accuracy (Caceres, 2002), (Franz, 2005), (Morrison et al., 2010). 
However, there are practical issues. During mass rearing, the genetic sexing mechanism 
can be disabled by rare recombination events, removing its ability to provide a male-
only population (Kerremans and Franz, 1995), (Caceres, 2002). Although this risk has 
been substantially addressed by periodically re-establishing mass-rearing colonies from 
small, independently maintained filter colonies, it would be preferable to develop a 
sexing mechanism that was more stable (Robinson et al., 2002), (Shelly, 2012). Such a 
transgenic line has been developed at Oxitec (OX3097/OX3864), and is discussed later 
(Fu et al., 2007), (Leftwich et al., 2014). 
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 Additionally, it is extremely important to monitor the competitiveness of 
released males, and to understand the reproductive biology and distribution of the wild 
population, as a successful strategy will require that sterile males mate wild females at 
an acceptable frequency (Knipling et al., 1968), (Calkins and Ashley, 1989), (Dyck et 
al., 2005). Field data suggests that SIT programmes in Medfly have been affected by 
poor competitiveness; in trials in Guatemala and Hawaii, releases of males in 
hundredfold excess of the wild population failed to achieve a net egg sterility target of 
77% (Shelly and McInnis, 2016). Species with complex courtship, such as Medfly, may 
require higher release ratios, because the likelihood of rejection is greater (Shelly and 
McInnis, 2016). The scale of sterile male release and its effect on the population can be 
performed by comparing the ratio of released to wild insects on traps (Hendrichs et al., 
1995), (Rendón et al., 2004). Furthermore, the mating ability of sterile males in the field 
can be assessed, by scoring the female reproductive tract for the presence of wild-type 
sperm, as well as irradiated sperm or transgenically marked sperm (McInnis, 1993), 
(Zimowska et al., 2009).  
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1.4 The Oxitec strategy is a male sterility platform improved by genetic 
engineering 
 
1.4.1 Summary of the method 
 This study is primarily concerned with devising an enhanced strategy for the 
reproductive control of Medfly, by addressing the fundamental issues with traditional, 
radiation-based SIT (Alphey, 2006). The requirements to effectively control pest 
populations with sterile male release, as described in the previous section, are well 
understood. However, they have proven difficult to achieve in practice, primarily due to 
the negative effects of irradiation, laboratory colonisation, and mass-rearing on male 
fitness. In certain respects, the Oxitec solution is similar to traditional SIT, because it 
inhibits male fertility (Ant et al., 2012). However, the primary difference is the extent of 
targeting. Tightly regulated transgenic effectors mediate sterility, potentially avoiding 
the substantial off-target effects of radiation (Black et al., 2011).  
 
 We describe the development of an engineered platform to control Medfly, with 
repressible male sterility mediated by nuclease expression in spermatids and sperm (Jin, 
2011). This is expected to reduce non-specific effects upon male fitness, by limiting 
translation of the sterilising effector to male germline tissue. To facilitate effective 
mass-rearing, efficient female removal is engineered by genetic sexing (Fu et al., 2007). 
Finally, field traceability is engineered by expression of fluorescent markers expressed 
in the body and sperm (Scolari et al., 2008). The initial characterisation of most of these 
components was performed by staff at Oxitec and three prior PhD students (Jin, 2011), 
(Bilski, 2012), (Asadi, 2013).  
 
1.4.2 Male sterility by repressible nuclease expression (tetO-protamine-FokI) 
1.4.2.1 Requirements of the system 
 As previously discussed, the male sterility system must be paternal effect 
embryo lethal, to prevent fruit destruction by hatching larvae (Wimmer, 2005). 
Furthermore, expression of the sterility effector in males should remove the viability of 
all progeny, to ensure effective suppression of the population, and prevent vertical 
transmission of the transgene to the wild population. Selective expression of the 
nuclease effector would ideally allow males to retain high mating competitiveness and 
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the ability to transfer morphologically normal (but sterile) sperm and seminal 
compounds to females during mating.  
 
1.4.2.2 Protamine-FokI is a male sterility effector that cleaves sperm DNA 
 The male sterility effector is a chimeric DNA endonuclease (Figure 1.7), a 
protamine-like protein fused to the non-sequence specific DNA cleavage domain of 
FokI nuclease (protamine-FokI). This facilitates DNA binding and cleavage in 
spermatids and sperm (Asadi, 2013). The function of both components is discussed 
below. Protamine family genes are small, basic, positively-charged proteins that tightly 
package sperm DNA in a manner comparable to, but structurally very different to 
histones (Queralt et al., 1995), (Braun, 2001), (Balhorn, 2007). In Drosophila, the genes 
are termed protamine-like because they have a different evolutionary origin, 
demonstrating a clear homology to somatic histone H1 (Eirin-Lopez, 2006), (White-
Cooper, Doggett & Ellis, 2008). They are transcribed in primary spermatocytes but 
translated in spermatids, and the proteins are components of mature sperm (Barckmann 
et al., 2013). During spermiogenesis, histones are removed from spermatid DNA and 
replaced by protamine-like proteins, which bind DNA through positively-charged 
domains (Jayaramaiah Raja and Renkawitz-Pohl, 2005). Protamine-DNA complexes 
associate with one another by the formation of disulphide bonds between cysteine 
residues of adjacent protamines, facilitating a greater extent of DNA compaction 
compared to histones (Balhorn, 2007). Three protamine-like genes have been identified 
in D. melanogaster: Mst35Ba (Dmprot1), Mst35Bb (Dmprot2) and Mst77F. Curiously, 
Mst77F is essential for male fertility, but Mst35Ba and Bb mutants are partially fertile 
(White-Cooper, Doggett & Ellis, 2008), (Tirmarche et al., 2014). In Drosophila, 
Mst77F is thought to bind DNA by electrostatic interaction, without sequence 
specificity. Thereafter, multimerisation of several DNA-Mst77F complexes tightly 
compacts DNA (Kost et al., 2015). Two protamine-like genes (Ccprot1 and Ccprot2) 
were identified in Medfly by homology searching (Section 4.2). Dmprot1, Dmprot2, 
Ccprot1 and Ccprot2 were applied in this study.  
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 FokI is a restriction enzyme isolated from Flavobacterium okeanokoites (Li et 
al., 1992). It is a type IIS restriction enzyme, cleaving DNA at 9-13 nucleotides from 
the asymmetric recognition site GGATG (Pingoud and Jeltsch, 2001). The structure of 
FokI is unusual, with independent domains for DNA recognition and cleavage (Wah et 
al., 1997). This property has made FokI incredibly useful for genetic engineering, 
because the cleavage domain does not demonstrate sequence specificity 
(Chandrasegaran, 1996). Therefore, chimeric restriction enzymes with novel specificity 
can be generated, by fusing a DNA-binding element to the non-specific FokI cleavage 
domain, as we have done with protamine-FokI (Smith et al., 1999), (Gaj et al., 2013). 
The native enzyme exists as a monomer in solution, but magnesium-dependent 
dimerisation of two adjacent FokI molecules is required to cut DNA (Vanamee et al., 
2001). In the unbound state, associations between the two domains prevent the cutting 
domain from engaging in non-specific activity (Wah et al., 1998). However, DNA 
binding induces a conformational change that frees the cutting domain, allowing it to 
dimerise with an adjacent FokI molecule and cleave target DNA. Because we removed 
the N-terminal recognition domain in the chimeric protamine-FokI enzyme, this 
conformational change is not expected to occur. 
 
1.4.2.3 tetO-protamine-FokI is repressibly regulated by Ccβ2tubulin-tTAV in the 
male germline 
 To minimise off-target effects, protamine-FokI should be expressed exclusively 
in the male germline. This is mediated by a two-part expression system (Jin, 2011), 
(Alphey, 2015). The first component is a tetracycline-repressible transcriptional 
activator (tTAV) transcribed and translated in the male germline (tetO-Ccβ2tubulin 
promoter-5’UTR[short]-Cchsp83 minipromoter-Cchsp83 5’UTR-tTAV-SV40 3’UTR). 
In the absence of tetracycline, tTAV protein accumulates in the primary spermatocytes 
of individuals with this expression construct. Thereafter, tTAV, bound to its 
transcriptional target site tetO, activates transcription of a protamine-FokI fusion 
protein. Additionally, tTAV is expected to increase its own expression because the tetO 
sequence is bi-directionally active, and located between the two transcriptional units, 
which are cloned in head-to-head orientation. In the presence of tetracycline, there 
should be minimal or no activation of expression of the tTAV target genes (Gossen, 
1992), (Schönig et al., 2011). The expression of these two components (tTAV and tetO-
protamine-FokI) within a single piggyBac vector (OX4353) has previously been shown 
to mediate penetrant and repressible male sterility in olive fly and Medfly (Jin, 2011), 
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(Asadi, 2013). However, leaky expression has been demonstrated: both on-tetracycline 
and in somatic tissue, for at least some strains (Asadi, 2013). Therefore, it is essential to 
assess transgenic strains for leakiness and investigate the potential effects on 
competitiveness or longevity. 
 
 Importantly, this system provides a mechanism to repress the engineered male 
sterility, allowing the strain to be propagated in the lab (Alphey, 2002). Furthermore, 
the requirement of tetracycline for fertility prevents both the accidental release of non-
sterile males, as well as the persistence of transgenes in the wild (Alphey et al., 2008). 
However, engineering these features has proven difficult because of the unusual 
dynamics of gene expression in the male germline. Although primary spermatocytes are 
highly transcriptionally active, there is very little post-meiotic transcription in D. 
melanogaster (Barreau et al., 2008), (Vibranovski et al., 2010). Therefore, genes that 
are required for post-meiotic development in the male germline are stored as mRNAs 
and translationally repressed, often by elements within the 5’UTR (Kempe et al., 1993), 
(Jayaramaiah Raja and Renkawitz-Pohl, 2005), (White-Cooper, 2009), (Barckmann et 
al., 2013).  
 
 Adequate pre-meiotic translation of tTAV is therefore required to activate 
transcription of protamine-FokI to sufficient levels, in advance of the transcriptional 
arrest. Although early transcription of protamine-FokI is desirable, it should be noted 
that early translation is not. The protamine-FokI transcript must therefore incorporate 
appropriate signals for translational delay. If this is not achieved, translation of the male 
sterility effector will not occur in all spermatids at the appropriate time. If translation of 
protamine-FokI is too late, sperm are likely to retain an intact genome, and will 
therefore remain fertile. In contrast, early translation of protamine-FokI would be 
anticipated to disrupt the meiotic divisions, or cause significant defects in spermatid 
nuclear shaping, leading to failure of spermatid individualisation. Either outcome would 
be extremely problematic, because the primary objective of this study is to engineer 
sterile sperm that are capable of fertilisation, thereby inducing a paternal effect lethal 
phenotype. This is expected to improve upon radiation-based SIT, for which negative 
impacts on sperm morphology and number have been demonstrated, in certain instances 
(McInnis, 1993), (Helinski and Knols, 2009). 
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1.4.2.4 Development of the two-component system for repressible male sterility 
 A functioning system for the repressible expression of the male sterility effector 
was described prior to the initiation of this study (Jin, 2011). Substantial 
experimentation was required, because of the difficulty of engineering appropriate 
transcription and translation of transgenic effectors in the male germline (Figure 1.8). 
The most important experiments are summarised here.  
 
 The tetracycline-repressible transcriptional activator was developed first, 
primarily from components of Ccβ2tubulin and Cchsp83 (Figure 1.8). β2tubulin is a 
highly conserved gene that is transcribed specifically in the testes of a variety of insect 
species (Michiels et al., 1989), (White-Cooper, Doggett & Ellis, 2008), (Nielsen et al., 
2010). In D. melanogaster, a 14 bp promoter element (β2UE1) is required for testis-
specific transcription (Michiels et al., 1989). Two additional downstream elements, one 
within the promoter (β2UE2) and one within the 5’UTR (β2DE1), enhance expression 
but are dispensible for testis-specific expression (Michiels et al., 1993), (Santel, 2000). 
Sequence motifs with homology to β2UE1 and β2UE2 were computationally identified 
in the Medfly homologue (Ccβ2tubulin), but in this instance, they are present in the 
putative 5’UTR (Scolari et al., 2008). It is notable that their functionality in Medfly is 
inferred by homology, and not yet experimentally confirmed. It was anticipated that the 
Ccβ2tubulin promoter-5’UTR fragment could mediate early transcription and 
translation of tTAV, suitable for activating early transcription of tetO-protamine-FokI. 
 
 A fragment based on the Ccβ2tubulin promoter, Ccβ2tubulin 5’UTR and SV40 
3’UTR (Figure 1.8) was able to facilitate pre-meiotic transcription and translation of a 
dsRed2 reporter, in spermatocytes (OX3671: Ccβ2tubulin promoter-Ccβ2tubulin 
5’UTR-dsRed2-SV40 3’UTR). However, visible reporter translation was not observed 
in all spermatocytes, indicating that the system would not mediate sufficiently early 
translation of tTAV (Jin, 2011). To solve this issue, 233 bp of the Ccβ2tubulin 5’UTR 
were truncated, to remove putative signals within the 5’UTR that delayed translation. 
The resulting Ccβ2tubulin promoter-Ccβ2tubulin 5’UTR[short] fragment (1030 bp  
797 bp) retained the majority of the β2UE1 element expected to confer testis-specific 
transcription, but lost the β2UE2 element (Scolari et al., 2008), (Jin, 2011).  
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 To enhance early expression, a minimal promoter fragment and 5’UTR from 
Cchsp83 (a gene with earlier transcription and translation), was added downstream of 
the Ccβ2tubulin promoter-Ccβ2tubulin 5’UTR fragment (Ding et al., 1993). This 
chimeric fragment was found to facilitate appropriately early transcription and 
translation of a fluorescent reporter in spermatocytes (Jin, 2011). Subsequently, the 
chimeric Ccβ2tubulin-Cchsp83 driver was able to appropriately promote expression of 
tTAV, and this was able to activate a tetO-driven Dmprot2-FokI effector in the male 
germline (OX4353: tetO14-Dmhsp70 minipromoter-Dmprot2-FokI). This resulted in 
penetrant, repressible male sterility (Jin, 2011), (Asadi, 2013). Therefore, it appeared 
that the truncation of Ccβ2tubulin 5’UTR and addition of Cchsp83 minipromoter-
Cchsp83 5’UTR had the desired effect of both increasing transcription level and 
enhancing early translation of tTAV. 
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1.4.3 Genetic removal of females facilitates a male-only release 
 A functional protamine-FokI male sterility system would be combined with a 
previously described tetracycline-repressible female-lethal system (OX3864, Figure 
1.9), which serves as an effective Medfly sexing strain (Leftwich et al., 2014). This 
system applies an autoregulatory, positive feedback loop to fatally overexpress tTAV in 
females alone (Fu et al., 2007). This specificity is engineered by the inclusion of introns 
from tra, which are spliced to remove a stop codon in females, but not males (Pane et 
al., 2002). Therefore, female-specific expression of tTAV may be engineered by 
inclusion of female-specific tra introns within the coding sequence. Thereafter, tTAV 
positively regulates its own expression at an array of tetO operator sequences (the target 
site) immediately upstream (Gossen, 1992). tTAV accumulates to fatal levels at the 
larval stage (Gong et al., 2005), ostensibly due to sequestration of the transcriptional 
machinery (Morrison et al., 2009). Tetracycline inhibits this feedback loop, when 
supplied in larval diet. This disables the male-selection system and allows the strain to 
be propagated for mass-rearing (Fu et al., 2007).  
 
 The OX3864 sexing system can be applied as a population control system in its 
own right (Leftwich et al., 2014). All female progeny of released OX3864 homozygous 
males would die (half of all progeny); only heterozygous F1 male offspring would 
survive. However, an issue with this strategy is that the F2 progeny of heterozygous F1 
males and wild females would be 75% viable. This is because 25% of these F2 progeny 
are heterozygous females, which die; all other progeny are viable. This incomplete 
sterility means that transgenes would propagate vertically in the field, through the viable 
male progeny of crosses between wild females and transgenic males. Furthermore, the 
OX3864 sexing system kills females as larvae, and allows all males to survive. 
Therefore, progeny resulting from the mating of a wild female to a released male, would 
still damage crops substantially. For these reasons, an engineered system for complete 
sterility (protamine-FokI expression) is superior, assuming it can mediate highly 
penetrant sterility and retain a fitness profile similar to wild males. 
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1.4.4 Fluorescent marking in the body and sperm 
 An effective population control strategy requires monitoring in the field, to 
determine the ratio of wild to released males (Vreysen, 2005). Released males can be 
marked with fluorescent dye (Hagler and Jackson, 2001). However, these marked males 
may be misscored if the dye dissipates (Robinson et al., 2004). This has been addressed 
by the constitutive expression of the fluorescent marker dsRed2 in muscle, using 
components of the Mexfly muscle actin gene, namely the promoter, 5’UTR and 3’UTR 
(Koukidou et al., 2016). This facilitates highly accurate scoring of transgenic 
individuals, in some instances by the naked eye. These transgenic strains could be 
further improved by engineering fluorescent marker expression in sperm nuclei, to 
monitor mating competitiveness in the field (Scolari et al., 2014). The frequency at 
which females mate released males can be scored by transfer of adhesive chemicals to 
females; the presence of irradiated sperm in the spermathecae (if morphologically 
different); or by PCR for sequences specific to the mass-reared strain (McInnis, 1993), 
(San Andres et al., 2007), (Armsworth et al., 2008). However, the scoring of 
fluorescently marked sperm would be expected to improve upon these methods.  
 
 A fluorescent sperm marking system would remove the necessity for an 
adhesive chemical and the risk of its dissipation in the field. It would be substantially 
easier to score fluorescent sperm than morphological variations induced in sperm, 
which are not present in all species, and which would be variable between individuals 
(Helinski and Knols, 2009). Finally, it would preclude the use of PCR screens and allow 
for a quantitative estimate of mating, possibly with greater accuracy than PCR. A series 
of fluorescent sperm markers linked to the male sterility effector (tetO-protamine-
mCherry-FokI) or tetracycline-repressible transcriptional activator (tetO-Ccβ2tubulin 
promoter-Ccβ2tubulin 5’UTR-dsRed2-SV40 3’UTR) had been previously tested, but 
these did not reliably mark the nuclei of all sperm (Jin, 2011), (Asadi, 2013). The 
molecular components of these systems and their performance are fully detailed in the 
next chapter, where the development of a novel fluorescent sperm marking system is 
considered. 
 
1.4.5 piggyBac expression constructs can be genomically immobilised 
 The components of this system have been engineered as piggyBac expression 
constructs integrated into the insect genome by transposition (Li et al., 2005). The 
expression profile of these features could be altered by re-transposition to a novel 
CONFIDENTIAL Chapter 1 - Introduction  
 
47 
insertion site (Wimmer, 2003). For instance, mobilisation of the transposon to 
transcriptionally silent heterochromatin could prevent the expression of the sterilant or 
the fluorescent markers (Markstein et al., 2008), potentially allowing the vertical 
transmission of transgenic sequences into the wild population. An additional concern is 
horizontal gene transfer, which could potentially introduce the transposon to other wild 
insect species (Lohe et al., 1995), (Silva et al., 2004). Therefore, the ability to fully 
immobilise the transgenic insertion would potentially enhance biosafety.  
 
 To achieve this end, Oxitec has developed a piggyBac vector system capable of 
complete excision of the transposable ends. This system applies a composite transposon 
with two pairs of piggyBac ends. A central element flanked by these two pairs contains 
the transgenic effectors required for the male sterility expression system. When crossed 
to a transgenic line expressing piggyBac transposase in the germline, the ends 
containing the transposable elements are mobilised away from the central element. This 
stabilises the transgenic effectors within the genome, because they are no longer 
associated with any transposon sequences (Dafa’alla et al., 2006). Excision of the ends 
can be screened for the absence of transposon sequences by PCR. Additionally, it is 
possible to design expression constructs with markers between each piggyBac end pair. 
This allows loss of ends to be screened visually (by the absence of fluorescent marker 
expression). Therefore, the application of the four-ended piggyBac system with a 
repressible protamine-FokI male sterility effector and fluorescent markers expressed in 
the body and sperm, could potentially provide an effective, novel and highly traceable 
method for the population control of Medfly, a pest which remains problematic despite 
decades of research.  
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Chapter 2 – Materials and methods 
2.1 Molecular biology 
 
2.1.1 Genomic DNA (gDNA) extraction 
 Two methods were applied. Generally, the PureLink Genomic DNA kit (Life 
Technologies K182000) was used with manufacturer’s instructions. Alternatively, 
extraction was performed by high temperature, sodium hydroxide extraction in a 
thermocycler. Within a 96-well PCR plate, samples were placed in 100 mM NaOH (50 
μl for adults and third instar larvae; 25 μl for a leg) and heated in a PCR thermocycler 
(99° C, 30 minutes). To neutralise, Solution B (50 mM HCl, 250 mM Tris-HCl [pH 
8.5], 0.04% phenol red) was added: 2 μl for legs, 5 μl for larvae and adults. The second 
method was used where a large number of reactions needed to be performed quickly 
and in parallel.  
 
2.1.2 RNA extraction 
 Total RNA of whole adult Medfly or the reproductive tract were extracted with 
the Total RNA kit (Norgen #17200) with manufacturer’s instructions, for downstream 
use in RT-PCR, qRT-PCR, and 5’ RACE. 
 
2.1.3 Polymerase chain reaction (PCR)  
 All primers used in the study (Table 8.1) and the list of amplicons generated 
(Tables 8.2-8.3) are provided in the Appendix. 
 
2.1.3.1 General PCR 
 The standard procedure was touchdown PCR with 35-40 cycles (10 cycles at 60° 
C annealing temperature, the remainder at 55° C). The annealing temperatures were 
adjusted where this did not provide adequate amplification. Q5 polymerase (NEB 
M0491) was used for cloning, 5’RACE and sequencing of CRISPR-induced mutations. 
BioTaq polymerase (PCR Biosystems BIO-21040) was used for all other applications. 
In both instances, PCR was performed by manufacturer’s instructions. The general 
thermocycling programme is provided (Table 2.1).  
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Table 2.1 General PCR thermocycling programme 
Step Cycles Description Temp (° C) Time (seconds) 
1 1 Denaturation 95 120 
2 10 Denaturation 95 15 
3 Annealing 55-65 30  
4 Extension 72 15 per kb  
5 25-30 Denaturation 95 15  
6 Annealing 55-65 30  
7 Extension 72 15-90 
8 1 Final extension 72 300 
9 1 Holding 4  ∞ 
 
 
2.1.3.2 Cloning and sequencing of PCR products 
 PCR products without non-specific bands were purified with the QiaQuick PCR 
purification kit (Qiagen #28104) by manufacturer’s instructions. Where non-specific 
products were present, target bands were excised with a scalpel and purified with the 
QiaQuick gel extraction kit (Qiagen #28704). Where possible, PCR reactions were 
directly sequenced with an internal primer at Eurofins MWG Operon (Germany). 
Where this did not provide clean sequences, the products were blunt ended and cloned 
into the pJET vector with the CloneJET kit (Life Technologies K1231) and transformed 
into E. coli XL10 (Agilent Technologies) by heat shock-calcium chloride 
transformation, using manufacturer’s instructions. Single colonies were screened by 
colony PCR in 10 μl reactions by standard methods, usually with pJET specific forward 
and reverse primers (TD1156 and TD1157). Cultures with the target insert were grown 
in in LB-ampicillin medium (100 μg/mL) with shaking incubation overnight (250 rpm, 
37° C). Plasmids were mini-prepped with the GeneJET Plasmid Miniprep Kit (Life 
Technologies K0502) by manufacturer’s instructions and sent for sequencing, as 
previously described.  
 
2.1.3.3 Reverse transcription PCR (RT-PCR) 
 cDNA was synthesised from total RNA extractions with the RevertAid First 
Strand cDNA Synthesis Kit (ThermoFisher K1621) by manufacturer’s instructions. A 
1:1 ratio of random hexamer primers and poly(A) annealing primers was applied. 
Thereafter, RT-PCR was performed in 20 μl reactions with 1 μl of cDNA template, 
generally under the standard conditions previously described for genotyping PCR (35-
40 cycles: 10 at 60° C, the remainder at 55° C). For semi-quantitative RT-PCR, samples 
were aliquoted at 25, 30, 35 and 40 cycles (the first 10 cycles were performed at 60° C 
annealing temperature, and all subsequent cycles at 55° C annealing temperature). 
CONFIDENTIAL Chapter 2 – Materials and methods 
 
50 
Constitutively expressed control genes (internal standards) were amplified, Medfly 
alcohol dehydrogenase (adh) or ribosomal protein P0 (Cc-RpP0).  
 
2.1.3.4 Quantitative RT-PCR (qRT-PCR) 
 The SuperScript III Platinum SYBR Green One-Step qRT-PCR Kit 
(ThermoFisher 12574030) was used with manufacturer’s instructions. The 
thermocycling programme is provided (Table 2.2). Rox was used as a reference dye, 
and the Ct values were first normalised to Rox. Dissociation curves from the melt curve 
analysis were monitored to identify primer dimers or non-specific product. Relative 
gene expression was calculated with the ΔΔCt method (Yuan et al., 2006). For each 
sample, Ct values for the transgene amplicon were normalised to those of the 
endogenous control amplicon Cc-Rp17S (by subtraction of the Ct for the transgene from 
the Ct for the control gene), to derive the ΔCt. Thereafter, a reference experimental 
group was chosen as a calibrator (a transgenic strain with minimal or no expression). 
The average ΔCt for each experimental group was normalised to the average ΔCt of the 
reference group (by subtraction of the ΔCt of each experimental group from the ΔCt of 
the control group, to derive the ΔΔCt. To express fold-change, the measurements were 
log transformed: 2 -ΔΔCt. To express uncertainty, standard deviation or standard error 
(“s”) were calculated from the Ct values of each experimental group, and subsequently 
log transformed: 2 –ΔΔCt ± s. 
Table 2.2 qRT-PCR thermocycling programme 
Step Cycles Description Temp (° C) Time (seconds) 
1 1 cDNA synthesis 50 180 
2  Denaturation 95 300 
3 40 Denaturation 95 15 
4 Annealing 60 30  
5 Extension 40 60 
6 1 Melt curve analysis 95 60  
7 55 30 
8 95 (collections at 
every 0.5° C) 
30 
 
2.1.3.5 Inverse PCR and adapter ligation PCR 
 To isolate gDNA flanking transposon insertions, inverse PCR was performed 
with a modified protocol from Buckholz et al. Two sets of PCR reactions were 
performed at each end, to isolate gDNA upstream (5’) and downstream (3’) of the 
transgenic insertion site. Digestions were performed with SauAI, HpyCh4IV, TaqαI and 
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HaeIII (5’ end) or HhaI, AvaII, HaeIII and MspI (3’ end) to yield short fragments 
spanning the genomic DNA and transgenic expression construct. The restriction 
fragments were circularised by blunt-ending and ligation with the CloneJET kit (Life 
Technologies K1231), following manufacturer’s instructions. PCR reactions were 
performed in 20 μl volumes with BioTaq polymerase buffer, 0.5 μM primers, BSA (0.1 
mg/ml), BioTaq polymerase, and template (first reaction: 5 μl of the ligated restriction 
fragments; second reaction: 0.5 μl of the first PCR). The thermocycling programme is 
provided (Table 2.3). The dominant band of the second (nested) reaction from each end 
(5’ and 3’) was gel excised, blunt ended, cloned into the pJET vector and transformed 
into E. coli XL-10; all as previously described (Section 2.1.3.2). Colonies were 
screened, grown overnight in LB-ampicillin culture, and plasmids were miniprepped 
and sequenced as previously described, to identify the flanking sequences upstream and 
downstream of the insertion.  
Table 2.3 Inverse PCR thermocycling programme 
Step Cycles Description Temp (° C) Time (seconds) 
1 1 Denaturation 95 300 
2 34 Denaturation 95 30 
3 Annealing 55 60 
4 Extension 72 60 
5 1 Final extension 72 120 
6 1 Holding 4  ∞ 
 
 Alternatively, it is possible to restriction digest gDNA and ligate an adapter 
fragment to the 5’ and 3’ end. Three nested PCRs (each with an adapter-specific and 
transposon-specific primer) are thereafter performed, prior to sequencing across the 
adapter, flanking gDNA, and transgenic expression construct. This was used by a 
colleague (Caroline Phillips, Oxitec) to isolate the OX4718A-resolved flanking 
sequence.  
 
2.1.3.6 Rapid amplification of cDNA ends (RACE) 
 5’ RACE was performed to identify the transcriptional start site (TSS) of Medfly 
protamine-like genes. The SMARTer RACE 5'/3' Kit (Clontech 634858) was used with 
manufacturer’s instructions. cDNA is synthesised with poly(A) annealing primers and a 
proprietary adapter sequence is added to the 5’ terminus of the cDNA by the terminal 
transferase activity of the enzyme, labelling the putative TSS. The cDNA of the target 
gene was amplified by two nested PCRs with Q5 polymerase, each with a gene-specific 
reverse primer and the proprietary universal forward primer (UFP) mix. The standard 
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touchdown thermocycling conditions were applied. The dominant band of the first PCR 
reaction (pre-nesting) was processed as previously described: gel purified, cloned into 
the pJET vector, transformed into E. coli XL-10; thereafter, colonies were screened for 
the presence of the insert by colony PCR with gene-specific primers. Colonies with the 
correct insert were grown overnight in LB-ampicillin medium, and the plasmids 
miniprepped. Multiple clones were sequenced with a gene-specific reverse primer. 
Sequences were aligned and trimmed to the terminus of the proprietary adapter, to 
identify the putative TSS. Thereafter, the results were compared to those obtained via 
high throughput transcript sequencing (NCBI, 2016).  
 
2.1.3.7 Synthesis of CRISPR sgRNAs 
 All CRISPR experiments utilised the Cas9 nuclease from S. pyogenes (Sp-
Cas9). In theory, any site can be targeted as long as an nGG protospacer adjacent motif 
(PAM) follows the target sequence (Brouns et al., 2008). To clarify, the target genomic 
sequence is sense, relative to the sgRNA. It is possible to target other motifs, but the 
efficiency of cutting is typically reduced (Zhang et al., 2014). Target-specific CRISPR 
sgRNAs were synthesised by no-template PCR, in vitro transcription, and phenol-
chloroform extraction, essentially as previously reported (Bassett et al., 2013). The no-
template PCR applies a forward primer specific to the target and a common reverse 
primer (SS1713); the product is a primer dimer. The degenerate forward primer: 
GAAATTAATACGACTCACTATA[N]20GTTTTAGAGCTAGAAATAGC comprises the T7 
promoter (bold), a 20 nucleotide seed sequence that is identical or nearly identical to the 
genomic target (italics), and a complementarity region for the reverse primer 
(underlined). To facilitate efficient in vitro transcription from the T7 promoter, the two 
5’ nucleotides of the seed sequence were changed to GG (Kuzmine et al., 2003). In 
most cases, this did not match the genomic target. However, mismatches at the 5’ end 
are well-tolerated in CRISPR platforms (Cradick et al., 2013); these slightly off-target 
sgRNAs were shown to mediate efficient mutagenesis (Chapter 6). Reactions were 
comprised of: Q5 buffer, target specific forward primer (0.4 μM), common reverse 
primer SS1713 (0.4 μM), dNTPs (0.2 mM) and Q5 polymerase. Reactions were 
amplified for 35 cycles with the standard touchdown PCR method described previously 
(Table 2.1).  
 
 The product was directly purified with the Fermentas GeneJet PCR Purification 
Kit (ThermoScientific K0701) and 500 ng of this DNA intermediate was converted to 
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sgRNA by in vitro transcription from the T7 promoter, with the Ambion 
Megashortscript T7 kit (ThermoScientific AM1354). The sgRNAs were purified by 
phenol-chloroform extraction. To each reaction, 150 μl phenol-chloroform was added 
prior to centrifugation (14600 rpm, 5 min). The aqueous phase was transferred to 150 μl 
chloroform and centrifuged (14600 rpm, 5 min). The aqueous phase was transferred to 
300 μl ethanol and incubated (15 min, -20° C) prior to centrifugation (14000 rpm, 15 
min, 4° C). The supernatant was removed and the pellet was resuspended to 1 μg/μl 
RNA, and stored at -80° C. A list of sgRNA sequences is provided in the Appendix 
(Table 8.4).  
 
 To pre-validate the cutting activity of sgRNAs, an assay was performed with 
manufacturer’s instructions (PNA Biotech). Reactions (10 μl) were comprised of 500 ng 
Cas9 protein, 250 ng sgRNA, 200 ng of target PCR product or linearised plasmid, NEB 
Buffer 3 and BSA (0.1 mg/ml). The reaction was incubated at 37° C for 30-60 minutes 
and the reaction stopped with 4 μg RNaseA (10 min, 37° C) prior to addition of 1 μl 
stop solution (30% glycerol, 1.2% SDS, 250 mM EDTA pH 8) and incubation (10 min, 
37° C). Cleavage of the target fragment was visualised by gel electrophoresis.  
 
2.1.4 Computational and statistical analysis  
  DNA and protein sequences were aligned for sequence homology with T-Coffee 
or M-Coffee Multiple Sequence Alignment (MSA). Protein sequences were assessed with 
EMBL Interpro. The TSS of genes of interest were identified from high-throughput 
transcript sequencing data (FlyBase or NCBI) or 5’RACE. All statistical analyses were 
performed with the standard R package (version 3.3.0, Mac OS X). Sequence alignment 
and expression construct design were performed with SnapGene software (GSL Biotech, 
v2.6.2, Mac OS X). To compare homologous proteins, a similarity index was calculated, 
as the ratio of conserved residues (identical or conservative substitutions) to the mean 
number of residues: 
 
A
(B+ C)/2
 *100 
A: Identical residues or conservative substitutions 
B: Residues in first sequence 
C: Residues in second sequence 
 
2.2 Medfly rearing 
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 Rearing was generally as previously described (Saul, 1982a). Typically, 
conditions were 26° ± 2° C and 50% ± 10% relative humidity with a photoperiod of 12 
hours light (07:00-19:00) and 12 hours dark (19:00-07:00). Rearing was occasionally 
performed at 18° ± 1° C, 20° ± 1° C or 30° ± 1° C to alter the rate of development, 
which is increased by higher temperatures and decreased by lower temperatures (Duyck 
and Quilici, 2002). The WT culture was the Toliman strain from Guatemala (Lance et 
al., 2000). It has been in continuous culture at Oxitec since 2004 (about 175 
generations). All transgenic lines were derived by piggyBac transformation of this 
background. 
 
Adults were cultured in plastic cages with a mesh-coated surface for oviposition 
and separate vessels for water and adult diet (80% sucrose [Tate & Lyle] and 20% 
autolysed yeast [Fisher 10255153]). Flies requiring tetracycline to repress transcription 
of transgenic elements regulated by tetO-minimal promoter (Gossen, 1992) were 
supplied water with 100 μg/ml tetracycline (Sigma-Aldrich T7660). Five types of cages 
were used for culturing. Four were developed at Oxitec (small, medium, large and extra 
large) and one was commercially obtained (BugDorm cages, Megaview Science). 
Images of the cages (Figure 2.1) and their properties (Table 2.4) are provided. WT flies 
and homozygous lines were reared at a 1:1 sex ratio, in extra-large cages and 
medium/large cages, respectively. Non-homozygous transgenic lines were usually 
maintained by backcrossing transgenic males to WT females at a 1:2 ratio (♂:♀), in 
small cages. Mating was allowed for at least four days. BugDorm cages were used for 
competition assays. Small cages were used for all other experiments (unless noted 
otherwise).  
 
Table 2.4: Properties of cages for adult rearing 
Cage Dimensions (cm, length x width x height) Adult population 
Small 10 x 10 x 10 1-40 
Medium 15 x 13 x13 30-150 
Large 18 x 17 x 17 100-300 
Extra large 24 x 50 x 26 500-1500 
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Females of the Oxitec Toliman strain accept mates from the second or third day 
post-eclosion, and begin to lay eggs on the third day. Eggs are brushed from the 
oviposition mesh into a collection tray filled with distilled water. Eggs were collected 
between days 4-10, filtered through Fisherbrand QL125 paper (Fisherbrand 11754233) 
and folded to fit in 250 ml plastic bottles (F L Plastics, UK) with larval diet (66.5 g 
maize meal [Holland & Barrett “Amazing Maize Meal”], 73 g sucrose [Tate & Lyle], 
46.5 g autolysed yeast [Fisher 10255153], 10 g agar [BTP Drewitt], 2.5 g methyl-4-
hydroxybenzoate [Sigma-Aldrich W271004], with dH2O to 1 L). The sucrose content 
was 7.3% and the protein content 3%, calculated from the manufacturer’s specification 
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of the maize meal and an average 56% protein content of yeast powder (Bayarjargal et 
al., 2014). Tetracycline was added at 100 μg/ml, where required to suppress tetO-
minimal promoter regulated transgenic elements (Gossen, 1992). 
 
Five days after seeding, bottles were enclosed within sealed plastic boxes (18 cm 
x 11 cm x 7 cm), with a mesh-covered airhole. Sand (Argos 365/0574) sterilised by dry 
heating in an oven (121° C, 4 hours), was added to 1 cm depth as a substrate for 
pupation (Vargas et al., 1986). A cone was formed from five sheets of QL135 filter 
paper (Fisher 11704213) and pressed to the bottom of the bottle, to absorb excess 
moisture and aid larval exit. Pupae were collected through a coarse sieve 7-10 days 
later. Transgenic lines were screened by microscopy for the presence of the fluorescent 
transformation marker (Olympus SZX12 microscope and Olympus U-RFL-T 
fluorescent burner). Adult flies were anaesthetised on ice and collected no later than 24 
hours (26° C) or 48 hours (20° C) post-eclosion, to ensure virginity.  
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2.3 Microinjection and transgenesis  
2.3.1 Expression constructs used in the study 
 A list of expression constructs evaluated in the study and the phenotypes 
observed after transgenesis, is provided in the Appendix (Table 8.5). Diagrams of the 
constructs are provided in Figure 2.2; these are repeated in the results section where 
phenotypic assessment was performed. A loose copy of this figure is provided, for 
reference throughout the thesis. 
 
2.3.1.1 piggyBac vectors 
 All genomically integrated expression constructs were piggyBac vectors. 
Generally, standard two-ended vectors were applied (Handler et al., 1998). For product 
candidates, four-ended vectors that allow removal of the sequences required for 
transposition were used. Remobilisation of the two pairs of piggyBac ends effectively 
locks the construct at the genomic insertion site (Dafa’alla et al., 2006). OX5140, 
OX5150, OX5182, OX5184, OX5186, and OX5173 were synthesised by the author by 
standard methods (PCR, restriction digest and ligation; or Gibson Assembly). All other 
constructs were kindly synthesised by the Oxitec Molecular Team (Caroline Phillips, 
Tarig Dafa’alla, Sarah Scaife, Andrea Miles & Tabi Jenkins) or former students (Li Jin, 
Michal Bilski & Romisa Asadi). Lines of OX3133, OX3671, OX4014, OX4282, 
OX4353, OX4705, OX4718 and OX4801 were assessed prior to the initiation of this 
studentship. All other lines were obtained and assessed by the author. Assistance from 
colleagues was generally provided for microinjection, usually one or two persons 
(Romisa Asadi, Thea Marubbi, Dylan Noone, Christa Kistenpfennig, Charilaos Megas 
or Carlos Pedraz) to line up eggs in an appropriate orientation for microinjection. This 
was the case for microinjections of all piggyBac constructs and CRISPR sgRNAs in this 
study, with the exception of OX5182, OX5184, OX5186, OX5134, OX5154 and 
OX5173. 
 
2.3.1.2 CRISPR expression constructs and materials 
 Recombinant Cas9 protein from S. pyogenes was purchased from PNA Biotech 
(CP01). OX5173 transgenic lines, which express nanos-regulated Cas9 in the germline, 
were obtained by piggyBac transgenesis. Target-specific CRISPR sgRNAs were 
synthesised as previously described (Section 2.1.3.7); the genomic targets of all 
sgRNAs are provided in the Appendix (Table 8.4) and referenced in the relevant 
Results section (Chapter 6).
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2.3.2 Microinjection of embryos 
 For piggyBac transgenesis, buffered injection mixes (0.1 mM sodium phosphate 
pH 7.8, 5 mM potassium chloride) were prepared with the helper plasmid (OX3022) 
and the piggyBac vector at 300 ng/μl and 600 ng/μl, respectively. Additional 
transposase was occasionally supplied as mRNA (OX3081) at 300 ng/μl. The 
components of all CRISPR injection mixes are outlined in the relevant results section. 
Mixes were centrifuged (15 min, 14600 rpm), and the upper (soluble) fraction removed 
and assessed by gel electrophoresis.  
 
 WT embryos were injected for piggyBac transgenesis. For CRISPR studies, the 
injection genotype was the fluorescent marker expressing line OX4014A-homozygous 
(dsRed2 and zsGreen); all studies involved the mutagenesis of fluorescent marker or 
piggyBac sequences. Four to ten days after eclosion, embryos were collected in cycles 
of 30-90 minutes, to avoid injection of post-blastodermal eggs (Beech et al., 2006). 
Embryos were passed through a fine sieve to remove water, and treated with a ten-fold 
dilution of sodium hypochlorite solution (Sigma-Aldrich 425044) until visibly 
dechorionated (about 90 seconds). With a fine needle, embryos were transferred to 
cover slips with glue (Scotch double-sided tape dissolved in heptane).  
 
 To prevent bursting when injected, embryos were desiccated at 37 °C until they 
appeared suitably dry (3-7 minutes) and coated with a 7:1 mixture of halocarbon oils 
700 and 27 (Sigma-Aldrich H8898 and H8773), prior to microinjection at the posterior 
pole. Femtotips II needles (Eppendorf) were used with the following microinjector 
setup: Eclipse Ti-S microscope (Nikon), Transferman NK2 micromanipulator 
(Eppendorf), FemtoJet pressure supply (Eppendorf), and air compressor (Jun-Air 
1109020). The operating pressure of the microinjector (usually 30-200 hPa) was 
adjusted to suit the needle width and mix viscosity. The coverslips with injected 
embryos were placed in Petri dishes with agar-fruit juice (15 g agar, 12.5 g sucrose, 2 g 
methyl-4-hydroxybenzoate, 250 ml fruit juice, 750 ml H2O) and a moist Whatman 
grade 3 filter paper in the lid, prior to sealing with Parafilm. 
 
 With a fine needle or paintbrush, surviving larvae were transferred to a bottle 
with standard larval diet or a Petri dish with enriched medium (158 g corn grits, 84 g 
sucrose, 64 g autolysed yeast powder, 1 g sodium benzoate, 2.3 g methyl-4-
hydroxybenzoate, 1 g guar gum, 6 g citric acid, 84 g wheat germ, 1 g vitamin mix 
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#6265 [BioServ], 65 g cellulose, 550 ml water, 0.6 ml 37% hydrochloric acid). After 
larvae developed to the third instar, the vessel with diet was transferred to a box with 
sand to allow pupation. For piggyBac transgenesis, pupae that survived microinjection 
were screened for transient expression of the fluorescent marker (HR5IE1-dsRed2, 
3xp3-zsGreen or AlMAct-dsRed2), to confirm successful microinjection.  
 
2.3.3 Establishment of transgenic lines and assessment of the transgenic copy 
number and insertion site 
To isolate transgenic lines, microinjection survivors (Go adults) were 
backcrossed to WT in pools comprised of Go adults of a single sex. The number of 
individuals crossed in each pool was adjusted to reflect the number of Go adults 
obtained and the number of transgenic lines required (all crosses are stated in the 
relevant results section). Usually, 5-15 Go males were crossed to 15-30 WT females. 
For the reciprocal crosses, 5-30 Go females were crossed to 10-20 WT males. G1 
progeny with transgenic insertion(s) were identified by expression of the fluorescent 
marker under a stereoscope (Olympus SZX12 microscope and U-RFL-T fluorescent 
burner). Single transgenic G1 individuals of each pool were backcrossed to WT (2 males 
or 3 females). For CRISPR experiments, G0 injection survivors were backcrossed to WT 
as previously described and G1 progeny were screened by fluorescence microscopy for 
phenotypic reversion (loss of the fluorescent markers). 
 
 To identify the copy number and insertion site of piggyBac expression 
constructs (autosomal or sex-linked), G2 or G3 progeny were assessed by Mendelian 
analysis of the inheritance of the dominant marker. Medfly have five autosomes and a 
pair of XX or XY sex chromosomes (Zacharopoulou, 1990). Therefore, for a single 
insertion, or multiple insertions to the same chromosome, the proportion of transgenic 
progeny is 0.5. If the vector inserts into both homologous chromosomes, all progeny are 
marked at the G2 stage, but not in subsequent generations. For multiple insertions to 
heterologous chromosomes, each additional insertion increases the proportion of 
marker-expressing progeny by 50% of the previous value. This is summarised by: 1-
(1/2n), where n is the number of heterologous chromosomes with transgenic insertions 
(Table 2.5). To assess sex-linkage, the sex ratio of transgenic individuals is scored. The 
outcome is dependent on the sex of the transgenic parent. For a male individual with a 
single insertion, transgenic progeny are male-only if Y-linked, female-only if X-linked, 
and bisexual if autosomal. For a female individual with a single insertion, the transgenic 
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progeny are bisexual regardless of the insertion site. However, if transgenic males of the 
subsequent generation are crossed, an X-linked insertion is reflected by the absence of 
male transgenic progeny (Figure 2.3). 
 
Table 2.5 Proportion of marker-expressing progeny for multiple insertions to 
heterologous chromosomes 
Heterologous chromosomes with insertions Proportion of marker-expressing progeny 
1 0.5 
2 0.75 
3 0.88 
4 0.94 
5 0.97 
6 0.98 
Single and double insertions were obtained, but an individual with three or more insertions was never 
observed in this study. 
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2.3.4 Genomic immobilisation of four-ended piggyBac transposons 
 The sequences required for the transposition of piggyBac vectors can be 
removed with the four-ended piggyBac vector system, locking the construct at the 
genomic insertion site (Dafa’alla et al., 2006). These vectors are composite transposons 
with two pairs of piggyBac ends that self-excise (“resolve”), when crossed to a 
transgenic line expressing piggyBac transposase in the germline (OX3133). Thereafter, 
the piggyBac end pairs transpose away from the central element with the transgenic 
effectors, leaving it immobile. Fluorescent markers at each piggyBac end pair are 
generally included (eg. OX5195, Figure 2.2), to facilitate microscopic screening of 
piggyBac end excision (by marker loss). Subsequent backcrossing to WT generates 
individuals lacking the piggyBac ends but retaining the central element of the construct 
to be immobilised. The excision is thereafter verified by PCR (absence of the piggyBac 
end sequences) and sequencing across the junction of genomic DNA and expression 
construct. It is possible that the central element can transpose to a new insertion site 
during the immobilisation process, potentially altering the phenotype. Therefore, the 
male sterility phenotype should be reassessed prior to establishing a homozygous strain. 
The process is summarised in Figure 2.4. 
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2.3.5 Establishment of homozygous transgenic strains 
2.3.5.1 Single pair crosses 
 Single pairs were randomly crossed from a pool containing a mixture of 
homozygotes and heterozygotes; the lack of WT progeny in subsequent generations of 
sibling crosses confirms that the colony is homozygous (Figure 2.5). First, the 
transgenic allele was enriched in the population by crossing heterozygotes for one or 
two generations (F0). After removing WT individuals, which do not express the 
transgenic marker, the population is approximately 1/3 homozygous and 2/3 
heterozygous (if there are no fitness penalties associated with homozygosity). Single 
pairs of F1 individuals randomly selected from this pool were crossed in small cages 
(usually 20 pairs). The proportion of single pair crosses yielding a homozygous colony 
is 1/9 (assuming no fitness penalties). F2 progeny were screened to eliminate crosses of 
two heterozygotes (25% of progeny of these crosses are WT). Thereafter, homozygous 
colonies were differentiated from colonies originating from one homozygous and one 
heterozygous parent. F2 progeny of the remaining colonies (siblings) were 
independently crossed in medium cages for two more generations (n > 100). 
Homozygosity is indicated by absence of WT progeny in the F3 and F4 generations. The 
strategy is time-effective and does not require molecular analysis. However, it can 
reduce fitness because it constrains the genetic diversity of the colony to two 
individuals. It was suitable for certain applications, such as the generation of a 
homozygous fluorescent marker expressing strain (OX4014) for CRISPR method 
development (Chapter 6). However, it cannot be used for development of homozygous 
strains to be used in the field for population control, as the risk of a fitness penalty is too 
high. 
 
2.3.5.2 PCR genotyping of homozygotes 
 For applications requiring a genetically diverse population, PCR genotyping is 
necessary to establish a genetically diverse homozygous colony (ideally, originating 
from at least 50 individuals). However, this requires the genomic sequences flanking the 
insertion, to differentiate heterozygotes and homozygotes. As previously described, 
genomic flanking sequence may be identified by inverse PCR or related techniques. To 
perform homozygous genotyping by PCR, two reactions are required. The first 
amplifies genomic sequence upstream and downstream of the transgenic insertion 
(“flanking-specific”). The intervening transposon is too long to be amplified; hence the 
reaction only amplifies the WT allele, and therefore distinguishes WT and heterozygous 
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transgenics from homozygous transgenics. The second reaction specifically amplifies 
the insertion allele, as the primers are designed against genomic sequence and 
immediately adjacent construct sequence (“transgene-specific”). This distinguishes WT 
from heterozygous or homozygous transgenic individuals. Therefore, PCR on 
homozygous individuals generates products for the second reaction, but not the first. 
However, the genomic sequences of the region containing the genomic insertion site 
may vary within the population. This can lead to a false indication of homozygosis (the 
flanking-specific reaction might fail, in both heterozygous and homozygous 
individuals). Therefore, it is necessary to genotype a large number of WT or 
heterozygous individuals with the flanking-specific PCR reaction, to confirm that an 
amplicon is generated in all instances. This was usually performed on 90 individuals.  
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2.4 Microdissection and microscopy of the male and female reproductive tract 
 Flies were anaesthetised on ice or within a chest freezer prior to dissection, for 
immediate microscopic analysis (Figure 2.6) or downstream molecular biology. Care 
was taken to avoid over-exposure of females to cold temperatures; prolonged exposure 
causes female D. melanogaster to expel sperm (Ashburner et al., 2011). Dissection was 
performed in PBS (Sigma P4417) or testis buffer (187 mM KCl, 47 mM NaCl, 10 mM 
Tris pH 6.8), under a stereoscope and lamp (Olympus SZH10 and Photonic PL2000, or 
similar). The anaesthetised fly was transferred to a single drop of buffer on a 
microscope slide or plastic plate. The body was firmly held with a pair of tweezers and 
the male or female genital tract carefully removed by pulling the posterior with a fine 
pair of tweezers. For DNA extraction, samples were preserved in PBS or testis buffer at 
-20° C. For RNA extraction, samples were stored in lysis buffer (Norgen Total RNA 
kit) at -80° C. To image the cells present in the male germline or the presence of sperm 
in the female reproductive tract, the dissected testes or female reproductive tract were 
gently squashed under a cover slip and observed at Cardiff University (Olympus BX50 
microscope, Hamamatsu Orca 05G Digital Camera, and Olympus U-RFL-T 
Fluorescence Lamp) or Oxitec (Motic BA210 microscope, Fraen fluorescence 
FLUOLED lamp, Lumenera Infinity 2 camera). Generally, for testis dissections, 20x 
and 40x magnification were used; and for the female reproductive tract, 10x and 20x. 
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2.5 Phenotypic analysis of expression systems for fluorescent sperm marking 
 
2.5.1 Analysis of fluorescent marker localisation in the male germline  
 These experiments were performed to assess the performance of transgenic 
systems for the fluorescent marking of sperm nuclei (Chapters 3-5), or to evaluate the 
ability of regulatory sequences to appropriately regulate translation of a fluorescent 
reporter in the male germline (Chapter 4). Transgenic males were collected < 8 hours 
post-eclosion (day 0) and kept virgin in small cages (10-20 individuals per cage). Testes 
were dissected and imaged as previously described, at Cardiff University or at Oxitec. 
Five to twenty males per line were assessed (generally ten). Localisation of the 
fluorescent marker in spermatocytes, spermatids and sperm was investigated. 
 
2.5.2 Assessing the presence of fluorescently marked sperm in the female 
reproductive tract 
 It was necessary to confirm that the expression of transgenic effectors for 
repressible male sterility or fluorescent marking of sperm nuclei, were not associated 
with effects on the morphology, motility, or number of sperm transferred to WT females 
after mating. These studies were performed either in parallel with an assessment of the 
mating competitiveness of males (Section 2.6.2), or independently. When performed 
independently, crosses of transgenic males to WT females were performed in small 
cages. Several studies were performed; details of the crosses are provided in the 
relevant results section. Between days 5-7 after the cross was initiated, females were 
removed from the cage after careful anaesthetisation in a chest freezer (-20° C), until 
females were unable to fly but still able to walk (about 10 minutes).  
 
 When performed in parallel with mating competition assays (Section 2.6.2), 
mating pairs were captured immediately in mating chambers (30 ml plastic tubes with 
airholes), allowed to copulate until dissociation, and the male was removed. Food was 
added to the tube and the females assessed 24-48 hours later, after immobilizing them 
by crushing the head. In all studies, the reproductive tract was removed by 
microdissection and imaged as previously described, at Cardiff University or Oxitec.  
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2.5.3 Fluorescence microscopy assay to distinguish females that had mated WT 
males or transgenic males 
 To study the detectability of fluorescently marked sperm in the female 
reproductive tract under field-simulated trapping conditions, and therefore differentiate 
whether females had mated WT or transgenic males, the following test was performed. 
WT females (n = 100) were independently crossed to transgenic males (n = 100) or WT 
males (n = 100) in single large cages; mating was allowed for 5 days. To control for 
fitness differences resulting from rearing density, flies were reared with equal cohorts (n 
= 700 eggs per bottle). Females were removed from the cages by careful 
anaesthetisation in the freezer, as previously described. 20 females from each group 
(mated to WT or transgenic males) were affixed to yellow sticky traps (Seabright 
Laboratories) for 0, 1, 7, or 14 days prior to scoring; this was done to simulate the 
process of monitoring released insects in the field (Harris et al., 1971). Double blind 
scoring was applied to preclude experimenter bias (the genotype of the male was not 
known prior to scoring). Flies were detached from the trap with tweezers and placed 
into tubes with distilled water and rinsed by inverting the tube. The abdomen was 
excised and spermathecae dissected in PBS, prior to gentle squashing under a cover slip 
and imaging. Frequently, the aged samples (7-14 days) were heavily degraded (due to 
decomposition after dying on the trap), preventing specific dissection of intact 
spermathecae. In these instances, the entire abdominal tagma was crushed under a cover 
slip and imaged as described previously. At each timepoint, we scored the number of 
individuals for which the male genotype was correctly identified; misidentified as WT 
(false negatives); or misidentified as transgenic (false positives). 
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2.6 Phenotypic analysis of transgenic expression systems for repressible male 
sterility (tetO-protamine-FokI) 
 
2.6.1 Egg hatch rate assays 
 The rates of egg hatching in the progeny of males reared with tetracycline [T] 
and without tetracycline [NT] were compared, to evaluate the penetrance and 
repressibility of the male sterility phenotype conferred by the tetO-protamine-FokI 
effector (Figure 2.7). Transgenic males reared off tetracycline should have a paternal 
effect lethal phenotype if the line is penetrant, wherein the hatch rate of progeny is 
minimal or zero. Conversely, the progeny of transgenic males reared on tetracycline 
should hatch at a rate similar, and ideally equivalent, to the WT control. 
 In the generation before the assay, two F0 crosses were performed. In the first, 
males or females heterozygous for the expression construct were backcrossed to WT in 
a small or medium cage (to amplify the population of heterozygous males for further 
experimentation). Transgenic males were generally used, but in some instances, this 
was not possible (certain strains were irrepressibly male sterile). In the second, WT was 
reared in extra large cages under standard conditions, for use as a control in the study. 
Eggs from both crosses were independently filtered onto media with tetracycline [T] or 
without tetracycline [NT]. WT and transgenic males of the F1 generation, reared with 
and without tetracycline, were independently collected on eclosion. Thereafter, each 
group was crossed in small or medium cages to WT females reared off tetracycline. 
There were four experimental groups, comprising the two male genotypes, reared with 
and without tetracycline (Table 2.6).  
 
Table 2.6 Crosses performed in the egg hatch rate assay 
Group Male   Female  Expected result 
 Genotype Tetracycline Genotype Tetracycline  
1 Transgenic NT WT NT Low hatch rate 
2 T Normal hatch rate 
3 WT  NT 
4 T 
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 The laying pots were cleared the day before the assay, to facilitate a 24 hour 
collection of 100-300 eggs, usually on day 7. Eggs were passed through a coarse sieve 
to remove water from the collection tray, and transferred with a fine paintbrush or 
Pasteur pipette to a moist, gridded Whatman grade 3 filter paper (Sigma-Aldrich 
Z240427) under a stereoscope. This was placed in a hatching chamber (an inverted Petri 
dish sealed with Parafilm) and the hatch rate scored four or five days later. For 
preliminary tests to identify lines with commercially suitable phenotypes, measurements 
were pseudoreplicated (collections were taken from the same cage), two or three times. 
The rationale was that it was unnecessary to conduct an overpowered study at this stage, 
because most lines would not demonstrate a suitable male sterility phenotype (Jin, 
2011), (Asadi, 2013). For lines that demonstrated a commercially promising phenotype, 
the study was repeated with true replication (four collections from independent crosses). 
The details of the crosses and collections performed are provided in the relevant results 
section. 
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 Replicates were tested by correction-free chi-square testing for significant 
variance, prior to pooling individual replicates. Penetrance and repressibility were 
calculated based on the mean hatch rates for the transgenic [NT] and [T] crosses, 
relative to the WT [NT] and WT [T] controls. Formulae are provided below. The 
statistical significance of the penetrance of male sterility was calculated by correction-
free chi-square testing of the number of hatched and unhatched individuals of the 
transgenic [NT] cross, against the WT [NT] control. The statistical significance of the 
repressibility of male sterility was calculated equivalently against the WT [T] control, in 
the instances where this control was performed. For lines that appeared to be non-
repressible, the extent of repressibility was assessed by correction-free chi square 
testing of the [NT] and [T] hatch rates for each line. Standard error and 95% Wilson 
confidence interval (CI) were calculated by the methods recommended for categorical 
data (Xu et al., 2010).  
 
𝑃𝑒𝑛𝑒𝑡𝑟𝑎𝑛𝑐𝑒 = 100 − (
𝑇𝑟𝑎𝑛𝑠𝑔𝑒𝑛𝑖𝑐[𝑁𝑇] ℎ𝑎𝑡𝑐ℎ 𝑟𝑎𝑡𝑒
𝑊𝑇[𝑁𝑇] ℎ𝑎𝑡𝑐ℎ 𝑟𝑎𝑡𝑒
∗ 100) 
 
𝑅𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦 =
𝑇𝑟𝑎𝑛𝑠𝑔𝑒𝑛𝑖𝑐[𝑇] ℎ𝑎𝑡𝑐ℎ 𝑟𝑎𝑡𝑒
𝑊𝑇[𝑇] ℎ𝑎𝑡𝑐ℎ 𝑟𝑎𝑡𝑒
∗ 100 
 
2.6.2 Lab-scale mating competition assays  
 These tests were performed according to IAEA guidelines (FAO et al., 2003) to 
assess if transgenic, conditionally sterile males could compete equally with wild-type 
males for mates (Figure 2.8). These tests are only expected to highlight severe fitness 
defects because they are performed in an enclosed space at high population densities. 
Furthermore, mating behaviour observed in a laboratory environment does not 
accurately reflect wild behaviour (Liimatainen et al., 1997), (Briceño and Eberhard, 
1998). Hence, it is therefore necessary to perform further testing under conditions that 
more effectively simulate wild conditions, such as greenhouses, preferably with wild 
males (rather than WT). 
 
 We only assessed WT and transgenic males that had been reared off tetracycline 
(NT). If these transgenically sterilised males were able to compete adequately, it would 
obviate the need to assess the performance of tetracycline-reared males, which would be 
expected to express the male sterility effector to a lesser extent (it would be repressed). 
Furthermore, the mating competitiveness of tet-reared males was relatively unimportant, 
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because tet-reared males will not be released into the field. Rears were quality 
controlled by weighing young pupae on an Ohaus Pioneer Analytical Balance PA64 (< 
24 hours post-pupation); rears with a mean pupal mass under 7 mg were rejected (FAO 
et al., 2003). Upon eclosion, WT males, transgenic males and WT females were 
collected as virgins and reared as separate groups, in small cages with 25 individuals. 
The assay was performed five days after eclosion in the morning (initiated between 
08:00-10:00), in Bugdorm cages with equal numbers of transgenic males, WT males 
and WT virgin females (n = 50 each).  
 
 Males of both genotypes were released into the Bugdorm cage and left for one 
hour to establish territory. Wild-type females were then added; mating usually begins 
within five minutes. Any females that had not attempted mating within one hour were 
excluded from the analysis. After mating pairs stabilised (about 5 minutes), they were 
trapped within a mating chamber (a 30 ml universal tube with airholes), allowed to walk 
up the side, and the chamber sealed. The chambers were placed atop a tray and the tubes 
observed every 10 minutes, to record the duration of mating. Pairs mating for less than 
one hour were discarded. The genotype of the male was scored (by the presence or 
absence of the AlMAct-dsRed2 transformation marker). Three or five replicates were 
performed, and the observations pooled after verifying that there were no significant 
differences between the replicates, by chi-square testing. Differences in mating duration 
between WT and transgenic males were assessed by independent sample, two-tailed t-
test. The relative sterility index (RSI), a metric of competitiveness defining the 
proportion of females paired with transgenic males (Ntg) relative to total mating events 
(Ntg + Nwt), was calculated (Cayol et al., 1999): 
RSI = 
𝑵𝒕𝒈
𝑵𝒕𝒈+ 𝑵𝒘𝒕
 
 
 Therefore, the RSI value indicates whether, under these conditions, transgenic 
males are more competitive relative to WT (RSI > 0.5), less competitive (RSI < 0.5), or 
equally competitive (RSI = 0.5), for mating events with females.  
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 Assistance from colleagues was provided for both of the two strains assessed in 
this study (OX4718A and OX5122M). Three or five replicates were performed per 
study. For each replicate, one individual collected the mating pairs from a single cage 
over the course of one hour. The author conducted one replicate; the other replicates 
were assessed in parallel by colleagues (Thea Marubbi, Ben Granville, Charilaos Megas 
or Christa Kistenpfennig). The subsequent data collection and processing (genotyping 
the males, recording the mating duration, post-collection dissections, and data analysis) 
were conducted by the author. 
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2.6.3 Visualisation of the paternal effect lethal phenotype by nuclear staining of 
embryos  
 Expression systems for male sterility should arrest the development of all 
embryonic progeny of off-tet reared males (NT), for both heterozygous and 
homozygous transgenic lines. However, it is likely that the effect will be stronger in 
homozygotes, because of increased transgene expression from the presence of a second 
copy of the effector. The crosses performed were essentially as described for the egg 
hatch assay. Off-tet and on-tet reared transgenic males were crossed independently to 
off-tet reared WT females. Controls were equivalent crosses with WT males (non-tet 
and tet-reared) and WT females. Therefore, there were four experimental groups (Table 
2.7). 
 
Table 2.7 Experimental groups for the embryonic nuclear staining assay 
Group Male   Female  Expected result 
 Genotype Tetracycline Genotype Tetracycline  
1 Transgenic NT WT NT Minimal development 
2 T Normal development 
3 WT  NT 
4 T 
 
  Eggs were collected from each cross in four hour cycles, fixed and stained (days 
7-9). Two timepoints were assessed: 0-4 hours and 20-24 hours after oviposition. To fix, 
embryos were dechorionated with 10% sodium hypochlorite solution (2 minutes) and 
rinsed with water to remove bleach, essentially as described for microinjection. 
Dechorionated embryos were transferred with a fine brush to 10 ml glass vials with 
heptane (5 ml) and 4% paraformaldehyde in PBS (2 ml). To devitellinate and fixate the 
embryos, they were left in a shaking incubator (room temperature, 2 hours, 250 rpm). The 
fixative (lower layer) was removed with a micropipette, 5 ml methanol added, and the 
mixture shaken by hand for 30 seconds. Fixed embryos were transferred to a microfuge 
tube, rinsed with methanol three times, and all methanol removed thereafter. All 
subsequent washes and incubations were performed for 15 minutes with a microfuge tube 
rotator: first, in 50% PBS with 0.1% Tween (50% PBST) and 50% methanol, and 
thereafter in PBST. Embryos were incubated with RNaseA (0.25 mg/ml) and washed 
three times with PBST. To stain, incubation was performed with Hoechst 33258 (1 
ng/μl), prior to washing with PBST. All buffer was removed and embryos mounted in 
85% glycerol with 2.5% n-propyl gallate under a siliconised coverslip, and the edge 
sealed with clear nail varnish. Embryos were imaged by fluorescence and phase contrast 
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microscopy (UV filter) at Cardiff University, at 10x magnification with the previously 
described apparatus (Olympus BX50 microscope, Hamamatsu Orca 05G Digital Camera, 
and Olympus U-RFL-T Fluorescence Lamp). 
 
  At least 10 individuals were scored from each group, for the extent of 
development. From the 0-4 hour collection, embryos were scored as developing or not 
developing (several nuclei visible or only first nucleus visible). From the 20-24 hour 
collection, embryos were scored as morphologically normal, morphologically aberrant, or 
no visible development (Figure 2.9). For statistical analysis, data was divided by 
timepoint and correction-free chi-square testing was performed with the counts of 
embryos at each stage, relative to the appropriate WT control ([NT] or [T]). Repression 
was calculated by equivalent testing of the counts of embryos at each stage, for the [NT] 
group against the [T] group, for each line. WT was equivalently assessed to control for a 
effect of tetracycline that affected viability, independently of the male sterility effector. 
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Chapter 3 – Expression systems for fluorescent sperm marking and Dmprot2-FokI 
mediated repressible male sterility  
 
3.1 Previous development of male sterility and fluorescent sperm marking systems 
 In prior study (Jin, 2011), a fragment based on the Ccβ2tubulin promoter and 
5’UTR (OX3671: Ccβ2tubulin promoter-Ccβ2tubulin 5’UTR[full]-dsRed2-SV40 
3’UTR) mediated localisation of the dsRed2 fluorescent reporter in spermatocytes, 
spermatids and sperm, indicating that this fragment would be able to localise tTAV in 
the male germline, largely as required (Figure 3.1). However, translation was not as 
early as desired (not robustly expressed in all spermatocytes). High levels of pre-meiotic 
transcription and translation of tTAV in the male germline were required for sufficient 
transcriptional activation of the protamine-FokI male sterility effector, at the target tetO 
sites. The practical reasons for this were fully outlined previously (Section 1.4.2.3). 
Briefly, it is necessary for adequate protamine-FokI transcript to accumulate prior to 
meiosis, because transcription is highly reduced in the male germline after this point. 
However, the translation of protamine-FokI must be delayed until spermatid elongation,  
to avoid disruption of the meiotic divisions, or defects in spermatid nuclear shaping that 
might prevent spermatid individualisation. 
 To achieve an earlier translational profile, the Ccβ2tubulin 5’UTR was truncated 
to remove putative elements that could delay translation, and attached to a minimal 
promoter fragment and 5’UTR from Cchsp83, a gene with earlier transcription and 
translation (Jin, 2011). The resulting Ccβ2tubulin-Cchsp83 chimeric fragment 
(OX4282: tetO14-Ccβ2tubulin promoter-5’UTR[short]-Cchsp83 minipromoter- 5’UTR-
tTAV-SV40 3’UTR) was found to facilitate appropriately early transcription and 
translation of a reporter (tetO14-Dmhsp70 minipromoter-adh intron-tGFP-SV40 
3’UTR); it was robustly localised to spermatocytes. This indicated that the fragment 
would be suitable to regulate appropriately early expression of tTAV. This same 
chimeric Ccβ2tubulin-Cchsp83 driver was subsequently confirmed to appropriately 
promote expression of a Dmprot2-FokI effector cloned downstream of the tTAV target 
sites (tetO), in the male germline (OX4353: tetO14-Dmhsp70 minipromoter[+89 bp 
5’UTR]-Dmprot2-FokI; Figure 3.2). This resulted in penetrant and repressible male 
sterility (Jin, 2011), (Asadi, 2013).  
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 Neither reporter construct (OX3671 or OX4282) was functional as a system for 
fluorescent sperm marking. In OX3671, approximately half of sperm were weakly 
marked with the dsRed2 reporter. In OX4282, visible marking was observed in only one 
of five lines. Crucially, neither reporter was associated with a DNA-binding element 
(for instance, protamine), which would be expected to spatially aggregate fluorescent 
molecules upon the sperm genome, and hence improve the visibility of the marking 
system. It was therefore reasoned that a fusion of protamine-fluorescent marker-FokI 
could simultaneously function as an effector of penetrant and repressible male sterility, 
and fluorescent sperm marking. However, these constructs did not function as well as 
anticipated (Figure 3.3) because the fluorescent sperm marker and male sterility 
effector appeared to affect the function of one another (Asadi, 2013). A linker-free 
fusion of Dmprot2-mCherry-FokI (OX4705) demonstrated penetrant and repressible 
sterility in two of four olive fly lines, and semi-penetrant sterility in one line. However, 
fluorescent sperm marking was not observed in any line. Thereafter, it was considered if 
addition of short flexible peptide linkers (SG4) between the sperm marker and 
protamine-FokI effector, could improve the phenotype. OX4801 (tetO21-Dmprot2-SG4 
linker-mCherry-SG4 linker-FokI) demonstrated weak but visible sperm marking in all 
six olive fly lines evaluated, but the penetrance of male sterility was unacceptably 
reduced (mean hatch rate: 20%). Therefore, if it can be assumed that the effectors 
function equivalently in olive fly and Medfly, the inclusion of linkers would improve 
fluorescent sperm marking, but unacceptably reduce penetrance.   
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3.2 Transgenic expression systems for repressible male sterility and fluorescent 
sperm marking evaluated in this study 
 We decided to first evaluate the linker-free Dmprot2-mCherry-FokI effector in 
Medfly, as it was previously shown to mediate penetrant and repressible sterility in 
olive fly, though the fluorescent sperm marking phenotype was relatively poor. This 
was cloned into a four-ended piggyBac vector (OX4718), which allows excision of the 
transposable ends after genomic integration (Dafa’alla et al., 2006), preventing 
subsequent re-transposition (a concern of agencies regulating the use and release of 
genetically modified organisms). We intended to evaluate the ability of this system to 
mediate penetrant and repressible sterility, whilst attempting to improve the sperm 
marking system in a parallel study. We therefore expected to observe penetrant and 
repressible male sterility with minimal or no marking, if the molecule functioned 
equivalently in Medfly relative to olive fly, where it was originally characterised. A 
penetrant and repressible male sterility phenotype was demonstrated for an OX4718 line 
(Bilski, 2012). However, the functionality of fluorescent sperm marking and the effects 
of protamine-FokI expression on mating competitiveness, and the appearance and 
quantity of engineered sperm transferred to females upon mating, were not yet 
evaluated.  
  In parallel, we tested a protamine-free sperm marking system in OX5036, 
which was regulated by tetracycline-repressible, positive feedback expression of tTAV 
(tetO21-Ccβ2tubulin promoter-5’UTR[short]-Cchsp83 minipromoter-Cchsp83 5’UTR-
tTAV-T2A-nls-zsGreen-nls-Cchsp83 3’UTR). In the absence of tetracycline, it was 
anticipated that this fragment would positively regulate its own expression (tTAV-
mediated transactivation at the tetO target sequences), leading to high levels of 
expression. In this design, two polypeptides were translated from the same mRNA 
(tTAV and nls-zsGreen-nls), separated at the T2A translational skipping element. 
Translation should occur in primary spermatocytes, and thereafter the nls-zsGreen-nls 
marker was expected to localise to the nucleus and persist through spermiogenesis, to 
eventually label the sperm nucleus. It was thought that separation of Dmprot2-FokI 
from the sperm marker might enhance brightness, because fusions of protamine-marker-
FokI were previously demonstrated to mediate poor marking (OX4705), even when 
separated with linkers (OX4751).  
 The fragment regulating the male sterility effector in OX5036 (tetO21-Dmhsp70 
minipromoter[+89 bp 5’UTR]-Dmprot2 5’UTR-Dmprot2 ORF [no introns]–SG4 linker-
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FokI-SV40 3’UTR) was modified from the version in OX4718A. The primary 
difference was that the mCherry marker between Dmprot2 and FokI was removed. 
Further changes were made to the effector, in an attempt to enhance penetrance of male 
sterility (Figure 3.4). Introns were removed from the Dmprot2 ORF; the presence of 
introns can be associated with reduced expression in the male germline (White-Cooper 
and Caporilli, 2013). The C-terminal end of Dmprot2 was also altered slightly relative 
to prior constructs. The full WT sequence was included (the C-terminal lysine in 
OX4718 & OX4353 was removed) and a small tripeptide at the C-terminus was 
removed. This TMA tripeptide (present in OX4718 & OX4353), was not part of the 
Dmprot2 coding sequence. Presumably, it had been included in previous constructs to 
introduce a spacer between Dmprot2 and FokI, which was no longer necessary, because 
an SG4 linker sequence was included. Neither of these changes were expected to affect 
localisation of the molecule. It was previously shown that the inclusion of an SG4-
mCherry-SG4 fragment (Dmprot2-SG4-mCherry-SG4-FokI) had a negative effect on 
the penetrance of male sterility. However, it remained possible that a shorter sequence 
(Dmprot2-SG4-FokI rather than Dmprot2-SG4-mCherry-SG4-FokI) would generate a 
favourable spatial conformation, and enhance the penetrance of male sterility.  
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3.3 OX4718 heterozygous males demonstrate penetrant and repressible sterility 
but weak fluorescent sperm marking 
 Two single autosomal insertions (OX4718A & B) were assessed by Michal 
Bilski prior to this studentship. Penetrance of the male sterility phenotype had been 
investigated by comparing the egg hatch rate of progeny from OX4718 heterozygous 
males, reared on- and off-tetracycline, to equivalent control crosses with wild-type 
males (Bilski, 2012). The assays were initiated on day 4 post-eclosion and scored on 
day 8. OX4718A appeared highly penetrant (98.8%) and OX4718B largely impenetrant 
(Table 3.1). The hatch rates of progeny of OX4718A males reared on-tet were identical 
to the equivalent WT control, indicating full phenotypic repression of sterility.  
 
Table 3.1 Penetrance and repressibility of the male sterility phenotype in OX4718  
Line Mean hatch rate (%) Penetrance (%) Repressibility (%) 
 
 NT T   
OX4718A 1.1 92 99 100 
OX4718B 81 91 11 100 
WT 91 91   
Penetrance and repressibility were calculated relative to the respective control hatch rate, WT [NT] or 
[T]. Standard error was not calculated (sample sizes were not provided). Note: these experiments were 
not performed by the author (Bilski, 2012).   
 
 The localisation of the male sterility effector-fluorescent sperm marker fusion 
(Dmprot2-mCherry-FokI) in the male germline, was investigated by dissection of 
sexually mature OX4718 heterozygous males, reared off-tet and on-tet. OX4718B was 
not assessed; it was an impenetrant (fertile) line and was discarded before the study 
began. Heterozygous OX4718A male medfly were collected on eclosion (day 0) and 
kept in small cages (20 males per cage). They were re-fed on day three and dissected on 
day five. Testes from at least ten males per line were dissected by standard protocol in 
testis buffer, gently squashed under a coverslip and imaged at Cardiff University using 
phase contrast and fluorescence microscopy (Olympus BX50 microscope, Hamamatsu 
Orca 05G digital camera, and Olympus U-RFL-T fluorescence lamp). Spermatocytes, 
spermatids and sperm were imaged to identify cell-specific fluorescence, at 20x and 40x 
magnification. The fluorescent sperm marking system was partially functional, but not 
fit for purpose (not present in all mature sperm). The relatively poor performance of the 
sperm marker was not surprising, as a prior evaluation demonstrated that linker-free 
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fusions of Dmprot2-mCherry-FokI (OX4705) did not perform well in olive fly (Asadi, 
2013). Effector localisation (Dmprot2-mCherry-FokI) was observed in spermatocytes, 
spermatids and sperm (Figure 3.5). Translation in spermatocytes indicated that 
Dmprot2-mCherry-FokI was present earlier than expected; the Dmprot2 5’UTR was 
anticipated to delay translation until spermatids were elongated (Jayaramaiah Raja and 
Renkawitz-Pohl, 2005). The effector was not completely repressed by tetracycline; and 
not uniformly expressed in all sperm. This was consistent with the observation that a 
small proportion of embryos hatched (1.1%). Although incomplete repression of the 
effector was observed (the mCherry fluorescence was detected even when the flies had 
been reared in the presence of tet), it did not appear sufficient to reduce fertility in tet-
reared males, because the egg hatch rate was similar to WT. This was probably because 
FokI requires dimerisation for activity, and hence a direct correlation of concentration 
and activity is not expected. In terms of fluorescent sperm marking, expression in 
spermatocytes was not problematic per se. However, failure to detect fluorescence in an 
overwhelming majority of sperm were factors that needed to be solved by redesign of 
the sperm marking system. Finally, fluorescent marker expression in spermatocytes was 
nuclear, but in spermatids the whole cell was labeled, not just the nucleus. This suggests 
that the fusion protein is not behaving as expected. 
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3.4 Immobilisation of the OX4718A insertion and re-assessment of the repressible 
male sterility phenotype 
 The penetrant and repressible male sterility phenotype, and fluorescent body and 
sperm markers are key biosafety features. Penetrant sterility prevents vertical 
transmission of the engineered genetic elements into the wild population; and the 
markers facilitate traceability of the engineered males in the wild (ie. they can be 
differentiated from wild males). Theoretically, the expression profile of these features 
could be removed, attenuated or otherwise altered by re-transposition to a novel 
insertion site. Furthermore, it is theoretically possible that the presence of transposable 
ends could facilitate horizontal gene transfer, for instance to an invading retrovirus and 
thereafter to novel insect species (Lohe et al., 1995), (Silva et al., 2004). Therefore, a 
unique selling point of this repressible male sterility platform is the ability to 
immobilise the transgenic insertion, by removal of sequences required for transposition 
from the piggyBac vector (Dafa’alla et al., 2006). This is anticipated to hasten the 
regulatory process and improve public acceptance of the product.  
 
 OX4718 is a composite transposon with two pairs of piggyBac ends that self-
excise (“resolve”), when crossed to a transgenic line expressing piggyBac transposase in 
the germline (OX3133: Cchsp70-pB transposase-pB 3’UTR). Fluorescent markers at 
each piggyBac end pair (left: HR5IE1 promoter-AmCyan-BmHsp83 3’UTR; right: 
HR5IE1 promoter-zsGreen-DmK10 3’UTR) facilitate microscopic screening of 
piggyBac end excision (by marker loss). piggyBac end excision was performed largely 
as described previously (Chapter 2). All crosses were carried out in the presence of 
tetracycline. OX4718A heterozygous males were crossed to OX3133 heterozygous 
females. F1 progeny carrying both constructs (OX4718A/OX3133) were selected by 
fluorescence microscopy (DsRed2 & PhiYellow expression). OX4718A/OX3133 males 
were then crossed to WT females; the reciprocal cross was also performed as excision 
can occur in both the male and female germlines. F2 progeny were screened by 
fluorescence microscopy for the absence of zsGreen and AmCyan.  
  
CONFIDENTIAL  Chapter 3 – Fluorescent sperm marking and Dmprot2-FokI mediated sterility 
 
99 
 Thereafter, genomic DNA was extracted from four apparent positives to confirm 
end loss by PCR; all individuals had indeed lost both ends (Figure 3.6). A single 
transgenic OX4718A-resolved individual was backcrossed to WT for two generations to 
re-establish a genetically diverse transposon-free transgenic line. The male sterility 
phenotype was re-assessed by egg hatch rate assay at this stage, because it was possible 
that the transposon had remobilised to a novel genomic site. The assessment was 
essentially as previously described (Chapter 2). Fifteen heterozygous OX4718A-
resolved males of each treatment (non-tet [NT] or tet [T] reared) were crossed to fifteen 
WT[NT] females. Controls were equivalent crosses with WT males and WT females. 
Crosses were performed in quadruplicate. A 24-hour egg collection (250 eggs) was 
performed four days later (four replicates per group, 1000 eggs total) and the hatch rate 
was assessed (day 8). The male sterility phenotype was equivalent to the unresolved 
OX4718A insertion (Table 3.2); it did not seem to have been affected by piggyBac end 
excision. Interestingly, three of four OX4718A-resolved [NT] cages did not give rise to 
hatching progeny; in one cage 6% of eggs hatched. Assuming there was no 
contamination with tetracycline, this may indicate that spermatocytes occasionally do 
not accumulate sufficient effector transcript, and the descendent sperm remain viable. 
No significant difference in male fertility was observed between crosses involving 
OX4718[T] and WT[T] males, indicating that the sterility is fully repressible by the 
addition of tet. However, statistically significant variation in hatch rate was observed in 
every group, when performing within-group testing on individual replicates (Table 3.3). 
This indicated that improving the reproducibility of the assay would improve the 
validity of future analysis. An optimisation assay later confirmed that survival was 
improved, when less water was applied to the moist filter paper in the hatching 
chamber. When this was adopted in subsequent experiments (Chapter 5), it was rare that 
significant variations across replicates of the same group were observed. 
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Table 3.2 Penetrance and repressibility of the male sterility phenotype in 
OX4718A-resolved  
Line Mean hatch rate (± SE) Penetrance Repressibility 
 NT T % X2 P[df] %  X2  P[df] 
OX4718A-resolved 1.6 ± 0.4 85.3 ± 1.12 98 1423 < 0.001[1] 100 3.4 0.07[1] 
WT 85.2 ± 1.12 88.1 ± 1.02       
Penetrance and repressibility were calculated relative to their respective control hatch rate, WT [NT] or 
[T]. Significance values were from chi-square tests of the numbers of hatched and unhatched eggs, 
relative to the respective values for the control (WT [NT] or [T]). SE: standard error. Df: degrees of 
freedom.  
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Table 3.3 Biological variation in the OX4718-A assay  
Line NT  T 
 Hatch rate (%) Significance Hatch rate (%) Significance 
 R1 R2 R3 R4 X2 P[df] R1 R2 R3 R4 X2 P[df] 
OX4718A-resolved 0 0 0 6.4 36.2 < 0.001[3] 74.4  82.4 89.6 94.8 47.0 < 0.001[3] 
WT 65.6  90.4 91.6 93.2 102.3 < 0.001[3] 80.4  87.6  88.8 95.6 27.7 < 0.001[3] 
Replicate is abbreviated as “R”. Outliers in boldface. Significant variation was indicated by chi-square 
testing the number of hatched and unhatched eggs, between the four replicate values for each group.  
3.5 Establishing a homozygous OX4718A-resolved line 
 Homozygosity of the transgenic insertion is required for product lines, because it 
removes the need to screen transgenics during mass-rearing and may enhance the 
penetrance of male sterility by doubling copy number of the effector. A homozygous 
colony is easily established by PCR to genotype founders, but typically requires the 
sequences flanking the insertion, to differentiate heterozygotes and homozygotes. The 
OX4718A-resolved genomic flanking sequence (Figure 3.7) was isolated by Caroline 
Phillips (Oxitec Molecular Team) by restriction digest, ligation of an adapter of known 
sequence; and sequencing across the adapter, flanking genomic DNA, and transgenic 
expression construct. Unfortunately, a parallel analysis (next section) revealed that 
sperm transfer in OX4718A was deficient, limiting its usefulness as a product line. We 
therefore aborted homozygosis. 
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3.6 OX4718A-resolved heterozygous males compete well against WT males for 
mates, but transfer sperm with reduced motility, at a lower quantity  
 Fluorescence microscopy had confirmed translation of the male sterility 
effector-fluorescent sperm marker in spermatocytes (Dmprot2-mCherry-FokI), which 
indicated that undesirable effects on the quantity or motility of sperm transferred to 
females were possible. This could potentially encourage mated females to seek re-
mating with other males (if the extent of sperm transfer was not adequate). Therefore, 
we next assessed the mating competitiveness of OX4718A-resolved males and the 
health of sperm transferred upon mating. OX4718A-resolved heterozygous males, WT 
males and WT females (all reared off-tet) were collected on eclosion after quality 
controlling the rears by mean pupal mass (> 7 mg), according to IAEA guidelines (FAO 
et al., 2003). On day 5, fifty individuals of each group were released into a Bugdorm 
cage (five replicates) and the duration of mating for each pair recorded. The male of 
each pair was genotyped (presence or absence of the AlMAct-dsRed2 fluorescent 
marker), to assess RSI (the proportion of mating events initiated by transgenic males). 
An RSI of 0.5 would indicate that OX4718A-resolved and wildtype males are equally 
competitive. To assess sperm transfer, females mated for > 60 minutes in the 
experiment were randomly selected and dissected at Cardiff University 24-48 hours 
later (same microscope as previously described, at 10x and 20x magnification).  
 The five replicates of the mating competition assay were pooled after verifying 
that there were no significant differences between the replicates, in terms of female 
mating preference (chi square test, χ² = 1.5352, df = 4, p = 0.82). Females did not 
preferentially mate with either WT or OX4718A-resolved males (RSI = 0.5, χ² = 0.005, 
df = 1, p = 0.95; Table 3.4). OX4718 males mated for 8 minutes longer on average (114 
min) relative to WT males (106 min). This small effect was statistically significant 
(independent samples, two-tailed t-test; t = -2.0597, df = 195, p = 0.04). However, the 
effect was no longer significant when t-testing was re-performed on individual 
replicates. This indicates an artefactual difference, probably caused by handling 
differences in the three people (Ryan Turkel, Charilaos Megas and Ben Granville) 
working together to conduct the study. The mean durations of mating for both 
genotypes were less than the average for mass-reared Medfly males reported elsewhere, 
approximately 135 minutes (Shelly and Kennelly, 2002).  In subsequent analyses 
(Section 4.3.3), the reported duration of mating (138-142 minutes) was greater than this 
published value (135 minutes). This suggests that experience with the assay (perhaps 
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the ability to delicately handle pairs in copula), had a substantial effect on the duration 
of mating. 
Table 3.4: Mating preference of WT females in OX4718A-res competition assay 
Replicate Mating preference X2 P
[df]
 
 Transgenic WT Total RSI Unmated   
1 20 25 45 0.44 5 0.56 0.46[1] 
2 22 25 47 0.47 3 0.19 0.66[1] 
3 21 23 44 0.48 6 0.09 0.76[1] 
4 25 15 40 0.63 10 2.5 0.11[1] 
5 21 20 41 0.51 9 0.02 0.88[1] 
Total 109 108 217 0.50 33 0.005 0.95[1] 
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 13/15 females crossed to WT males had detectable sperm; in all but one 
individual they were too numerous to count. In contrast, 12/16 (75%) of females crossed 
to OX4718A-resolved males lacked detectable sperm. In the four instances where 
OX4718A-resolved sperm were observed, fewer than 100 were present in the entire 
female genital tract. Hundreds or thousands are typically present, when the male to 
which females are mated, is WT (Taylor and Yuval, 1999), (Twig and Yuval, 2005). 
OX4718A-resolved sperm frequently had unusual morphology (uncurled and 
presumably dead), were generally immotile, and never detectably marked (Figure 3.8). 
Occasionally, weakly swimming sperm were found in the oviduct. These appeared to be 
trapped and unable to pass into the spermathecae. Therefore, it appears that expression 
of the male sterility effector (Dmprot2-mCherry-FokI) in OX4718A-resolved males 
promotes genomic inviability of sperm as intended. However, in most instances, it 
appears to reduce the quantity and motility of sperm transferred to the female 
reproductive tract. 
 Therefore, it is likely that a large proportion of embryos that do not develop in 
OX4718A-resolved hatch assays are unfertilised, rather than inviable as a result of 
paternal effect lethality. It is not entirely clear why certain sperm are less affected than 
others; but it seems likely that expression levels of the effector in sperm are not 
perfectly uniform. This was corroborated by the localisation pattern of the Dmprot2-
mCherry-FokI effector, which marked particular sperm and spermatids more brightly 
than others. Curiously, marking was not observed in mature sperm that were transferred 
to WT females from OX4718A-resolved males; though it was occasionally visible in 
testes (Figure 3.5). A speculative explanation is that the nuclease activity of Dmprot2-
mCherry-FokI fragments the sperm genomic DNA, spatially de-aggregating the 
fluorescent proteins and therefore reducing their visibility. The presence of weak but 
detectable fluorescence in the male germline is probably related to two factors: (1) a 
greater concentration of spermatids and sperm (ie. cells in which the fluorescence 
should be visible); and (2) the presence of newly forming sperm, which may have been 
exposed to the Dmprot2-mCherry-FokI nuclease for a lesser time period (it is possible 
that the genome is relatively intact).  
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 Interestingly, the observation of a low, but not zero, hatch rate in crosses of WT 
females to OX4718 males reared-off tet, indicates that a minority of sperm retain a 
genome sufficiently intact to mediate hatching of the fertilised embryo. Such an effect 
could be mediated by stochastic variation in expression of the tet system across cells, or 
by the spatial dynamics of distribution of effector transcript and protein, as 
spermatocytes develop into sperm. The negative effect on sperm fitness was not 
unexpected, because the previous analysis demonstrated translation in spermatocytes 
(protamine-mCherry-FokI). As previously described, the 5’UTR is a key mediator of 
translational repression in Drosophila melanogaster protamine-like genes (Barckmann 
et al., 2013). The OX4718 construct retains a portion of Dmhsp70 5’UTR (89 bp 
associated with the Dmhsp70 minipromoter (tetO21-Dmhsp70 minipromoter[+89 bp 
5’UTR]-Dmprot2 5’UTR). As this gene is translated earlier than Dmprot2 
(embryonically), it was possible that the Dmhsp70 5’UTR fragment may have 
attenuated the ability of the adjacent Dmprot2 5’UTR, to mediate appropriate 
translational delay. It was additionally possible that the Dmprot2 5’UTR was not 
functional in Medfly. Clearly, a redesign of this system would be preferable, to facilitate 
a male mating phenotype similar to WT.  
3.7 Establishment and Mendelian assessment of transgenic OX5036 lines 
 OX5036 (tetO21-Dmprot2 ORF[no introns]-SG4 linker-FokI; 
Ccβ2tubulin[short]-Cchsp83-tTAV-T2A-nls-zsGreen-nls) was primarily evaluated to 
test the feasibility of a new sperm marking design, as a penetrant and repressible male 
sterility effector had been previously described (OX4353/4718). The alterations made to 
the male sterility effector (Dmprot2 ORF[no introns]-SG4 linker-FokI), relative to the 
previous design (OX4718) were: the removal of introns from Dmprot2, alterations to 
the C-terminal end of Dmprot2, and the addition of an SG4 linker between Dmprot2 and 
FokI (outlined fully in Section 3.2). These were considered to possibly enhance the 
penetrance of sterility; a complete lack of embryonic hatching would have been 
preferable. The tetracycline-repressible transcriptional regulator was altered to include a 
linked fluorescent sperm marking system (tetO21-Ccβ2tubulin promoter[short]-
Cchsp83-tTAV-T2A-nls-zsGreen-nls).  
 Microinjection and backcrossing to WT (Tables 3.5-3.6) were performed as 
described in Chapter 2. Buffered injection mixes were prepared with piggyBac helper 
transposase plasmid OX3022 (300 ng/μl) and OX5036 (600 ng/μl). Successful 
microinjection was confirmed by transient expression of the AlMAct-dsRed2 
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transformation marker. The adult survival rate (46%) was higher than the average rate 
for Medfly microinjections at Oxitec (25%) (Gregory et al., 2016). Fourteen lines were 
generated. Ten were assessed for penetrance of the male sterility phenotype (egg hatch 
assay). The three most penetrant lines and an impenetrant line were assessed for 
fluorescent sperm marking in the male germline (fluorescence microscopy). Mendelian 
properties of each insertion were assessed by marker inheritance in G2 progeny, as 
described previously (Table 3.7). A single insertion provides a 1:1 ratio of transgenic to 
WT progeny. Crosses of a male transgenic individual with a single insertion will yield 
male-only transgenic progeny if Y-linked, and female-only transgenic progeny if X-
linked.  
Table 3.5: Microinjection logistics for OX5036  
Embryos Larvae Pupae Adults Lines 
1186 545 (46%) 433 (37%) 391 (33%) 14 (3.6%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed).  
Table 3.6: G0 backcrosses to establish OX5036 lines 
Underlined pools yielded transgenics. Transgenic lines were established from a single individual and 
assessed from OX5036A, K, M, O, S, V,Y, AC, AD & AG.  
  
OX5036A 19 ♀ x 19 WT ♂  OX5036B 10 ♂ x 30 WT ♀  OX5036C 10 ♂ x 30 WT ♀ 
OX5036D 11 ♂ x 30 WT ♀ OX5036E 10 ♀ x 10 WT ♂  OX5036F 10 ♀ x 10 WT ♂  
OX5036G 10 ♂ x 30 WT ♀ OX5036H 10 ♀ x 10 WT ♂  OX5036I 10 ♂ x 30 WT ♀ 
OX5036J 10 ♂ x 30 WT ♀ OX5036K 10 ♀ x 10 WT ♂  OX5036L 10 ♂ x 30 WT ♀ 
OX5036M 10 ♂ x 30 WT ♀ OX5036N 10 ♀ x 10 WT ♂  OX5036O 6 ♀ x 6 WT ♂  
OX5036P 10 ♀ x 10 WT ♂  OX5036Q 7 ♂ x 30 WT ♀ OX5036R 10 ♂ x 30 WT ♀ 
OX5036S 11 ♂ x 30 WT ♀ OX5036T 10 ♂ x 30 WT ♀ OX5036U 20 ♀ x 20 WT ♂  
OX5036V 20 ♀ x 20 WT ♂  OX5036W 7 ♀ x 7 WT ♂  OX5036X 10 ♂ x 30 WT ♀ 
OX5036Y 20 ♀ x 10 WT ♂  OX5036Z 10 ♂ x 30 WT ♀ OX5036AA 4 ♂ x 12 WT ♀ 
OX5036AB 4 ♀ x 4 WT ♂  OX5036AC 20 ♀ x 10 WT ♂  OX5036AD 20 ♀ x 10 WT ♂  
OX5036AE 12 ♀ x 10 WT ♂  OX5036AF 11 ♂ x 30 WT ♀ OX5036AG 13 ♂ x 30 WT ♀ 
OX5036AH 10 ♂ x 30 WT ♀ OX5036AI 11 ♂ x 30 WT ♀   
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Table 3.7: Mendelian analysis of OX5036 transgenic lines  
Line Sex Copy number  Sex-linkage 
Summary Penetrance 
  
Transgenic (%) 
n Sex ratio (M/F) 
n Copies Location  
OX5036V ♂ 53.2 
139 
1.1 65 
1 Autosome 95% 
OX5036S ♂ 58.8 
136 
0.7 75 
1 Autosome 92% 
OX5036O ♂ 48.9 
399 
0.8 168 
1 Autosome 91% 
OX5036A ♂ 57.5 
120 
1.0 120 
1 Autosome 89%  
OX5036K ♂ 51.4 
109 
1.4 40 
1 Autosome 88% 
OX5036M ♂ 48.1 
79 
1.3 35 
1 Autosome 86% 
OX5036Y ♂ 51.5 
299 
1.0 131 
1 Autosome 77% 
OX5036AD ♂ 50.0 
34 
0.7 15 
1 Autosome 29% 
OX5036AC ♂ 50.2 
243 
Female only 118 
1 X 0% 
OX5036AG ♂ 60.3 
179 
Male only 105 
1 Y 0% 
All lines were single insertions. OX5036AC was X-linked and OX5036AG was Y-linked. All other 
insertions appeared to be autosomal. Penetrance and repressibility of the male sterility phenotype were 
assessed in the subsequent section. “n”: number of individuals assessed. 
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3.8 OX5036 heterozygous lines demonstrate reduced penetrance of male sterility, 
relative to prior constructs (OX4718 & OX4353)  
 Penetrance was investigated by egg hatch assay, essentially as previously 
described for OX4718 (Section 3.3). However, to identify highly penetrant lines for 
further study, the initial screen was performed with off-tet reared males only (we 
investigated the penetrance of sterility, but not repressibility). It was not subsequently 
necessary to investigate repressibility (by repeating the egg hatch assay with off-tet and 
on-tet reared males), because none of the lines demonstrated adequate penetrance. 
Twenty-five heterozygous OX5036 males reared off-tet [NT] were crossed to fifty 
WT[NT] females. The control was an equivalent cross with WT[NT] males and 
WT[NT] females. On day 4, three collections of 150-300 eggs (< 24 hours old) were 
taken from a 24 hour collection of the same cage (pseudo-replication). Eggs were left to 
hatch in a humid chamber as previously described. Hatch rate was scored on day 8.  
 Penetrance of the male sterility phenotype was highly insertion sensitive (Table 
3.8, Table 3.9, Figure 3.9), varying widely across lines (0-95%). Interestingly, the only 
two completely impenetrant lines (OX5036AC & AG) were sex-linked. An insertion 
equally penetrant to OX4718A-resolved (98%) was not identified, despite screening 8 
lines where the sterility effector was clearly expressed (reduction in egg hatch rate 
observed). OX5036V was the most penetrant line tested (95%). The extent of 
penetrance was deemed to be insufficient for commercial use, as the release of partially 
fertile transgenic males into the wild is contentious from a regulatory and practical 
perspective. It was found that two non-sterile transgenic lines (OX5036AC & AG) 
demonstrated significantly higher hatch rates than WT; there is no reasonable biological 
basis for this effect. For this reason, significance analysis of the differences in hatch rate 
between lines should be interpreted with caution (Table 3.8), even though the 
differences in hatch rates observed for replicates of the same line were not generally 
statistically significant (Table 3.9). Comparing the WT hatch rates (56%) observed in 
this study to those of other equivalent studies (70%-95%), suggested that the conditions 
in the hatching chambers were not ideal (Bilski, 2012), (Asadi, 2013). The results 
therefore indicated that penetrance was probably overestimated (because the hatching 
conditions used in the assay reduced the viability of eggs, relative to perfect conditions). 
Colleagues experienced in the assay suggested that the hatching chambers may have 
been maintained in an overmoistened state. In future experiments, we attempted to 
improve the method by more carefully checking the humidity of the chambers.   
CONFIDENTIAL  Chapter 3 – Fluorescent sperm marking and Dmprot2-FokI mediated sterility 
 
110 
Table 3.8 Penetrance and repressibility of male sterility in OX5036  
Line Mean hatch rate (± SE) Penetrance 
 NT % X2 P[df] 
5036V  2.6 ± 0.6 95 573.1 < 0.001[1] 
5036S  4.4 ± 0.7 92 509.6 < 0.001[1] 
5036O  4.8 ± 0.8 91 485.1 < 0.001[1] 
5036A  6.2 ± 0.8 89 485.5 < 0.001[1] 
5036K  6.5 ± 0.9 89 460.6 < 0.001[1] 
5036M  7.8 ± 1.0 86 416.0 < 0.001[1] 
5036Y  12.7 ± 1.2 77 331.4 < 0.001[1] 
5036AD  39.9 ± 1.9 29 38.5 < 0.001[1] 
5036AC  62.7 ± 1.7 0 7.3 0.006[1] 
5036AG  68.8 ± 1.6 0 27.2 < 0.001[1] 
WT  56.1 ± 1.8    
Penetrance was calculated relative to the control hatch rate, WT [NT]. Significance values were from chi-
square tests of the numbers of hatched and unhatched eggs, relative to the respective values for the 
control (WT[NT]). SE: standard error. Df: degrees of freedom.  
 
Table 3.9 Biological variation in the OX5036 egg hatch assay  
Line Hatch rate (%), NT Significance 
 R1 R2 R3 X2 P[df] 
5036V  3.3  2.2 2.0 1.1 0.59[2] 
5036S  5.0 4.4 3.9 0.37 0.83[2] 
5036O  5.6 5.5 3.2 2.0 0.37[2] 
5036A  8.2 5.8 4.8 3.1 0.22[2] 
5036K  9.9 4.8 4.6 8.21 0.02[2] 
5036M  10.2  7.3 6.1 3.15 0.21[2] 
5036Y  13.5  13.1 11.6 0.51 0.78[2] 
5036AD  45.1 41.0  35.9 3.7 0.16[2] 
WT  58.5 57.4 52.0 2.4 0.30[2] 
5036AC  65.4 62.0 60.4 1.6 0.46[2] 
5036AG  69.6   69.0 67.9 0.2 0.90[2] 
Replicate is abbreviated as “R”. Significant variation was assessed by chi-square testing the number of 
hatched and unhatched eggs, between the three replicate values for each group; it was only detected for 
OX5036K.  
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 These results indicated that changes made to the Dmprot2-FokI effector were 
responsible for reducing penetrance. The removal of mCherry from the effector was not 
considered likely to be responsible, as a marker-free effector (OX4353) of similar 
construction routinely demonstrated highly or fully penetrant insertions. We therefore 
compared the architecture of the tetracycline-repressible transcriptional activators and 
the male sterility effectors of OX4353 and OX5036 (Figure 3.10). The presence of 
seven additional copies of tetO (tetO14  tetO21) should not have altered the 
phenotype. If anything, it was predicted to make expression stronger because OX4353 
was fully penetrant with fewer copies of tetO. The 3’UTR substitution (SV40  
Cchsp83) in the tetracycline-repressible transcriptional activator is very unlikely to have 
been responsible, because OX4718A demonstrated a fully penetrant and repressible 
phenotype with this 3’UTR. Additionally, it was unlikely that the removal of Dmprot2 
introns from the open reading frame would reduce transcription, because intron-
containing genes expressed in the male germline are frequently transcribed to a lesser 
extent (White-Cooper and Caporilli, 2013). Alterations made to the C-terminal region of 
the Dmprot2 coding sequence may have had an effect. In OX5036, the full wildtype 
sequence was used; in OX4353, the C-terminal lysine was removed and there were 
three residues (TMA) immediately preceding the fusion to FokI; these were absent in 
OX5036. However, we considered that the inclusion of SG4 linkers between Dmprot2 
and FokI was the most likely factor, because their inclusion between mCherry-Dmprot2 
and FokI (SG4 linker-mCherry-Dmprot2-SG4 linker-FokI) reduced the penetrance of 
male sterility in OX4801 (Asadi, 2013). Therefore, we eschewed the use of linker 
sequences in subsequent product design.  
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3.9 The fluorescent sperm marking system in OX5036 is not functional 
 Despite demonstrating an unacceptably impenetrant male sterility phenotype, it 
remained possible that the OX5036 sperm marking system could be applied in future 
research and development (a reliable system had not been identified yet). We therefore 
assessed the three most penetrant lines (OX5036V, S & A) and an impenetrant line 
(OX5036AG) for fluorescent marker expression in the male germline, on- and off-tet. 
This analysis was essentially as described for OX4718A. Virgin OX5036 and WT 
males reared off-tet or on-tet were aged for 5 days. Dissection was performed on at least 
10 males per line and imaged by fluorescence microscopy at Cardiff University. The 
20x, rather than 40x, objective was used (to gather a larger number of spermatocytes, 
spermatids and sperm in the same image). Fluorescence intensity was inferior to 
OX4718A and reliably present in spermatocytes only (Figure 3.11). As expected, the 
brightness correlated with penetrance of male sterility (OX5036V, the most penetrant 
line, was brightest). Although the fluorescent sperm marking system was not suitable, 
analysis of reporter translation provided interesting mechanistic insights into the 
expression dynamics of its regulator (the tetracycline-repressible transcriptional 
activator: tetO21-Ccβ2tubulin [short]-Cchsp83-tTAV-T2A-nls-zsGreen-nls).  
 
 Fluorescent marking was visible in spermatocyte nuclei of penetrant lines 
(OX5036V, S & A). Spermatocytes were marked to a greater extent in the most 
penetrant line (OX5036V), suggesting that early accumulation of the transcriptional 
activator (tTAV) is associated with penetrant sterility, as expected. Furthermore, it 
suggests that the insertion sensitivity of the chimeric Ccβ2tubulin[short]-Cchsp83 
fragment is an important factor in determining the penetrance of a given transgenic 
insertion. Not all spermatocytes were marked; this may explain why a minority of 
sperm escape the sterilising effect of the system. Marker expression in spermatids and 
sperm was only clearly visible in OX5036V, consistent with its highly penetrant sterile 
phenotype. Fluorescent marker expression was almost completely repressed by 
tetracycline in all lines, suggesting that basal germline expression of tTAV is low, as 
desired, at least in the male germline (preventing leakiness). It is not possible to directly 
infer the extent of expression of the male sterility effector (Dmprot2-FokI), as it was not 
associated with a fluorescent reporter. It would be interesting to investigate the 
relationship between tTAV and effector (Dmprot2-FokI) expression with a construct 
applying a secondary reporter (Dmprot2-mCherry). Because fluorescent sperm marking 
in OX5036 strains is weaker relative to strains expressing a protamine-marker fusion 
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(eg. OX4718), it appears that fusion to protamine or another DNA-binding protein is 
required for adequate fluorescent sperm marking.  
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3.10 Conclusions 
 The primary objective of this study was to identify expression systems to 
suitably express effectors for fluorescent sperm marking and repressible male sterility. 
It was desirable to engineer systems that would minimally affect male reproductive 
competitiveness, in all aspects except the ability to support embryonic development. 
This was an important consideration, because it had been demonstrated that sterile 
males applied in prior mass release programmes were adversely affected by irradiation, 
which limited their ability to mate females in the field (Shelly et al., 1994), (Alphey, 
2006). Specifically, it was highly preferable that sperm expressing protamine-FokI 
would retain the ability to be normally transferred to the spermathecae and fertilisation 
chamber, and thereafter enter the embryo. This would be expected to provide the cues 
associated with a typical fertile mating, lowering the probability of further re-mating 
with fertile, wild males (Mossinson and Yuval, 2003).  
 To this end, we evaluated two constructs (OX4718 & OX5036). In OX4718, the 
repressible male sterility effector was fused to mCherry, as a single molecule system for 
sterility and fluorescent sperm marking (tetO21-Dmhsp70 minipromoter-Dmprot2-
mCherry-FokI). A variant of this effector that did not incorporate an mCherry marker 
(OX4353: tetO21-Dmhsp70 minipromoter-Dmprot2-FokI) had previously mediated 
penetrant and repressible male sterility in Medfly (Asadi, 2013). The sterility effector in 
OX5036 was, similarly, not associated with mCherry. Further changes were made to the 
male sterility system of OX5036 (tetO21-Dmhsp70 minipromoter-Dmprot2[no introns]-
SG4-FokI), in an attempt to improve penetrance of male sterility. Introns are associated 
with reduced expression in some male germline genes (White-Cooper and Caporilli, 
2013). Therefore, their removal from Dmprot2 could potentially enhance expression. 
The C-terminal end of Dmprot2 was also altered slightly relative to prior constructs and 
an SG4 linker sequence was added (Dmprot2-SG4-FokI), as previously described. 
Finally, the tetracycline-repressible enhancer regulating the effector in OX5036 was 
altered to include a linked fluorescent sperm marker (tTAV-T2A-nls-zsGreen-nls). 
tTAV and nls-zsGreen-nls were translated from the same mRNA as two polypeptides, 
and separated at the T2A sequence. 
 Sterility was penetrant and fully repressible in OX4718A, although the 
fluorescent sperm marker performed poorly (it did not localise to the majority of sperm 
nuclei). OX4718A-resolved males demonstrated a highly competitive phenotype in lab-
scale mating competition assays; WT females demonstrated no significant preference 
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for WT males or OX4718A-resolved males. It should be noted, however, that the 
mating behaviour of Medfly reared in the lab is not an accurate indication of the wild 
equivalent (Liimatainen et al., 1997), (Briceño and Eberhard, 1998). Furthermore, the 
conditions of the assay are highly artificial. For instance, flies are assayed at a high 
population density, which is associated with a greater rate of re-mating (Shelly et al., 
2004). Furthermore, the use of wild-type males as competitors (rather than wild-caught 
males) will tend to overestimate the competitiveness of the sterile line, because the 
wild-type strain is more likely to demonstrate lab adapted behaviour and the equivalent 
reductions in fitness associated with lab colonisation and rearing (Liimatainen et al., 
1997). In greenhouse trials that simulate field conditions more accurately, it has been 
shown that strains which previously appeared to have no defects in competitiveness (as 
indicated in lab-scale assays), are substantially less able to compete for mates than their 
wild counterparts (Martha Koukidou, personal correspondence). Although it is known 
that the genetic changes associated with lab adaptation can reduce mating 
competitiveness or alter mating behaviour (Blay and Yuval, 1997), (Alphey, 2006); 
sterilisation by irradiation is directly associated with reductions in male competitiveness 
and sperm transfer, which we attempted to avoid by selective expression of protamine-
FokI in the male germline. 
 
  Despite this attempt, dissection of WT females mated to OX4718A-resolved 
males demonstrated that expression of Dmprot2-mCherry-FokI was associated with a 
reduction in the number of sperm transferred, in most instances. The sperm present 
frequently demonstrated an unusual, uncurled morphology and were often immotile, 
indicating that the sperm were weakened or dead. We also noticed that sperm were 
prone to becoming trapped in the oviduct, consistent with a reduction in fitness. This 
failure to behave normally in the female reproductive tract may indicate that the primary 
factor mediating sterility in the system is not a result of paternal effect lethality, but 
rather a lack of sperm transfer, and of fertilisation itself. An investigation of effector 
localisation (tetO21-Dmprot2-mCherry-FokI) by fluorescence microscopy provided 
limited explanation of this effect. Reporter expression was observed in spermatids and 
sperm, as intended, but also spermatocytes. The theoretically perfect system would 
demonstrate substantially later translation (ie. not in spermatocytes), to minimise the 
possibility of negative effects on sperm production, motility and morphology. OX4718 
contains a partial Dmhsp70 5’UTR, immediately preceding the Dmprot2 5’UTR 
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(tetO21-Dmhsp70 minipromoter[+89 bp 5’UTR]-Dmprot2 5’UTR). This may act to 
enhance early translation (as observed when the Ccβ2tubulin 5’UTR was truncated and 
stitched to Cchsp83 minipromoter-5’UTR in OX4282), or prevent a translational delay 
mediated by Dmprot2 5’UTR. It was additionally possible that the Dmprot2 5’UTR is 
not sufficient to mediate an equivalent translational delay in the male germline of 
Medfly, as it does in D. melanogaster (Jayaramaiah Raja and Renkawitz-Pohl, 2005). 
 Variations in the intensity of fluorescent marker localisation (tetO21-Dmprot2-
mCherry-FokI) in sperm of OX4718A-resolved indicated that expression levels of the 
effector in sperm are not perfectly uniform. This was corroborated by the observation 
that only a small minority of sperm are motile, and that a small number of sperm are 
able retain a genome sufficiently intact to allow hatching of the fertilised embryo (1% 
hatch rate). The observation that sperm transfer to some females was essentially zero 
indicated that in many instances, the dominant mode of sterility was not paternal effect 
lethality as anticipated, but rather a lack of fertilisation. This appeared to be mediated in 
some instances by a severe deficiency in sperm transfer, and in other instances by poor 
motility of the transferred sperm. This is significant, because there is an inverse 
relationship between the number of sperm transferred and the tendency to re-mate in 
Medfly (Mossinson and Yuval, 2003). Therefore, transfer of sperm is essential; but 
transfer of weakened sperm in adequate quantities might be expected to induce female 
refractoriness to re-mating, at least partially. It would be interesting to further 
investigate the proportion of embryos that demonstrate a paternal effect lethal 
phenotype, for instance by visualizing embryonic development with nuclear staining. 
An assay based on staining was later developed and successfully applied to investigate 
the effect of protamine-FokI expression on embryos fertilised with sperm of transgenic 
lines (Section 5.2.6).  
 In contrast to OX4718A, the OX5036 male sterility effector was associated with 
a systematic reduction in the penetrance of sterility (no lines were more than 96% 
penetrant). A highly similar construct was previously shown to mediate highly penetrant 
sterility (OX4353; two of four lines were > 99% penetrant). Comparison of the OX4353 
and OX5036 effectors indicated that either the inclusion of the SG4 linker was 
responsible, or sequence changes to the C-terminal end of Dmprot2 (OX5036 included 
the full Dmprot2 sequence and a TMA tripeptide not associated with Dmprot2 was 
removed; in OX4353, the C-terminal lysine of Dmprot2 was removed and the TMA 
tripeptide included). However, it could not be excluded that the removal of Dmprot2 
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introns or the inclusion of a T2A-nls-zsGreen-nls fragment associated with the 
tetracycline-repressible transcriptional activator (tTAV) were responsible. Therefore, 
we decided to use a version of the Dmprot2-FokI effector more similar to that of 
OX4353, in future applications (Chapter 5). 
 In terms of fluorescent sperm marking, neither system (OX4718 or OX5036) 
was suitable for purpose. We observed weak fluorescence in most spermatids of 
OX4718A-resolved males (Dmprot2-mCherry-FokI), but it was not possible to reliably 
identify fluorescently labelled sperm, post-individualisation. This was not surprising, as 
an equivalent olive fly construct (OX4705: tetO21-Dmprot2-mCherry-FokI) 
demonstrated no marking (Asadi, 2013). The OX5036 system (Ccβ2tubulin[short]-
Cchsp83-tTAV-T2A-nls-zsGreen-nls), in which the fluorescent marker protein was 
translated from the same mRNA as tTAV, was essentially invisible in most sperm. It 
was therefore necessary to design an entirely new fluorescent sperm marking system, 
ideally constitutively expressed, and not associated with the male sterility effector or 
tetracycline-repressible transcriptional activator. Furthermore, it was necessary to 
characterise a repressible male sterility effector with later translation. This was 
anticipated to require removal of the Dmhsp70 5’UTR and incorporation of a 5’UTR 
capable of imposing the appropriate translational delay. To achieve these aims, we 
selected systems based on two protamine-like genes of Medfly (Ccprot1 and Ccprot2) 
and another protamine-like gene from D. melanogaster (Dmprot1/Mst35Ba). As 
protamine-like genes are strongly and selectively localised to spermatids and sperm of 
D. melanogaster, this indicated that they could be applied for appropriate localisation of 
the male sterility and fluorescent sperm marking effectors in Medfly (Barckmann et al., 
2013). Reporter constructs for these systems are evaluated in the next chapter, where the 
Medfly protamine-like genes were confirmed to possess desirable patterns of expression 
to engineer transgenic effectors for repressible male sterility and fluorescent sperm 
marking. 
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Chapter 4 – Novel regulators for effectors of repressible male sterility and a 
fluorescent sperm marking system to monitor mating ability in the field  
 
4.1 Identification of protamine-like genes and expression construct design  
 The promoter, UTRs, and open reading frame of three protamine-like genes 
were selected as candidate regulatory systems of transgenic effectors in the male 
germline. Two sequences were selected from Medfly (Ccprot1 and Ccprot2) and one 
from D. melanogaster (Dmprot1). D. melanogaster protamine-like genes (Dmprot1 and 
Dmprot2) were identified from literature reports (Jayaramaiah Raja and Renkawitz-
Pohl, 2005), (Tirmarche et al., 2014). Notably, Dmprot2 protein (almost identical to 
Dmprot1) was previously tested in OX4353, OX4718 and OX5036, with a different 
conformation (under transcriptional regulation of the tetracycline-repressible male 
germline expression system [tetO21-Dmhsp70 minipromoter-Dmprot2-FokI], rather 
than the protamine promoter. The protamine family is rapidly diverging, despite a high 
degree of functional conservation and an important role in male sexual development 
(Queralt et al., 1995), (Braun, 2001). As previously discussed (Section 1.4.2.2), they are 
typically small, basic, positively charged and contain high-mobility group (HMG) box 
motifs for DNA binding; this facilitated computational identification of Medfly 
protamine-like genes (Ccprot1 and Ccprot2) by Tarig Dafa’alla (Figure 4.1). A 
similarity index was calculated between sequences of interest, as the ratio of conserved 
residues (identical or conservative substitutions) to the mean number of residues. As 
expected, Medfly protamine-like genes were not very similar to D. melanogaster; the 
species diverged about 100 million years ago (Wulbeck and Simpson, 2000). 
Conservation was mostly limited to the DNA-binding domains (HMG motifs) and C-
termini. 
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 We thereafter tested the ability of regulatory systems based on Ccprot1, Ccprot2 
and Dmprot1 to localise expression of a fluorescent reporter (zsGreen or mCherry) to 
the male germline (Figure 4.2): the zsGreen or mCherry ORF was cloned as a C-
terminal fusion with the protamine ORF, to reveal protein production and localisation 
(protamine promoter-protamine 5’UTR-protamine ORF-zsGreen/mCherry-protamine 
3’UTR). The Ccprot1 and Ccprot2 ORFs incorporated the native introns; they were 
removed in Dmprot1. The ideal phenotype would demonstrate reproducible expression 
(not insertion sensitive) of the fluorescent reporter, with robust localisation to the 
nucleus of sperm and spermatids, but not spermatocytes. This would indicate that an 
element of the regulatory system mediated translational delay. The protamine-like genes 
of D. melanogaster are known to be translationally repressed by sequences within the 
5’UTR; it was therefore likely that Medfly protamine-like genes were equivalently 
regulated (Jayaramaiah Raja and Renkawitz-Pohl, 2005). As previously discussed, it 
would be preferable to delay the localisation of protamine-FokI to elongating 
spermatids; early translation would be anticipated to disrupt the meiotic divisions or 
cause significant defects in spermatid nuclear shaping, leading to failure of spermatid 
individualisation.  
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 It was also essential that there would be no effect on male mating 
competitiveness, associated with expression of the reporter in the male germline. 
Furthermore, the fluorescent marking system needed to be applicable to field study, 
demonstrating successful transfer of marked, motile sperm to females with detectable 
fluorescence persisting at least one week after death of the mated female (to assess 
mating competitiveness in the field). Functioning candidates were to be used in the 
design of a new generation of all-in-one constructs for repressible male sterility and 
fluorescent sperm marking. Modification of the protamine-reporter fragment would 
thereafter be required to generate a male sterility effector (Section 4.5).  
 
 
4.2 Evaluation of Ccprot1 (OX5122/OX5123), Ccprot2 (OX5150), and Dmprot1 
(OX5140) constructs expressing fluorescent reporters in the male germline 
 
4.2.1 Establishment of OX5122, OX5123, OX5140 and OX5150 transgenic lines 
 Microinjection (Table 4.1) and backcrossing to WT (Table 4.2) were performed 
as previously described (Chapter 2), using piggyBac helper OX3022 (300 ng/μl) and 
one of four expression constructs OX5122, OX5123, OX5140 or OX5150 (600 ng/μl). 
Each construct was injected independently. To verify successful microinjection, 
surviving G0 pupae were screened for transient expression of the AlMAct-dsRed2 
transformation marker. Adult survival was greater than the average rate for Medfly 
microinjections at Oxitec (25%), for OX5122 and OX5123, and less for OX5140 and 
OX5150 (Gregory et al., 2016). In general, four lines were kept for each construct for 
initial phenotypic analysis (three for OX5150; one line failed to propagate).  
 
 From each pool, one transgenic G1 male was outcrossed to three WT females 
and eggs collected five days later to establish a transgenic line. As previously described, 
each line was assessed for Mendelian characteristics: insertion copy number (transgenic 
to wildtype ratio) and sex-linkage (sex distribution of transgenic progeny). In certain 
instances, surplus male transgenic G1 individuals were immediately dissected, to 
provide a preliminary analysis of the performance of the transgenic regulator one 
generation earlier (with the caveat that different insertions may have been assessed 
within each pool, because molecular genotyping of insertions was not performed on 
these individuals).  
 
Table 4.1: Microinjection logistics for OX5122, OX5123, OX5140 & OX5150 
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Construct Embryos Larvae Pupae Adults Lines 
OX5122 963 451 (47%) 350 (36%) 348 (36%) 11 (3%) 
OX5123 766 376 (49%) 318 (42%) 310 (40%) 17 (5%) 
OX5140 1339 398 (30%) 353 (26%) 232 (17%) 8 (3%) 
OX5150 466 111 (24%) 93 (20%) 79 (17%) 7 (9%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed).  
 
 
 
Table 4.2: G0 backcrosses to establish OX5122, OX5123, OX5140 & OX5150 lines 
Underlined pools yielded transgenics. Permanent transgenic lines were established from OX5122D, E, G, 
K & M; OX5123C, D, G, J & U; OX5140E, F, K, L; and OX5150B, F and H. Additional individuals 
were assessed at the G1 stage without molecular genotyping or the establishment of permanent lines, from 
pools OX5140E, F, K & L; and OX5150B, C, F & H. 
 
  
OX5122A 30 ♂ x 90 WT ♀ OX5122B 30 ♂ x 90 WT ♀ OX5122C 20 ♀ x 20 WT ♂ 
OX5122D 20 ♀ x 20 WT ♂ OX5122E 30 ♂ x 90 WT ♀ OX5122F 20 ♀ x 20 WT ♂ 
OX5122G 30 ♂ x 90 WT ♀ OX5122H 20 ♀ x 20 WT ♂ OX5122I 20 ♀ x 20 WT ♂ 
OX5122J 30 ♂ x 90 WT ♀ OX5122K 15 ♀ x 15 WT ♂ OX5122L 21 ♂ x 21 WT ♀ 
OX5122M 24 ♀ x 16 WT ♂ OX5122N 24 ♂ x 16 WT ♀ OX5122O 11 ♂ x 13 WT ♀ 
      
OX5123A 30 ♂ x 90 WT ♀ OX5123B 10 ♂ x 25 WT ♀  OX5123C 20 ♀ x 10 WT ♂ 
OX5123D 20 ♀ x 10 WT ♂ OX5123E 10 ♂ x 25 WT ♀  OX5123F 11 ♂ x 25 WT ♀  
OX5123G 10 ♂ x 25 WT ♀  OX5123H 10 ♂ x 25 WT ♀  OX5123I 10 ♂ x 25 WT ♀  
OX5123J 10 ♂ x 25 WT ♀  OX5123K 10 ♂ x 25 WT ♀  OX5123L 10 ♂ x 25 WT ♀  
OX5123M 10 ♂ x 25 WT ♀  OX5123N 10 ♂ x 25 WT ♀  OX5123O 10 ♂ x 25 WT ♀  
OX5123P 20 ♀ x 10 WT ♂ OX5123Q 20 ♀ x 10 WT ♂ OX5123R 20 ♀ x 10 WT ♂ 
OX5123S 20 ♀ x 10 WT ♂ OX5123T 20 ♀ x 10 WT ♂ OX5123U 14 ♀ x 10 WT ♂ 
OX5123V 8 ♂ x 7 ♀      
      
OX5140A 15 ♂ x 25 WT ♀ OX5140B 15 ♂ x 25 WT ♀ OX5140C 15 ♂ x 25 WT ♀ 
OX5140D 15 ♂ x 25 WT ♀ OX5140E 15 ♂ x 25 WT ♀ OX5140F 15 ♂ x 25 WT ♀ 
OX5140G 8 ♂ x 25 WT ♀ OX5140H 25 ♀ x 10 WT ♂ OX5140I 25 ♀ x 10 WT ♂ 
OX5140J 24 ♀ x 10 WT ♂ OX5140K 15 ♂ x 25 WT ♀  OX5140L 25 ♀ x 10 WT ♂ 
OX5140M 20 ♀ x 10 WT ♂     
      
OX5150A 8 ♀ x 8 WT ♂ OX5150B 10 ♀ x 10 WT ♂  OX5150C 10 ♀ x 10 WT ♂ 
OX5150D 10 ♀ x 10 WT ♂ OX5150E 10 ♂ x 30 WT ♀  OX5150F 10 ♂ x 30 WT ♀  
OX5150G 9 ♂ x 30 WT ♀  OX5150H 8 ♂ x 30 WT ♀    
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4.2.2 The Ccprot1 regulatory system successfully mediates zsGreen (OX5122) or 
mCherry (OX5123) expression in the male germline 
 The fluorescent proteins zsGreen (OX5122) and mCherry (OX5123) were 
evaluated under regulatory control of an identical Ccprot1 system (Ccprot1 promoter-
Ccprot1 5’UTR-Ccprot1 ORF-zsGreen/mCherry-Ccprot1 3’UTR) to determine which 
reporter provided the strongest sperm marking. Five stable lines were established for 
each construct (Table 4.3).  
 
Table 4.3: Mendelian analysis of OX5122 and OX5123 transgenic lines  
Line Sex Copy number Sex-linkage 
Summary Fluorescence in 
testes 
  
Transgenic 
(%) n 
Sex ratio 
(M/F) 
n Copies Location  
OX5122D ♂ 54 353 1.3 177 
1 Autosome Yes 
OX5122E ♂ 49 255 1.2 101 
1 Autosome Yes 
OX5122G ♂ 54 229 1.7 101 
1 Autosome Yes  
OX5122K ♂ 60 125 1.1 51 
1 Autosome Yes 
OX5122M ♂ 48 182 2.1 66 
1 Autosome Yes 
OX5123C ♂ 51 227 0.6 94 
1 Autosome Yes 
OX5123D ♂ 50 304 1.5 131 
1 Autosome Yes 
OX5123U ♂ 77 220 1.0 143 
2 Autosome Yes 
OX5123G ♂ 74 257 2.0 163 
2 Autosome No 
OX5123J ♂ 78 300 2.4 176 
2 Autosome No 
All lines except OX5123G, U and J appear to be double insertions. At least one of the insertions of 
OX5123G, U and J appear to be autosomal. All other lines were single, autosomal insertions. “N” refers 
to number screened. Localisation of the fluorescent reporter in testes was assessed in the subsequent 
sections. 
 
Heterozygous G2 OX5122 (Ccprot1-zsGreen) and OX5123 (Ccprot1-mCherry) 
males (n=20) were collected on eclosion. Strong fluorescence was seen in spermatids 
and sperm, but not spermatocytes, of all OX5122 lines and 3/5 OX5123 heterozygous 
lines (Figure 4.3).  
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 This indicated post-meiotic translation consistent with the desired expression 
profile; the nuclear localisation of the marker was also ideal. Marking in OX5122 
(Ccprot1-zsGreen) lines appeared less sensitive to insertion site: all five OX5122 lines 
were brightly marked, but two of five OX5123 lines were not visibly marked. We 
therefore concluded that Ccprot1 is a strong candidate system to regulate effectors of 
repressible male sterility; and that the Ccprot1-zsGreen fluorescent sperm marking 
system (OX5122) outperformed the Ccprot1-mCherry system (OX5123). As the 
Ccprot1 system was to be applied extensively in future product candidates, we decided 
to investigate potential effects on mating competitiveness and fluorescent marker 
persistence in sperm transferred to mated females. These results are presented (Section 
4.3), after the assessments of fluorescent reporter localisation in the other systems 
(OX5150 [Ccprot2-zsGreen] and OX5140 [Dmprot1-zsGreen]). 
 
4.2.3 The Ccprot2 regulatory system (OX5150) successfully mediates zsGreen 
expression in the male germline 
 The ability of the Ccprot1 regulatory system (OX5122/5123) to localise a 
protamine-reporter fusion in the male germline, led us to expect a similar result for 
Ccprot2 (OX5150), because the D. melanogaster homologues have overlapping 
expression and function (Jayaramaiah Raja and Renkawitz-Pohl, 2005). The construct 
was evaluated essentially as described for OX5122, with exceptions noted below. 
Transgenic lines were established from single G1 individuals of three of four pools 
(OX5150B, F and H; OX5150C died pre-establishment). The remaining male transgenic 
G1 individuals (n = 21) from these four pools were immediately dissected (without 
establishing lines), as a preliminary analysis of performance of the Ccprot2-zsGreen 
system (with the caveat that individuals of the same pool were likely to demonstrate the 
same insertion, in some instances). No fluorescence was observed in the testes of most 
individuals (16/21). Results are summarised in Table 4.4 and Figure 4.4.  
 
Table 4.4: Ccprot2-zsGreen expression in transgenic OX5150 G1 males  
Pool Individuals expressing Ccprot2-zsGreen in testes Conclusion 
OX5150B 2/5 ≥ 2 lines assessed 
OX5150C 2/3 ≥ 2 lines assessed 
OX5150F 1/10 ≥ 2 lines assessed 
OX5150H 0/3 ≥ 1 lines assessed 
Summary  5/21 ≥ 7 lines assessed 
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 The remaining individuals (5/21) demonstrated bright fluorescence in their 
testes, which did not appear noticeably different to Ccprot1-zsGreen (OX5122). Three 
of four pools (OX5150B, C, F) included males with and without fluorescent reporter 
localisation in testes; all individuals of OX5150H (n=3) lacked visible fluorescence. As 
molecular genotyping was not performed, it was not possible to determine if individuals 
of the same pool that demonstrated equivalent phenotypes, shared the same insertion. 
Therefore, it appears that at least two independent insertions were assessed from 
OX5150B, C & F (reporter localisation observed in certain, but not all, individuals); and 
at least one from OX5150H (reporter localisation not observed in any individuals). This 
assumes that a particular insertion results in a similar phenotype across all individuals, 
which was observed for all ten OX5122/OX5123 lines.   
 
 The established transgenic lines (OX5150B3, OX5150F3 & OX5150H2) were 
all single insertions (Table 4.5); two were y-linked and one was autosomal. OX5150C3 
failed to propagate. These were assessed in a similar manner to OX5122, but scored for 
germline fluorescence on the Oxitec imaging setup at 10x magnification. It was not 
equipped with a camera at this stage, so imaging was not possible. The observed 
phenotype was consistent across all individuals of a particular line. zsGreen did not 
localise to the germline for individuals of two lines (OX5150F3 & H2); localisation was 
observed in individuals of one line (OX5150B3). This analysis did not provide further 
information regarding the functionality of Ccprot2-zsGreen, because negative 
individuals had already been identified from OX5150F and OX5150H transgenic pools, 
and positive individuals from OX5150B, in the prior generation. As these previously 
noted phenotypes were not linked to a particular insertion, it is likely that OX5150B3, 
F3 and H2 were equivalent respectively to OX5150B1, F2 and H1. It was not deemed 
necessary to repeat the experiment to obtain images for these three redundant 
phenotypes. 
Table 4.5: Mendelian analysis of OX5150 transgenic lines 
Line Sex Copy number  Sex-linkage 
 
Summary 
Fluorescence in 
testes 
  
Transgenic 
(%) n 
Sexes 
observed 
n Copies Location  
OX5150B3 ♂ 44 90 Both 
> 
20 
1 Autosome Yes 
OX5150F3 ♂ 50 167 Male-only 
> 
20 
1 Y No 
OX5150H2 ♂ 50 72 Male-only 
> 
20 
1 Y No 
All lines are single insertions. OX5150F3 and H3 are Y-linked, which is likely to have explained why 
fluorescent reporter expression was not observed. “N” refers to number screened.  
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 That we frequently observed a lack of fluorescence in the male germline of 
OX5150 individuals, indicated that the Ccprot2 (OX5150) promoter fragment was 
potentially more insertion-site sensitive than the Ccprot1 equivalent 
(OX5122/OX5123), where strong expression was observed in eight of ten autosomal 
insertions. However, both of the negative lines that were genotyped for insertion were 
y-linked (OX5150F3 and H2). This site is not typically favourable for male germline 
expression; we observed weak expression of transgenic effectors in the male germline, 
for y-linked insertions of other expression constructs (OX5036: Section 3.7; OX5257: 
Section 5.5). Individuals lacking fluorescent protein expression in testes, were observed 
during dissection of transgenic G1 individuals from all four pools (OX5150B, C, F & 
H), but these individuals were not genotyped for insertion site. In retrospect, a superior 
analysis could have been performed by backcrossing all G1 individuals, dissecting the 
testes after lines were established, and finally performing Mendelian analysis and 
further phenotypic assessment on those lines that demonstrated the phenotypes of 
interest.  
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4.2.4 The Dmprot1 regulatory system (OX5140) does not express zsGreen in the 
male germline despite detectable transcription 
 Analysis of OX5140 lines (Dmprot1-zsGreen) was essentially as described for 
OX5150. Transgenic lines were established from single individuals of four pools 
(OX5140E, F, K & L). As a preliminary analysis, testes of surplus male transgenic G1 
individuals (n=15) from these four pools, and three additional pools (OX5140B, H & I) 
were dissected (ie. at least seven insertions were assessed). Reporter expression was 
never detected, indicating that the Dmprot1 system (OX5140) would require 
modification to be developed into a useful expression system in Medfly. Although 
OX5140 appeared unsuitable for future use, it was necessary to exclude the possibility 
that poor expression resulted from insertion site (sex-linked insertions are frequently 
weak, as demonstrated in Section 4.2.3). It was also of interest, but not commercially 
essential, to investigate the source of failure; this would facilitate the future 
development of a modified, functional Dmprot1 system. We investigated four lines 
established from single individuals (OX5140E, F, K and L). All were single autosomal 
insertions (Table 4.6). Reporter expression in the male germline was assessed exactly 
as described for OX5122/OX5123 (ten pairs of testes dissected from each line at Cardiff 
University). Expression of the fluorescent reporter in testes was not observed in any of 
four lines (Figure 4.5), suggesting that lack of expression was not a consequence of 
insertion site, but rather was because of inherently poor performance of the construct. 
From these results, it was not possible to conclusively associate a lack of expression 
with the Dmprot1 promoter, untranslated regions or Dmprot1-zsGreen fusion.  
 
Table 4.6: Mendelian analysis of OX5140 transgenic lines 
Line Sex Copy number  Sex-linkage 
Summary Fluorescence in 
testes 
  
Transgenic 
(%) n 
Sexes 
observed 
n Copies Location  
OX5140E ♂ 46 362 Both 
> 
20 
1 Autosome No 
OX5140F ♂ 55 100 Both 
> 
20 
1 Autosome No 
OX5140K ♂ 50 254 Both 
> 
20 
1 Autosome No 
OX5140L ♂ 49 170 Both 
> 
20 
1 Autosome No 
All lines were single autosomal insertions. “N” refers to number screened. 
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 RT-PCR was used to test whether Dmprot1-zsGreen transcript was produced in 
the transgenic lines. Failure to detect transcript would implicate the promoter, whereas 
the presence of transcript would implicate either the untranslated regions or the 
Dmprot1-zsGreen fusion. RNA was extracted from a single pair of testes of five 
OX5140E individuals. The expression of Dmprot1-zsGreen and an endogenous control 
(adh) was assessed. It was not possible to design primers differentiating cDNA and 
gDNA for Dmprot1-zsGreen, because the Dmprot1 ORF lacked introns. However, 
controls lacking reverse transcriptase were used, to identify potential gDNA 
contamination. The RT-PCR revealed that the Dmprot1-zsGreen mRNA was present in 
OX5140E testes; therefore the Dmprot1 promoter is capable of driving expression of a 
transgene in the Medfly testis (Figure 4.6). It appeared that the failure to observe 
reporter translation was associated with the 5’UTR or the Dmprot1-zsGreen fusion. The 
3’UTR was excluded as a likely source of failure, because the Dmprot1 promoter-
5’UTR fragment is sufficient to recapitulate endogenous expression, if provided a 
minimal 3’UTR (Jayaramaiah Raja and Renkawitz-Pohl, 2005).  
 
 We next considered if the coding sequence of Dmprot1 was not sufficient to 
mediate reporter localisation. This was unlikely because it is essentially identical to the 
Dmprot2 protein (97% conserved), which was able to localise Dmprot2-mCherry-FokI 
to DNA, in the male germline (OX4718, Figure 3.5). However, the fusion of Dmprot1 
to ZsGreen may prevented its localisation to nuclear DNA; therefore it might not be 
detectable despite translation, because it was diffuse throughout the cell. It was 
alternatively possible that the fluorescence of zsGreen was blocked by the fusion. The 
Dmprot1-zsGreen fusion protein incorporated a short peptide (RYRST), preceding the 
fusion to zsGreen. It was not expected to have an effect, as it was present in Ccprot1-
zsGreen and Ccprot2-zsGreen, both of which demonstrated extremely bright fluorescent 
reporter localisation. Interestingly, the homologous Dmprot2 protein was previously 
shown to poorly tolerate certain C-terminal fusions of Dmprot2 to mCherry, even when 
a short linker tripeptide (TMA) was present. For instance, fluorescent marker 
localisation in sperm of OX4801 (tetO21-Dmprot2-SG4-mCherry-SG4-FokI) and 
OX4705/4718 (tetO21-Dmprot2-mCherry-FokI) lines was frequently weak or absent 
(Asadi, 2013), (Figure 3.3 & Figure 3.5). This suggests that the fusion is likely to be 
responsible for the poor translation of the fluorescent marker in the male germline, 
although it cannot be excluded that the Dmprot1 5’UTR does not mediate sufficient 
localisation in spermatids and sperm of Medfly. 
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4.3 The Ccprot1-zsGreen (OX5122) fluorescent sperm marking system can be used 
to monitor the mating ability of transgenic males in the field  
  
4.3.1 Ccprot1-zsGreen (OX5122) heterozygotes transfer fluorescently marked 
sperm and demonstrate mating competitiveness similar to WT  
 Functioning protamine-fluorescent marker fusions described in this chapter 
(OX5122, OX5123 or OX5150) were to be used without modification as fluorescent 
sperm marking systems, in future transgenic expression systems for commercial 
application in Medfly population control. For this reason, additional phenotypic aspects 
of the system that demonstrated best performance (OX5122 [Ccprot1-zsGreen]) were 
evaluated. We assessed four lines (OX5122D, G, K & M) for ability to transfer sperm, a 
crucial factor that was deficient in a previously characterised line that was otherwise 
promising as a commercial product (OX4718A, Figure 3.8). A single line (OX5122M) 
was subjected to further analysis (mating competitiveness, visibility of WT and 
transgenic sperm in a twice-mated female, and the persistence of the fluorescent sperm 
marker in females under field-like trapping conditions). The rationale was to gather 
CONFIDENTIAL   Chapter 4 – Novel regulators for male sterility and fluorescent sperm marking   
 
138 
evidence that transgenic males could compete with wild males. Future product 
candidates (transgenic lines incorporating independent systems for fluorescent sperm 
marking and repressible male sterility) will require thorough analysis, prior to 
application to appropriate regulatory bodies for permission to conduct field trials and 
eventual commercial releases. Therefore, this initial investigation was intentionally 
limited in scope. 
 
 To assess the mating competiveness of OX5122M heterozygous males, three 
genotypes were collected on eclosion and reared independently in small cages (n=25 per 
cage): wild-type males, wild-type females and OX5122M heterozygous males (all 
reared off-tet). Five days after eclosion, wild-type and transgenic males (n=50 each) 
were released into the same Bugdorm cage in the morning (08:00-09:00) and left for an 
hour to disperse and establish territory. Wild-type females (n=50) were then added to 
the cages. Mating pairs were captured in 30 ml universal tubes with airholes and 
removed from the cage. Pairs were checked every 10 minutes and mating duration 
recorded. For each mating pair, the genotype of the male was determined based on the 
DsRed2 fluorescence marker, and the Relative Sterility Index (RSI) calculated as the 
proportion of females paired with transgenic males relative to all mating events, as 
previously described (Cayol et al., 1999). 
 
 The experiment was performed in triplicate and statistical significance was 
assessed by correction-free chi-square testing of pooled data, after it was confirmed by 
chi-square testing that there was no significant variation between replicates, in terms of 
female mating preference (χ² = 0.1318, d.f. = 2, p = 0.93). After genotyping, males were 
removed from the vials and larval diet added for the female. Twenty females from each 
mating category were retained for two days, and then at least ten were dissected to 
assess the presence of sperm in the female genital tract. OX5122M heterozygous males 
did not vary significantly in mating competitiveness, relative to wild-type males (RSI = 
0.5, χ² = 1, d.f. = 1, p > 0.999, n = 136, Table 4.7). This indicates that, in the absence of 
defects caused by insertion site, expression of Ccprot1-zsGreen does not strongly 
impact on the ability of the heterozygous males to compete with wild-type males for 
mating events. There was a small, statistically significant difference in the mean mating 
duration (12 min) for WT (114 min) and OX5122M het males (126 min) when assessed 
by two sample t-test (t = -2.31, d.f. = 122, p = 0.022). This was no longer significant 
when replicates were assessed independently, which would control for handling 
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differences between the three people conducting the experiment (Ryan Turkel, Thea 
Marubbi and Charilaos Megas). Both mean durations of mating were less than the 
average for mass-reared WT males reported previously: 135 minutes (Shelly and 
Kennelly, 2002). The significance of this is considered subsequently (Section 4.3.3). 
The other OX5122 lines (OX5122D, K and G) were not assessed for mating 
competitiveness, but their ability to transfer marked sperm was considered. 
 
Table 4.7: Mating preference of WT females in OX5122M competition assay 
Replicate Transgenic WT Total RSI Unmated females 
1 25 (51%) 24 (49%) 49 0.51 1 (2%) 
2 22 (48%) 24 (52%) 46 0.48 4 (8%) 
3 21 (51%) 20 (49%) 41 0.51 9 (18%) 
Summary 68 (50%) 68 (50%) 136 0.50 14 (9%) 
The rate of mating refusal may have increased across replicates because tests were conducted 20-30 
minutes apart; the peak rate of Medfly mating is in the early morning and late afternoon.  
 
 To assess the possibility of insertion site dependent variation in phenotype, three 
additional OX5122 lines (OX5122D, G & K) were assessed for transfer of fluorescently 
marked sperm (Table 4.8). Two groups were collected on eclosion and reared 
independently in small cages (n=25 per cage): wild-type females and OX5122 
heterozygous males (all reared off-tet). As this test was not an assessment of mating 
competitiveness, WT males were not used. Wild-type females (n=25) were then added 
to the cages. A separate cage was used for each male genotype (OX5122D, G & K). 
Mating pairs were captured and confirmed to mate for at least one hour, prior to 
dissection. Control images (WT females mated to WT males) were shared with the 
previous experiment (OX5122M mating competitiveness), which was conducted one 
week previously. 
 
Table 4.8: Mating frequencies of WT females and males of OX5122D, K and G 
Line Mated Unmated Total 
OX5122D 22 (88%) 3 (12%) 25 
OX5122K 22 (88%) 3 (12%) 25 
OX5122G 21 (84%) 4 (16%) 25 
WT Images from the OX5122M competition assay were used 
 
 In terms of sperm transfer (assessed one to two days after mating), all females 
mated to OX5122 heterozygotes (OX5122D, G, K & M) had brightly marked green 
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fluorescent sperm in the spermathecae (Figure 4.7). The quantity, morphology and 
motility of sperm was not obviously different for females mated to OX5122 males 
relative to WT, although an exact comparison would require PCR analysis, 
quantification of fluorescence, or counting of serial dilutions of spermathecal extracts 
under high magnification. These results indicated that the Ccprot1-zsGreen sperm 
marking system was a strong candidate for future commercial use, as it performed well 
in all four insertions tested. However, it would be interesting to develop a more 
quantitative assay to detect sperm transfer, for future use. 
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4.3.2 Sperm of Ccprot1-zsGreen heterozygotes (OX5122M) remain visible after 
females are re-mated to WT males 
 It was previously shown that it was simple to differentiate between WT females 
mated once, to either OX5122M heterozygous males or WT males (Section 4.3.1), a 
key requirement for field application of the fluorescent sperm marking system. 
However, it had not yet been demonstrated that it was possible to identify WT females 
that had mated both a WT and OX5122 male. Species such as Medfly frequently accept 
second mates in the wild (Bonizzoni et al., 2002), (Kraaijeveld et al., 2005), which 
would reduce the suppressive ability of sterile male release, if females frequently re-
mated with fertile wild males. This effect is magnified by a last mate precedence of 
paternity: more than 50% of offspring are sired from the male mated most recently, 
though this precedence decreases with time (Bertin et al., 2010), (Scolari et al., 2014). 
Because males sterilised with irradiation are generally less competitive and less able to 
induce refractoriness to re-mating than their non-sterile counterparts (Hendrichs et al., 
2002), (Robinson et al., 2002), (Kraaijeveld and Chapman, 2004), it would be useful to 
investigate if the system for repressible male sterility developed in this study was 
associated with similar deficits.  
 
 We investigated the females' receptivity to mating with males of the opposite 
genotype to which they had already mated. The experiment would also indicate whether 
the transgene affected the males' ability or motivation to remate, though a full 
investigation of the effect of fluorescent sperm marker expression on re-mating 
tendency was outside the scope of this preliminary investigation. The analysis was 
performed with pairs captured in the prior mating competition experiment (OX5122M 
heterozygous: Section 4.3.1). We allowed the following four groups to recover 
overnight in small cages with fresh food and water, with 30 flies per cage: (1) wild-type 
males, (2) OX5122M heterozygous males, (3) wild-type females which had mated to 
wild-type males; and (4) wild-type females which had mated to OX5122M 
heterozygous males. The following morning, we set up two Bugdorm cages to facilitate 
re-mating with the opposite male genotype (Table 4.9). This experiment was similar to 
the mating competition study, with two exceptions: (1) males of only one genotype 
were used per group and (2) thirty males and thirty females were used per group. As 
before, males were allowed 1 hour to disperse prior to addition of females. Mating pairs 
were captured in 30 ml tubes, and the mating duration recorded. Males were removed, 
larval diet added to the tube and the female genital tract dissected one day later. 
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Females from the single mating experiment (Section 4.3.1) and this re-mating 
experiment, were dissected at the same time: at Cardiff University, as described 
previously.  
 
Table 4.9: Experimental groups of the OX5122M/WT re-mating study 
Group Male Female 
 Genotype Genotype Partner for first mating 
1 WT WT OX5122M 
2 OX5122M WT WT 
 
We were not attempting to robustly assess variances in re-mating tendency, but it was 
obvious that a substantial minority (about 23%) of the females chose to re-mate; this did 
not appear to vary with the genotype of the first mating partner (Table 4.10). We were 
able to collect 8 females mated to OX5122M then WT males; and 6 females of the 
reciprocal group. One female from each group died prior to dissection; these were 
discarded from the analysis. These results gave an indication, though preliminary, that 
females mated to OX5122M males were not more likely to seek additional mates than 
females first mated to WT males. This was promising, because males of a commercially 
ideal transgenic line would induce female refractoriness to further re-mating, as 
efficiently as WT males do. However, a robust analysis to confirm this observation 
would require a larger sample size with replication, under conditions more similar to the 
field (larger cages with vegetation and reduced population density).  
 
Table 4.10: Re-mating tendency of females previously mated to OX5122M or WT 
Group First partner Second partner Mated  Unmated 
1 OX5122M WT 8 22 (73%) 
2 WT OX5122M 6 24 (80%) 
 
 Fluorescent (OX5122M) and non-fluorescent (WT) sperm were observed in all 
but one female, independent of the genotype of the last mating partner. This single 
female had mated OX5122M prior to mating WT; it is possible that the first mating was 
associated with little or no transfer of sperm. This has been observed in other studies, 
though at a relatively infrequent proportion of total mating events (Taylor and Yuval, 
1999), (Taylor et al., 2000), (Bertin et al., 2010). Due to the difficulty of simultaneously 
scoring fluorescence of hundreds of non-fluorescent and fluorescent sperm in a tightly 
overlapping space, it was not possible to make precise conclusions of the ratio of 
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unmarked to marked sperm. On average, it appeared that females mated to OX5122M 
then WT demonstrated a lesser intensity of fluorescent sperm marking than females 
mated singly to OX5122M, or to WT then OX5122M (Figure 4.8).  
 
Initially, this was taken to indicate that transgenic sperm were successfully able 
to displace wild-type sperm of a prior male. However, this conclusion was contradicted 
by several observations. First, the number of sperm transferred to the spermathecae after 
a mating event is highly variable. In three studies with laboratory reared strains, the 
mean number of sperm transferred to the spermathecae was determined as 3192 (range: 
140-10400) in the first, 3576 (range not provided) in the second, and 1173 (range: 0-
4300) in the third (Taylor and Yuval, 1999), (Twig and Yuval, 2005), (Bertin et al., 
2010). In a study with wild-caught males, the median number of sperm transferred was 
2608 (range: 285-9249) (Taylor et al., 2000). Therefore, it is highly likely that the 
observed variations in the intensity of fluorescence, resulted from differences in the 
number of sperm transferred, rather than direct displacement. There were additional 
factors that suggested that direct displacement did not occur. First, experimenter bias 
was possible, as the genotypes of all individuals were known. To address this, we 
applied double blind scoring in subsequent experiments. Secondly, the storage of sperm 
in the spermathecae is generally asymmetric (Taylor and Yuval, 1999), (Twig and 
Yuval, 2005), which may have led to an overestimation of the proportion of 
fluorescently marked sperm, relative to conditions where the distribution of sperm was 
more equal. This was likely, because it was not possible to visually differentiate all 
unique sperm within tightly aggregated clusters, using the microscope conditions 
applied in the study. Finally, the number of sperm transferred to the spermathecae from 
the first and second partner has been shown to be approximately equal (Bertin et al., 
2010), which indicates that active displacement in the spermathecae does not occur, at 
least not in a sense equivalent to that suggested for D. melanogaster (Price et al., 1999).  
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 Instead, the last mate precedence in paternity is likely to be mediated by 
stratification of sperm in the fertilisation chamber. Fluorescence microscopy of the 
fertilisation chamber of females mated twice, to males with differentially marked 
fluorescent sperm, has been investigated by another group. This indicated a greater 
concentration of sperm from the second partner near the central portion of the alveoli, 
which could bias paternity to the second partner (Marchini et al., 2001), (Scolari et al., 
2014). Two further pieces of information are relevant. First, the quantity of sperm in the 
fertilisation chamber reaches a peak immediately after mating, which declines in the 
subsequent days (Twig and Yuval, 2005). Secondly, it was demonstrated that males 
partition the transfer of sperm between the storage organs of females, with about 20% of 
sperm directed to the fertilisation chamber and 80% to the spermathecae (Bertin et al., 
2010). Therefore, the most parsimonious explanation of the last mate precedence in 
paternity is that a comparatively greater quantity of sperm from the most recent mate, is 
localised in the areas of the fertilisation chamber through which eggs pass prior to 
oviposition (Marchini et al., 2001), (Scolari et al., 2014). Thereafter, these sperm are 
depleted through fertilisation and the chamber is replenished by the spermathecae, 
which appears to retain sperm of the first and second males, in the same proportion as 
these males originally transferred. In other words, there is a stratification of sperm from 
the most recent mate in the fertilisation chamber, but not the spermathecae.  
 
 It would be interesting to repeat this study with double blind scoring, to confirm 
beyond reasonable doubt that an experienced person could differentiate females that had 
mated a single WT male, a single OX5122 male, or twice (to both male genotypes). We 
decided to wait until an adequate system for repressible male sterility had been 
developed, as it was likely that expression of this effector could influence female 
decision to remate. Therefore, it would have been unwise to devote excessive study to 
the dynamics of remating, at this stage.  
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4.3.3 Ccprot1-zsGreen homozygotes (OX5122M-hom1) are competitive for mates 
and transfer healthy marked sperm to females 
 As product lines are maintained as homozygous colonies, we next evaluated if 
homozygosity would enhance fluorescence intensity, reduce male mating 
competitiveness, or affect the dynamics of sperm transfer. To ensure comparability with 
the heterozygous situation we again selected the single autosomal insertion line 
OX5122M, which was previously assessed for mating competitiveness and the 
dynamics of sperm transfer (Sections 4.3.1-4.3.2). The line was made homozygous by 
random single pair crosses, as previously described (Figure 2.5). This quickly 
establishes homozygosity, but potentially reduces fitness by constraining genetic 
diversity to two individuals. First, the transgenic allele was enriched by crossing 
transgenics for two generations. Thereafter, twenty single pair crosses were set up to 
establish homozygous pools. Twelve of twenty pools (60%) were productive (three 
refused mating; five did not yield sufficient progeny to continue). Then, G3 progeny 
were screened to eliminate crosses of two heterozygotes (indicated by WT progeny). 
Six of twelve pools were eliminated, leaving pools where one or both parents were 
homozygous. Finally, homozygous pools were discriminated from pools with one 
homozygous and one heterozygous parent. Siblings from the six remaining pools were 
crossed in medium cages for two more generations to facilitate selection of truly 
homozygous pools (no WT progeny). Two homozygous pools were obtained. 
 
 One homozygous pool was randomly selected (OX5122M-hom1) and assessed 
for mating competitiveness, as described for the heterozygous OX5122M line (Section 
4.3.1); tests were conducted one hour later, between 10:00-11:00. The data across three 
replicates (Table 4.11) were pooled after verifying that there were no significant 
differences between replicates in terms of female mating preference (χ² = 0.313, d.f. = 
2, p = 0.855). We found no significant difference in competitiveness between transgenic 
males and WT males (RSI = 0.49, χ² = 0.008, d.f. = 1, p = 0.927, n = 116). There was 
no significant difference in mean mating duration of OX5122M-hom1 males (142 min) 
relative to WT (138 min) when assessed by independent two-sample t-test (two-tailed, t 
= -0.47, d.f. = 91, p = 0.638). It is interesting to note that in this instance, the mean 
mating duration for both groups were greater than those reported in published study: 
135 minutes (Shelly and Kennelly, 2002). This was the third time the study had been 
performed: for the OX4718A-resolved assay (Section 3.6), the mean mating durations 
were 106 min (WT) and 114 min (OX4718A-resolved). For the OX5122M-het assay 
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(Section 4.3.1), the mean mating durations were 114 min (WT) and 126 min. The 
gradual increase in the observed durations of mating, suggests that experience with the 
assay is a possible explanatory factor.   
 
Table 4.11 Mating preference of WT females in OX5122M-hom1 competition 
assay 
Replicate Transgenic WT Total RSI Unmated 
1 18 (46%) 21 (54%) 39 0.46 11 (22%) 
2 23 (52%) 21 (48%) 44 0.52 6 (12%) 
3 18 (50%) 18 (50%) 36 0.50 14 (28%) 
Summary 59 (50%) 60 (50%) 119 0.50 31 (21%) 
The number of females refusing to mate in this study (21%) may have been greater than in the previous 
study of OX5122M heterozygotes (13%, Section 4.3.1) as it was conducted one hour later. Future studies 
were designed to start at the same time (09:00), to control for this potentially important variable. 
 
 We also considered the possibility of reduced sperm motility or fluorescence 
intensity after mating to WT females (ie. after sperm passed into the female 
reproductive tract). Females were processed, generally as described previously (the 
male was removed; larval diet was supplied; the female transferred to Cardiff 
University and dissected one, rather than two, days later). The motility and quantity of 
sperm transferred to females, did not appear to differ between OX5122M-hom1 males 
and WT males. When comparing images of females mated to OX5122M-hom1 males 
(this study) and OX5122M-het males (Section 4.3.1), we did not notice an obvious 
difference in fluorescence intensity (Figure 4.9). However, it would be necessary to 
compare images of the reproductive tract of females mated to OX5122M heterozygous 
males and homozygous males obtained at the same time, with equivalent camera 
settings, if this was necessary to completely exclude this possibility. This was not 
pursued, because the system clearly performed adequately for future use in product 
development.  
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4.3.4 The fluorescence of Ccprot1-zsGreen (OX5122M-hom1) sperm is highly 
persistent in dead females trapped under field-like conditions 
 To evaluate the field relevance of the fluorescent sperm marking system, a 
marker persistence assay simulating wild conditions was devised. WT females of two 
groups (mated to WT males or OX5122M-hom1 males) were affixed to a yellow sticky 
trap for 0, 1, 7, or 14 days. We assessed 10 females of each group, for each timepoint 
(80 total). Spermathecae were dissected in PBS, prior to gentle squashing under a cover 
slip and microscopic observation at Oxitec (Motic BA210 microscope and Fraen 
fluorescence FLUOLED lamp, at 10x magnification). The male genotype to which 
females were mated was genotyped by the presence or absence of fluorescently marked 
sperm (OX5122M-hom1 or WT, respectively). Double blind scoring was applied, to 
preclude experimenter bias. The male was correctly identified in most instances (72/79; 
91%), even after the female was left on a trap for 2 weeks (Table 4.12). This was the 
first time the assessment was performed; it is possible that with practice the accuracy 
would be increased. 
 
Table 4.12 Field simulation of Ccprot1-zsGreen (OX5122M-hom1) sperm marking 
persistence in mated females 
Days on trap Accuracy of scoring 
 Correct Incorrect 
  WT misidentified as OX5122 OX5122M misidentified as WT 
0 17/20 1/20 2/20 
3 17/19 1/19 1/19 
7 19/20 0/20 1/20 
14 19/20 0/20 1/20 
One sample was lost during processing in the day 3 group. 
 
4.4 Modification of Ccprot1 and Ccprot2 to regulate effectors of repressible male 
sterility 
  
4.4.1 Identification of the Ccprot1 and Ccprot2 transcriptional start sites 
 Having developed functional expression systems for a fluorescent marker in the 
male germline (Ccprot1-zsGreen [OX5122]; Ccprot2-zsGreen [OX5150]), we next 
attempted to modify these components to regulate a repressible male sterility effector, 
for future application in a single construct incorporating both components. From prior 
results (Section 4.2), we concluded that both Ccprot1-zsGreen (OX5122) and Ccprot2-
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zsGreen (OX5150) functioned equivalently when integrated at a favourable genomic 
insertion site. It was possible that Ccprot1-zsGreen (OX5122) was less insertion 
sensitive than Ccprot2-zsGreen (OX5150), because we observed impenetrant OX5150 
phenotypes more frequently. Consequently, we decided to first develop a construct 
based on Ccprot1, and revert to Ccprot2 if the former was non-functional. The changes 
required to mediate repressible male sterility are summarised here. 
 
 First, substitution of FokI for zsGreen was required, to replace fluorescent 
reporter localisation with protamine-FokI mediated cleavage of the sperm genome. 
Thereafter, integration with the previously described, tetracycline-repressible male 
germline switch (tetO21-β2T[short]-Cchsp83-tTAV) was necessary. This involved 
placement of a Ccprot-FokI system in a head-to-head configuration to the male 
germline switch, to put the tetO21 site upstream of the Ccprot-Fok1 transcription unit, 
and thus facilitate tetracycline repression. Finally, substitution of the Ccprot1 promoter 
for a minimal promoter fragment (from Dmhsp70) was required. Minimal promoters are 
generally required for tetracycline responsive systems, where they facilitate tight 
repression, with minimal transgene expression when tetracycline is present (Stebbins 
and Yin, 2001), (Schönig et al., 2011). The Ccprot1 promoter fragment is substantially 
longer (1.4 kb) than Dmhsp70 minimal promoter, and considering the intensity of 
reporter translation in the male germline, evidently quite strong (Figure 4.3). Therefore, 
it was possible that its inclusion in a tet-repressible system, might reduce sensitivity to 
tetracycline. Considering that tetO-Dmhsp70 minimal promoter-protamine-FokI 
fragments were previously demonstrated (in OX4353/4718A/5036; Chapter 3) to 
mediate penetrant and repressible male sterility, the argument for replacing the Ccprot1 
promoter with this fragment was compelling. 
 
 To facilitate ligation of tetO-Dmhsp70 minimal promoter to Ccprot1 or Ccprot2 
5’UTR without disrupting the regulatory capacity of each component, we wished to 
identify the transcriptional start site (TSS) by 5’ RACE. For convenience, RNA that had 
been extracted from the phenotypically normal testes of OX5140E (Dmprot1-zsGreen) 
flies, rather than a fresh extraction from WT testes, was used for the 5' RACE. Nested 
PCR reactions were performed with gene-specific reverse primers for Ccprot1 and 
Ccprot2; and the proprietary 5’RACE forward primer mix (UFP1 and UFP2). The 
position of each gene-specific reverse primer relative to the first codon (ATG) is 
provided (Table 4.13). After confirming the presence of a specific product in the second 
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(nested) reaction, the dominant band of the first reaction PCR product (pre-nesting) was 
gel purified. Thereafter, it was cloned into the pJET vector and ten individual colonies 
were sequenced with the protamine-specific reverse primer of the second (nested) PCR 
reaction. All ten Ccprot1 clones generated high quality sequence, while only 7/10 
Ccprot2 clones gave good sequence (potentially an issue with the gene-specific reverse 
primer used for sequencing). The results did not indicate a single TSS for either Ccprot1 
or Ccprot2. We investigated the Medfly RNA-seq data on the NCBI database to 
compare our results to those obtained via high throughput transcript sequencing (Figure 
4.10). Between the 5’ RACE result and the high-throughput RNA sequencing data, we 
chose to use the most upstream of the potential TSS, to enhance the probability of 
retaining the ability of the Ccprot1 or Ccprot2 5’UTR to mediate translational 
repression.  
 
Table 4.13 Positions of gene-specific 5’ RACE primers, relative to first codon 
Name Target Nested PCR reaction Position relative to ATG (+1) 
TD3938 Ccprot1 First + 188 to 209 
TD3939 Second + 92 to 110 
TD3940 Ccprot2 First + 101 to 122 
TD3941 Second + 72 to 92 
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4.4.2 Dmhsp70 promoter-Ccprot1 5’UTR-zsGreen fusions (OX5182, OX5184 & 
OX5186) are translationally repressed in the male germline  
 We next tested whether transcripts expressed from a construct containing 
a fusion of Dmhsp70 promoter (not Dmhsp70 minimal promoter) to Ccprot1, in a 
similar conformation to those applied for effectors of repressible male sterility, would 
retain the translational profile conferred by the Ccprot1 5’UTR (delayed to elongating 
spermatid stage: Figure 4.3). The full-length Dmhsp70 promoter was used here, 
because the minimal promoter was not expected to mediate high levels of transcription, 
if not activated by tTAV at its target tetO sequences. We tested three fusions of variable 
lengths of the Dmhsp70 promoter fragment to Ccprot1 5’UTR-Ccprot1 ORF-zsGreen-
Ccprot1 3’UTR, to observe localisation of zsGreen in the male germline (Figure 4.11). 
All promoter fragments retained less of the predicted Dmhsp70 5’UTR, relative to 
previous constructs (OX4353/4718/5036: 89 bp). The lengths of predicted Dmhsp70 
5’UTR retained were: 16 bp (OX5182), 21 bp (OX5184), or 31 bp (OX5186). Previous 
constructs using the Dmhsp70 minipromoter and 5'UTR had generated transcripts that 
were not subject to translational delay. Therefore, we attempted to remove the majority 
of Dmhsp70 5’UTR from the fragment whilst retaining its promoter capacity; and to 
delay translation by inclusion of the Ccprot1 5’UTR. This could potentially remove the 
negative effects on sperm fitness observed in the prior system (OX4718, Figure 3.8). 
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 Microinjection (Table 4.14) and backcrossing to WT (Table 4.15) were 
performed with piggyBac helper OX3022 (300 ng/μl) and one of three expression 
constructs OX5182, OX5184, or OX5186 (600 ng/μl). To verify successful 
microinjection, surviving G0 pupae were screened for transient expression of the 
AlMAct-dsRed2 transformation marker: this was observed for all constructs. Adult 
survival was better than the average rate for Medfly microinjections at Oxitec (25%), 
for OX5182 (53%) and OX5184 (56%); and less than average for OX5186 (14%) 
(Gregory et al., 2016). Six lines were kept from each construct for phenotypic analysis. 
From each pool, one transgenic G1 individual was backcrossed to wildtype and eggs 
collected six days later to establish a transgenic line. As previously described, progeny 
of each transgenic line were assessed for Mendelian characteristics: insertion copy 
number and sex-linkage (Table 4.16).  
 
Table 4.14: Microinjection logistics for OX5182, OX5184, & OX5186 
Construct Embryos Larvae Pupae Adults Lines 
OX5182 450 348 (77%) 244 (54%) 240 (53%) 10 (4%) 
OX5184 444 377 (85%) 292 (66%) 248 (56%) 10 (4%) 
OX5186 550 134 (24%) 90 (16%) 75 (14%) 7 (9%) 
 Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed). Although the 
apparent transformation efficiency is lower for OX5182 and OX5184 than for OX5186, this appears to be 
an artifact of pool size (smaller pools were used in OX5186).  
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Table 4.15 G0 backcrosses to establish OX5182, OX5184 & OX5186 lines 
Underlined pools yielded transgenics. OX5182L contained both male and female injection survivors. 22 
adults (8 males and 14 females) of OX5184 injection survivors were not crossed. Assessed lines were 
OX5182B, C, E, F, I & J; OX5184A, B, C, E, F & K; and OX5186F, G, J, L, M & N. 
 
  
OX5182A 20 ♂ x 20 WT ♀ OX5182B 20 ♂ x 20 WT ♀ OX5182C 20 ♂ x 20 WT ♀ 
OX5182D 20 ♂ x 20 WT ♀ OX5182E 20 ♂ x 20 WT ♀ OX5182F 23 ♂ x 23 WT ♀ 
OX5182G 20 ♀ x 10 WT ♂ OX5182H 20 ♀ x 10 WT ♂ OX5182I 20 ♀ x 10 WT ♂ 
OX5182J 20 ♀ x 10 WT ♂ OX5182K 20 ♀ x 10 WT ♂ OX5182L 24 ♂ x 44 ♀ 
      
OX5184A 20 ♂ x 20 WT ♀ OX5184B 20 ♂ x 20 WT ♀ OX5184C 20 ♂ x 20 WT ♀ 
OX5184D 20 ♂ x 20 WT ♀ OX5184E 20 ♂ x 20 WT ♀ OX5184F 20 ♂ x 20 WT ♀ 
OX5184G 20 ♀ x 10 WT ♂ OX5184H 20 ♀ x 10 WT ♂ OX5184I 20 ♀ x 10 WT ♂ 
OX5184J 20 ♀ x 10 WT ♂ OX5184K 20 ♀ x 10 WT ♂ OX5184L 20 ♀ x 10 WT ♂ 
      
OX5186A 5 ♀ x 5 WT ♂ OX5186B 5 ♀ x 5 WT ♂ OX5186C 5 ♀ x 5 WT ♂ 
OX5186D 5 ♀ x 5 WT ♂ OX5186E 5 ♂ x 20 WT ♀ OX5186F 5 ♂ x 20 WT ♀ 
OX5186G 5 ♂ x 20 WT ♀ OX5186H 5 ♂ x 20 WT ♀ OX5186I 5 ♂ x 20 WT ♀ 
OX5186J 5 ♂ x 20 WT ♀ OX5186K 5 ♂ x 20 WT ♀ OX5186L 3 ♀ x 5 WT ♂ 
OX5186M 4 ♀ x 5 WT ♂ OX5186N 8 ♂ x 25 WT ♀ OX5186O 5 ♀ x 5 WT ♂ 
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Table 4.16 Mendelian analysis of OX5182, OX5184 & OX5186 transgenic lines  
Line Sex 
 
Copy number Sex-linkage 
 
Summary 
Fluorescence in 
testes 
  
Transgenic 
(%) n 
Sex ratio 
(M/F) 
n Copies Location  
OX5182C 
♂ 
49 169 1.1 64 
1 Autosome No 
OX5182E 
♂ 
54 149 1.0 74 
1 Autosome Yes 
OX5182F 
♂ 
78 116 1.5 54 
2 Autosome No 
OX5182I 
♂ 
81 90 2.0 42 
2 Autosome Yes 
OX5182J 
♂ 
47 110 0.9 50 
1 Autosome Yes 
OX5182B ♀ 51 89 1.8 33 
1  No 
OX5184A 
♂ 
49 170 1.2 76 
1 Autosome Yes 
OX5184C 
♂ 
46 72 1.4 29 
1 Autosome Yes 
OX5184E 
♂ 
55 124 0.9 62 
1 Autosome Yes 
OX5184F 
♂ 
56 109 1.4 50 
1 Autosome Yes 
OX5184B 
♀ 
 45 71 0.5 19 
1  No 
OX5184K 
♀ 
 62 68 0.7 19 
1  Yes 
OX5186F ♂ 47 47 Male-only 13 
1 Y No 
OX5186G 
♀ 
48 109 1.2 40 
1  No 
OX5186J 
♀ 
53 83 1.3 27 
1  No 
OX5186L 
♀ 
46 90 0.9 28 
1  Yes 
OX5186M 
♀ 
55 99 3.0 40 
1  Yes 
OX5186N 
♀ 
43 68 1.8 25 
1  Yes 
All lines appear to be single insertions, except OX5182F and I (potential double insertions). Sex-linkage 
is only apparent from crosses in which the transgenic parent is male. Where it was possible to determine 
linkage, all lines appeared autosomal except OX5186F (Y-linkage). “N” refers to number screened. 
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Heterozygous G2 OX5182, OX5184, or OX5186 males (n=10) were collected on 
eclosion in small cages. Males aged 5-7 days post-eclosion were dissected at Cardiff 
University, as previously described. Testes from at least five males per line were 
dissected in testis buffer, gently pressed under a coverslip and examined to identify 
zsGreen reporter localisation in spermatocytes, spermatids and sperm (Figures 4.12-
4.14). Approximately half of lines demonstrated no visible fluorescence in testes (7/18). 
In the other lines, expression was generally observed in spermatids and sperm, but not 
spermatocytes. This suggested pre-meiotic transcription mediated by the truncated 
Dmhsp70 promoter variants, with delayed translation mediated by Ccprot1 5’UTR, as 
desired for the appropriate expression of effectors for repressible male sterility. It is 
interesting to note that stochastic variation was observed in expression between some 
lines, and within cells of the same individual. For instance, spermatids are poorly 
marked in OX5182I, but not OX5182E. In OX5184F, spermatids of similar age were 
marked with varied intensity. This was not observed during the analysis of OX5122, 
which featured a full-length Ccprot1 promoter. Therefore, it was anticipated that the 
penetrance of male sterility would be relatively insertion sensitive in future tetO-
Dmhsp70-Ccprot1-FokI lines.  
 
 Furthermore, the reporter was frequently localised to spermatids that had not 
completed elongation (for instance in OX5184E, Figure 4.13); localisation of 
protamine-FokI at this stage could still potentially affect spermatid nuclear shaping, and 
therefore reduce the rate of individualisation and the proportion of healthy mature 
sperm. The marker expression phenotypes observed between the three constructs were 
similar, indicating that all were fit-for-purpose in future research and development. 
However, it remained to be proven that this expression profile would be retained when 
combined with a tetracycline-repressible system, and that the sperm would be 
minimally affected by the expression of FokI.
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4.5 Conclusions  
 The present study intended to improve upon previous designs for a transgenic 
system expressing effectors for repressible male sterility and fluorescent sperm 
marking. The tetO-Dmprot2-FokI system mediated repressible sterility reproducibly 
(OX4353, OX4718, and OX5036). However, investigation of Dmhsp70-Dmprot2-
mCherry-FokI expression and sperm transfer to mated females (OX4718A) indicated 
that its translation was earlier than desired, and reduced the ability of sperm to behave 
normally in the female reproductive tract (Figures 3.5 and 3.8). One, or both, of the 
following were considered likely to have mediated this effect. First, the effector 
featured a partial 5’ UTR (89 bp) from Dmhsp70, a gene with embryonic translation, 
preceding the Dmprot2 5’UTR (Dmhsp70 5’UTR-Dmprot2 5’UTR). This might have 
contributed to early translation, which the inclusion of the Dmprot2 5’ UTR was 
intended to prevent. Alternatively, it was possible that the Dmprot2 5’UTR did not 
mediate a translational delay in Medfly equivalent to that observed in D. melanogaster 
(Jayaramaiah Raja and Renkawitz-Pohl, 2005), (Barckmann et al., 2013). Therefore, we 
reasoned that translation of the male sterility effector could be appropriately delayed by 
replacing the chimeric Dmhsp70 5’UTR-Dmprot2 5’UTR with a single 5’UTR from a 
Dmprot gene or, more preferably, its homologues in Medfly. Similarly, a suitable 
fluorescent sperm marking system could be engineered by placing a fluorescent marker 
under the transcriptional and translational control of these protamine-like genes, as a 
module independent of the male sterility effector.  
 We therefore investigated the production and localisation of a reporter, regulated 
by three new protamine sequences (Ccprot1, Ccprot2 & Dmprot1), in the male 
germline. Fluorescence was not visible in testes of Dmprot1-zsGreen expressing males 
(OX5140) of four lines, despite the presence of transcript in OX5140E (the other three 
lines were not assessed). Because fusions of a fluorescent protein to the C-terminus of 
the highly similar Dmprot2 protein were previously shown to perform poorly 
(OX4718/4751/4801), we concluded that this fusion (Dmprot1-zsGreen) may similarly, 
have been poorly tolerated. However, it could not be excluded that the Dmprot1 5’UTR 
does not mediate translational repression in Medfly, equivalently to D. melanogaster. It 
should be noted that translational delay was not observed in a Dmprot2-FokI fragment 
regulated by Dmhsp70 5’UTR-Dmprot2 5’UTR (Figure 3.5); though it could not be 
excluded that the presence of Dmhsp70 5’UTR was responsible for this effect. It would 
not be possible to conclusively identify which factor was responsible, without 
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substituting the Dmprot1-zsGreen fusion or the Dmprot1 5’UTR into a different 
expression system, wherein all other components were shown to mediate reporter 
localisation to spermatids and sperm. For instance, assessing the zsGreen localisation 
mediated by a Ccprot1 promoter-Dmprot1 5’UTR-Ccprot1 ORF-zsGreen-Ccprot1 
3’UTR fragment, would confirm if the Dmprot1 5’UTR was capable of mediating 
translational delay. 
 
 Despite the failure of Dmprot1-zsGreen (OX5140) to regulate a transgenic 
effector in the male germline appropriately, three other systems were successful: 
Ccprot1-zsGreen (OX5122), Ccprot1-mCherry (OX5123) and Ccprot2-zsGreen 
(OX5150). All mediated strong fluorescent reporter localisation to sperm and 
spermatids, but not spermatocytes. In addition to confirming their functionality as 
fluorescent sperm marking systems, this indicated that a modification of these 
transgenic systems could mediate the appropriate translational delay of a protamine-
FokI effector, until the elongated spermatid stage. To facilitate the design of such an 
effector, the TSS of Ccprot1 and Ccprot2 were investigated by 5’RACE and analysis of 
NCBI RNA-seq data; this would allow the effector to be modified for tetracycline-
repressible expression, as previously described (Section 4.4). A single TSS was not 
clearly defined for either of Ccprot1 or Ccprot2; we therefore selected the most 
upstream potential TSS (as indicated by 5’RACE or high-throughput transcript 
sequencing), to ensure that all elements likely to mediate the observed translational 
delay were retained. 
 
 That this Ccprot1 5’UTR sequence was sufficient to mediate translational delay, 
was indicated by the observation that a Dmhsp70 promoter-Ccprot1 5’UTR-Ccprot1 
ORF-zsGreen-Ccprot1 3’UTR fragment retained localisation of zsGreen to elongating 
spermatids and sperm (OX5184). Notably, the Dmhsp70 promoter fragment had been 
truncated, retaining 21 bp of Dmhsp70 5’UTR (relative to the 89 bp in 
OX4353/OX4718). Therefore, this alteration removed the hypothetical ability of the 
Dmhsp70 5’UTR to confer early translation, without abolishing transcription. This 
provided evidence that the fragment was suitable to regulate an effector of male 
sterility, which was assessed in the subsequent chapter, in expression constructs 
including the Ccprot1-zsGreen fluorescent sperm marking system as a separate module. 
 We assessed the performance of the Ccprot1-zsGreen fluorescent sperm marking 
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system independently of a male sterility effector, to avoid the potentially confounding 
effects of protamine-FokI expression on sperm. There were no obvious effects of 
Ccprot1-zsGreen expression on male mating competitiveness in OX5122M 
heterozygotes or homozygotes, which were equally competitive with wild-type in lab-
scale testing. Furthermore, in double mating experiments, the genotype of the male to 
which females were first mated (WT or OX5122M) did not appear to have any effect on 
the desire of females to re-mate. However, the sample size was quite small because 
most females (46/60), did not choose to re-mate. Although these tests were a promising 
indication that the transgenic system performed well, the limitations of lab-scale mating 
competition assays should be considered, to assess their ability to reflect the complex 
biology of mating in Medfly.  
 First, laboratory rearing affects the mating behaviour of males, in particular 
reducing the duration of key courtship activities during lekking; these are associated 
with reproductive success (Liimatainen et al., 1997), (Briceño and Eberhard, 1998). The 
high densities of lab conditions have also been suggested to habituate males to close 
contact, making them less aggressive, and potentially less dominant for mates (Briceño 
et al., 1999); though the role of aggression in reproductive success has been contested 
(Whittier et al., 1992). Interestingly, the composition of emitted male pheromones also 
differs in mass-reared and wild individuals (Vaníčková et al., 2012). As the OX5122M 
line is derived from the wild-type background and reared under equivalent conditions, 
males of both genotypes would be expected to exhibit similar changes in terms of 
behaviour and semiochemical composition. Therefore, the test would not highlight 
potential differences in factors that influence mating competitiveness, which are related 
to mass-rearing or laboratory colonisation, but are independent of the transgene. 
Furthermore, laboratory cages are not an accurate simulation of the field, which present 
several stimuli that influence mating behaviour. For instance, vegetation typically 
provides an environment around which males congregate, to form the lek and compete 
for females (Prokopy and Hendrichs, 1979). We have observed lekking behaviour in 
laboratory cages, but in many instances, males who scramble for females without 
lekking appear to secure mating events. This behaviour, which is substantially different 
to the circumstances observed in the field, has been reported elsewhere (Mossinson and 
Yuval, 2003). Additionally, aromatic compounds are present in fruit around which 
Medfly congregate; these are attractive, and some been shown to affect the reproductive 
success of males (Shelly et al., 2004), (Papadopoulos et al., 2006). Therefore, after a 
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candidate strain with a suitable male sterility and fluorescent sperm marking phenotype 
is isolated, it should be tested under field-like conditions, in greenhouses with natural 
light, vegetation, low population densities, and with competition against wild-caught 
males. However, an assessment of this rigour would be unnecessary at this stage, and 
waste resources that could be applied to develop the necessary transgenic strain 
incorporating repressible male sterility and fluorescent sperm marking.   
 We gathered further evidence to validate the ability of the Ccprot1-zsGreen 
fluorescent sperm marking system, to assess the mating ability of transgenic males in 
the field. This would be highly useful to assess whether males were competitive for 
mating events in the field. Females mated twice (to WT and OX5122 males) contained 
visible sperm of both genotypes (fluorescently marked and non-marked), indicating that 
the system could be used to score multiple mating events in the field. However, a more 
detailed analysis should be performed when the system is combined with an effector for 
repressible male sterility, ideally with a more quantitative and less biased mode of 
scoring (qPCR or fluorescence quantification, with double blind scoring). High rates of 
sperm transfer were observed in four transgenic lines (OX5122D, G, K & M), 
indicating that the system would be likely to function reproducibly for most autosomal 
insertions. It was also promising that the quantity and quality of sperm transferred to 
females upon mating, did not appear to vary between OX5122M heterozygotes and 
homozygotes, relative to WT. Furthermore, the fluorescence of sperm transferred to WT 
females by OX5122M homozygous males persisted for at least two weeks after death on 
a sticky trap, and facilitated differential scoring of the male genotype to which females 
had mated (wild-type or OX5122M), with > 90% accuracy. As a whole, these results 
indicated that the mating ability of OX5122 males was relatively similar to wild-type, 
despite expression of the transgenic marker system. However, it will be interesting to 
determine if these conclusions remain valid, when a repressible male sterility effector is 
expressed within the same expression construct; this was investigated in the subsequent 
chapter. 
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Chapter 5 – Characterisation of transgenic lines with penetrant and repressible 
male sterility and fluorescent sperm marking 
 
5.1 Single expression constructs for repressible male sterility and fluorescent 
sperm marking (OX5195, OX5241, OX5242 & OX5257) 
 The prior study (Chapter 4) demonstrated that a suitable fluorescent marking 
system could be engineered by placing a fluorescent reporter (zsGreen or mCherry) 
under the transcriptional and translational control of Medfly protamine-like genes 
(protamine promoter-protamine 5’UTR-protamine ORF-fluorescent reporter-protamine 
3’UTR). The Ccprot1-ZsGreen system (OX5122) performed best; strong zsGreen 
localisation was observed in the nuclei of sperm and spermatids (5/5 lines). The 
Ccprot1-mCherry (OX5123) and Ccprot2–zsGreen systems (OX5150) performed 
acceptably, but appeared more sensitive to positional effect (not all insertions 
demonstrated fluorescent reporter localisation in nuclei of spermatids and sperm). 
Therefore, it appeared that the Ccprot1-zsGreen (OX5122), Ccprot1-mCherry 
(OX5123), or Ccprot2-zsGreen (OX5150) systems could be modified to appropriately 
regulate the effector of repressible male sterility, engineering a translational delay to the 
elongated spermatid stage.  
 
 This was important, because translational repression was not observed in the 
prior male sterility system (OX4718: Figure 3.5 and Figure 3.8). We subsequently 
demonstrated that a Dmhsp70 promoter-Ccprot1 5’UTR-zsGreen-Ccprot1 3’UTR 
fragment (truncated to remove all but 21 bp of the predicted Dmhsp70 5’UTR), was 
able to specifically localise the zsGreen reporter to elongating spermatids and mature 
sperm. Therefore, it appeared that this system could potentially enhance the mating 
competitiveness of an engineered line, facilitating a reduced scale of sterile male 
release. 
 
 However, it was still necessary to adapt the Ccprot1 and Ccprot2 sequences to 
regulate the effector of male sterility in a tetracycline-repressible manner (Figure 5.1). 
First, substitution of FokI for zsGreen/mCherry was required, to replace sperm marking 
with protamine-mediated cleavage of the sperm genome. Thereafter, integration with 
the previously described, tetracycline-repressible male germline switch (tetO21-Ccβ2T-
Cchsp83-tTAV) to provide repressible sterility was necessary. This involved placement 
of a Ccprot1-FokI or Ccprot2-FokI system in a head-to-head configuration to the male 
CONFIDENTIAL  Chapter 5 – Lines with repressible male sterility and fluorescent sperm marking  
 
171 
germline switch, to put the tetO21 site upstream of the Ccprot-Fok1 transcription unit, 
and thus facilitate tetracycline repression. Finally, substitution of the Ccprot1 or 
Ccprot2 promoter for a minimal promoter fragment (from Dmhsp70) was required, for 
compatibility with the tet-off system. To facilitate ligation of tetO-Dmhsp70 minimal 
promoter to Ccprot1 or Ccprot2 5’UTR without disrupting the regulatory capacity of 
each component, we selected the most conservative (longest) 5’UTR, as indicated by 5’ 
RACE, or the high throughput transcript sequencing data available from NCBI. It 
remained possible that the expression profile of the effector would be modified, when it 
was combined with the tetracycline-repressible system. Four candidates were generated, 
which featured the Ccprot1-zsGreen system for fluorescent sperm marking, and one of 
four effectors of repressible male sterility. 
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 The first candidate (OX5195) applied Ccprot1 and Dmhsp70 elements for 
repressible male sterility, largely as previously described (tetO21-Dmhsp70 
minipromoter-Ccprot1 5’UTR-Ccprot1 ORF-FokI-Ccprot1 3’UTR; hereafter Ccprot1-
full 5’UTR-FokI). The construct mediated highly penetrant male sterility, but was not 
repressible (Section 5.2). We concluded that irrepressibility potentially resulted from a 
minimal promoter within the predicted Ccprot1 5’UTR, circumventing tetracycline-
mediated repression. Consequently, we shortened the predicted 5’UTRs of Ccprot1 and 
Ccprot2 to attempt removal of non-repressible elements, and investigated their 
functionality in equivalent expression systems: OX5241 (Ccprot2-short 5’UTR-FokI) 
and OX5242 (Ccprot1-short 5’UTR-FokI). These were evaluated in Sections 5.3 and 
5.4, respectively. 
 
 A backup was required to mediate the risk of sequence elements behaving in 
unpredicted ways. The Dmprot2-chimeric-old-mCherry-FokI effector (OX4718, Figure 
3.5) mediated penetrant and repressible male sterility. We reasoned that fluorescent 
sperm marking could be engineered by addition of Ccprot1-ZsGreen (validated in 
OX5122). However, a high rate of transfer of morphologically normal sperm appeared 
unlikely, if the expression system behaved consistently in all penetrant lines (it was 
previously demonstrated that sperm of one line were negatively affected by Dmprot2-
chimeric-old-mCherry-FokI expression; Figure 3.8). The effector was essentially 
unmodified, to reduce the risk of altering the previously characterised phenotype, 
though two changes were performed: (1) mCherry was removed (inclusion of a semi-
functional marker would complicate licensing) and (2) the SV40 3’UTR was substituted 
for Ccprot2 3’UTR (a marketing decision, to avoid inclusion of virally derived 
elements). It should be noted that a single copy of SV40 3’UTR was retained as a 
regulator of zsGreen, used to visually monitor excision of one piggyBac end pair. This 
was not considered to be problematic, because the sequence would be absent in the final 
product (following piggyBac end removal). The longer, partial Dmhsp70 5’UTR (89 bp; 
21 bp in all other constructs) of the parent molecule was retained. Alteration of these 
elements (mCherry and SV40 3’UTR) could theoretically modify the phenotype, either 
by alteration of translational stability (the novel Ccprot2 3’UTR) or the structure of the 
effector molecule (mCherry removal). Neither was considered likely, because constructs 
applying Dmprot2-chimeric-FokI without mCherry were penetrant and repressible 
previously (eg. OX4353/5036); and because a generic 3’UTR is usually sufficient to 
facilitate appropriate translation in the male germline of D. melanogaster (Michiels et 
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al., 1989), (Jayaramaiah Raja and Renkawitz-Pohl, 2005). The resulting effector of male 
sterility was termed Dmprot2-chimeric-new-FokI (OX5257).  
 
 All constructs (Figure 5.2) were 4-ended piggyBac vectors incorporating 
resolvable ends (two pairs of piggyBac ends with fluorescent markers); fluorescent 
sperm marking (Ccprot1-zsGreen); a transformation marker brightly expressed in 
muscle tissue (mActin-dsRed2); and a tetracycline repressible transcriptional activator 
in the male germline (Ccβ2T-Cchsp83-tTAV2) that regulates the tetO21-protamine-
FokI male sterility effector. Difficulty sequencing adjacent repetitions of Cchsp83 
3’UTR (OX5195), which were associated with (1) the zsGreen fluorescent marker in the 
left-handed piggyBac pair and (2) tTAV2, indicated secondary structure that could 
prevent excision of piggyBac ends. For this reason, one Cchsp83 3’UTR copy was 
substituted in subsequent constructs (ZsGreen-Cchsp83 3’UTR  ZsGreen-SV40 
3’UTR).  
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5.2 OX5195 (Ccprot1-full 5’UTR-FokI) males are irrepressibly sterile in penetrant 
insertions 
 
5.2.1 Establishment of OX5195 transgenic lines 
 Microinjection (Table 5.1), backcrossing to WT (Table 5.2), screening for 
transient expression of the transformation marker, and Mendelian assessment of 
insertions were generally as previously described. Buffered injection mixes were 
prepared with tetracycline (100 ng/μl), OX5195 (600 ng/μl), mRNA helper OX3081 
and DNA helper OX3022 (300 ng/μl each). Transient AlMAct-dsRed2 expression was 
observed in G0 pupae, indicating successful microinjection. Adult survival (32%) was 
similar to typical results for injection of Medfly (25%) (Gregory et al., 2016). Two 
rounds of injection were performed, denoted (1) or (2). Transformation efficiency was 
poor (1.2%), despite large adult G0 cohorts (n=1182). 
 
Table 5.1: Microinjection logistics for OX5195  
Round Embryos Larvae Pupae Adults Lines 
1 1343 981 (73%) 143 (11%) 122 (9%) 2 (1.6%) 
2 2360 1410 (60%) 1114 (47%) 1060 (45%) 13 (1.2%) 
Total 3703  2391 (65%) 1257 (34%) 1182 (32%) 15 (1.3%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed).  
 
Table 5.2: G0 backcrosses to establish OX5195 lines 
OX5195(1)A 10 ♀ x 10 WT ♂ OX5195(1)B 12 ♀ x 10 WT ♂ OX5195(1)C 12 ♀ x 10 WT ♂ 
OX5195(1)D 13 ♀ x 10 WT ♂ OX5195(1)E 11 ♀ x 10 WT ♂ OX5195(1)F 4 ♀ x 4 WT ♂ 
OX5195(2)A 10 ♂ x 30 WT ♀ OX5195(2)B 10 ♂ x 30 WT ♀ OX5195(2)C 23 ♀ x 10 WT ♂ 
OX5195(2)D 10 ♂ x 30 WT ♀ OX5195(2)E 11 ♂ x 30 WT ♀ OX5195(2)F 11 ♂ x 30 WT ♀ 
OX5195(2)G 11 ♂ x 30 WT ♀ OX5195(2)H 23 ♀ x 10 WT ♂ OX5195(2)I 10 ♂ x 30 WT ♀ 
OX5195(2)J 10 ♂ x 30 WT ♀ OX5195(2)K 10 ♂ x 30 WT ♀ OX5195(2)L 10 ♂ x 30 WT ♀ 
OX5195(2)M 10 ♂ x 30 WT ♀ OX5195(2)N 10 ♂ x 30 WT ♀ OX5195(2)O 10 ♂ x 30 WT ♀ 
OX5195(2)P 22 ♀ x 10 WT ♂ OX5195(2)Q 22 ♀ x 10 WT ♂ OX5195(2)R 11 ♂ x 30 WT ♀ 
OX5195(2)S 11 ♂ x 30 WT ♀ OX5195(2)T 11 ♂ x 30 WT ♀ OX5195(2)U 11 ♂ x 30 WT ♀ 
OX5195(2)V 11 ♂ x 30 WT ♀ OX5195(2)W 11 ♂ x 30 WT ♀ OX5195(2)X 11 ♂ x 30 WT ♀ 
OX5195(2)Y 10 ♂ x 30 WT ♀ OX5195(2)Z 21 ♀ x 10 WT ♂ OX5195(2)AA 21 ♀ x 10 WT ♂ 
OX5195(2)AB 21 ♀ x 10 WT ♂ OX5195(2)AC 21 ♀ x 10 WT ♂ OX5195(2)AD 10 ♂ x 30 WT ♀ 
OX5195(2)AE 10 ♂ x 30 WT ♀ OX5195(2)AF 10 ♂ x 30 WT ♀ OX5195(2)AG 10 ♂ x 30 WT ♀ 
OX5195(2)AH 10 ♂ x 30 WT ♀ OX5195(2)AI 10 ♂ x 30 WT ♀ OX5195(2)AJ 10 ♂ x 30 WT ♀ 
OX5195(2)AK 10 ♂ x 30 WT ♀ OX5195(2)AL 10 ♂ x 30 WT ♀ OX5195(2)AM 10 ♂ x 30 WT ♀ 
OX5195(2)AN 10 ♂ x 30 WT ♀ OX5195(2)AO 21 ♀ x 10 WT ♂ OX5195(2)AP 21 ♀ x 10 WT ♂ 
OX5195(2)AQ 21 ♀ x 10 WT ♂ OX5195(2)AR 21 ♀ x 10 WT ♂ OX5195(2)AS 21 ♀ x 10 WT ♂ 
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OX5195(2)AT 21 ♀ x 10 WT ♂ OX5195(2)AU 20 ♀ x 10 WT ♂ OX5195(2)AV 20 ♀ x 10 WT ♂ 
OX5195(2)AW 20 ♀ x 10 WT ♂ OX5195(2)AX 20 ♀ x 10 WT ♂ OX5195(2)AY 11 ♂ x 30 WT ♀ 
OX5195(2)AZ 11 ♂ x 30 WT ♀ OX5195(2)BA 11 ♂ x 30 WT ♀ OX5195(2)BB 11 ♂ x 30 WT ♀ 
OX5195(2)BC 11 ♂ x 30 WT ♀ OX5195(2)BD 11 ♂ x 30 WT ♀ OX5195(2)BE 11 ♂ x 30 WT ♀ 
OX5195(2)BF 11 ♂ x 30 WT ♀ OX5195(2)BG 11 ♂ x 30 WT ♀ OX5195(2)BH 10 ♂ x 30 WT ♀ 
OX5195(2)BI 11 ♂ x 30 WT ♀ OX5195(2)BJ 11 ♂ x 30 WT ♀ OX5195(2)BK 11 ♂ x 30 WT ♀ 
OX5195(2)BL 11 ♂ x 30 WT ♀ OX5195(2)BM 11 ♂ x 30 WT ♀ OX5195(2)BN 11 ♂ x 30 WT ♀ 
OX5195(2)BO 10 ♂ x 30 WT ♀ OX5195(2)BP 18 ♀ x 10 WT ♂ OX5195(2)BQ 17 ♀ x 10 WT ♂ 
OX5195(2)BR 17 ♀ x 10 WT ♂ OX5195(2)BS 88 ♂ x 25 ♀   
Underlined crosses gave transgenic lines. The OX5195(2)BS cross used male and female survivors. 
  
5.2.2 OX5195 transgenic G1 male individuals are frequently infertile  
 Only data from OX5195(2) lines are presented in detail, because OX5195(1) 
injections generated only two lines. One was impenetrant (OX5195(1)C); the other 
(OX5195(1)E) was lost because male transgenics were infertile, even when reared on-
tet. Thirteen OX5195(2) lines were derived, facilitating a thorough phenotypic analysis 
that accounted for potential male irrepressibility. Where possible, tet-reared G1 
transgenic males (1 x 5 WT) and females (1 x 2 WT) of each pool were independently 
backcrossed to prevent line loss (in case males were infertile, even in the presence of 
tetracycline in the larval diet). Fertility was preliminarily assessed by larval growth on 
diet for males; for females, surplus individuals were filtered (day 10) and assessed 
under egg hatch assay conditions. WT females mated to transgenic males were 
qualitatively scored for marked sperm (day 8) under the Oxitec microscope setup 
(Motic BA210 microscope, Fraen fluorescence FLUOLED lamp, Lumenera Infinity 2 
camera, at 10x magnification).  
 
 Transgenic G1 male individuals were frequently infertile, indicating male-
specific non-repressibility of the sterility phenotype (Table 5.3). Individuals from 11/13 
pools (n=34) were assessed. G1 transgenic males were observed in 6/11 pools. Males of 
four pools were sterile (OX5195(2)P, AC, AU & AW); males of two pools were fertile 
(OX5195(2)AI & BA). Female individuals were fertile in all pools (9/9). Male 
infertility and sperm marking were correlated; infertile males produced sperm with 
visible fluorescence. This suggested that fluorescent sperm marking in G1 individuals 
can be used as a preliminary screen for penetrant lines (Figure 5.3); this was 
recapitulated in subsequent analyses (Sections 5.3-5.5).  
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Table 5.3 Infertility of male OX5195(2) G1 individuals indicates that protamine-
FokI expression is frequently non-repressible 
G1 pool Fertility  Sperm marking Apparent phenotype 
 Male Female   
 % n % n   
OX5195(2)P 0  1 100  1 Yes Penetrant but non-repressible 
male sterility with fluorescent 
sperm marking OX5195(2)AC 0  1 100  3 Yes 
OX5195(2)AU 0  4 100  6 Yes 
OX5195(2)AW 0  2   Yes 
OX5195(2)AI 100  2 100  2 No Impenetrant, no fluorescent 
sperm marking 
OX5195(2)BA 100  2   No 
OX5195(2)H   100  3  Male G1 individuals were not 
present 
OX5195(2)AR   100  2  
OX5195(2)AY   100  6  
OX5195(2)BK   90  10  
OX5195(2)BG   100  2  
Lines providing only females (OX5195(2)H, AR, AY, BK & BG) could not be assessed for male-
specific, non-repressible infertility or sperm marking at this stage. The presence of fluorescent marking in 
the male germline is assessed in Figure 5.3. “n”: number of individuals assessed. 
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 Two pools were lost: OX5195(2)AW (no females present; all males were sterile) 
and OX5195(2)P (the male was sterile and the female cross was not kept), leaving 9 
pools. Although the OX5195 system (Ccprot1-full 5’UTR-FokI) was frequently non-
repressible, we continued analysis because it was theoretically possible to recover 
repressible insertions from pools where males were fertile (OX5195(2)AI & BA) or not 
yet analysed (OX5195(2)H, AR, AY, BK, BG). Furthermore, it was preferable to 
confirm that non-repressibility was reproducible by replicated egg hatch assay; and to 
investigate the effect of Ccprot1-FokI expression on sperm fitness on a higher 
resolution microscope (Cardiff University). The rationale was that even if this version 
of the system was non-functional due to irrepressibility, a novel variant of the Ccprot1-
full 5’UTR-FokI system would be engineered, for full repressibility. A single line was 
established from each pool (generally from a female as males were frequently infertile) 
and evaluated further. For transgenic G1 pools where males were infertile, we predicted 
that males derived from a female transgenic lineage would have a penetrant and non-
repressible phenotype. This was because all individuals of the same pool were assumed 
to possess the same insertion; the transformation efficiency of OX5195 was low.  
 
 All lines were single insertions (Table 5.4). OX5195(2)BA1 was excluded from 
further analysis because it was Y-linked (cannot be made homozygous). Sex-linkage 
was not detected in other lines because transgenic females were used, to circumvent 
non-repressibility. It was possible to investigate male crosses of lines subsequently 
demonstrated repressible; it was not pursued because they were not useful commercially 
(impenetrant). 
Table 5.4: Mendelian assessment of OX5195(2) transgenic lines  
Line Sex Copy number  Sex-linkage 
Summary 
  
Transgenic (%) 
n 
Sex ratio 
(M/F) 
n Copies Location 
OX5195(2)BG1 ♀ 45 183 0.9 57 
1 Unknown 
OX5195(2)H1 ♀ 51 190 1.3 72 
1 Unknown 
OX5195(2)AI1 ♀ 54 151 1.0 68 
1 Unknown 
OX5195(2)BK1 ♀ 47 136 1.0 58 
1 Unknown 
OX5195(2)AR1 ♀ 55 237 1.0 110 
1 Unknown 
OX5195(2)AU1 ♀ 53 311 1.1 144 
1 Unknown 
OX5195(2)AC2 ♀ 53 207 1.4 90 
1 Unknown 
OX5195(2)AY1 ♀ 44 189 2.8 69 
1 Unknown 
OX5195(2)BA1 ♂ 
 
 Male-only 48 
1 Y 
The transgenic copy number of OX5195(2)BA1 was not assessed (it was Y-linked and therefore not 
commercially suitable). “n”: number of individuals assessed. 
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5.2.3 OX5195 lines with penetrant male sterility are not repressible and 
demonstrate undesirable effects on sperm  
 Penetrance and repressibility were assessed by egg hatch assay, generally as 
previously described. F0 crosses were 10 non-tet [NT] reared WT males to 20 tet-reared 
[T] heterozygous OX5195(2) females, with F1 progeny filtered to tet- and non-tet diet. 
Five F1 heterozygous males of each group (NT or T) were crossed to ten WT females 
[NT]. An equivalent cross with WT males [NT] was performed as control. A tet-reared 
WT control was not performed because prior tests (Figure 3.6) demonstrated no 
significant tetracycline-dependent effect on male viability. However, this was 
considered to be an oversight, because tetracycline-mediated transgenic repressibility is 
most accurately represented relative to an equivalent control. Therefore,  
subsequent assays (OX5241/5242/5257) included a tet-reared WT control (Sections 
5.3-5.5).  
 
 24 hour egg collections (n=100 eggs) were pseudo-duplicated (two replicated 
measures from the same cage on day 7). Replicates were tested by correction-free chi-
square testing for significant variance prior to pooling. Significance was assessed by 
chi-square testing the number of hatched and unhatched individuals, relative to the 
WT[NT] control. Penetrance and repressibility were calculated relative to the WT[NT] 
control. The extent of repressibility was investigated by comparing the number of 
hatched and unhatched progeny between [NT] and [T] reared males, of each line. 
Standard error and 95% CI (Wilson) were calculated as recommended for categorical 
data (Xu et al., 2010). All lines were assessed from single rears over a three day period 
to minimise environmental or rearing effects. 
 
 No lines were commercially applicable (Table 5.5). Tetracycline  only 
significantly rescued hatch rate in weakly penetrant lines (Table 5.6, Figure 5.4). In the 
subsequent generation, we investigated the effect of Ccprot1-full 5’UTR-FokI on the 
quantity of sperm transferred upon mating, under a higher resolution microscope 
(Cardiff University, Olympus BX50 microscope at 10x or 20x magnification). Only the 
crosses of non-tet reared transgenic males to WT females were investigated, because a 
minimal effect of tetracycline for most lines was established, and because we were 
primarily interested in the effect of Ccprot1-full 5’UTR-FokI at its maximally expressed 
state (non-repressed). Crosses were performed as described for the egg hatch assay and 
spermathecae dissected (day 7). Ccprot1-full 5’UTR-FokI expression was associated 
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with a reduced quantity of sperm transferred to WT females (Figure 5.5). Exact 
quantification was not possible; development of a qPCR assay for quantitative analysis 
could potentially be beneficial.  
 
Table 5.5 Penetrance and repressibility of male sterility in OX5195(2) lines 
Line Mean hatch rate (± SE) Penetrance Repressibility 
 
 NT T % X2 P[df] %  X2  P[df] 
OX5195(2)AU1 1 ± 0.70 1 ± 0.70 99 177 < 0.001[1] 1 177 < 0.001[1] 
OX5195(2)AC2 2.5 ± 1.10 3.5 ± 1.30 97 171.2 < 0.001[1] 4 167.5 < 0.001[1] 
OX5195(2)H1 7 ± 1.80 5 ± 1.54 93 154.9 < 0.001[1] 5 162.0 < 0.001[1] 
OX5195(2)AI1 63 ± 3.41 89.5 ± 2.17 34 30.9 < 0.001[1] 95 2.11 0.15[1] 
OX5195(2)BG1 79.5 ± 2.85 97 ± 1.21 16 10.8 0.001[1] 100 0.52 0.47[1] 
OX5195(2)AY1 90.5 ± 2.07 88 ± 2.30 4 1.51 0.22[1] 93 3.15 0.08[1] 
OX5195(2)BK1 91.5 ± 1.97 92 ± 1.92 3 0.97 0.32[1] 97 0.74 0.39[1] 
OX5195(2)AR2 98 ± 0.99 95.5 ± 1.47 0 1.3 0.25[1] 100 0.03 0.86[1] 
WT 95 ± 1.59        
SE: standard error. Df: degrees of freedom.  
Table 5.6 Extent of repressibility of male sterility in OX5195(2) lines 
Line Mean difference of hatch rates [NT – T] (%) Significance 
   X2  P[df] 
OX5195(2)AY1 -2.5 0.33 0.57[1] 
OX5195(2)AR2 -2.5 0.99 0.31[1] 
OX5195(2)H1 -2 0.35 0.55[1] 
OX5195(2)AU1 0.0 0 1[1] 
OX5195(2)BK1 0.5 0.02 0.90[1] 
OX5195(2)AC2 1.0 0.17 0.68[1] 
OX5195(2)BG1 17.5 14.8 < 0.001[1] 
OX5195(2)AI1 26.5 19.4 < 0.001[1] 
Only weakly penetrant lines (5195(2)BG1 and AI1) were fully repressible. 
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5.2.4 Non-repressible Ccprot1-full 5’UTR-FokI expression in males selects for 
weak insertions in male OX5195 G0 individuals 
 We observed a significant female bias in transgenic OX5195(2) G1 individuals 
(76% female, n=55, X2=8.2; df=1, p=0.004). The most likely explanation is selection 
for X-linked insertions in male G0 individuals (leading to female-specific inheritance of 
the expression construct in G1 progeny). From 12 pools of G0 individuals yielding 
transgenics (Table 5.7), male and female crosses were equally represented (six each). 
All lines derived from male G0 crosses (n=5) were impenetrant or weakly penetrant. 
Five of six lines derived from female G0 crosses were penetrant (all except 
OX5195(2)AR). Non-repressible expression would be expected to kill transformed 
germline cells in males but not females, because protamine-FokI should be exclusively 
expressed in males. Therefore, such insertions would be selected against. Although 
weak autosomal insertions are routinely observed, weak sex-linked insertions are more 
probable because essentially all of X and Y appear inhospitable for male germline 
expression. This is corroborated by published data (Parisi, 2003), (Koerich et al., 2008); 
and the observation that we have never recovered an X- or Y-linked insertion with 
penetrant expression in the male germline (OX5036 [Section 3.7], OX5150 [Section 
4.2.3], OX5257 [Section 5.5]).  
 
 Three of five male G0 lineages gave exclusively female transgenic progeny 
(OX5195(2)AY [n=7], BK [n=13] & BG [n=2]), consistent with X-linkage. The fourth 
(OX5195(2)AI) was a confirmed autosomal insertion and the fifth (OX5195(2)BA) was 
a confirmed Y-linked insertion. It would have been preferable to confirm this 
hypothesis experimentally by backcrossing heterozygous males of the impenetrant lines, 
but they had been discarded by the time the relationship was discovered. Consequently, 
we calculated probability of X-linkage for the male crosses deriving only females, 
assuming no secondary autosomal or Y insertions. This is represented by the inverse 
probability of randomly observing that particular sex distribution: 1-(1/2n), where n is 
number of females present. 
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Table 5.7: Non-repressible expression of Ccprot1-full 5’UTR-FokI (OX5195) 
selects for weak insertions in G0 microinjected males 
G0 pool G0 sex G1 progeny Male sterility phenotype Probability of X-linkage 
  ♂ ♀ Total Penetrance Repressibility  
OX5195(2)AY ♂ 0 7 7 None  99.2% 
OX5195(2)BG ♂ 0 2 2 Weak Full 75% 
OX5195(2)BK ♂ 0 13 13 None   > 99.9% 
OX5195(2)AI ♂ 2 2 4 Weak Full Known autosomal insertion 
OX5195(2)BA ♂ 2 0 2 None  Known Y-linked insertion 
OX5195(2)H ♀ 0 3 3 Strong None  
OX5195(2)P ♀ 1 1 2 Strong None  
OX5195(2)AC ♀ 1  3 4 Strong None  
OX5195(2)AR ♀ 0 2 2 None   
OX5195(2)AU ♀ 4 9 13 Strong None  
OX5195(2)AW ♀ 2 0 2 Strong None  
 
5.2.5 Transcription of Ccprot1-full 5’UTR-FokI is partially repressed in 
OX5195(2)AU1, but this does not improve embryonic viability 
 We investigated Ccprot1-FokI expression in testes by qPCR analysis of the most 
penetrant line (OX5195(2)AU1), and a relatively impenetrant line that demonstrated 
normal hatch rate in the presence of tetracycline (OX5195(2)AI1), to assess whether 
tetracycline had any repressive effect on the male sterility effector. Triplicated samples 
were five pairs of testes from OX5195(2) heterozygotes or WT (aged 7 days). 
Dissections, RNA extraction and qRT-PCR were as previously described (Section 
2.1.3.4). Expression levels were normalised to a housekeeping gene (Cc-Rp17S) and 
subsequently to the normalised mean expression level of tetracycline-reared 
OX5195(2)AI1 males (expected to indicate a baseline level of expression). Results are 
summarised in Table 5.8 and Figure 5.6. Partial repression was observed for the highly 
penetrant line OX5195(2)AU1[T] (71% repressed, relative to baseline). As the progeny 
of crosses of OX5195(2)AU1[NT] and [T] males were equally inviable, it appears that 
hundred-fold induction of Ccprot1-FokI is sufficient to reduce hatch rate to 1%. The 
results indicated considerable variation in expression between biological replicates 
(large standard error). Consequently, a detailed statistical analysis would likely be 
misleading. Future analysis would be improved by performing five biological replicates, 
each consisting of 15 pairs of testes, with an averaged measurement from three 
technical replicates of each biological replicate. It was not necessary to repeat these 
results, as we demonstrated in a parallel analysis that shortening the Ccprot1 5’UTR 
was sufficient to engineer almost complete repression (Section 5.4). Therefore, the 
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relative expression levels of Ccprot1-full 5’UTR-FokI in these lines were no longer of 
interest. 
 
Table 5.8 Normalised Ccprot1-FokI transcription levels in OX5195(2) testes  
Line Fold change (2 -
ΔΔCt) 
 NT T 
 Mean Range (Mean ± SE) Mean Range (Mean ± SE) 
OX5195(2)AU1 348.1 226.8-534.2 101.8 87.1-119.0 
OX5195(2)AI1 3.1 0.4-22.9 1 0.3-3.6 
WT 0.2 0.1-0.6 0.5 0.2-1.0 
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5.2.6. An embryonic staining assay to visualise the effect of paternal expression of 
protamine-FokI 
 We considered that the paternal effect of Ccprot1-FokI expression on embryonic 
development could be visualised by nuclear staining, providing context for the 
developmental effects of penetrant, but incompletely repressed Ccprot1-full 5’UTR-
FokI. This was intended as a preliminary experiment to determine the extent to which 
embryonic development was arrested by protamine-FokI expression, and to optimise 
testing for commercially relevant, fully repressible male sterility systems. Lines of 
varying penetrance were tested to maximise informational output for assay 
development: OX5195(2)AU1 [fully penetrant, non-repressible]; OX5195(2)AI1 [semi-
penetrant, fully repressible]; and OX5195(2)AR2 [completely impenetrant]). The F0 
cross was heterozygous transgenic females [T] (n=10) to WT males [NT] (n=5). F1 
progeny were filtered on- and off-tet. Heterozygous males (n=25) of each treatment (NT 
or T) were crossed to WT females [NT] (n=50). Controls were equivalent crosses with 
WT males (NT and T).  
 
 Eggs were collected in four hour cycles, fixed and stained. Two timepoints were 
assessed: 0-4 hours (fixed immediately on day 9) and 20-24 hours (collected on day 7, 
and left to develop for 20 hours). We imaged and phenotypically assessed at least 10 
individuals per group. Embryos from the 0-4 hour collection were staged as developing 
or not developing (several nuclei visible, or only the first nucleus visible); and from the 
20-24 hour collection as morphologically normal (N), morphologically aberrant (A), or 
no visible development (ND). For statistical analysis, data was divided by timepoint and 
correction-free chi-square testing was performed on the number of individuals from 
each category, relative to the appropriate WT control (NT or T). Repression was 
calculated by chi-square testing the number of individuals from each phenotypic 
category, for the [NT] and [T] observations for each line. We hypothesised the stage at 
which embryonic development would arrest, based on the observed hatch rate of 
progeny of off-tet and on-tet reared males, from the prior section (Table 5.9).  
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Table 5.9: Expected embryonic developmental phenotypes  
Line Mean hatch 
rate (%) 
Embryonic developmental phenotype 
   Expected Observed 
 NT T   
5195(2)AU1 1.0 1.0 Early developmental arrest in 
the majority of embryos, 
with no effect of tetracycline. 
Early and late development were affected, 
but embryos were able to proceed to a 
much later stage than expected. 
Tetracycline had no obvious effect. 
5195(2)AI1 63.0 89.5 Developmental arrest in a 
proportion of embryos, when 
reared off-tet. Normal 
development when reared 
on-tet. 
No effects on early development detected. 
Mild effects on late development were 
indicated (off-tet and on-tet), but were not 
statistically significant. Tetracycline 
appeared to rescue development, as 
expected. 
5195(2)AR2 98.0 95.5 Normal development 
WT 95  
 
 Early embryonic development (0-4 hours) was affected by paternal expression of 
Ccprot1-full 5’UTR-FokI for OX5195(2)AU1; a significantly higher rate of non-
development was observed both off-tet (n=12, X2 =26.0, p < 0.001[1]) and on-tet (n=10, 
X2 =6.84, p= 0.009[1]), relative to WT controls (Table 5.10). Neither OX5195(2)AI1 nor 
OX5195(2)AR2 differed significantly from controls. This indicated that the basis of 
reduced hatch rate in OX5195(2)AI1 might be later-acting; that the scoring method did 
not detect differences at this stage (binary scoring of embryos as developed or non-
developed, might not reveal minor effects); or that the sample size was too small to 
detect a minor effect on viability. Tetracycline-mediated developmental differences 
(repression) were not detected for any line, except for a small but marginally significant 
result for WT control (n=29 [NT=14, T=15], X2 =4.33, p=0.04[1]). This may indicate a 
genuine, tetracycline-mediated developmental delay; the impenetrant line 
OX5195(2)AR had a similar result (marginally non-significant, n=27 [NT=11, T=16], 
X2 =3.23, p=0.07[1]). However, the effect of small sample size and the possibility that a 
proportion of eggs were recently laid rather than undeveloped cannot be excluded. 
Hence, future assays would be improved by applying a larger sample size and a smaller 
window of collection (10-30 minute cycles rather than 4 hours). 
Table 5.10: Early embryonic development is arrested in OX5195(2)AU 
Line Embryo development Significance testing  
 NT T NT  T  Repression 
 Developed Not Developed Not X2 P[df] X2 P[df] X2 P[df] 
5195(2)AU1 0 12 2 8 26.0 <0.001[1] 6.84 0.009[1] 2.64 0.10[1] 
5195(2)AI1 11 2 12 3 2.33 0.13[1] 0.19 0.67[1] 0.10 0.75[1] 
5195(2)AR2 11 0 12 4 0.01 0.95[1] 0.01 0.92[1] 3.23 0.07[1] 
WT 14 0 11 4     4.33 0.04[1] 
Correction-free chi-square testing was performed on the number of individuals from each phenotypic 
category, relative to the appropriate WT control (NT or T). Repression was calculated by chi-square 
testing the number of individuals from each phenotypic category, between the [NT] and [T] observations 
for each line. 
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 The extent of late embryonic development (20-24 hours) was not as expected 
(Table 5.11, Figure 5.7). Despite early developmental delay (0-4 hours) in progeny of 
OX5195(2)AU1[NT] males, morphologically normal embryos were frequently 
observed (46%). It was not expected that development would proceed to such a late 
stage, given that embryos in the early assay (0-4 hours) did not generally appear to 
exhibit cellular divisions. Nonetheless, viability was significantly reduced relative to 
WT controls, both off-tet (n=24, X2 =11.1, p=0.004[1]) and on-tet (n=20, X
2 =11.7, 
p=0.003[1]). There was no significant difference in development for embryos of the 
semi-penetrant line OX5195(2)AI1, relative to WT controls (off-tet or on-tet). This was 
unexpected, as progeny of OX5195(2)AI1[NT] males demonstrated reduced hatch rate. 
Again, it is possible that the sample size was too small to detect a minor effect, or that 
the developmental arrest that underpinned a reduction in hatch rate tended to occur at a 
later stage than that assessed. As expected, the impenetrant line OX5195(2)AR2 did not 
differ significantly from controls. Tetracycline-mediated repression (improved viability 
in progeny of on-tet reared males) was only detected for OX5195(2)AI1 (n=40 [NT=20, 
T=20], X2 =10.0, p=0.007[1]), as expected from the observation that tetracycline rescued 
embryonic viability, in the prior hatch assay. No significant effect of tetracycline on WT 
development was observed (n=40 [NT=20, T=20], X2 =1.56, p=0.046[1]). This indicates 
that the differences in viability between WT[NT] and WT[T] in the prior assay (0-4 
hours), were likely to be artefactual.  
 
Table 5.11: Late embryonic development is arrested in OX5195(2)AU and rescued 
by tetracycline in OX5195(2)AI 
Line Embryo development Significance testing  
 NT T NT  T  Repression 
 ND A N ND A N X2 P[df] X2 P[df] X2 P[df] 
5195(2)AU1 9 4 11 5 10 5 11.1 0.004[1] 11.7 0.003[1] 5.65 0.06[1] 
5195(2)AI1 0 8 12 0 0 20 4.80 0.091[1] 5.71 0.06[1] 10.0 0.007[1] 
5195(2)AR2 2 0 18 0 0 20 4.0 0.14[1] 5.71 0.06[1] 2.11 0.35[1] 
WT 0 2 18 0 5 15     1.56 0.46[1] 
The assessment of statistical significance was conducted as described in the above table. Abbreviations: 
ND (no development), A (morphologically aberrant); or N (morphologically normal).  
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 The extent of post-blastodermal development in OX5195(2)AU was surprising, 
as we did not expect that a genome sufficiently damaged to block larval hatching would 
mediate organogenesis. It is likely that the maternal haploid genome is minimally 
affected (by degradation of protamine-FokI or titration by binding to paternal DNA) and 
hence can maintain partial development. Interestingly, a variety of mutants are known 
in D. melanogaster, wherein the paternal genome is prevented from mediating 
embryonic development. These may be maternal-effect (maternal haploid and sésame)  
or paternal-effect (sneaky and misfire). In homozygous maternal haploid (mh) mutants, 
the paternal chromatids do not form functional centrosomes. They are excluded in 
subsequent divisions, and a substantial proportion of embryos develop as haploid 
gynogenetic embryos from the maternal genome. About 22% reach a late stage of 
embryonic development, with cuticular deposition; however, none hatch (Loppin et al., 
2001). sésame is required for the decondensation of sperm chromatin; in mutants, the 
paternal DNA is excluded from subsequent divisions. Although hatching is not 
observed, the majority (72%) proceed to late embryonic development and form a 
cuticle; about 7% arrest in early development (Loppin et al., 2000). It is interesting to 
note that we observed organogenesis in a similar proportion, 15/24 (63%) of 
OX5195(2)AU1[NT] embryos at 20-24 hours. However, the frequency of early arrest 
(0-4 hours) was greater (no development in 9/24 [37%] of embryos). Sneaky and misfire 
mutants appear to be defective in the breakdown of the sperm plasma membrane upon 
entry into the egg, and the majority do not develop whatsoever. Interestingly, about 1% 
of embryos hatch, similar to the rate reported for OX5195(2)AU1, though the mode of 
action is clearly different. This is because OX5195(2)AU1 embryos frequently arrest in 
later development, rather than the first division (Fitch and Wakimoto, 1998), (Ohsako et 
al., 2003).  
 
 Although it is clear that Ccprot1-FokI expression induces double-stranded 
breaks sufficiently to prevent development to the larval stage, this is not sufficient to 
mediate early arrest, in the majority of instances. Aneuploidy is frequently observed in 
mh embryos, which nonetheless frequently develop as haploid embryos (Loppin et al., 
2001). From this observation, even severe paternal chromosomal aberrations resulting 
in aneuploidy, will not arrest embryonic development in every instance. This indicates 
that should an earlier arresting phenotype be desirable, that fragmentation of the 
paternal genome is not sufficient. Though this extent of late development was not 
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expected, it is not inherently problematic, because only 1% of embryos from crosses of 
WT females to heterozygous OX5195(2)AU1 transgenic males hatched. Viable adult 
progeny were never observed in crosses of heterozygous transgenic males (reared off-tet 
or on-tet), suggesting that the 1% of individuals that hatched died at a later stage 
(probably larval, as pupae were never observed). Of course, this would need to be 
confirmed by a replicated pupation and eclosion assay, for the observation to be fully 
valid.  
 
 From these results, it was not possible to determine if the undeveloped embryos 
resulted from an early paternal effect lethal phenotype; or if they were instead 
unfertilised (potentially as a consequence of deficient sperm transfer). To confirm the 
mode of sterility in these instances, it would be theoretically possible to determine if the 
male haploid nucleus was present using sensitive PCR techniques such as digital PCR 
(Ottesen et al., 2006). Alternatively, it would be interesting to determine if the whole 
sperm tail enters the egg as it does in D. melanogaster, as this would facilitate staining 
the egg to visualise the sperm tail (Karr, 1991). Fusions of GFP to don-juan (dj), a 
sperm tail protein have been developed in D. melanogaster (Santel et al., 1997), though 
we were unable to find a homologue in Medfly (NCBI, 2016). Alternatively, it may be 
possible to visualise the male haploid nucleus by Ccprot1-zsGreen (the fluorescent 
sperm marker) localisation. We did not image the embryos under the green filter; it 
would be interesting to determine if this was visible. 
 
 Improvements for future application of this assay are suggested. The sample size 
should be increased. Scoring more than 100 embryos would reduce probability of 
artefactual effects, which was indicated in two instances. First, progeny of WT[NT] 
males developed marginally better than WT[T] equivalent (early development: 0-4 
hours). Second, embryos of the semi-penetrant line OX5195(2)AI1 were marginally 
more viable on-tet than the WT control (though this result was not statistically 
significant). No reasonable biological basis could be ascribed to these findings, 
indicating that they are artefactual. Furthermore, shorter collection cycles should be 
performed. Across four hours, development differs considerably and may reduce 
scoring accuracy. This was pertinent for early scoring (0-4 hours), where certain eggs 
were possibly recently laid. Absence of undeveloped eggs in the WT [NT] control 
indicates this was not frequent. However, performing 10-30 minute collections and 
ageing to the desired stage would eliminate this possibility; and narrow the range of 
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development between embryos. It would also be useful assess later stages of 
development (> 24 hours). The penetrant line OX5195(2)AU1 demonstrates a 1% hatch 
rate; it would be interesting to investigate later embryonic development, which is clearly 
not arrested in every instance. Finally, the accuracy of scoring could be improved with 
proper staging. Early embryos (0-4 hours) were classed as developed/undeveloped, 
without respect to the number of divisions present. Late embryos (20-24 hours) were 
scored as morphologically normal, morphologically aberrant, or no visible 
development. Therefore, these classifications spanned very broad stages of embryonic 
development, and are vague in comparison with the stage classifications possible by 
other models, such as the 17-stage model widely used in D. melanogaster (Campos-
Ortega and Hartenstein, 1997). It would also be useful to pair the assessments of 
embryonic development, with quantitative molecular techniques. A molecular assay, 
such as qPCR estimation of genomic copy number, might enhance sensitivity. 
Comparable methods have been applied to quantify the number of viral genomes within 
insect tissue to determine the likelihood of infectiousness (Walker et al., 2011), (Bian et 
al., 2013).  
 
5.2.7 Modification of the Ccprot1-FokI and Ccprot2-FokI male sterility effectors to 
engineer repressibility 
 Next, we considered the potential factors mediating non-repressibility in 
OX5195 and revised construct design, to develop a tetracycline-repressible variant. 
First, we considered if repressibility might be insertion sensitive, which has been 
observed for tetracycline-repressible transgenic systems developed at Oxitec. An A. 
albopictus flightless line was non-repressible in about 20% of lines (Labbé et al., 2012). 
However, failure to isolate a single penetrant and repressible candidate from a panel of 
11 lines, indicates a non-repressible expression pattern that cannot be attenuated by 
insertion. Next, we considered if the dosage of tetracycline was inadequate to repress 
transcription of tetO-Ccprot1 full 5’UTR-FokI. Full repression of sterility in semi-
penetrant lines (OX5195(2)AI1 & BG1) indicated that the system was partially 
responsive to tetracycline. Similarly, q-RT-PCR analysis indicated partial repression of 
Ccprot1-full 5’UTR-FokI expression in the penetrant but non-repressible line 
OX5195(2)AU1, though to an insufficient extent to restore fertility. Possibly, higher 
dosage or stronger analogues (eg. doxycycline) could promote repression (Curtis et al., 
2015). Recently, an expression system in D. suzukii with a similar male sterility effector 
(tetO21-hsp70-Dmprot1-FokI) and transcriptional activator (Dmβ2T-Dmhsp83-tTAV) 
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was sterile but not repressible. A five-fold excess of tetracycline, relative to the standard 
Medfly rearing concentration (500 ng/μl), did not attenuate this effect (Megas et al., 
unpublished data). Furthermore, the same dosage of tetracycline applied in the 
OX5195(2) male sterility experiments (100 ng/μl), provided full repression of sterility 
in previously developed systems (OX4353/4718; Figure 3.2 and Figure 3.5). As the 
β2T-tTAV-tetO21-Dmhsp70 minipromoter fragment driving Dmprot2-chimeric-FokI 
was essentially identical (the Dmhsp70 5’UTR was shortened from 89 to 21 bp), it 
appeared likely that sequences within Ccprot1-FokI reduced repressive capacity.  
 
 The interaction of tTAV with tetO21-minimal promoter is required for 
transcriptional activation, and this is displaced by tetracycline (Gossen, 1992). 
Consequently, if a downstream promoter element is present (for example in the 5'UTR), 
it could potentially act independently of the tet-repressible system. The observed 
tetracycline-mediated, three-fold reduction in OX5195(2)AU1 transcript was consistent 
with this model; as was the indication of potential downstream transcriptional start sites 
(TSS) by 5’RACE on Ccprot1-zsGreen (Section 4.4.1). In D. melanogaster, sequences 
within the 5’UTR can enhance transcription in the male germline (Kempe et al., 1993). 
Therefore, we reasoned that shortened Ccprot1 or Ccprot2 5’UTRs were likely to 
provide repressible FokI expression. We attempted to engineer repressibility by 
shortening the Ccprot1 and Ccprot2 5’UTRs to a more minimal sequence (the furthest 
downstream TSS, as indicated by 5’RACE or NCBI high-throughput transcript 
sequencing data). This theory was tested by generating constructs applying truncated 
5’UTR sequences (Figure 5.8): OX5242 (Ccprot1-short 5’UTR-FokI) and OX5241 
(Ccprot2-short 5’UTR-FokI).  
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5.3 Heterozygous OX5241 (Ccprot2-short 5’UTR-FokI) males are irrepressibly 
sterile in penetrant insertions  
 
5.3.1 Establishment of OX5241 transgenic lines 
 Microinjection (Table 5.12), backcrossing to WT (Table 5.13), screening for 
transient expression of the transformation marker and Mendelian assessment of 
transgenic lines were largely as described for OX5195. Buffered mixes contained 
tetracycline (100 ng/μl), OX5241 (600 ng/μl), and piggyBac DNA helper OX3022 and 
RNA helper OX3081 (300 ng/μl each). Transient AlMAct-dsRed2 expression was 
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observed in G0 pupae, indicating successful microinjection. Adult survival (16%) was 
slightly reduced compared to typical results for injection of Medfly (25%) (Gregory et 
al., 2016). Transformation efficiency was low (1.2%), but typical for a very large 
construct (OX5195/OX5242/5257 microinjections [Sections 5.2, 5.4, 5.5]).  
 
Table 5.12 Microinjection logistics for OX5241 
Embryos Larvae Pupae Adults Lines 
2715 782 (29%) 492 (18%) 429 (16%) 5 (1.2%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed).  
 
Table 5.13 G0 backcrosses to establish OX5241 lines 
OX5241A 10 ♂ x 30 WT ♀ OX5241B 6 ♂ x 30 WT ♀ OX5241C 10 ♀ x 10 WT ♂ 
OX5241D 10 ♂ x 30 WT ♀ OX5241E 9 ♂ x 30 WT ♀ OX5241F 8 ♀ x 8 WT ♂ 
OX5241G 8 ♀ x 8 WT ♂ OX5241H 8 ♂ x 30 WT ♀ OX5241I 7 ♂ x 30 WT ♀ 
OX5241J 7 ♀ x 7 WT ♂ OX5241K 7 ♀ x 7 WT ♂ OX5241L 20 ♀ x 10 WT ♂ 
OX5241M 10 ♂ x 30 WT ♀ OX5241N 10 ♂ x 30 WT ♀ OX5241O 4 ♂ x 30 WT ♀ 
OX5241P 10 ♂ x 30 WT ♀ OX5241Q 5 ♂ x 30 WT ♀ OX5241R 10 ♀ x 10 WT ♂ 
OX5241S 19 ♀ x 10 WT ♂ OX5241T 9 ♂ x 30 WT ♀ OX5241U 10 ♂ x 30 WT ♀ 
OX5241V 7 ♂ x 30 WT ♀ OX5241W 20 ♀ x 10 WT ♂ OX5241X 11 ♂ x 30 WT ♀ 
OX5241Y 11 ♂ x 30 WT ♀ OX5241Z 11 ♂ x 30 WT ♀ OX5241AA 10 ♂ x 30 WT ♀ 
OX5241AB 22 ♀ x 10 WT ♂ OX5241AC 20 ♀ x 10 WT ♂ OX5241AD 19 ♀ x 10 WT ♂ 
OX5241AE 23 ♀ x 10 WT ♂ OX5241AF 13 ♂ x 30 WT ♀ OX5241AG 13 ♂ x 30 WT ♀ 
OX5241AH 13 ♂ x 30 WT ♀ OX5241AI 14 ♂ x 30 WT ♀ OX5241AJ 8 ♂ x 30 WT ♀ 
OX5241AK 17 ♀ x 10 WT ♂     
Underlined crosses gave rise to transgenic lines.  
 
5.3.2 OX5241 transgenic G1 male individuals are frequently infertile  
 Five transgenic pools were isolated: OX5241F, AA, AB, AC, & AK. As a 
preliminary test of repressibility, males and females from each pool were independently 
crossed to WT. All rearing and crosses were performed in the presence of tetracycline. 
Eggs were filtered to diet (day 7) and qualitatively scored for development (day 12). 
Spermathecae of females mated to transgenic males were dissected and scored for 
marked sperm (day 7), an indicator of penetrance (at Oxitec). A detailed investigation of 
fluorescent sperm marking was not pursued because no lines provided a commercially 
applicable phenotype (penetrant and repressible sterility). 
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 Infertility of male G1 individuals was observed in three of the four pools where 
males were present (OX5241AA, AB & AK). Females in all four of the four pools 
where females were present (OX5241F, AB, AC & AK) were fertile (Table 5.14). 
Males were absent in OX5241AC and females absent in OX5241AA. Interestingly, 
OX5241AB1 (♂) appeared semi-fertile, when reared on tetracycline. Transgenic males 
transferred sperm to WT females on mating, in all cases. Fluorescent marking in sperm 
nuclei was observed in OX5241AA1, AB1 & AK1 (infertile individuals); but not 
OX5241F3 (fertile individual). Therefore, as with OX5195 (Ccprot1-full 5’UTR-FokI), 
penetrance of the male sterility phenotype and sperm marking appeared to be correlated 
(Figure 5.9). We performed further analysis in the G2 generation for lines OX5241F3, 
AB1, AC2, and AK3 (the male infertile OX5241AA1 insertion was lost). All lines 
except OX5241F3 were established from females (because the males were infertile). 
Given the low transformation efficiency of the construct, it was assumed that males and 
female transgenic individuals of the same pool had the same transgenic insertion, and 
therefore hypothesised that all penetrant lines would be confirmed non-repressible.  
 
Table 5.14: Fertility of OX5241 transgenic G1 individuals 
G1 individual Sex Fertile Sperm marking Apparent phenotype 
  
   
OX5241F3 ♂ 
Yes No Impenetrant male sterility, no 
fluorescent sperm marking 
OX5241AB1 ♂ 
Partially Yes Semi-penetrant male sterility with 
fluorescent sperm marking 
OX5241AA1 ♂ 
No Yes Penetrant but non-repressible male 
sterility with fluorescent sperm 
marking OX5241AK1 ♂ No Yes 
OX5241F1 ♀ Yes   
OX5241AB3 ♀ Yes   
OX5241AC2 ♀ Yes   
OX5241AK3 ♀ Yes   
Boldface crosses were used to establish permanent transgenic lines for further phenotypic analysis.  
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5.3.3 OX5241 lines with penetrant male sterility are not repressible 
 Mendelian properties of each insertion were assessed as previously described 
(Table 5.15). OX5241F3 was a single X-linked insertion; OX5241AB1 was autosomal; 
the others were not determined (sex-linkage is not evident from crosses of transgenic 
females). The penetrance and repressibility of the male sterility phenotype were 
assessed by egg hatch assay, essentially as described for OX5195(2) [Section 5.2.3]. 
Five heterozygous males of each treatment (non-tet or tet reared) were independently 
crossed to ten non-tet reared WT females. Controls were equivalent crosses with WT 
males and WT females. 24 hour egg collections (n=100 eggs) were performed on day 5, 
6 and 7 post-cross. Statistical assessment was as described for OX5195(2).  
 
 
Table 5.15 Mendelian analysis of established OX5241 transgenic lines 
Line Sex Copy number Sex-linkage Summary 
  Transgenic (%)  n Ratio (M/F) n Copies Location 
OX5241F3 ♂ 47 437 Female only 
86 1 X 
OX5241AB1 ♂ 48 83 2.5 
28 1 Autosome 
OX5241AC2 ♀ 47 199 1 81 1 Unknown 
OX5241AK3 ♀ 52 113 1.4 60 1 Unknown 
All transgenic insertions appeared to be single copy. OX5241F3 was X-linked and OX5241AB1 was 
autosomal. It was not possible to assess sex-linkage of 5241AC2 and AK3 because insertions were male 
infertile. “n”: number of individuals assessed.  
 
 
 The assay results generally recapitulated the phenotypes indicated by the 
presence of infertile males in the G1 transgenic crosses (Tables 5.16-5.17 & Figure 
5.10). One line was impenetrant (OX5241F3); three were fully penetrant but not 
repressible (OX5241AB1, AC2 and AK3). Full penetrance of OX5241AB1 was not 
expected, because its transgenic male founder was semi-fertile. The reason for this 
discrepancy was not obvious, because all previous male sterility phenotypes were 
generationally stable. Ccprot2-short 5’UTR-FokI (OX5241) appeared stronger than 
Ccprot1-full 5’UTR-FokI (OX5195). All lines of OX5241 demonstrating a reduction in 
egg viability were > 99% penetrant (only 1/5 lines for OX5195); and semi-penetrant 
lines were not observed (2/5 lines for OX5195). No further assessment was performed 
because the lines were not commercially valuable. We concluded that Ccprot2-short 
5’UTR-FokI requires modification if applied further; and that uncharacterised factors 
underpinning a generational variation in transgenic phenotype are possible 
(OX5241AB1). 
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Table 5.16 Penetrance and repressibility of male sterility in OX5241 heterozygous 
males 
Line Mean hatch rate (± SE) Penetrance Repressibility 
 NT T % X2 P[df] %  X2  P[df] 
OX5241AC2 0  0  100  176.3  <0.001[1] 0 153.0  <0.001[1] 
OX5241AB1 0.3 ± 0.33 0.3 ± 0.33 99.6 175.1  <0.001[1] 0.38 151.9  <0.001[1] 
OX5241AK3  0.7 ± 0.47 0  99.3 173.5  <0.001[1] 0 153.0  <0.001[1] 
OX5241F3 92.3 ± 1.54 89.3 ± 1.78 1.4 0.150 0.698[1] 100 0.320 0.572[1] 
WT 93.7 ± 1.41 86.7 ± 1.96       
Penetrance and repressibility were calculated relative to their respective control hatch rate, WT [NT] or 
[T]. Significance values were from chi-square tests of the numbers of hatched and unhatched eggs, 
relative to the respective values for the control (WT [NT] or [T]).  
 
 
Table 5.17 Extent of repressibility of male sterility in OX5241 lines 
Line Mean difference of hatch rates [NT – T] (%) Significance 
   X2  P[df] 
OX5241AC2 0 0 1[1] 
OX5241AB1 0 0 1[1] 
OX5241AK3  -0.7 0.70 0.40[1] 
OX5241F3 -3.0 0.53 0.46[1] 
WT -7.0 2.77 0.10[1] 
The difference of the mean hatch rate for [NT] and [T] reared males of each line was calculated. 
Significance testing was performed with chi-square tests of the numbers of hatched and unhatched eggs, 
between the [NT] and [T] reared individuals of each line. Penetrant lines were not repressible.  
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5.4 Heterozygous OX5242 (Ccprot1-short 5’UTR-FokI) males have a mostly 
repressible sterility phenotype  
 
5.4.1 Establishment of OX5242 transgenic lines  
 Microinjection (Table 5.18), backcrossing to WT (Table 5.19), screening for 
transient expression of the transformation marker, and Mendelian assessment of 
transgenic lines were essentially as described for OX5195/5241. Buffered mixes 
contained tetracycline (100 ng/μl), OX5242 (600 ng/μl), and piggyBac DNA helper 
OX3022 (300 ng/μl). RNA helper OX3081 was not used (there was no high quality 
RNA available at the time). Transient AlMAct-dsRed2 expression was observed in G0 
pupae, indicating successful microinjection. Adult survival (25%) was exactly average, 
compared to typical results for injection of Medfly (Gregory et al., 2016). Two rounds 
of injection were performed, denoted (1) or (2). Transformation efficiency was very 
poor in the first injection set (0.23%). There was insufficient time to assess OX5242(2) 
lines.  
 
Table 5.18 Microinjection logistics for OX5242 
Round Embryos Larvae Pupae Adults Lines 
1 1100 648 (59%) 463 (42%) 422 (38%) 1 (0.23%) 
2 2210 887 (40%) 482 (22%) 404 (18%) 3 (0.74%) 
Both 3310 1535 (46%) 945 (29%) 826  (25%) 4 (0.48%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed).  
 
 
Table 5.19 G0 backcrosses to establish OX5242 lines 
OX5242(1)A 8 ♂ x 30 WT ♀ OX5242(1)B 7 ♂ x 30 WT ♀ OX5242(1)C 20 ♀ x 10 WT ♂ 
OX5242(1)D 21 ♀ x 10 WT ♂ OX5242(1)E 21 ♀ x 10 WT ♂ OX5242(1)F 21 ♀ x 10 WT ♂ 
OX5242(1)G 20 ♀ x 10 WT ♂ OX5242(1)H 20 ♀ x 10 WT ♂ OX5242(1)I 20 ♀ x 10 WT ♂ 
OX5242(1)J 11 ♂ x 30 WT ♀ OX5242(1)K 11 ♂ x 30 WT ♀ OX5242(1)L 11 ♂ x 30 WT ♀ 
OX5242(1)M 11 ♂ x 30 WT ♀ OX5242(1)N 11 ♂ x 30 WT ♀ OX5242(1)O 11 ♂ x 30 WT ♀ 
OX5242(1)P 10 ♂ x 30 WT ♀ OX5242(1)Q 10 ♂ x 30 WT ♀ OX5242(1)R 10 ♂ x 30 WT ♀ 
OX5242(1)S 10 ♂ x 30 WT ♀ OX5242(1)T 10 ♂ x 30 WT ♀ OX5242(1)U 10 ♂ x 30 WT ♀ 
OX5242(1)V 18 ♀ x 10 WT ♂ OX5242(1)W 18 ♀ x 10 WT ♂ OX5242(1)X 18 ♀ x 10 WT ♂ 
OX5242(1)Y 9 ♂ x 30 WT ♀ OX5242(1)Z 9 ♂ x 30 WT ♀ OX5242(1)AA 9 ♂ x 30 WT ♀ 
OX5242(1)AB 9 ♂ x 30 WT ♀ OX5242(1)AC 10 ♂ x 30 WT ♀ OX5242(1)AD 20 ♀ x 10 WT ♂ 
OX5242(1)AE 8 ♂ x 30 WT ♀ OX5242(1)AF 10 ♂ x 30 WT ♀ OX5242(2)A 10 ♂ x 30 WT ♀ 
OX5242(2)B 10 ♂ x 30 WT ♀ OX5242(2)C 8 ♂ x 30 WT ♀ OX5242(2)D 16 ♀ x 8 WT ♂ 
OX5242(2)E 16 ♀ x 8 WT ♂ OX5242(2)F 10 ♂ x 30 WT ♀ OX5242(2)G 10 ♂ x 30 WT ♀ 
OX5242(2)H 10 ♂ x 30 WT ♀ OX5242(2)I 10 ♂ x 30 WT ♀ OX5242(2)J 10 ♂ x 30 WT ♀ 
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OX5242(2)K 10 ♂ x 30 WT ♀ OX5242(2)L 8 ♂ x 30 WT ♀ OX5242(2)M 20 ♀ x 10 WT ♂ 
OX5242(2)N 18 ♀ x 10 WT ♂ OX5242(2)O 18 ♀ x 10 WT ♂ OX5242(2)P 18 ♀ x 10 WT ♂ 
OX5242(2)Q 9 ♂ x 30 WT ♀ OX5242(2)R 8 ♂ x 30 WT ♀ OX5242(2)S 8 ♂ x 30 WT ♀ 
OX5242(2)T 8 ♂ x 30 WT ♀ OX5242(2)U 12 ♀ x 10 WT ♂ OX5242(2)V 11 ♀ x 10 WT ♂ 
OX5242(2)W 30 ♀ x 10 WT ♂ OX5242(2)X 10 ♂ x 30 WT ♀ OX5242(2)Y 10 ♂ x 30 WT ♀ 
OX5242(2)Z 9 ♀ x 5 WT ♂ OX5242(2)AA 7 ♂ x 21 WT ♀ OX5242(2)AB 10 ♂ x 30 WT ♀ 
OX5242(2)AC 10 ♂ x 30 WT ♀ OX5242(2)AD 23 ♀ x 12 WT ♂ OX5242(2)AE 2 ♂ x 15 WT ♀ 
OX5242(2)AF 10 ♂ x 24 WT ♀ OX5242(2)AG 9 ♀ x 5 WT ♂ OX5242(2)AH 8 ♂ x 25 WT ♀ 
OX5242(2)AI 7 ♂ x 25 WT ♀ OX5242(2)AJ 11 ♀ x 10 WT ♂   
Underlined crosses gave rise to transgenic lines. 
 
5.4.2 Heterozygous OX5242(1)H1 males demonstrate penetrant and mostly 
repressible sterility 
  The single transgenic G1 individual isolated from the first round of 
microinjections (OX5242(1)H1) was a fertile female. The second round of injection was 
not assessed at the time of writing. Mendelian analysis was performed using a 
transgenic G2 male backcrossed to WT (Table 5.20). G2 females were backcrossed to 
WT males and filtered on- and off-tetracycline to assess G3 progeny for a penetrant and 
repressible male sterility phenotype by egg hatch assay, as described for OX5241. 24 
hour egg collections (100 eggs) were performed on day 5, 6 and 7 post-cross; 
significance testing was as previously described. The OX5242(1)H1 male sterility 
phenotype was penetrant (99%) and mostly repressible (81%); the reductions in egg 
hatch rate of progeny of transgenic males reared off-tet and on-tet were significant (p < 
0.001) relative to off-tet and on-tet reared WT controls (Table 5.21, Table 5.22, Figure 
5.11). Mean hatch rates differed (p < 0.001) between off-tet and on-tet reared 
OX5242(1)H1, but not WT, indicating that repressibility was significant but 
incomplete, and that viability differences were not mediated by an independent effect of 
tetracycline itself. 
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Table 5.20 Mendelian analysis of OX5242(1)H1 
Line Sex Copy number Sex-linkage Summary 
  Transgenic (%)  n Ratio (M/F) n Copies Location 
OX5242(1)H1 ♂ 47 675 1.0 281 1 Autosome 
 
 
Table 5.21 Penetrance and repressibility of male sterility in OX5242(1)H 
heterozygous males  
Line Mean hatch rate (± SE) Penetrance Repressibility 
 
 NT T % X2 P[df] %  X2  P[df] 
OX5242(1)H 1.3 ± 0.66 73.7 ± 2.54 99 169.8 < 0.001[1] 81 10.3 0.001[1] 
WT 93.3 ± 1.44 91.0 ± 1.65         
Penetrance and repressibility were calculated relative to their respective control hatch rate, WT [NT] or 
[T]. Significance values were from chi-square tests of the numbers of hatched and unhatched eggs, 
relative to the respective values for the control (WT [NT] or [T]).  
 
Table 5.22 Extent of repressibility of male sterility in OX5242 lines 
Line Mean difference of hatch rates [NT – T] (%) Significance 
   X2  P[df] 
5242(1)H  72.3 111.8  < 0.001[1] 
WT  -2.3 0.37 0.55 
The difference of the mean hatch rate for [NT] and [T] reared males of each line was calculated. 
Significance testing was performed with chi-square tests of the numbers of hatched and unhatched eggs, 
between the [NT] and [T] reared individuals of each line.  
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5.4.3 Heterozygous OX5242(1)H1 males transfer fluorescently marked sperm to 
mated females, but there is a reduction in quantity and motility  
 The nuclear localisation of the Ccprot1-zsGreen fluorescent sperm marker, and 
the quantity and motility of OX5242(1)H1 sperm transferred upon mating, were next 
assessed. Equivalent crosses to the egg hatch assay were initiated. Spermathecae of the 
WT females were dissected 7 days later at Cardiff University, as previously described 
for OX5195 (Section 5.2.3). We estimated the quantity of sperm present and their 
motility and appearance (ten individuals from each group). Sperm transfer and motility 
were markedly reduced in OX5242(1)H1[NT] relative to OX5242(1)H1[T], WT[NT] 
and WT[T] (Figure 5.12). However, the transfer of detectably marked sperm was an 
improvement on the prior design (OX4718). For the OX5242(1)H1[NT] crosses, sperm 
were detected in 14/14 instances (> 100 sperm in 6/14 instances); for OX4718A-res 
[NT], sperm were detected in 4/16 instances (> 100 sperm were not detected in any 
instance). For reference, in the WT[NT] and WT[T] crosses, >100 sperm were detected 
in 9/10 and 10/10 instances, respectively. We did not detect any effects on the 
morphology of sperm of OX5242(1)H1 males. In some instances, sperm that appeared 
to have been crushed by the cover slip were observed; but these were also present in the 
WT samples. It would be interesting to perform further investigation at a higher 
magnification, and with a haemocytometer or similar device that would not risk 
crushing any cells under investigation, to completely exclude the possibility of 
morphological differences. 
 
 For the OX5242(1)H1[T] crosses, sperm were observed in every instance 
(12/12); more than 100 were present in 11/12 instances. This provided further evidence 
that reducing the expression of Ccprot1-short 5’UTR-FokI increased the quantity of 
sperm transferred upon mating. Consistent with the incomplete repression observed in 
the egg hatch assay, the number of sperm transferred appeared to be slightly reduced 
relative to the WT[T] crosses. However, it should be noted that it was not possible to 
precisely confirm a non-profound effect on the quantity of sperm transfer under these 
experimental conditions (squashes of spermathecae containing live sperm, directly 
observed at 10-40x magnification). More precise quantification is possible with stained 
samples under high magnification (Taylor et al., 2000). However, the technique is 
laborious and prone to inaccuracy due to the tendency of sperm to aggregate, and the 
necessity to accurately dilute samples for counting (Yuval et al., 1996). PCR-based 
strategies to quantify sperm by amplification of male-specific sequences are known, for 
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instance in the Tephritid pest A. suspensa (Fritz et al., 2010), (Doyle et al., 2011). 
Should it be necessary to correlate the number of sperm transferred with female 
tendency to re-mate, it would be interesting to develop a similar method for Medfly, 
which does not appear to exist currently.  
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  5.4.4 The OX5242(1)H1 transgenic insertion is homozygous viable 
 Tet-reared OX5242(1)H1 heterozygous males (n=3) and females (n=3) were 
crossed and F1 progeny filtered from two egg collections, on-tet. Chi-square testing was 
performed on the observed and expected ratios of transgenic progeny (25% WT 
progeny are expected from a cross of two individuals heterozygous for a dominant 
trait). Both rears were assessed for significant variance prior to pooling; none was 
detected (X2 = 1.553, df = 1, p = 0.2127). The results indicated homozygous viability; 
about 75% of progeny were transgenic (Table 5.23).   
Table 5.23 Homozygous viability of OX5242(1)H1 
 Fluorescent marker inheritance in F1 progeny    
 
 
Fluorescent Not fluorescent Total X2 P[df] 
 Observed Expected Observed Expected    
OX5242(1)H 201 (78.5%) 192 (75%) 55 (21.5%) 64 (25%) 256 0.887 0.35[1] 
 
5.5 Heterozygous OX5257V1 (Dmprot2-chimeric-new-FokI) males have a mostly 
repressible male sterility phenotype 
 OX5257 (Dmprot2-chimeric-new-FokI) was generated as a backup to the 
Ccprot1-short 5’UTR-FokI (OX5242) and Ccprot2-short 5’UTR-FokI (OX5241) 
constructs, to mediate the risk of sequence elements behaving in unpredicted ways. This 
was a modification of a previously evaluated system, Dmprot2-chimeric-old-mCherry-
FokI (OX4718, Figure 3.4), which featured penetrant and repressible sterility but 
lacked motile, fluorescently marked sperm in most instances. Fluorescent sperm 
marking was engineered by addition of the Ccprot1-ZsGreen system, and removal of 
mCherry from the Dmprot2-chimeric-old-mCherry-FokI component of OX4718, 
which functioned poorly in prior investigation (Figure 3.5). This was expected to 
provide fluorescent sperm marking and maintain the prior penetrant and repressible 
male sterility phenotype. To avoid abolishing this phenotype, only two minimal changes 
were performed, as previously described: (1) SV40 3’UTR was substituted for Ccprot2 
3’UTR and (2) the non-functional mCherry marker was removed (Figure 5.13).  
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5.5.1 Establishment of OX5257 transgenic lines  
 Microinjection (Table 5.24), backcrossing to WT (Table 5.25), screening for 
transient expression of the transformation marker, and Mendelian assessment of 
transgenic lines were essentially as described for OX5195/5241/5242. Buffered mixes 
contained tetracycline (100 ng/μl), OX5242 (600 ng/μl), and piggyBac DNA helper 
OX3022 (300 ng/μl). As for OX5241, RNA helper OX3081 was not used. Transient 
AlMAct-dsRed2 expression was observed in G0 pupae. Adult survival (10%) was 
substantially lower than average, compared to typical results for injection of Medfly 
(25%) (Gregory et al., 2016). Phenotypic analysis was largely as for OX5242; 
investigation of three lines (OX5257G, V, & AX) was initiated at the time of writing.  
 
Table 5.24 Microinjection logistics for OX5257 
Embryos Larvae Pupae Adults Lines 
6315 1334 (21%) 693  (11%) 607 (10%) 4 (0.7%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (transgenic lines/G0 adults crossed).  
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Table 5.25 G0 backcrosses to establish OX5257 lines 
OX5257A 7 ♂ x 21 WT ♀ OX5257B 6 ♀ x 6 WT ♂ OX5257C 5 ♂ x 15 WT ♀ 
OX5257D 6 ♀ x 6 WT ♂ OX5257E 2 ♂ x 6 WT ♀ OX5257F 4 ♀ x 4 WT ♂ 
OX5257G 11 ♂ x 30 WT ♀ OX5257H 12 ♀ x 6 WT ♂ OX5257I 6 ♂ x 30 WT ♀ 
OX5257J 7 ♂ x 30 WT ♀ OX5257K 6 ♀ x 3 WT ♂ OX5257L 7 ♂ x 30 WT ♀ 
OX5257M 10 ♀ x 5 WT ♂ OX5257N 11 ♂ x 30 WT ♀ OX5257O 10 ♀ x 5 WT ♂ 
OX5257P 4 ♂ x 15 WT ♀ OX5257Q 7 ♀ x 7 WT ♂ OX5257R 9 ♂ x 30 WT ♀ 
OX5257S 8 ♂ x 30 WT ♀ OX5257T 10 ♀ x 5 WT ♂ OX5257U 7 ♂ x 30 WT ♀ 
OX5257V 7 ♀ x 4 WT ♂ OX5257W 6 ♂ x 18 WT ♀ OX5257X 11 ♀ x 6 WT ♂ 
OX5257Y 12 ♂ x 30 WT ♀ OX5257Z 17 ♀ x 9 WT ♂ OX5257AA 11 ♂ x 30 WT ♀ 
OX5257AB 10 ♂ x 30 WT ♀ OX5257AC 13 ♀ x 7 WT ♂ OX5257AD 8 ♂ x 30 WT ♀ 
OX5257AE 8 ♀ x 4 WT ♂ OX5257AF 12 ♂ x 30 WT ♀ OX5257AG 6 ♀ x 3 WT ♂ 
OX5257AH 8 ♂ x 30 WT ♀ OX5257AI 9 ♂ x 30 WT ♀ OX5257AJ 16 ♀ x 6 WT ♂ 
OX5257AK 8 ♂ x 25 WT ♀ OX5257AL 7 ♀ x 4 WT ♂ OX5257AM 8 ♂ x 25 WT ♀ 
OX5257AN 7 ♂ x 25 WT ♀ OX5257AO 18 ♀ x 9 WT ♂ OX5257AP 10 ♂ x 30 WT ♀ 
OX5257AQ 10 ♂ x 30 WT ♀ OX5257AR 18 ♀ x 9 WT ♂ OX5257AS 10 ♂ x 30 WT ♀ 
OX5257AT 10 ♂ x 30 WT ♀ OX5257AU 10 ♂ x 30 WT ♀ OX5257AV 11 ♂ x 30 WT ♀ 
OX5257AW 14 ♀ x 10 WT ♂ OX5257AX 17 ♀ x 10 WT ♂ OX5257AY 5 ♂ x 15 WT ♀ 
OX5257AZ 8 ♂ x 30 WT ♀ OX5257BA 7 ♂ x 30 WT ♀ OX5257BB 11 ♀ x 10 WT ♂ 
OX5257BC 14 ♀ x 7 WT ♂ OX5257BD 10 ♂ x 29 WT ♀ OX5257BE 4 ♂ x 12 WT ♀ 
OX5257BF 8 ♂ x 30 WT ♀ OX5257BG 7 ♂ x 30 WT ♀ OX5257BH 7 ♂ x 30 WT ♀ 
OX5257BI 12 ♀ x 7 WT ♂ OX5257BJ 12 ♀ x 7 WT ♂ OX5257BK 20 ♀ x 10 WT ♂ 
OX5257BL 10 ♂ x 30 WT ♀ OX5257BM 5 ♂ x 15 WT ♀   
Underlined crosses gave rise to transgenic lines.  
 
5.5.2 OX5257 transgenic G1 male individuals are fertile  
 G1 transgenic backcrosses were monitored for fertility and the presence of 
fluorescently marked sperm (Table 5.26, Figure 5.14). All microscopy was performed 
at Oxitec, as previously described. Males and females were fertile in all instances. 
Stable heterozygous transgenic lines were established from individuals OX5257B1, G1, 
V1 and AX1. Mendelian properties of each insertion were assessed (Table 5.27). There 
was insufficient time to investigate in detail the post-mating sperm transfer phenotype at 
Cardiff University. The OX5257G1 insertion was y-linked and not assessed further; 
evaluation proceeded for OX5257B1, V1 & AX1. 
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Table 5.26 Fertility of OX5257 transgenic G1 individuals 
Individual Sex Fertile Sperm marking Apparent phenotype 
OX5257G1 ♂ Yes 
 
No 
 
Impenetrant male sterility with no 
fluorescent sperm marking 
OX5257G2 ♂ 
OX5257V1 ♂ Yes Penetrant and repressible male sterility with  
fluorescent sperm marking OX5257AX1 ♂ 
OX5257B1 ♀   
OX5257B2 ♀   
OX5257V2 ♀   
OX5257AX2 ♀   
Permanent lines were established from boldface entries.  
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Table 5.27 Mendelian analysis of OX5257 transgenic lines 
Line Sex Copy number Sex-linkage 
Summary 
  Transgenic (%)  n Ratio (M/F) 
n Copies Location 
     
   
OX5257B1 ♂    
   
OX5257G1 ♂   Male-only 
49  Y 
OX5257V1 ♂ 46 37 0.86 
13 1 Autosome 
OX5257AX1 ♂    
   
OX5257G1 was not assessed for copy number because it was Y-linked. Time was insufficient to assess 
OX5257B1 and AX1. 
 
5.5.3 OX5257V1 heterozygous males demonstrate penetrant and mostly repressible 
sterility  
 Assessment of the penetrance and repressibility of male sterility was performed 
by egg hatch assay, largely as described for OX5242(1)H1. F0 crosses were 10 tet-
reared OX5257 males to 20 non-tet reared WT females. All subsequent crosses, egg 
collections and statistical assessment were as described for OX5242(1)H1. There was 
only sufficient time to assess OX5257V1 (Table 5.28, Figure 5.15), which was fully 
penetrant and mostly repressible (71%). Mean hatch rates differed significantly between 
progeny of tet-reared and non-tet reared males of OX5257V1, but not WT, indicating 
that there was no significant independent effect of tetracycline on viability (Table 5.29). 
OX5257V1 demonstrated a similar profile to OX5242(1)H1; slightly more penetrant 
(1%) but less repressible (10%). Although OX5242(1)H1 [Ccprot1-short 5’UTR-FokI] 
and OX5257V1 [Dmprot2-chimeric-new-FokI] are both promising for commercial use, 
it remains possible that a superior, fully repressible line will be isolated from the strains 
not yet evaluated. 
 
Table 5.28 Penetrance and repressibility of male sterility in OX5257 heterozygous 
males 
Line Mean hatch rate (± SE) Penetrance Repressibility 
 
 NT T % X2 P[df] %  X2  P[df] 
OX5257V1 0 67.3 ± 2.71  100 188.4 > 0.001[1] 71.1 24.2 > 0.001[1] 
WT 97 ± 0.98 94.6 ± 1.30       
Penetrance and repressibility were calculated relative to WT [NT] hatch rate. Significance values were 
from chi-square tests of the numbers of hatched and unhatched eggs, relative to the respective values for 
the control (WT [NT] or [T]).  
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Table 5.29 Extent of repressibility of male sterility in OX5257 lines 
Line Mean difference of hatch rates [NT – T] (%) Significance 
   X2  P[df] 
5257V1  67.3 101.4 > 0.001[1] 
WT -2.4 0.72 0.40[1] 
The difference of the mean hatch rates for [NT] and [T] reared males of each line was calculated. 
Significance values were from chi-square tests of the numbers of hatched and unhatched eggs, relative to 
the respective values for the control (WT [NT] or [T]).  
  5.6 Conclusions 
 This study attempted to generate a functional product candidate with repressible 
male sterility and fluorescent sperm marking, suitable for integration with the male-
selecting strain OX3864A in a final, stacked trait product. A primary objective was to 
delay translation of the protamine-FokI effector protein by removal of the Dmhsp70 
5’UTR element and inclusion of Medfly protamine 5’UTR sequences. This was 
expected to enhance the competitive phenotype of sterile sperm, which was severely 
affected in a prior transgenic strain (OX4718); few sperm were transferred to females 
after mating, and the majority did not swim. This was considered likely to reduce the 
suppressive ability of such a strategy in population control, because females would be 
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more likely to re-mate, potentially with wild males (Lin et al., 1996), (Mossinson and 
Yuval, 2003). 
 
 Four variant designs were tested, and two provided a line with the desired 
properties (OX5242: Ccprot1-short 5’UTR-FokI; OX5257: Dmprot2-chimeric-new-
FokI; OX5195: Ccprot1-full 5’UTR-FokI; and OX5241: Ccprot2-short 5’UTR-FokI). 
At the time of writing, OX5242(1)H1 met several preliminary criteria for an acceptable 
product (single autosomal insertion; penetrant and repressible male sterility; transfer of 
fluorescently marked sperm to females; and homozygous viability). OX5257V1 met the 
first two criteria, but neither homozygous viability nor the ability of the strain to transfer 
fluorescently marked sperm to females (when reared off-tet) have yet been assessed. 
This is vital, as a highly similar expression construct (OX4718) was associated with a 
reduction in the quantity of sperm transferred.  
 
 We had previously confirmed that fusion of Dmhsp70 promoter to Ccprot1 
retained the translational expression profile conferred by Ccprot1 5’UTR (Chapter 4: 
OX5184 [DmHsp70 promoter [+21 bp 5’UTR]-Ccprot1-zsGreen]). However, when we 
altered this system to mediate repressible male sterility, we found that it was not 
repressible (OX5195: Ccprot1-full 5’UTR-FokI). This was not entirely surprising, as 
the reporter construct (OX5184) did not incorporate the tetracycline-repressible 
regulatory element (ie. placement of the Ccprot1-zsGreen system in a head-to-head 
configuration to the male germline switch, to put the tetO21 site upstream of the 
Ccprot1-zsGreen transcription unit, and thus facilitate tetracycline repression). 
Therefore, it would not have been possible to detect such an effect; it was an oversight 
to not investigate this at the time. A theoretical expression construct that would have 
facilitated this analysis is provided for context (Figure 5.16). This would have provided 
the benefits of directly confirming tetracycline-mediated repressibility (or lack thereof) 
in the male germline, with a simpler and more rapid analysis. This construct would 
include the previously validated transformation (AlMAct-dsRed2) and sperm markers 
(Ccprot1-zsGreen); and a reporter system designed to test a novel protamine for future 
use as a regulator of repressible male sterility: tetO21-Dmhsp70-novel protamine-
mCherry). The level, timing and repressibility of tetO-protamine localised effector 
expression would be confirmed by differential expression of mCherry in the male 
germline (strong off-tet and weak or absent on-tet). This would allow the inference of 
phenotype immediately and directly (by fluorescent microscopy rather than egg hatch 
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assay), without the confounding factor of non-repressible male sterility (leading to line 
loss).  
 
 
 We concluded that the non-repressible male sterility phenotype of OX5195 
(Ccprot1-full 5’UTR-FokI) was mediated by cryptic elements in the Ccprot1 5’UTR, 
which promoted transcription. This was based upon the observation that prior constructs 
applying a tetO21-Dmhsp70 minipromoter-Dmprot2-FokI fragment (eg. OX4353/4718) 
were fully repressible with equivalent tetracycline; that partial sensitivity to tetracycline 
was observed; that multiple transcriptional start sites were indicated by 5’ RACE 
(Section 5.2.7); and that D. melanogaster genes are known with promoter elements in 
the 5’UTR (Kempe et al., 1993). This hypothesis was strongly supported by the 
subsequent isolation of repressible strains, after the Ccprot1 5’UTR was truncated 
(OX5242: Ccprot1-short 5’UTR-FokI). Therefore, this putative secondary promoter 
appeared to be trimmed to minimal activity, or brought into a spatially repressible 
conformation by its proximity to tetO21-Dmhsp70 minipromoter. Interestingly, 
shortening the Ccprot2 5’UTR fragment had no detectable effect; male sterility was 
completely penetrant and not repressed by tetracycline. It remains possible that further 
truncation could enhance repressibility whilst maintaining the favourable post-
transcriptional control conferred by the Ccprot2 5’UTR. However, this was not pursued, 
as there is no commercial benefit to developing a redundant system at present.  
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 We were surprised to find that a transgenic line with a strongly paternal effect 
lethal phenotype (OX5195(2)AU1: Ccprot1-full 5’UTR-FokI) did not generally arrest 
embryonic development at a pre-blastodermal stage. In D. melanogaster, a proportion 
of embryos derived from mutants for maternal haploid (22%) and sésame (72%) are 
able to proceed to very late stages of embryonic development (cuticle formation), 
despite essentially zero contribution of the paternal genome to development, and the 
frequent observation of aneuploidy (Loppin et al., 2000), (Loppin et al., 2001). 
Therefore, fragmentation of the paternal genome does not appear sufficient to block 
embryonic development in every instance. From the practical standpoint of using 
protamine-FokI expressing sterile males for Medfly population control, this is not a 
major issue. Only 1% of Ccprot1-FokI expressing embryos hatch into larvae 
(OX5195/5242), and at present, it appears that none survive to adulthood. Therefore, 
there would be minimal damage to fruit mediated by larval hatching, and no risk of 
transgenes propagating vertically in the wild. It is expected that the paternal effect of 
Ccprot1-short 5’UTR-FokI expression (OX5242), which has not yet been assessed, will 
be similar in the progeny of off-tet reared males. However, we expect minimal effects 
upon progeny of on-tet reared males (repression was successfully engineered). There 
was insufficient time to perform this analysis, but it will be particularly interesting to 
investigate the effects on very late development (48-72 hours), and to confirm that the 
rate of adult eclosion is 0%, as expected from preliminary data. 
 
 The effect of protamine-FokI expression on the quantity of sperm transferred 
after mating, and their motility, appears to be systematically negative; penetrance was 
associated with reduced quantity and motility of transferred sperm in three designs 
(OX4718: Dmprot2-chimeric-old-mCherry-FokI; OX5195: Ccprot1-full 5’UTR-FokI 
and OX5242: Ccprot1-short 5’UTR-FokI). This was not assessed in detail for OX5241 
(Ccprot2-short 5’UTR-FokI) or OX5257 (Dmprot2-chimeric-new-FokI) at the time of 
writing. It therefore appears that considerable modification to the repressible male 
sterility expression system would be required to provide a sterile phenotype without any 
effect on the motility of sperm, or the number transferred after mating. An inverse 
association was observed between penetrance of male sterility and the quantity of sperm 
transferred, in an assessment of several OX5195 (Ccprot1-full 5’UTR-FokI) lines. This 
indicated that delayed translation was not sufficient to fully restore the fitness of 
protamine-FokI expressing sperm, which was unexpected. However, it is not entirely 
surprising, as Dmhsp70 promoter-Ccprot1 5’UTR-Ccprot1 ORF-zsGreen-Ccprot1 
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3’UTR (OX5184) was found to localise to spermatids which had not yet fully elongated 
(Figure 4.14). Even at this stage, extensive cleavage of nuclear DNA could be 
anticipated to disrupt nuclear shaping and subsequent individualisation. Sterilisation by 
irradiation is known to reduce the number of sperm in Medfly, and reduce the size of 
the sperm head (Seo et al., 1990), (McInnis, 1993). Notably, both irradiation and 
expression of protamine-FokI are known to induce double-strand breaks, though in the 
case of radiation, single-strand breaks and nucleotide damage also result (Fedrigo et al., 
2012). We observed a clear reduction in the quantity of sperm, but no effect on the 
heads of sperm or their morphology were detected. It is possible that investigation at a 
higher magnification would be required to detect this, however. 
 
 We were surprised that the Dmprot2-chimeric-new-FokI system (OX5257) 
demonstrated incomplete repression in the single line tested, OX5257V1. A similar 
expression construct mediated penetrant and fully repressible sterility in the single strain 
tested (OX4718A-resolved; Figure 3.5). Relative to OX4718, several changes were 
made. First, the spatial orientation of elements on the OX5257 construct were changed. 
For instance, a Ccprot1-zsGreen fluorescent sperm marking system was added. This 
would not be expected to have an effect, because the relative orientation of the 
tetracycline-repressible switch and male sterility effector were retained. Additionally, 
mCherry was removed from the protamine-FokI effector. This might be expected to 
affect penetrance by altering the physical interaction with target DNA, but an effect on 
repressibility would not be expected. Finally, the 3’UTR attached to Dmprot2-FokI was 
altered from SV40 to Ccprot2. Because the 3’UTR is typically dispensible for 
appropriate post-transcriptional germline regulation in Drosophila (White-Cooper, 
2009), it was assumed that this would not have an effect. It is not certain if this is a line-
specific effect, as only OX5257V1 was tested at time of writing. Although repressibility 
was not attenuated by insertion in certain systems (Ccprot1-full 5’UTR-FokI 
[OX5195]), line-specific non-repressibility has been described elsewhere in a female-
specific flightless mosquito line (Labbé et al., 2012). Consequently, it is possible that a 
fully repressible line of OX5242 or OX5257 may be obtained. Although repression is 
incomplete in OX5242(1)H1 and OX5257V1, it is adequate to facilitate mass-rearing of 
the strain, and therefore these designs remain commercially viable. 
 
 Despite the improvements to the transgenic expression systems for repressible 
male sterility described herein, substantial work remains in characterizing the 
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commercial suitability of these strains for population control of Medfly. These include 
an investigation of compatibility with the genetic male selection component (OX3864), 
a full assessment of mating competitiveness in the double homozygous state, and a 
comparison of life history traits (mass, flight ability, longevity, lifetime fecundity, 
mating competitiveness, and stress tolerance to starvation and thirst) against wildtype, 
to assess the effects of transgene expression on viability. We anticipate that a product 
line successfully meeting these criteria will be an invaluable tool for area-wide 
population control of Medfly, and may provide useful components and engineering 
principles for making equivalent strains in other pest insects.  
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Chapter 6 – Gene editing in Medfly with CRISPR 
 
6.1 Introduction 
6.1.1 Gene editing 
 The modification of a genome with target-specific effectors is a rapidly 
developing field with diverse applications in academic research (Wang et al., 2013), 
medicine (Gersbach and Perez-Pinera, 2014) and industry (van Erp et al., 2015). The 
effector is generally a DNA endonuclease that generates double-strand breaks. 
Subsequently, the target is modified by non-homologous end-joining (NHEJ) or 
homologous recombination (HR), in a cell-cycle dependent fashion (Saleh-Gohari, 
2004), (Gasiunas and Siksnys, 2013), (Lin et al., 2014a). NHEJ is error-prone and 
frequently leaves an insertion-deletion (indel) footprint, useful for mutagenesis or 
targeted deletion. Homologous recombination repairs the DNA damage by copying a 
template of similar sequence. This allows precise genomic engineering of the repair 
outcome, facilitating diverse modifications ranging from a single nucleotide substitution 
to site-specific integration of a transgenic expression construct (Gratz et al., 2013). 
Emerging technologies may apply diverse, non-nuclease effectors such as 
transcriptional or epigenetic activators/repressors; this extends functional capability far 
beyond simple edits of genomic sequences (Larson et al., 2013), (Hilton et al., 2015). 
Three modular technologies have been widely applied (Figure 6.1): zinc-finger 
nuclease (ZFN), transcription activator-like effector nuclease (TALEN) and clustered 
regularly interspersed palindromic repeats (CRISPR) (Gaj et al., 2013).  
CONFIDENTIAL       Chapter 6 – Gene editing in Medfly with CRISPR  
 
225 
 
CONFIDENTIAL       Chapter 6 – Gene editing in Medfly with CRISPR  
 
226 
6.1.2 ZFNs and TALENs 
 ZFNs apply DNA binding modules from zinc-finger transcription factors: a 30 
residue motif binds specifically to 3 bp of target sequence (Liu et al., 1997). The key 
programming benefit is the molecular separation of DNA-binding elements into discrete 
units, which are then placed in an array on the protein, separated by linkers. This 
facilitates development of targeted nucleases (Wah et al., 1997), (Gaj et al., 2013) or 
other cis-acting regulators. For each target site, a pair of ZFNs is designed that flanks 
the desired cut sequence. Dimerisation of the FokI cutting domains (one copy on each 
ZFN) generates an active endonuclease. Similarly, TALENs (transcription activator-like 
effector nucleases) are based on Xanthomonas DNA-binding proteins that modulate 
host gene expression with an N-terminal translocation domain, central DNA-binding 
domain and C-terminal transactivation domain (Morbitzer et al., 2010). The central 
region contains repeat variable dipeptides (RVDs), each specifying a single target 
nucleotide (Moscou and Bogdanove, 2009).  
 
 RVDs facilitate recognition of target nucleotides, with two exceptions. The last 
nucleotide is recognised by a half-repeat RVD and the first (usually thymine) by 
elements immediately upstream of the RVDs (Moscou and Bogdanove, 2009), (Miller 
et al., 2011). A different scaffold is required to target an alternative first nucleotide, 
because the mode of interaction is cryptic and not equivalent to the RVDs (Sanjana et 
al., 2012). Efficient designs have applied 9-19 RVDs per TALEN pair (Reyon et al., 
2012). As with ZFNs, two adjacent sequences are typically targeted with a TALEN pair, 
directing the cut to the intervening sequence. However, single-chain TALEN designs 
with two intra-molecular FokI subunits have been described (Sun and Zhao, 2014). It is 
understood that target site, TALEN length and spacer distance can affect activity (Miller 
et al., 2011). Although a role of DNA-binding energy has been suggested (Guilinger et 
al., 2014a), a holistic model explaining the relative contribution of target sequence, 
chromatin structure, TALEN length and spacer distance remains to be developed.  
 
6.1.3 CRISPR 
 CRISPR technology applies Cas9 nuclease and a guiding RNA complex. In 
native bacterial systems, CRISPR functions as an adaptive immune system (Brouns et 
al., 2008). CRISPR exists in most bacterial and archaeal species, demonstrating diverse 
modes of regulation (Makarova et al., 2013). Phylogenetic analysis suggests five major 
groups: classes II and V have been adapted for genetic engineering (Makarova et al., 
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2015). Class II systems have been most widely applied, and are the focus of this study. 
In this system, cas-associated proteins cleave and genomically integrate invading DNA 
into operons with palindromic repeats, as protospacers (Jansen et al., 2002), (Makarova 
et al., 2011). Thereafter, transcription and processing leads to mature, target-specific 
CRISPR RNAs (crRNAs). A trans-activating CRISPR RNA (tracrRNA) molecule 
mediates three-way interaction with the mature crRNA and Cas9 nuclease, facilitating 
target binding and cleavage immediately upstream of the required protospacer adjacent 
motif (PAM) (Brouns et al., 2008), (Wiedenheft et al., 2012), (Tsai and Joung, 2016).  
 
 The targeting features of the tracrRNA and crRNA may be combined into a 
single guide RNA (sgRNA), simplifying genetic engineering (Jinek et al., 2012), 
(Bassett et al., 2013). This single molecule features invariant hairpins for interaction 
with Cas9, and a variable, target-specific motif. Targeting is mediated by 
complementary Watson-Crick binding of the sgRNA to genomic DNA. Simplicity of 
sgRNA synthesis (template-free PCR with a common reverse primer and target-specific 
forward primer, followed by in vitro transcription), facilitates powerful and cost-
effective screens. In contrast, TALEN and ZFN technologies require unique vectors 
with difficult cloning, because repetitive codons specify single nucleotide readout 
(TALEN: 2 codons; ZFNs: 10 codons). Therefore, the simplicity, transferability, and 
expanding resource pool of CRISPR underpin its recognition as a major scientific 
innovation (Ledford, 2015).  
 
 The CRISPR system demonstrates unique practical constraints. Cutting can 
occur without perfect complementarity (mismatches to the 5' region of the sgRNA are 
often tolerated), contributing to off-target effects (Cradick et al., 2013), (Lin et al., 
2014b). Recent improvements for enhanced specificity have been described, including a 
truncated sgRNA design (Fu et al., 2014), dual sgRNA targeting (Xu et al., 2014), and 
Cas9 proteins modified for reduced off-target activity (Slaymaker et al., 2016). Not all 
sequences can be targeted, because an NGG proto-spacer motif is usually required 
immediately downstream of the 20 nt seed sequence (Díez-Villaseñor et al., 2009). 
Activity is possible with nAG or nGA motifs, but is frequently reduced by 50% or more 
(Zhang et al., 2014). However, reprogramming without reduced activity is possible by 
applying orthologous Cas9 proteins with alternative proto-spacer recognition; for 
instance, the C. jejuni Cas9 PAM is nnnnACA (Fonfara et al., 2014). Further 
innovations include a modular toolkit of Cas9-effector fusions and Cas9 isoforms with 
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novel activity, notably an RNA-editing Cas9 (Doudna and Charpentier, 2014), 
(Abudayyeh et al., 2016). Consequently, the utility of the CRISPR platform is likely to 
increase as the field develops. 
 
 The simplest application of editing technologies is the modification of a 
sequence to study function, enabling sophisticated reverse genetics screens. Various 
recombination-mediated technologies for targeted editing have been developed in 
diverse organisms including bacteria (Yu et al., 2000), yeast (Matsuzaki et al., 1990), 
insects (Huang et al., 2009), and mice (Chen et al., 2001). However, these were 
frequently limited by low efficiency (Baena-Lopez et al., 2013) and poor transferability 
to other species, due to the application of species-specific elements such as endogenous 
recombinases. Nuclease-mediated double-stranded breaks enhance successful 
recombination (Saintigny, 2001), facilitating efficient sequence replacement or deletion 
in a variety of organisms. Alternative applications of gene-editing technologies have 
been described, typically applying nuclease-defective isoforms to localise effectors 
(Table 6.1).  
 
Table 6.1: Selected applications of gene editing technologies 
Application Reference 
RNA editing (O’Connell et al., 2014) 
High-throughput gene function screens  (Shalem et al., 2014) 
Doxycycline inducible gene disruption (Dow et al., 2015) 
Organoid models of human diseases (Freedman et al., 2015) 
Gene drive for Anopheles control (Hammond et al., 2015) 
Targeted epigenetic modification (Hilton et al., 2015) 
Correction of muscular dystrophy phenotype in patient 
derived stem cells 
(Li et al., 2015) 
Germline correction of β-thalassemia (Liang et al., 2015) 
Light mediated gene induction (Polstein and Gersbach, 2015) 
Oncogenic enhancer screening (Korkmaz et al., 2016) 
Scalable protein localisation in single neurons  (Mikuni et al., 2016) 
RNA tracking (Nelles et al., 2016) 
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6.1.4 Objectives of the study 
 We intended to design a modular toolkit for precise genetic engineering with 
CRISPR, to optimise internal product development and confirm that the system would 
allow the targeted removal or modification of genes of interest. We were particularly 
interested in two related applications: transposon immobilisation by targeted removal of 
piggyBac transposition sequences and site-specific construct integration by homologous 
recombination. Other applications were possible, for instance the development of 
tetracycline-repressible targeted repressors of genes required for male fertility; this 
could be applied for population control systems similar to those described in the 
subsequent chapters. However, targeted repression of many of these genes (eg. Cc-aly 
or Cc-topi) would be expected to completely block the development of mature 
spermatozoa, which would be undesirable (Lin et al., 1996), (Mossinson and Yuval, 
2003). However, this would not preclude the use of CRISPR technology to investigate 
novel sequences to regulate transgenic effectors in the male germline, or further develop 
the understanding of genetic regulators of male and female fertility in Medfly, for which 
essentially nothing has been experimentally validated. 
 
 A highly functional system for transposon immobilisation, applying nested 
piggyBac transposition, has been applied herein and elsewhere (Dafa’alla et al., 2006). 
However, practical difficulties are apparent, using the latest male-sterile candidate 
construct (Chapter 5: OX5257) as an example. First, four-ended piggyBac (4-PB) 
constructs are larger (4.6 kb associated with the two markers sequences at each end) and 
more repetitive (multiple piggyBac elements), than two-ended piggyBac (2-PB) 
equivalents. This increases the difficulty and cost of vector synthesis, and reduces 
transformation, because piggyBac integration efficiency is generally size-dependent 
(Handler and Ii, 1999), (Lorenzen et al., 2003). However, the relationship between size 
and transformation efficiency appears to be complex; the transformation efficiency of a 
large 2-PB construct (OX5173: 15 kb) tested in this chapter was acceptable (8%). In 
comparison, the 4-PB constructs (17-18 kb) evaluated previously (Chapter 5) were 
extremely difficult to transform, despite being only 20% larger (OX5195, OX5242, 
OX5257: 1% efficiency). This suggests that either the composite transposon is less 
efficiently transformed, or that the transformation efficiency rapidly decreases above 15 
kb. The former is particularly interesting, because it was previously demonstrated that 
certain mini-transposons of the composite 4-PB vector can transposase more efficiently 
than others, even when larger (Condon et al., 2007). Therefore, it is possible that 
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reduced transformation efficiency in 4-PB constructs is mediated by the composite 
transposon structure, rather than size alone. Large injection cohorts (n > 2000), in one 
instance spanning a month (OX5257), yielded fewer than 3 lines.  
  
 A second issue is the presence of three fluorescent markers (OX5257: AlMAct-
dsRed2; HR5IE1-AmCyan; OPIE2-ZsGreen) that are difficult to be independently 
distinguished in some instances. This complicates visual selection of individuals from 
which both flanking piggyBac elements have excised. In particular, the zsGreen marker 
was frequently misscored as absent, by multiple experimenters (false negatives were 
confirmed by PCR). Furthermore, the excision of transposable ends (resolution) 
requires three generations, and subsequent PCR validation. Finally, resolution has 
proved impossible for some lines, for unknown reasons. It is possible that the adjacent 
genomic sequence has an effect, explaining why some insertions are difficult or 
impossible to resolve. However, it is difficult to explain why integration could occur at 
a given site, but not subsequent re-transposition of the ends. It is therefore likely that the 
requirements for efficient initial integration, are different to the requirements for 
subsequent remobilisation of the piggyBac ends.   
 
 To address these issues, we propose three solutions (Figure 6.2). The first is 
largely independent of the methods applied in this chapter, but included for context: to 
remove the fluorescent marker sequences from the 4-PB vector, thereby substantially 
reducing its size. This has been successfully applied for P. gossypiella (pink bollworm) 
transgenic expression constructs at Oxitec, with one individual yielding 6% of progeny 
without piggyBac ends (Morrison, 2007). In Medfly, the rate of excision of one end or 
the entire transposon (both pairs of ends and the central element) was estimated at 7% 
for one line (Dafa’alla et al., 2006). However, the number of individuals retaining the 
central element (the desired outcome of excision), without both pairs of piggyBac ends, 
was not stated. Therefore, it is clear that PCR screening could be applied to select 
events where the insertion lacks piggyBac ends, but further experiments would need to 
be performed to determine the efficiency of the process. 
 
 Alternatively, a traditional two-ended piggyBac vector could be applied, with 
subsequent deletion of the transposable ends by CRISPR. It remains possible that 
validated CRISPR systems may not resolve certain insertions, due to local chromatin 
effects. Therefore, the relevance and efficiency of this proposed system would require 
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substantial characterisation. As a final alternative, site-specific integration could be 
applied; resolution would not be required, because it is transposon-free. There exist 
further theoretical advantages, assuming adequate efficiency. First, it would be possible 
to modify previously obtained lines (for instance, to add an additional transgenic 
effector, such as a fluorescent sperm marking system). Secondly, it would be possible to 
target constructs to validated expression sites. When developing transgenic, repressible 
male sterility systems, selecting phenotypically ideal lines from a panel of random 
insertions is the major time constraint. This is because most lines do not perform as well 
as required, due to effects of the insertion site (Schönig et al., 2011). Consequently, 
enhanced selection by targeted integration to a known site with strong expression of 
transgenic effectors in the male germline, would be advantageous. Several sites were 
characterised in this study (Chapters 4-5). Finally, there is no need to determine the 
insertion site; and a single insertion is guaranteed, a requirement of a final commercial 
product. 
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6.2 Anti-zsGreen sgRNAs (SS1928-SS1931) with co-injected recombinant Cas9 
protein mediate high-efficiency zsGreen mutagenesis 
 We optimised CRISPR parameters using the simplest experiment: indel-
mediated knockout of a fluorescent marker sequence; site-specific integration by 
targeted recombination is size-dependent and comparably inefficient (Auer et al., 2014), 
(Gratz et al., 2014). Several formats exist for Cas9 (plasmid DNA, synthetic mRNA, 
recombinant protein, and transgenic lines expressing Cas9 in the germline) and for 
sgRNAs (plasmid DNA, synthetic mRNA, and genomically integrated U6 promoter-
sgRNA transgenic lines), with promising reports for each (Bassett et al., 2013),  
(Gagnon et al., 2014), (Gratz et al., 2014). Germline-expressed Cas9 was apparently 
most efficient in Drosophila (Kondo and Ueda, 2013), (Ren et al., 2013), (Gratz et al., 
2014). However, the practical difficulty of validating an equivalent Medfly strain 
(transgenesis, analysis of expression and functional validation) rationalised a parallel 
investigation of recombinant protein Cas9 (PNA Biotech CP01), which did not require 
the generation of transgenic lines. There was an additional advantage of microinjecting 
Cas9 as recombinant protein: it was directly transferrable to other species (no 
requirement to characterise efficient promoters and UTRs for each insect species, and 
clone expression constructs). Only in vitro transcribed sgRNAs were tested because 
several reports confirmed their functionality (Bassett et al., 2013), (Cho et al., 2013), 
(Jinek et al., 2013), (Yu et al., 2013), (Niu et al., 2014), (Zuris et al., 2014), and due to 
time availability, it was necessary to limit the scope of the study. 
  
 The standard piggyBac microinjection protocol was essentially used (Chapter 
2), but we microinjected into the OX4014-A homozygous background (expresses 
AlMAct-dsRed2 and HR5IE1-zsGreen), rather than WT (Figure 6.3). Four anti-
ZsGreen sgRNAs (SS1928-1931) were validated, to avoid inefficient sequences 
masking an efficient Cas9 effector. SS1928-SS1931 were assayed in vitro for their 
ability to target Cas9 protein to a zsGreen PCR amplicon. Activity was detected for 
SS1931, but not SS1928-1930. It was subsequently determined (after microinjection) 
that SS1928-1930 were accidentally synthesised with incorrect forward primers; we 
unintentionally generated sgRNAs that would bind to the opposite strand. These would 
not be expected to have cutting activity, because an nGG PAM motif was not present at 
the terminus of the binding site (Brouns et al., 2008).  
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 The injection mix contained sgRNAs SS1928-1931 (250 ng/μl each) and Cas9 
protein (1 μg/μl). Adult injection survival was less (19%) than the average results for 
injection of Medfly (25%) (Gregory et al., 2016). Surviving G0 individuals were 
backcrossed to WT (Tables 6.2-6.3) and G1 progeny screened for phenotypic reversion 
(presence of DsRed2, with loss of zsGreen).  
 
Table 6.2 Injection logistics for Protein Cas9-SS1928-1931 
Injection mix Embryos  Larvae Pupae Adults Knockouts 
Protein Cas9-SS1928-1931 414 211 (51%) 119 (29%) 78 (19%) 33 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates.  
 
Table 6.3 G0 backcrosses to isolate zsGreen edits from Protein Cas9-SS1928-1931 
injections 
ProC9-SS1928-1931 A 10 ♂ x 30 WT ♀ ProC9-SS1928-1931 F 5 ♀ x 5 WT ♂ 
ProC9-SS1928-1931 B 10 ♀ x 10 WT ♂ ProC9-SS1928-1931 G 6 ♂ x 30 WT ♀ 
ProC9-SS1928-1931 C 10 ♂ x 30 WT ♀ ProC9-SS1928-1931 H 6 ♂ x 30 WT ♀ 
ProC9-SS1928-1931 D 10 ♀ x 10 WT ♂ ProC9-SS1928-1931 I 7 ♀ x 7 WT ♂ 
ProC9-SS1928-1931 E 5 ♂ x 15 WT ♀ ProC9-SS1928-1931 J 9 ♀ x 9 WT ♂ 
Underlined pools yielded edits. 
 
 
 Protein Cas9-SS1928-SS1931 microinjections yielded 33 positives from 6/10 
pools, all attributed to SS1931, as expected (Table 6.4). A PCR amplicon spanning the 
zsGreen target site was generated from each putatively mutagenised individual, ligated 
into the pJET vector, and sequenced as previously described. Three independent edits 
were detected in pool ProC9-SS1928-SS1931-C. Mutations in the other pools (A, D, E, 
F and J) were consistent between individuals of the same pool (Figure 6.4). Sequencing 
failed for one individual (D2). All events except ProC9-SS1928-SS1931-J were 
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frameshifting indels. The results indicated that Cas9 mutagenesis leaves a distinct 
footprint, because (1) identical mutations were not found for individuals of different 
pools and (2) mutations for individuals of the same pool were generally identical 
(probably resulting from segregation of the edited chromosome to multiple cells during 
germline development). Efficiencies calculated were parental (pools with edited 
progeny/G0 adult population) and progenital (proportion of G1 progeny with a zsGreen 
knockout). The G1 population was estimated by mean pupal weight from 30 replicates 
of 10 measured pupae (Table 6.5).  
 
Table 6.4 Gene edits recovered from Protein Cas9-SS1928-SS1931 microinjections 
Individual Active sgRNA Edit Sequence change 
A1 SS1931 2 bp deleted F43R43 & frameshift 
C1 2 bp deleted K42N42 & frameshift 
C2, C3, C5 2 bp deleted 
4 bp inserted 
H41R41 & frameshift 
C4 1 bp substituted 
4 bp deleted 
H41R41 & frameshift 
D1, D3-D10 4 bp inserted 
5 bp deleted 
K42V42 & frameshift 
E1-E6 2 bp deleted F43R43 & frameshift 
F1-F2 8 bp deleted K42N42 & frameshift 
J1-J9 21 bp deleted In-frame deletion of H41-G49 
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Table 6.5 Efficiency calculations for Protein Cas9-SS1928-SS1931 microinjections 
 Estimating G1 screening population Edits observed Efficiency (%) 
 Mass      
 
Mean (mg) Total (g) Population  Pools Progeny Parental Progenital 
Protein Cas9 
SS1928-SS1931 8.10 
119.4 
14747 ± 895 
6 32 ≥ 7.7 0.2 ± 0.01 
OX5173  
transgenesis 7.39 
78.3 
10590 ± 605  
6 41 ≥ 7.9 0.39 ± 0.02 
Efficiency calculations: parental (pools with edited progeny/G0 adult population) and progenital 
(proportion of G1 progeny with zsGreen knockouts). Parental efficiencies were stated as greater than or 
equal to (≥), because it is possible that multiple G0 individuals of the same pool demonstrated germline 
mutagenesis. The mean mass of 30 replicated measurements of 10 pupae were used to estimate the size of 
the screened G1 population. Uncertainty given as standard deviation.  
 
 The calculation of progenital efficiency was particularly important, because high 
efficiency editing is required for non-laborious PCR screening of invisible mutations, 
such as piggyBac end removal or the loss of haplosufficient genes (genes required for 
male fertility that might be of commercial interest, are expected to be haplosufficient). 
For reference to the efficiency of piggyBac transgenesis, equivalent calculations were 
applied to the concurrently performed OX5173 (nanos-Cas9) transgenesis 
microinjection dataset. We next investigated whether promising reports of a germline-
based delivery system in D. melanogaster could provide an equally valuable tool in 
Medfly.  
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6.3 Validation of a high efficiency germline (nanos-Cas9) expression system  
 
6.3.1 Expression constructs used in the study 
 In D. melanogaster, nanos- or vasa-mediated germline Cas9 expression 
enhanced CRISPR editing efficiency, ostensibly from targeted maternal deposition of 
Cas9 to embryos (Kondo and Ueda, 2013), (Ren et al., 2013). nanos is conserved 
amongst diverse insects; it was therefore likely that the Medfly homologue (Ccnanos) 
would suitably regulate Cas9 (Curtis et al., 1995), (Lall et al., 2003). Sarah Scaife 
cloned a piggyBac vector (OX5134) with Ccnanos-Cas9 (nanos promoter-nanos 
5’UTR-S. pyogenes Cas9-nanos 3’UTR) and an eye-specific transformation marker 
commonly used in Drosophila, but untested in Medfly (3xP3-zsGreen). Tissue-specific 
3xP3 was chosen to minimise interference with other fluorescent markers (when crossed 
to other lines). Transformants were not recovered, indicating lack of 3xP3-ZsGreen 
function in Medfly. To confirm this, a double marker construct (OX5154) with (1) 
3xP3-zsGreen and (2) previously validated HR5IE1-dsRed2 was generated (by Sarah 
Scaife). Transformants visibly expressed HR5IE1-DsRed2 but not 3xP3-ZsGreen, 
indicating 3xP3-zsGreen inactivity. Consequently, we selected HR5IE1-DsRed2 as the 
transformation marker and structured future experiments around the limitation that 
HR5IE1-dsRed2 is present in other constructs, and that its expression can be masked by 
the stronger AlMAct-dsRed2 transformation marker. A new vector (OX5173) was 
generated by modification of OX5134 (3xP3-green; Ccnanos-Cas9), substituting 3xP3-
green for HR5IE1-dsRed2. These expression constructs are summarised in Figure 6.5 
with experiment-specific results below. 
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6.3.2 Failure to isolate OX5134 transgenic lines indicates inactivity of 3xP3-
zsGreen in Medfly 
 Microinjection and backcrossing to WT (Table 6.6) were performed as 
previously described, using piggyBac helper OX3022 (300 ng/μl) and OX5134 (600 
ng/μl). Transient 3xP3-zsGreen expression was not observed in G0 pupae, the first 
indication that 3xP3-zsGreen was not visibly translated in Medfly. Adult survival (43%) 
was better than the average results for injection of Medfly (25%) (Gregory et al., 2016). 
Despite a large sample size (n = 359), transformants were not observed. Off-target Cas9 
nuclease activity was not possible, because the sgRNAs required for activity were not 
present (Cradick et al., 2013). Therefore, it appeared that 3xP3-zsGreen was inactive, 
substantiated by unpublished data cited within a prior report (Schetelig and Handler, 
2013). 
 
Table 6.6 Microinjection logistics for OX5134 
Construct Embryos  Larvae Pupae Adults Lines  
OX5134 841 446 (53%) 363 (43%) 359 (43%) 0  
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates.  
 
 
6.3.3 Expression of HR5IE1-dsRed2 but not 3xP3-ZsGreen in OX5154 confirms 
lack of 3xP3 activity in Medfly 
 The eye-specific 3xP3 marker would be useful in other projects within Oxitec. 
Consequently, we decided to directly test for activity. Microinjection and backcrossing 
of a two-marker construct (OX5154) were conducted exactly as for OX5134 (Tables 
6.7-6.8). Adult survival (51%) was higher than the average results for injection of 
Medfly (25%) (Gregory et al., 2016). In all five lines, HR5IE1-dsRed2 was visible, but 
not 3xP3-zsGreen. We investigated expression by RT-PCR to determine if the fragment 
had any activity. RNA was extracted from heads of flies (n=3) of 3 lines and used for 
cDNA synthesis with equivalent concentrations of RNA template for each sample (500 
ng). OX5173E1 was tested in duplicate as a no-RT control. Non-quantitative RT-PCR 
was performed, monitoring expression of zsGreen and the constitutively expressed Cc-
RpP0 gene. Products were detected in OX5154 transgenic samples but not control, 
indicating transcription of 3xP3-zsGreen (Figure 6.6). Lack of fluorescence could be 
attributable to insufficient translation. We therefore modified the prior nanos-Cas9 
vector (OX5134) to include a HR5IE1-dsRed2 transformation marker (OX5173). 
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Table 6.7 Microinjection logistics for OX5154 
Construct Embryos Larvae Pupae Adults Lines 
OX5154  311 186 (60%) 169 (54%) 161 (51%) 5 (3%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (injection survivors yielding transgenic progeny). 
 
Table 6.8 G0 backcrosses to establish OX5154 lines 
OX5154A 20 ♀ x 10 WT ♂ OX5154B 20 ♀ x 10 WT ♂ OX5154C 22 ♀ x 10 WT ♂ 
OX5154D 20 ♂ x 20 WT ♀ OX5154E 20 ♂ x 20 WT ♀ OX5154F 20 ♂ x 20 WT ♀ 
OX5154G 20 ♂ x 20 WT ♀ OX5154H 6 ♂ x 13 ♀   
Underlined crosses yielded transgenic lines.  
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6.3.4 OX5173 (nanos-Cas9) lines express Cas9 in the ovaries and embryonic 
surface (maternal deposition) 
 Microinjection and backcrossing to WT was conducted exactly as for 
OX5134/OX5154 (Tables 6.9-6.10). Adult survival (51%) was higher than the average 
results for injection of Medfly (25%) (Gregory et al., 2016). Mendelian assessment of 
transgenic lines was performed as previously described (Table 6.11). Eleven lines 
(OX5173C, D, E1-E5, G1-G2, I, L) were isolated from 6 pools (OX5173E and 
OX5173G provided five and two distinct lines). OX5173C was randomly discarded to 
reduce line number to ten. All lines except OX5173E5 were single insertions. The 
insertion sites of OX5173E1, E4, E5 & G2 were not determined (female crosses). 
OX5173E2 and E3 were Y-linked and OX5173L was X-linked. All other lines 
(OX5173D, G1 & I) were autosomal insertions. Double insertions require segregation 
to determine if one or both insertions are associated with active transgenic expression. 
Y-linked transgenes cannot be propagated in females; the female lineage is required for 
maternal deposition of nanos-Cas9. Consequently, we selected single autosomal 
insertion lines (OX5173D, E1, E4, G1, G2, I) and an X-linked insertion (OX5173L) to 
confirm Cas9 expression by RT-PCR.  
 
Table 6.9 Injection logistics for OX5173 
Embryos Larvae Pupae Adults Lines  
279 211 (78%) 149 (53%) 139 (50%) 11 (8%) 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates. The percentage in the 
“lines” column is the transformation efficiency (injection survivors yielding transgenic progeny). 
 
Table 6.10 G0 backcrosses to establish OX5173 lines 
OX5173A 10 ♂ x 30 WT ♀ OX5173B 10 ♂ x 30 WT ♀ OX5173C 10 ♂ x 30 WT ♀ 
OX5173D 10 ♂ x 30 WT ♀ OX5173E 10 ♂ x 30 WT ♀ OX5173F 20 ♀ x 10 WT ♂  
OX5173G 17 ♀ x 10 WT ♂  OX5173H 10 ♂ x 30 WT ♀ OX5173I 8 ♂ x 24 WT ♀ 
OX5173J 8 ♂ x 24 WT ♀ OX5173K 13 ♀ x 10 WT ♂  OX5173L 13 ♀ x 10 WT ♂  
Underlined pools yielded transgenics. 
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Table 6.11 Mendelian analysis of OX5173 transgenic lines  
   
Line Sex Copy number  Sex-linkage 
 
Summary 
Cas9 cDNA in 
ovaries 
  
Transgenic 
(%) n 
Sex ratio 
(M/F) 
 
n 
 
Copies 
 
Location 
 
OX5173D ♂ 55 
121 
1.1 29 
1 Autosome Yes 
OX5173E2 ♂ 50 239 Male-only 23 
1 Y  
OX5173E3 ♂ 50 58 Male-only 60 
1 Y  
OX5173G1 ♂ 49 
274 
0.9 54 
1 Autosome Yes 
OX5173I ♂ 53 134 0.7 37 
1 Autosome Yes 
OX5173L ♂ 39 31 Female-only 8 
1 X No 
OX5173E1 ♀ 63 
49 
1.0 30 
1  No 
OX5173E4 ♀ 62 45 0.6 27 
1  Yes 
OX5173E5 ♀ 77 39 2.0 18 
2   
OX5173G2 ♀ 48 
97 
0.9 27 
1  Yes 
Sex-linkage is only apparent from crosses in which the transgenic parent is male. Therefore, the sex-
linkage of female transgenic crosses was not determined (OX5173E1, E4, E5 & G2).  
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 Seven lines (OX5173D, E1, E4, G1, G2, I and L) were assessed for Cas9 
transcription in ovaries and embryos by RT-PCR, to select nanos-Cas9 lines with high 
expression for enhanced gene editing. Five virgin heterozygous females from each of 7 
OX5173 lines and WT (control) were crossed to WT males (1:1) and allowed to mate (7 
days). This was performed because mating can affect the expression of ovarian genes 
(McGraw et al., 2004), (McGraw et al., 2008). Ovaries were dissected and RNA 
extracted, prior to cDNA synthesis with equalised RNA template (500 ng RNA per 
sample). OX5173E1 was duplicated as a no-RT control. RT-PCR amplicons were 
generated for Cas9 and the constitutively expressed control gene Cc-RpP0. Reactions 
were duplicated for semi-quantitative assessment at 25, 30, 35 and 40 cycles. Cas9 was 
detected in the ovaries of 5 lines (OX5173D, E4, G1, G2 and I). After 35 cycles, 
OX5173D and OX5173G2 demonstrated the highest levels of Cas9 expression (Figure 
6.7).  
 
 As ovarian expression was not necessarily correlated with maternal deposition to 
embryos, further RT-PCR analysis was performed on eggs of OX5173 females. Crosses 
were 50 heterozygous OX5173 or WT (control) females to 50 WT males. Eggs from a 4 
hour egg collection (day 5) were homogenised by freezing and pestle crushing. Greater 
input RNA (750 ng) was used because reduced expression relative to ovaries was 
possible; the analysis was otherwise identical. The findings of the ovarian study were 
generally recapitualated (Figure 6.7). Surprisingly, ovarian expression was not always 
associated with maternal Cas9 deposition. Cas9 mRNA was detected in ovaries, but not 
eggs, from OX5173I. OX5173D and G1 were selected for future analysis on the basis of 
highest apparent expression (OX5173G1 and G2 were similar).  
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6.3.5 Microinjection of anti-dsRed2 sgRNAs (SS2045 & SS2047) into a nanos-Cas9 
expressing strain (OX5173D) mediates high-efficiency dsRed2 mutagenesis  
 We validated the germline-expressed nanos-Cas9 activity of OX5173 lines, 
again by mutagenesis of marker sequences. Difficulty screening zsGreen loss in the 
protein injection experiment (ProCas9-SS1928-SS1931) was considered to potentially 
underestimate efficiency (extremely early screening was required, HR5IE1-zsGreen is 
less visible than AlMAct-dsRed2). Consequently, we screened for DsRed2 mutagenesis. 
Microinjection and WT backcrosses were performed essentially as described for the 
protein Cas9-SS1928-SS1931 microinjections (Tables 6.12-6.13). OX5173D and G1 
were assessed concurrently. The injection background was F1 progeny of a homozygous 
OX4014 male (n=125) to heterozygous OX5173 female (n=250) cross. Buffered 
injection mixes contained activity-validated sgRNAs SS2045 & SS2047 (500 ng/μl 
each, provided by Justine Braguy and Sarah Scaife). Adult injection survival 
(OX5173D: 19%; OX5173G1: 27%) was similar to the average results for injection of 
Medfly (25%) (Gregory et al., 2016).  
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Table 6.12 Injection logistics for OX5173-SS2045-SS2047 injections  
Line Embryos Larvae Pupae Adults Knockouts 
OX5173D 565 257 (45%) 183 (32%) 106 (19%) 511 
OX5173G1 648 253 (39%) 209 (32%) 178 (27%)  0 
Percentages in the “larvae”, “pupae” and “adults” columns are survival rates.  
 
Table 6.13 G0 backcrosses to isolate OX5173-SS2045-SS2047 dsRed2 edits  
OX5173D-SS2045-SS2047-A 5 ♂ x 15 WT ♀ OX5173D-SS2045-SS2047-B 5 ♂ x 15 WT ♀ 
OX5173D-SS2045-SS2047-C 5 ♂ x 15 WT ♀ OX5173D-SS2045-SS2047-D 5 ♂ x 15 WT ♀ 
OX5173D-SS2045-SS2047-E 5 ♂ x 15 WT ♀ OX5173D-SS2045-SS2047-F 5 ♀ x 5 WT ♂ 
OX5173D-SS2045-SS2047-G 5 ♀ x 5 WT ♂ OX5173D-SS2045-SS2047-H 5 ♀ x 5 WT ♂ 
OX5173D-SS2045-SS2047-I 5 ♀ x 5 WT ♂ OX5173D-SS2045-SS2047-J 5 ♀ x 5 WT ♂ 
OX5173D-SS2045-SS2047-K 5 ♂ x 15 WT ♀  OX5173D-SS2045-SS2047-L 5 ♂ x 15 WT ♀  
OX5173D-SS2045-SS2047-M 5 ♀ x 5 WT ♂ OX5173D-SS2045-SS2047-N 5 ♀ x 5 WT ♂ 
OX5173D-SS2045-SS2047-O 25 ♂ x 75 WT ♀  OX5173D-SS2045-SS2047-P 25 ♀ x 25 WT ♂ 
    
OX5173G1-SS2045-SS2047-A 5 ♂ x 15 WT ♀ OX5173G1-SS2045-SS2047-B 5 ♂ x 15 WT ♀ 
OX5173G1-SS2045-SS2047-C 5 ♂ x 15 WT ♀ OX5173G1-SS2045-SS2047-D 5 ♂ x 15 WT ♀ 
OX5173G1-SS2045-SS2047-E 5 ♂ x 15 WT ♀ OX5173G1-SS2045-SS2047-F 5 ♀ x 5 WT ♂ 
OX5173G1-SS2045-SS2047-G 5 ♀ x 5 WT ♂ OX5173G1-SS2045-SS2047-H 5 ♀ x 5 WT ♂ 
OX5173G1-SS2045-SS2047-I 5 ♀ x 5 WT ♂ OX5173G1-SS2045-SS2047-J 5 ♀ x 5 WT ♂ 
OX5173G1-SS2045-SS2047-K 5 ♀ x 5 WT ♂ OX5173G1-SS2045-SS2047-L 5 ♀ x 5 WT ♂ 
OX5173G1-SS2045-SS2047-M 5 ♂ x 15 WT ♀ OX5173G1-SS2045-SS2047-N 5 ♂ x 15 WT ♀ 
OX5173G1-SS2045-SS2047-O 50 ♂ x 150 WT ♀ OX5173G1-SS2045-SS2047-P 50 ♀ x 50 WT ♂ 
Underlined pools yielded edits. 
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 For each genotype (OX5173D or OX5173G1), backcrosses of F1 microinjection 
survivors (seven pools per sex) were initiated with identical populations (n=5) to 
facilitate comparisons of efficiency. Surplus individuals were crossed in two sex-
specific pools. Relative to the prior experiment (Protein Cas9-SS1928-SS1931, Section 
6.2), we reduced and equalised pool size to (1) directly compare OX5173D/G1 and (2) 
limit underestimation of efficiency (matching unique edits to independent parents of a 
pool is impossible). Crosses of single individuals were not performed, because we were 
not yet certain that either OX5173 line could mediate mutagenesis. F2 progeny were 
screened for a HR5IE1-zsGreen positive, AlMAct-dsRed2 negative phenotype 
(HR5IE1-DsRed2 [OX5173] is readily distinguished from AlMAct-DsRed2 [OX4014]). 
The efficiency of editing was calculated, largely as described for the Protein Cas9-
SS1928-SS1931 experiment (Table 6.14). 
 
Table 6.14 Efficiency calculations for OX5173D-SS2045-SS2047 microinjections 
 Estimating F2 screening population Edits observed Efficiency (%) 
 Mass      
 
Mean (mg) Total (g) Population  Pools Progeny Parental Progenital 
OX5173D 
SS2045-SS2047 8.40 
161.1 
19168 ± 1593  
9 511 ≥ 13 2.7 ± 0.22 
OX5173G1 
SS2045-SS2047 8.37 
163.8 19572 ± 1677 
 
    
OX5173  
transgenesis 7.39 
78.3 10590 ± 605 
 
6 41 ≥ 7.9 0.39 ± 0.02 
The F2 population was estimated by mean pupal weight from 50 replicates of 10 measured pupae, except 
for OX5173 transgenesis (30 replicates of 10 pupae, scored concurrently with the Protein Cas9-SS1928-
SS1931 microinjection dataset). Uncertainty given as standard deviation. It was not calculated for 
parental efficiency, because these measures were not possible to replicate. 
 
 
 Mutagenesis was detected for F2 progeny of OX5173D (n = 511) but not for 
OX5173G1, despite a larger F1 cohort (Table 6.15). The parental efficiency was most 
likely underestimated because the presence of different edits within the same pool, 
indicated possible origin from independent parents (however, it was not possible to 
exclude the possibility of origin from the same parent). As we crossed injection 
survivors in pools of five, it was not possible to measure parental efficiency as greater 
than 20% (ie. 100/5). DsRed2 PCR amplicons were generated from two positives from 
each pool (n = 22 [11 x 2]) and the unmodified OX4014 background, prior to direct 
sequencing with internal primers. Fifteen independent events were confirmed. Thirteen 
were indels from a single sgRNA (SS2045: n=12, SS2047: n=1) and two were deletions 
that spanned the region between SS2045-SS2047. Sequencing data from 5 events is 
presented (Figure 6.8). The inability of OX5173G1 to mediate editing was unexpected, 
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as the RT-PCR indicated expression in ovaries and eggs. At this point, time expired to 
perform further experiments. Homozygosis of OX5173D was initiated and future 
recommendations for study are discussed subsequently.  
 
Table 6.15 Gene edits recovered from OX5173D-SS2045-SS2047 microinjections 
 
Individual Active sgRNA Edit Sequence change 
B1/B2 SS2045 32 nt deleted Frameshift at A2; 10 codons deleted 
C1 SS2045 1 nt inserted 
10 nt deleted 
Frameshift at M1; 3 codons deleted 
C2 SS2045 13 nt deleted Frameshift at A2; 4 codons deleted 
E1/E2 SS2045 13 nt deleted Frameshift at S4; 4 codons deleted 
F1 SS2045/SS2047 285 nt deleted In-frame deletion of S4-N98 
F2 SS2045 3 nt deleted Non-sense mutation at S4  
G1/G2 SS2045 34 nt deleted Frameshift at A2; 11 codons deleted 
H1/H2 SS2045 16 nt deleted Frameshift at M1; 5 codons deleted 
I1/I2  SS2045 30 nt deleted In-frame deletion of S4-R13 
J1/J2 SS2045 2 nt deleted Frameshift at S4 
K1/K2 SS2047 14 nt deleted Frameshift at R95; 4 codons deleted 
O1 SS2045/SS2047 284 nt deleted Frameshift at S4; 94 codons deleted 
O2 SS2045 11 nt deleted Frameshift at A2; 3 codons deleted 
P1 SS2045 11 nt deleted Frameshift at S4; 3 codons deleted 
P2 SS2045 13 nt deleted Frameshift at S4; 4 codons deleted 
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6.3.6 Isolation of genomic sequence flanking the OX5173D insertion site 
 The flanking genomic sequence of OX5173D would prove useful for PCR-
mediated homozygosis, and to characterise a transgenic docking site with favourable 
expression of maternally deposited transgenes (for future site-specific integration). 
Inverse PCR was successful for TaqαI (5’ end) and HhaI (3’ end) digestions. The 
dominant bands were gel purified, cloned into the pJET vector and sequenced. 
Contiguous fragments spanning the insertion site and genomic DNA were isolated 
(Figure 6.9) at the 5’ (778 bp) and 3’ ends (914 bp).  
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6.4 Conclusions 
 CRISPR technology was applied to mediate highly efficient gene editing of 
Medfly, and a protocol for modifying Medfly or related insects established. Although 
the microinjection of recombinant Cas9 protein was functional, the high efficiency 
observed for germline-expressed Cas9 (OX5173D) supports the creation of equivalent 
strains for other insects. This would be particularly important for site-specific 
integration, which is less efficient than the generation of indels (Gratz et al., 2014). 
Germline modification was induced in ≥ 13% of injection survivors (parental 
efficiency), with heritable mutations in 2.7% of screened progeny (progenital 
efficiency). This was substantially less than the average parental efficiency (100%) and 
progenital (60%) efficiency, reported in a D. melanogaster study (Kondo and Ueda, 
2013). However, there were substantial differences in the methodology of the two 
studies, which must be considered.  
 
 First, we crossed individuals in pools of five, as the ability of the OX5173 lines 
to mediate mutagenesis had not yet been confirmed. Therefore, it would not be possible 
to report a parental efficiency higher than 20%. The possibility of underestimation is 
substantiated by the frequent observation of different mutations in G2 progeny 
originating from the same pool; in the recombinant Cas9 protein experiment, almost all 
G2 progeny of the same pool had the same mutation. This suggests, but does not 
confirm, that multiple G1 individuals had germline mutations. It would be necessary to 
repeat the analysis with crosses of single individuals, to fully determine this efficiency. 
Furthermore, flies in the published study expressed sgRNA in the germline (U6 
promoter-sgRNA); sgRNAs were microinjected in our study. We observed a striking 
improvement in efficiency between the strain expressing Cas9 in the germline 
(OX5173), relative to the microinjection of Cas9 as recombinant protein. Therefore, it 
would be expected that the efficiencies would be improved by germline expression of 
sgRNA, relative to microinjection of in vitro transcribed sgRNAs. To mediate this, we 
isolated and cloned the U6 promoter sequences from Medfly (Appendix, Figure 8.2). 
Unfortunately, there was insufficient time to investigate their ability to mediate efficient 
germline mutagenesis. 
 
 Though preliminary, a framework is established for more technical experiments. 
Two applications were particularly relevant commercially: transposon immobilisation 
by mutagenesis and site-specific construct integration. CRISPR-mediated 
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immobilisation of two-ended constructs would allow for a substantial reduction in the 
size of expression constructs (3.8 kb), relative to the four-ended piggyBac system with 
three fluorescent markers applied in prior study (Chapter 5). As previously described, 
substantially greater effort was expended in the cloning and transformation of large 
constructs (Chapter 5: OX5195/OX5241/OX5242/OX5257). This suggests that the 
system could be improved by using CRISPR to remove the inverted terminal repeats 
from standard, two-ended piggyBac vectors. However, it would be possible to achieve 
the same results, by adapting the current 4-PB system to a marker-free state. In at least 
one line, the efficiency of the desired piggyBac end excision (loss of the two piggyBac 
paired ends, with retention of the central element) was about 6% in P. gossypiella 
(Morrison, 2007). Though this is expected to vary with different genomic insertion sites 
and insect species, it does demonstrate that a marker-free 4-PB system is theoretically, a 
viable alternative in Medfly (Dafa’alla et al., 2006), (Condon et al., 2007). It is 
interesting to note that the 4-PB system removes all piggyBac sequence, at both pairs of 
ends. There would be mechanistic difficulties associated with the full deletion of both 
ends from a two-ended construct with CRISPR. First, it would be necessary to apply 
three sgRNAs. The first would be targeted to the inverted terminal repeat (ITR) present 
at both ends. The second and third would, respectively, target sequences within the 
central element of the construct that border the piggyBac 5’ and 3’ elements. This would 
incur a risk of deleting the whole construct; CRISPR can mediate deletions of more than 
200 kb (Zhou et al., 2014). This risk is impossible to quantify without further 
experimentation. Alternatively, deletions may be associated with inversions (Kraft et 
al., 2015). This could theoretically be problematic, because the expression of 
tetracycline-repressible transgenic systems is affected by its position relative to cis-
acting genomic elements (Schönig et al., 2011). It is interesting to note that the removal 
of one ITR is expected to completely block transposition (Li et al., 2001a), and that the 
results of the fluorescent marker mutagenesis experiments demonstrated that this would 
be possible with acceptable efficiency. However, it is commercially difficult to justify 
the application of products that retain more piggyBac sequence than previous 
constructs, from which all pB sequence was removed with the 4-PB system. Therefore, 
the more simple option would be to first test the viability of a marker-free 4-PB system. 
 
 In terms of generating piggyBac sequence-free insertions, equivalent results to 
the 4-PB system or CRISPR-mediated deletion, could be achieved with site-specific 
integration. There are additional benefits: complete independence from piggyBac 
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vectors, and potentially improving the efficiency of product development by localising 
effectors to sites where the transgenic expression profile is already known. This study 
has characterised a small library of genomic insertion sites that confer a favourable 
expression profile to transgenes in the male germline (OX5122, OX5123, OX5195 and 
others; Chapters 3-5) and one for the female germline (OX5173D). Though the 
genomic insertion site is not yet known for many, it would be simple to isolate them; 
the efficiency at which novel expression systems could be integrated to these sites, 
however, remains to be demonstrated. Site-specific integration of a 1.2 kb fragment was 
observed in 11% of progeny for a particularly effective combination of sgRNAs and 
homologous template DNA in D. melanogaster (Gratz et al., 2014). Into mammalian 
cell culture, targeted integration of a 4.5 kb fragment was achieved (Chu et al., 2015). 
We are not aware of any reports in fruit flies achieving integration of fragments of 
equivalent size, but it remains theoretically possible. The efficiency of site-specific 
CRISPR integration remains an important consideration, because a commercially 
applicable male sterility phenotype is generally isolated from 5-10 random piggyBac 
insertions, for a functional expression construct. Therefore, the probability that this 
strategy will be commercially applicable, requires further experimentation to determine 
this efficiency.  
 
 The present dispute for patent rights of the CRISPR platform (Ledford, 2016) 
 casts uncertainty about the extent to which these systems can be applied to 
commodities protected as intellectual property in future (such as products developed at 
Oxitec). Potentially, licencing agreements could be necessary even if CRISPR is not a 
functional element of the final product (for instance, if they were only used for site-
specific integration, or the removal of piggyBac sequences). It is furthermore unclear 
whether the application of CRISPR/Cas9 variants with altered specificity or function 
will be subject to the restrictions that may be applied to the original S. pyogenes 
CRISPR system. Regardless, it is clear that the ability to easily modify or functionally 
adapt targeted sequences of DNA can be powerfully applied to study genetic function, 
develop bioproducts and potentially address debilitating diseases. If implemented 
responsibly, the technology will undoubtedly have profound positive effects on society. 
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Chapter 7 – Discussion 
 
7.1 Summary of the study and its objectives 
 We intended to develop transgenic systems for a population control strategy for 
Medfly similar to the sterile insect technique (SIT), but addressing its known limitations 
(Section 1.4), by the targeted expression of transgenes to mediate sterility and improve 
the ability to monitor strain performance in the field. The SIT has been applied with 
varying degrees of success against many invasive pest species (Section 1.3.7), including 
Medfly, across the world (Vanderplank, 1947), (Lindquist et al., 1992), (Vreysen et al., 
2000), (Kohama et al., 2003), (Oliva et al., 2012). The primary requirement of a 
successful programme is the reliable induction of male sterility and the release of 
enough sterile males to reliably overwhelm the capacity of wild females to accept 
fertile, wild males (Knipling, 1955), (Parker and Mehta, 2007), (Black et al., 2011). The 
current practice of irradiation reliably achieves 99-100% male sterility (Robinson et al., 
2002), (Bakri et al., 2005), (Mastrangelo et al., 2010). However, it is not specifically 
directed to the male germline. Therefore, it damages non-target tissue and undesirably 
reduces parameters such as lifespan and mating competitiveness, which must be 
retained to an acceptable level for sterile males to mate with wild females, at an 
acceptable frequency (Hafez and Shoukry, 1972), (Shelly et al., 1994), (Lance et al., 
2000), (Alphey, 2006).  
 
 These undesirable effects on male competitiveness vary between insect species; 
for instance, moths are very tolerant to irradiation (Hallman, 2004). The conditions of 
irradiation, such as dosage and the developmental stage of the insect, also affect the 
extent to which competitiveness is reduced (Anwar et al., 1971), (Fisher, 1997), 
(Robinson et al., 2002), (Alphey, 2006), (Hallman et al., 2010). Furthermore, 
competitive ability may be adversely affected by the genetic and behavioural effects of 
colonisation and adaptation to the lab, and the stressful conditions of mass rearing 
(Bush et al., 1976), (Ozaki and Kobayashi, 1981), (Liimatainen et al., 1997), (Briceño 
and Eberhard, 1998). Mass-rearing is a necessary requirement of this strategy, and 
therefore its effect must be considered, if a competitive male sterile strain is to be 
developed. The competitive profile of the released males can be improved, for instance 
by exposing males to aromatic compounds prior to dispersal, or periodically renewing 
the mass-rearing colony with a small population maintained under circumstances more 
similar to the field (Shelly et al., 2004), (Shelly, 2012). Therefore, the application of an 
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optimised dose of radiation under appropriate circumstances can reduce side-effects on 
longevity and mating competitiveness, though it is generally agreed that mass-rearing 
and sterilisation incur undesirable effects, even in carefully managed scenarios (Hooper, 
1972), (Shelly et al., 1994), (Shelly and Whittier, 1996), (Alphey, 2006). This is 
problematic, as it reduces the efficiency of the strategy and increases the required scale 
of release. To address these undesirable side-effects, we sought to develop a more 
targeted method to sterilise males, by the expression of a chimeric nuclease effector 
(protamine-FokI) in the male germline (Jin, 2011), (Bilski, 2012), (Alphey, 2015). In 
Chapter 5, two successful transgenic expression systems for repressible male sterility 
were obtained (OX5242: Ccprot1-short 5’UTR-FokI; OX5257: Dmprot2-chimeric-new-
FokI). Both demonstrated a highly penetrant and mostly repressible male sterility 
phenotype. Furthermore, males of one strain (OX5242(1)H) were confirmed to transfer 
acceptable quantities of fluorescently labeled sperm to WT females upon mating 
(Figure 5.12), indicating that they were suitable for field use. 
 
 To enhance monitoring in the field, it was also desirable to engineer two 
expression systems for fluorescent marking, one expressed in the body of the insect, and 
the second specifically in sperm nuclei (Scolari et al., 2008), (Harris et al., 2012), 
(Asadi, 2013). Several methods for marking the body of insects have been described, 
for instance with fluorescent powders or the ingestion of dyed food (Wilkinson et al., 
1972), (Nestel et al., 2007). The accuracy of these monitoring strategies can be reduced 
if not carefully managed; the markers can dissipate, reduce male fitness, or be 
transferred to wild males (Hagler and Jackson, 2001). A highly functional transgenic 
expression system for bright, whole-body fluorescent marker expression was previously 
developed at Oxitec: the dsRed2 fluorescent protein is expressed specifically in muscle 
with components of the Mexfly muscle actin gene (Koukidou et al., 2016). This 
facilitates the unambiguous differentiation of wild and transgenic males, without 
apparent effects on male fitness, the risk of dissipation in the field, or the possibility of 
transferring marking elements to wild males.  
 
 A system for fluorescent marking of sperm nuclei would facilitate a direct 
estimation of mating competitiveness, by scoring the presence of fluorescently marked 
sperm in females that had mated the transgenic strain (Scolari et al., 2008), (Scolari et 
al., 2014). It would also allow the identification of the mating partner of wild females: 
wild males, transgenic males, or both (Scolari et al., 2014), (Chapter 4). Practically, this 
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is an improvement on the current field practices: adhesive chemical or fluorescent 
powder can be applied, which are transferred from males to females during copulation 
(Jarvis and Rutledge, 1992), (Armsworth et al., 2008). These markers can dissipate in 
the field (Hagler and Jackson, 2001), and importantly, they would not indicate the 
number of sperm transferred or even that copulation had occurred. Alternatively, the 
presence of irradiated sperm in the spermathecae can be used to score mating events 
with sterile males. However, this relies on detectable morphological differences being 
induced by irradiation, which are known for Medfly (McInnis, 1993), but not all species 
(Helinski and Knols, 2009). Scoring the head size of sperm is, however, difficult in 
comparison with assessing the presence of an abundant fluorescent marker. We 
successfully developed a protamine-based expression system (Ccprot1-zsGreen) that 
fully labeled mature sperm (Figure 4.3), and this was successfully expressed alongside 
the effector of repressible male sterility and the whole-body fluorescent marker (Figure 
5.12). Therefore, we were able to generate a single strain with repressible male sterility 
and fluorescent labeling of the body and sperm, suitable for use in an area-wide control 
programme for Medfly. 
 
However, it is still necessary to integrate these components with a previously 
tested and highly efficient genetic sexing strain (OX3864), to engineer automated 
female removal for a male-only release. Thereafter, males of a transgenic strain 
expressing all four components (male sterility, fluorescent body marking, fluorescent 
sperm marking and genetic sexing) must be assessed for their ability to reduce 
populations of Medfly after sustained mass releases, in field-like conditions (Leftwich 
et al., 2014). We also described a series of CRISPR-based tools for the precise and 
highly efficient genetic engineering of Medfly, which could be applied to improve the 
efficiency of product development, modify previously evaluated transgenic strains for 
novel characteristics, or study novel sequences of developmental or commercial 
significance. A discussion of these systems and their practical relevance was previously 
provided, in Chapter 6 (Section 6.4). 
  
7.2 Transgenic expression systems for the fluorescent labelling of sperm nuclei can 
be applied to assess the mating performance of male sterile strains in the field  
 
7.2.1 Fluorescent marker expression systems regulated by Ccβ2tubulin or 
Ccβ2tubulin-tTAV do not effectively label sperm nuclei 
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 Three systems regulated by Ccβ2tubulin or Ccβ2tubulin-tTAV (OX3671, 
OX4282 & OX5036), were not effective in labeling the nuclei of sperm, and hence were 
not suitable for field use (Jin, 2011), (Chapter 3). However, the results were valuable in 
enabling us to subsequently develop a protamine-based expression system that 
demonstrated field-applicable properties (Chapter 4). The OX3671 fragment was based 
on a full-length Ccβ2tubulin promoter and 5’UTR fragment (Ccβ2tubulin promoter-
Ccβ2tubulin 5’UTR-dsRed2-SV40 3’UTR); there was no element providing 
tetracycline-repressible transcriptional activation (tTAV) in this design. The dsRed2 
reporter was visibly detectable in fewer than half of sperm (Figure 3.1), (Jin, 2011). 
This was a curious result, as the Ccβ2tubulin promoter and 5’UTR were shown to 
mediate bright fluorescent marking in the spermatids and sperm of C. capitata by 
another group (Scolari et al., 2008). Interestingly, the fluorescence observed within the 
testes of live, undissected OX3671 males appeared comparable to the strains assessed in 
the Scolari study (Jin, 2011). Therefore, the reasons why we did not observe fluorescent 
labeling of all sperm were unclear. We demonstrated that the levels of transcription and 
translation in the male germline, mediated by a modified Ccβ2tubulin fragment 
(truncated Ccβ2tubulin 5’UTR, fused to Cchsp83 minipromoter-5’UTR), were 
extremely sensitive to the insertion site of the transposon (OX5036, Figure 3.11). 
Therefore, it was possible that a strain with ability to fluorescently label sperm nuclei 
equivalent to that described in the Scolari study could be obtained, if a larger panel of 
lines were assessed. However, this result indicated that stronger and earlier expression 
of the fluorescent protein would be necessary, to mediate labeling of all mature sperm in 
the majority of strains tested.  
 
 To achieve this expression profile, the Ccβ2tubulin 5’UTR was truncated to 
remove putative translational delay elements, and attached to a minimal promoter 
fragment and 5’UTR from Cchsp83 (to mediate earlier transcription and translation). In 
OX4282, this fragment was used to regulate the expression of tTAV, to transactivate 
expression of the reporter at the tetO target sequences (tetO14-Dmhsp70 minipromoter-
adh intron-tGFP-SV40 3’UTR). tTAV was adjacent to the tetO operator (the two 
transcriptional units were cloned in a head-to-head orientation). Therefore, it was 
considered that the conformation might provide a tetracycline-repressible, positive 
feedback expression loop, wherein tTAV would activate both its own transcription and 
that of the tGFP marker, at the tetO target sites. This did not increase the proportion of 
sperm that were detectably marked (Figure 3.1), (Jin, 2011). Therefore, it appeared 
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likely that a stronger regulatory element, potentially with a translational profile specific 
to spermatids, would be required to facilitate strong labeling of all sperm nuclei. 
 
 We next considered if the application of a fluorescent protein that did not require 
dimerisation, might be sufficient to enhance labeling of sperm nuclei. It was reasoned 
that fluorescent proteins requiring dimerisation would demonstrate a non-linear 
relationship between concentration and activity; in contrast, the activity of a monomeric 
fluorescent protein would be relatively proportional to its concentration. Therefore, it 
was possible that the monomeric zsGreen protein might improve the labeling of sperm. 
In OX5036, tTAV and an nls-zsGreen-nls fluorescent marker were translated as two 
polypeptides from the same mRNA, separated at the T2A translational skipping element 
(tetO21-Ccβ2tubulin promoter-5’UTR[short]-Cchsp83 minipromoter-5’UTR-tTAV-
T2A-nls-zsGreen-nls-Cchsp83 3’UTR). As for OX4282, this conformation was 
expected to potentially provide a tetracycline-repressible, positive feedback expression 
loop, wherein tTAV would activate the transcription of itself (tTAV-T2A-nls-zsGreen-
nls). Marker expression was extremely weak, and generally absent from sperm. We 
were therefore surprised to find that this expression system was inferior to the previous 
systems, which applied tetrameric (dsRed2, OX3647) or dimeric (turbo GFP, OX4282) 
proteins. It is possible that, despite a non-linear response between concentration and 
activity, that the aggregation of fluorescent molecules by multimerisation enhances 
detectability. It is notable that none of these three systems (OX3647, OX4282 and 
OX5036) applied a fluorescent protein fused to a DNA-binding element. This would be 
expected to localise the fluorescent molecules to nuclear DNA, and hence improve the 
visibility. For this reason, it was investigated if protamine-fluorescent marker-FokI 
fusions could simultaneously localise the fluorescent marker and the male sterility 
effector to sperm DNA.  
 
7.2.2 Fusions of the male sterility effector and a fluorescent protein are 
problematic because the components affect the localisation of one another  
 Two expression constructs (OX4705 & OX4801), were previously tested in 
olive fly (Asadi, 2013). A linker-free fusion of tetO21-Dmprot2-mCherry-FokI 
(OX4705) was highly penetrant and repressible (2/4 lines), but marking of sperm nuclei 
was not observed in any line. Short flexible peptide linkers (SG4) were included 
between the fluorescent protein and protamine-FokI effector, to introduce a spacer 
element that might prevent the components from interfering with one another. OX4801 
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(tetO21-Dmprot2-SG4 linker-mCherry-SG4 linker-FokI) demonstrated weak but 
visible sperm marking in all six lines evaluated (Figure 3.3). However, the male 
sterility phenotype was not adequately penetrant (mean hatch rate: 20%). This indicated 
that both mCherry and FokI were highly sensitive to the conformation of the fusion, as 
the removal or addition of linker sequences was sufficient to alter the sperm marking 
and male sterility phenotypes observed.  
 
 When the linker-free tetO21-Dmprot2-mCherry-FokI was tested in Medfly 
(OX4718), we were surprised to find that the results were not equivalent. Penetrant and 
repressible sterility was observed in 1/2 lines (Bilski, 2012), as expected; however, the 
fluorescent protein was weakly visible in a minority of sperm, but a majority of late 
elongating spermatids, in the penetrant line (OX4718A, Figure 3.5). This contrasted 
with the phenotype in olive fly, where fluorescent labeling of sperm was not observed. 
Therefore, two explanations are possible. The expression systems may behave 
differently in Medfly and olive fly; this was indicated by a greater intensity of 
fluorescence in the male germline of Medfly (OX4718), relative to olive fly (OX4801). 
Alternatively, it was possible that linker-free Dmprot2-mCherry-FokI systems could 
theoretically facilitate penetrant male sterility and partial fluorescent marking of sperm 
in olive fly for certain insertions, but it was not observed experimentally, in those lines 
obtained.  
 
 It remained possible that an alternative fusion would be functional. The six 
possible linker-free fusions, including the one tested (underlined), are: (1) mCherry-
Dmprot2-FokI; (2) mCherry-FokI-Dmprot2; (3) Dmprot2-mCherry-FokI; (4) FokI-
mCherry-Dmprot2; (5) Dmprot2-FokI-mCherry; and (6) FokI-Dmprot2-mCherry. 
These combinations could be modified to include an SG4 linker preceding mCherry, an 
SG4 linker following mCherry, or two SG4 linkers between mCherry and the adjacent 
molecules. For each scenario, the number of possible combinations increases by six; 
there are 24 total possibilities. Here, we consider only the linker-free combinations.  
Prior results indicated that the fluorescence of mCherry was adversely affected by 
placement between two proteins (Dmprot2-mCherry-FokI), particularly if flexible 
linkers were not present between mCherry and the two proteins. Therefore, it appeared 
likely that the alternative fusion with mCherry in the middle of the three proteins (FokI-
mCherry-Dmprot2, instead of Dmprot2-mCherry-FokI), would also function poorly; 
though this would need to be confirmed experimentally. Similarly, we reasoned that it 
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was probable that any fusion where FokI was orientated in the middle of the three 
proteins (Dmprot2-FokI-mCherry or mCherry-FokI-Dmprot2), might not mediate 
substantial endonuclease activity. This is because dimerisation between the FokI 
cleavage domains is required for DNA endonuclease activity (Vanamee et al., 2001). 
Therefore, placing FokI in the middle of the fusion protein could potentially prevent 
dimerisation, by increasing the relative distance between the FokI monomers. This may 
be an oversimplified explanation, because the chromatin in sperm is highly compacted 
and spatially aggregated (Kost et al., 2015). Therefore, it remains theoretically possible 
that fusions with FokI in the middle would still be able to dimerise and therefore cleave 
DNA. 
 
 It is interesting to note, that in a variation of the CRISPR system, N-or C-
terminal fusions of FokI to defective Cas9 nuclease (dCas9-FokI and FokI-dCas9) were 
both able to mediate relatively efficient targeted endonuclease activity (Guilinger et al., 
2014b), suggesting that FokI-Dmprot2-mCherry or mCherry-Dmprot2-FokI could 
potentially be functional. Interestingly, an mCherry-lac repressor-FokI fusion mediated 
DNA binding, endonuclease activity and visible fluorescent marker expression 
(Shanbhag and Greenberg, 2013), which would be the features required of our effector 
molecule. This strongly suggested that a functional mCherry-Dmprot2-FokI fusion 
could be developed. These were not developed, however, because we reasoned that it 
would be simpler to design protamine-fluorescent protein fusions (regulated by 
protamine promoter, 5’UTR and 3’UTR) in a separate module from the effector protein. 
The functionality of these protamine-based fluorescent protein expression systems was 
subsequently confirmed (Chapter 4).  
 
7.2.3 Protamine-fluorescent marker fusions regulated by Ccprot1 or Ccprot2 
(OX5122, OX5123 and OX5150) visibly localise to the nuclei of all sperm 
 The translational profile of the D. melanogaster protamine-like genes was 
known to be strong and specific to elongating spermatids, with persistence of the 
translated protein to mature spermatozoa (Jayaramaiah Raja and Renkawitz-Pohl, 
2005), (Barckmann et al., 2013). Therefore, we reasoned that placing a fluorescent 
protein under the transcriptional and translational control of D. melanogaster or Medfly 
protamine-like genes (promoter-5’UTR-fluorescent protein-3’UTR) would provide 
strong and constitutive fluorescent sperm marking. A constitutive (non-repressible) 
fluorescent sperm marking system would enable a more powerful assessment of the 
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effects of a protamine-FokI effector, in the induced (off-tet) and repressed (on-tet) 
states, when both components were expressed from the same piggyBac vector. This was 
because fluorescently marked sperm are more easily recognised than unmarked sperm, 
and hence it would be easier to detect an effect of protamine-FokI expression on the 
quantity and morphology of sperm transferred to females, after mating. Because there is 
an inverse relationship between the quantity of sperm transferred and female desire to 
re-mate (Mossinson and Yuval, 2003), this would provide useful data regarding the 
suitability of this two-component transgenic system (repressible male sterility and 
fluorescent sperm marking) as a measure for population control. We assessed the 
suitability of three protamine-like genes to localise a fluorescent marker (zsGreen or 
mCherry) to spermatids and mature sperm: Dmprot1, Ccprot1 and Ccprot2.  
 
 None of four lines of the Dmprot1-zsGreen expression system (OX5140) had 
visible zsGreen fluorescence in testes, despite the demonstration of Dmprot1-zsGreen 
transcription in one line (OX5140E). The 3’UTR was unlikely to be responsible, 
because a minimal 3’UTR paired with the Dmprot1 promoter and 5’UTR is sufficient to 
mediate translation in elongating spermatids of D. melanogaster (Jayaramaiah Raja and 
Renkawitz-Pohl, 2005), (White-Cooper, 2009). The Dmprot1 coding domain is known 
to mediate DNA-binding in D. melanogaster (Jayaramaiah Raja, 2005), (Jayaramaiah 
Raja and Renkawitz-Pohl, 2005); and the virtually identical Dmprot2 protein was 
confirmed to bind DNA in Medfly (OX4718, Dmprot2-mCherry-FokI, Figure 3.5). 
However, it is interesting to note that this fusion of mCherry to the C-terminus of 
Dmprot2 was poorly tolerated (weak fluorescence). Therefore the C-terminal fusion of 
Dmprot1 to zsGreen may have similarly been responsible for the lack of observed 
fluorescence. It was additionally possible that the Dmprot1 5’UTR is not functional in 
Medfly (this was never experimentally confirmed). Notably, we did not observe a 
translational delay mediated by Dmprot2 5’UTR (OX4718; Figure 3.5), though in this 
instance, it was possible that the adjacent Dmhsp70 5’UTR blocked the ability of 
Dmprot2 5’UTR to mediate translational delay. The mode by which Medfly protamines 
are translationally repressed is not known; therefore it is not possible to conclude if the 
Dmprot 5’UTRs would be functional in Medfly, without further analysis. Because the 
Ccprot1 and Ccprot2 5’UTR fragments were subsequently indicated to mediate 
translational repression (Figure 4.3-4.4), extensive troubleshooting of the Dmprot1-
zsGreen expression system was not a valuable expenditure of resources. 
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 Ccprot2-zsGreen (OX5150) was functional as a fluorescent sperm marking 
system in one line of three lines. This did not appear to result from an inherently poor 
performance of the construct. Both lines that did not demonstrate localisation of 
zsGreen to the male germline were y-linked insertions, which generally perform poorly 
in the male germline. For instance, transgenic effectors were poorly expressed in the 
male germline of other y-linked transgenic lines (OX5036AG, OX5195(2)BA1 and 
OX5257G1: Figure 3.9, Figure 5.3, Figure 5.14). Nonetheless, the results 
demonstrated that the promoter, 5’UTR and 3’UTR of Ccprot2 were able to mediate 
localisation of the zsGreen reporter to the elongated spermatid stage, in lines with a 
favourable genomic insertion site (the phenotype was equivalent to that observed for 
Ccprot1). This was important, because it indicated that the Ccprot1 and Ccprot2 5’UTR 
elements would be sufficient to engineer a translational delay of a protamine-FokI 
effector, and therefore reduce the likelihood of adverse effects on the quantity and 
morphology of sperm transferred to females after mating. This was subsequently 
investigated, and a suitable effector derived for Ccprot1-FokI, but not Ccprot2-FokI 
(Figures 5.10-5.11). 
 
 The Ccprot1-zsGreen (OX5122) system mediated strong localisation of zsGreen 
to all sperm nuclei, in every line tested. We were surprised to find that the localisation 
of Ccprot1-mCherry (OX5123) appeared to be more sensitive to insertion site than that 
of Ccprot1-zsGreen (OX5122); the mCherry reporter was visibly localised to sperm 
nuclei in only 3/5 lines. The only differences between these two constructs were the 
fluorescent protein applied (mCherry/zsGreen); the alteration of two amino acids in the 
linker peptide between Ccprot1 and the fluorescent protein (OX5122: RYRST; 
OX5123: RYRY); and the absence of the N-terminal methionine from mCherry in 
OX5123. Both proteins were monomeric, and hence expected to demonstrate 
comparable intensity of fluorescence, if expression levels were similar. The expression 
of Ccprot1-mCherry in a given strain was binary (either highly visible, or not visible at 
all). Therefore, the observed lack of fluorescence in certain OX5123 lines seemed to be 
entirely a consequence of the insertion site, rather than a relative weakening of 
expression caused by alteration of the linker, removal of the N-terminal methionine of 
mCherry, or the possibility that mCherry was inherently less bright than zsGreen. We 
observed that certain autosomal insertion sites were superior to others, for mediating 
high levels of expression in the male germline of Medfly (OX5036: Figure 3.9). 
Because a small number of lines were assessed from OX5122 and OX5123 (five each), 
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it is possible that two weak autosomal insertions were derived by chance for OX5123, 
and that similarly weak autosomal insertions might have been observed for OX5122, 
had a larger panel of lines been screened. It would be possible to directly test this 
hypothesis, by characterizing the genomic insertion site of a weak OX5123 line (eg. 
OX5123G), using CRISPR-mediated site-specific integration to direct the OX5122 
construct to this locus, and observing the subsequent localisation of zsGreen in the male 
germline. However, such an assessment is of limited commercial relevance and would 
be extremely time-consuming; therefore it was not pursued. 
 
7.2.4 Practical uses of fluorescent sperm marking systems to assess mating 
competitiveness and reproductive biology 
 The development of two strains with differentially marked fluorescent sperm 
(Ccprot1-zsGreen [OX5122] and Ccprot1-mCherry [OX5123]) facilitates powerful 
analyses of the ability of transgenic strains to engage in wild-type mating behaviour, 
and thereafter induce refractoriness to re-mating in females; both factors would directly 
impact the success of this population control strategy in the field. Although a final 
commercial product would require only one fluorescent sperm marking system, it is 
useful to possess strains with different fluorescent markers, as this allows the interaction 
of sperm from multiple partners within the same female to be studied. The practical 
applications of these systems, and the extent to which they were investigated in this 
study, are next considered. 
 
 Heterozygous and homozygous males of one line (OX5122M [Ccprot1-
zsGreen]) were tested for mating competitiveness relative to WT males. No significant 
difference was observed, indicating that expression of the Ccprot1-zsGreen transgenic 
system did not severely impact male competitiveness. However, it is acknowledged that 
the competitiveness of sterile males under laboratory conditions does not accurately 
reflect performance in the field; mass-reared males appear to demonstrate variations in 
mating behaviour which may compromise reproductive success, and wild females 
appear to be more selective than lab-reared females (Liimatainen et al., 1997), (Briceño 
and Eberhard, 1998), (Lance et al., 2000). Therefore, the suitably of these strains for 
field use must be fully validated by an assessment under conditions more similar to the 
field, in large greenhouses with foliage to provide lekking sites (Morrison et al., 2009). 
Ideally, this analysis would be performed with wild-caught males rather than wildtype. 
The use of wildtype males as competitors is expected to overestimate the 
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competitiveness of the sterile line, because the wildtype strain is likely to demonstrate 
lab adapted behaviour and equivalent reductions in fitness associated with lab 
colonisation and rearing, which may still disadvantage these males in the field. Because 
the inclusion of a male sterility effector was previously shown to affect the motility and 
quantity of sperm transferred (OX4718: Figure 3.8), there was limited value to 
performing an intensive assessment of mating competitiveness, before a transgenic 
strain expressing both components (the male sterility effector and fluorescent marking 
system) was generated. Two strains (OX5242(1)H1 and OX5257V1) were generated at 
the end of the study, but time was insufficient to assess them. 
 
 The quantity and morphology of sperm transferred to females after mating did 
not appear to differ between wild-type males, heterozygous transgenic males 
(OX5122D, G, K & M) or homozygous transgenic males (OX5122M). This indicated 
that expression of the transgenic marker system did not visibly affect the ability of 
sperm to behave normally in the female reproductive tract. Furthermore, the ability of 
males of several transgenic lines to consistently transfer fluorescently marked sperm to 
females after mating, at similar quantities to WT, indicated that the system would be 
likely to function reproducibly for most autosomal insertions. A minimally insertion 
sensitive phenotype was ideal for commercial development, because it reduces the 
effort required to generate a strain with a commercially applicable phenotype. It should 
be noted that these modes of scoring were not quantitative, and a strong relationship 
between the number of sperm transferred to females and their desire to re-mate, has 
been demonstrated (Mossinson and Yuval, 2003). Therefore, it would be useful to 
develop a more quantitative mode of scoring; two methods are suggested. First, it would 
be possible to manually count dilutions of dissected spermathecal tissue under high 
magnification. Typically, this involves staining sperm with a fluorescent dye such as 
DAPI, but this could be omitted, as the sperm are already fluorescently marked. 
Alternatively, qPCR has been applied to quantify sperm DNA; such a method has been 
developed in the Tephritid pest A. suspensa (Fritz et al., 2010). The latter would be 
more likely to provide an immediate solution, as sufficiently high resolution 
microscopes are expensive. 
 
 In the field, it will be necessary to assess the rate at which transgenic sterile 
males mate wild females. Therefore, the fluorescent sperm marking system must 
demonstrate adequate persistence in the reproductive tract of females captured on traps, 
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and it must be possible to reliably detect the fluorescence after dissection. To evaluate 
these parameters, females which had been mated to WT or OX5122M-homozygous 
[Ccprot1-zsGreen] males were left on traps and subsequently dissected. Even after 2 
weeks, it was possible to assess whether the female had mated a WT or OX5122M-
homozygous male, with 95% accuracy. Across all timepoints (0, 3, 7 and 14 days), the 
rate of false negatives (mating events to OX5122M males, misidentified as WT because 
fluorescence was not observed) was considerably higher than the rate of false positives: 
5/79 and 2/79, respectively. This was presumably due to the fact that false negative 
scoring was likely to occur where sperm transfer upon mating was minimal; sperm 
degradation was high; or sperm were lost during dissection. The only instance in which 
false positives are likely to occur is if spermathecal autofluorescence is mistaken for 
fluorescent marker expression. A false positive (1/20) was scored for each of the two 
early timepoints, but not subsequently; therefore, it appears that this type of erroneous 
scoring can be reliably eliminated with practice. Therefore, although most events are 
scored correctly, mis-scoring events are slightly biased towards false negatives. In 
practical terms, this would lead to a slight underestimation of sterile male 
competitiveness, because occasionally mating events between transgenic males and 
wild females would be attributed to wild males. This would be preferable to the 
alternative scenario (an overestimation of competitiveness), because in practical terms it 
would be preferable to release sterile males in excess of the minimum required. It 
should be noted that under a microscope with sufficient resolution, it would be possible 
to score a complete absence of sperm (rather than an absence of fluorescence), and 
therefore substantially reduce the rate of false negatives.  
 
 Medfly females frequently accept second mates in the wild (Bonizzoni et al., 
2002), which would reduce the efficacy of sterile male release for population control, if 
females frequently re-mated with fertile wild males. This is furthermore problematic, 
because the majority of offspring are sired from the male mated most recently; about 
70-80% for the first five days, though this proportion declines thereafter (Bertin et al., 
2010), (Scolari et al., 2014). The likelihood of female re-mating is additionally 
enhanced if the quantity of sperm transferred is reduced (Mossinson and Yuval, 2003). 
This is an important consideration because we determined that males sterilised by 
expression of protamine-FokI transfer, on average, reduced quantities of sperm with 
lesser motility (OX4718: Figure 3.8; OX5195: Figure 5.5; OX5242: Figure 5.12). 
Notably, we did not detect such an effect when the fluorescent sperm marking system 
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was not expressed with an effector of male sterility (OX5122M heterozygotes and 
homozygotes: Figure 4.9). Therefore, it appears that expression of the male sterility 
effector, but not the fluorescent sperm marking system, has a deleterious effect upon 
sperm quantity and motility.  
 
 Re-mating tendency was investigated in females which were first mated to WT 
or OX5122M males, and then provided the opportunity to mate a second time, with 
males of the opposite genotype to which females had first mated (Section 4.3.2). We 
did not observe a substantial difference in re-mating tendency, between the two groups. 
However, the sample size was small, because most females did not remate (Table 4.10). 
The additional limitations of the study, were that females were not assessed for re-
mating over a long period (they were only provided the opportunity to remate once, on 
the subsequent day). As females are more likely to re-mate after their stores of sperm 
are relatively depleted (Twig and Yuval, 2005), it is likely that a substantially greater 
proportion of females would choose to remate one or two weeks later, for instance. 
Finally, the limitations of assessing competitiveness and re-mating under the artificial 
conditions of the laboratory, as described in the prior evaluation, apply here. We 
confirmed that females mated twice (to WT and OX5122) contained sperm of both 
genotypes, which could be differentiated by the presence or the absence of the 
fluorescent protein. This indicated that double mating events of this nature could 
potentially be scored reliably, in the field. However, further analysis with double blind 
scoring should be performed, to confirm that these events can be accurately scored if the 
male(s) to which the female has mated, are not known to the experimenter. It was not 
possible to draw precise conclusions of the ratio of unmarked to unmarked sperm, at the 
microscope resolutions applied in the study. Therefore, to differentiate the quantities of 
sperm transferred from first and second male partners, it would be necessary to perform 
counting at a higher resolution. This would be relatively laborious, and therefore it 
would be preferable to apply a qPCR-based assay to improve throughput, as previously 
described. 
 
 The last-mate precedence in paternity after multiple mating is well-documented 
in Medfly, and thought to be mediated by stratification of sperm in the fertilisation 
chamber (Bertin et al., 2010), (Scolari et al., 2014). After mating, the proportion of 
sperm in the fertilisation chamber reaches peak concentration, declines over several 
days, and is replenished by the spermathecae continuously (Twig and Yuval, 2005). 
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Therefore, after a secondary mating event, the quantity of sperm from the most recent 
mate is proportionally greater in the fertilisation chamber, through which eggs pass. The 
last-mate precedence subsequently declines, as the chamber is depleted and replenished 
by the spermathecae (Scolari et al., 2014). It would have been interesting to assess the 
dynamics of re-mating in females mated to sterile males, as it would be expected that a 
sterile transgenic strain able to induce last-mate precedence of paternity, would more 
efficiently suppress the wild population (a greater proportion of eggs would be fertilised 
with genetically sterile sperm). For this type of study, it would be extremely useful to 
apply males with differentially marked fluorescent sperm; two sets of crosses could be 
performed. In the first set, females would be crossed to a strain expressing a fluorescent 
sperm marking system (Ccprot1-zsGreen) and a male sterility effector (tetO-protamine-
FokI); and subsequently to a second line expressing a different fluorescent marker in 
sperm (Ccprot1-mCherry), but no male sterility effector. The second set of crosses 
would be the reciprocal of the first set. Assuming that the fitness penalties associated 
with expression of each fluorescent sperm marking component (Ccprot1-zsGreen or 
Ccprot1-mCherry) were equivalent, it would be possible to unambiguously assess the 
ability of sterile males to induce refractoriness to re-mating in females. In this analysis, 
the females could be monitored over a series of days to determine the extent to which 
they accepted secondary mates, and how this was affected by the genotype of the first 
partner (whether or not the first male was sterile). A particularly powerful analysis 
would account for other potential factors. For instance, it would be possible to dissect 
the spermathecae to correlate re-mating tendency with the quantity of sperm transferred 
upon mating. Furthermore, it would be possible to assess the extent to which last-mate 
precedence was induced by monitoring the proportion of inheritance of the zsGreen or 
mCherry transgenes in progeny (the developing eggs could be assessed by PCR to 
determine whether the father carried either the Ccprot1-zsGreen or Ccprot1-mCherry 
transgene); and to subsequently correlate this effect with the proportion of Ccprot1-
mCherry and Ccprot1-zsGreen marked sperm present in the fertilisation chamber. A 
similar strategy has been successfully applied in a published study (Scolari et al., 2014). 
Outside of the context of developing a population control strategy based on sterile male 
release, the re-mating behaviour of Medfly is complex, scientifically interesting, and not 
fully characterised despite considerable study (Bonizzoni et al., 2002), (Shelly and 
Kennelly, 2002), (Kraaijeveld and Chapman, 2004), (Kraaijeveld et al., 2005). 
Therefore, these transgenic lines may provide an interesting opportunity to address 
biologically interesting questions.  
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7.3 Development of a suitable protamine-FokI effector for penetrant and 
repressible male sterility 
 
7.3.1 The OX4718 male sterility effector (Dmprot2-mCherry-FokI) mediates 
penetrant and repressible male sterility, but the quantity and quality of sperm 
transferred to females after mating is reduced 
 Having described a functional system for fluorescent sperm marking, we sought 
to combine this with a penetrant and repressible male sterility effector. OX4718 was 
tested prior to the development of the Ccprot1-zsGreen fluorescent sperm marking 
system, and was primarily designed from components of the OX4705 construct tested in 
olive fly (tetO21-Dmprot2-mCherry-FokI), previously shown to mediate penetrant and 
repressible male sterility (Figure 3.3), (Asadi, 2013). The male sterility of OX4718A 
was highly penetrant (99%) and fully repressible (Figure 3.5). The OX4718A insertion 
was thereafter immobilised by transposition of the piggyBac ends (“resolved”), and it 
was confirmed that the penetrant and repressible sterile phenotype was not affected by 
the immobilisation (Figure 3.6). In lab-scale mating competition assays, WT females 
did not demonstrate a significant preference for OX4718A-resolved males or WT 
males. As previously discussed, the mating behaviour of Medfly reared in the lab is not 
an accurate indication of the wild equivalent; and therefore, further assessment was 
required to confirm that it could compete well with wild males in field conditions. This 
was not performed, because we subsequently discovered an issue with the sperm 
produced by the strain. 
  
  We determined that OX4718A-resolved males transferred lesser quantities of 
sperm in most instances, relative to WT males (Figure 3.8). The sperm present in 
females mated to OX4718A-resolved males frequently demonstrated an unusual, 
uncurled morphology; were often trapped in the oviduct; and generally immotile. These 
factors indicated that the sperm were weakened or dead. This was concerning, for two 
reasons. First, it indicated an increased likelihood of subsequent re-mating in females to 
which transgenic males had mated, because the quantity of sperm present in the female 
reproductive tract was reduced (Mossinson and Yuval, 2003). Secondly, it indicated that 
sterility in the system was not always mediated, or even potentially not primarily, by 
paternal effect lethality, but rather a lack of sperm transfer, and of fertilisation itself. 
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The viability of embryos formed by fertilisation with protamine-FokI expressing sperm 
would be expected to be essentially zero, thereby incurring a severe cost to female 
reproductive fitness, and increasing the efficacy of the population control strategy. 
However, if such fertilisation events did not occur or occurred only infrequently, then 
subsequent re-mating would completely or almost completely reverse the effect of 
mating to a sterile male. To investigate the proportion of embryos that demonstrate a 
paternal effect lethal phenotype, a nuclear staining assay was subsequently developed to 
monitor the extent of development (Figure 5.7). It was not applied to this line, because 
superior lines were simultaneously isolated (OX5242(1)H1 and OX5257V1; Figure 
5.12 and Figure 5.14).  
 
 The negative effects on sperm transferred to females by transgenic males were 
partially explained by the pattern of effector localisation (Dmprot2-mCherry-FokI). 
mCherry fluorescence was generally present in late spermatids, but individualised 
sperm were not visibly marked; this indicated a variability in Dmprot2-mCherry-FokI 
expression (or its stability) between sperm. This may explain why a minority of sperm 
are motile, or able to mediate the development of embryos to the larval stage (1% of 
embryos hatched). Although we noticed that sperm transferred to females that had 
mated OX4718A-resolved males were frequently unhealthy, such an effect had not been 
detected during dissection of testes from the OX4718A-resolved line. These were 
conducted at a relatively early stage of the study, and it is therefore possible that an 
experienced person would be able to revisit the experiments and detect potential 
impacts on sperm, when examined in the male germline. This is an important 
consideration, because the ability to detect defects in the male germline would facilitate 
the identification of poorly performing strains, at an earlier stage. Finally, we frequently 
observed visible translation of the reporter in spermatocytes. This was not ideal, 
because early translation of Dmprot2-FokI would be anticipated to disrupt the meiotic 
divisions, or cause significant defects in spermatid nuclear shaping, leading to failure of 
spermatid individualisation.  
 
 There were two primary explanations for the presence of translation in 
spermatocytes, which should not occur if the Dmprot2 5’UTR functions in Medfly as it 
does in D. melanogaster (Jayaramaiah Raja and Renkawitz-Pohl, 2005), (Barckmann et 
al., 2013). First, it was possible that the Dmprot2 5’UTR is not sufficient to mediate 
equivalent translational delay in the male germline of Medfly. This was indicated by the 
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visible translation of the fluorescent reporter in spermatocytes. Dmprot1 or Dmprot2 
reporter constructs in D. melanogaster, which feature the Dmprot promoter-5’UTR 
fragment linked to a fluorescent reporter and minimal 3’UTR, do not demonstrate this 
phenotype (Jayaramaiah Raja and Renkawitz-Pohl, 2005). The mechanism of 
translational repression of Medfly protamine-like genes is not known; therefore it 
cannot be guaranteed that the Dmprot2 5’UTR mediates translational delay effectively 
in Medfly. However, there is a confounding factor: a partial Dmhsp70 5’UTR (89 bp) 
immediately preceded the Dmprot2 5’UTR. This may have contributed to early 
translation, as observed when the Ccβ2tubulin 5’UTR was truncated and attached to a 
Cchsp83 minipromoter-5’UTR fragment in OX4282 (Figure 3.1), (Jin, 2011). This 
could potentially remove the ability of the Dmprot2 5’UTR to mediate translational 
delay, if the Dmprot2 5’UTR was indeed functional in Medfly. To address these issues, 
the Dmhsp70 5’UTR was truncated in subsequently evaluated constructs 
(OX5195/5241/5242). Furthermore, we applied regulatory sequences from Medfly 
protamines (the 5’UTR, coding domain and 3’UTR of Ccprot1 or Ccprot2) in these 
constructs, in an attempt to include sequences that might adequately delay the 
translation of the male sterility effector (protamine-FokI). 
7.3.2 Ccprot1-full 5’UTR-FokI (OX5195) mediates penetrant male sterility but is 
not repressible, presumably due to a minimal promoter fragment within the 
Ccprot1 5’UTR  
 The localisation of Ccprot1 promoter-Ccprot1 5’UTR-Ccprot1 ORF-zsGreen-
Ccprot1 3’UTR (OX5122) indicated that the fragment mediated an appropriate 
translational delay in the male germline; zsGreen was visible in the nuclei of elongating 
spermatids and individualised sperm, but not in spermatocytes. When the Ccprot1 
promoter was replaced with the full-length Dmhsp70 promoter (OX5184: Dmhsp70 
promoter-Ccprot1 5’UTR-Ccprot1 ORF-zsGreen-Ccprot1 3’UTR), specific translation 
in spermatids was still observed. This confirmed that translational repression was 
conferred by elements within an untranslated region. This was presumably the 5’UTR, 
because in D. melanogaster, sequences within the 5’UTR of Dmprot1 and Dmprot2 are 
responsible for this translational delay (Jayaramaiah Raja and Renkawitz-Pohl, 2005); 
this applies to other genes such as dj and Mst87F (Kempe et al., 1993), (White-Cooper, 
2009).  
 To engineer a translational delay absent in the previously tested strain 
(OX4718), we therefore developed a Ccprot1-FokI male sterility effector. A tetO21-
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Dmhsp70 minipromoter-Ccprot1 5’UTR-Ccprot1 ORF-FokI-Ccprot1 3’UTR fragment 
was cloned in a head-to-head configuration with the previously described tetracycline-
repressible, male-germline specific expression system (tetO21-β2T-Cchsp83-tTAV). 
This was performed to facilitate tetracycline repression of the Ccprot1-FokI effector. 
The resulting construct, and all those tested subsequently, incorporated the Ccprot1-
zsGreen sperm marking system as a separate module, to mediate the assessment of male 
mating competitiveness. The resulting OX5195 expression construct (tetO21-Ccprot1-
full 5’UTR-FokI; Ccprot1-zsGreen) demonstrated a highly penetrant male sterility 
phenotype in certain lines (3/8 were highly penetrant; 2/8 were semi-penetrant). We 
were surprised to find that the tetO21-Ccprot1-FokI effector was generally insensitive to 
tetracycline, which did not improve the hatch rate of progeny of OX5195 males; with 
the exception of two semi-penetrant lines (these were fully repressed).  
 Several observations suggested that a cryptic promoter element within the 
Ccprot1 5’UTR fragment was present: prior constructs applying a tetO21-Dmhsp70 
minipromoter-Dmprot2-FokI fragment (eg. OX4718/5036/4353) were fully repressible; 
sensitivity to tetracycline was observed in semi-penetrant lines; multiple transcriptional 
start sites were indicated by 5’ RACE (Section 5.2.7); and D. melanogaster genes with 
promoter elements in the 5’UTR are known (Kempe et al., 1993). This hypothesis was 
strongly supported by the subsequent isolation of repressible strains, where the Ccprot1 
5’UTR was truncated (OX5242: Ccprot1-short 5’UTR-FokI). Therefore, it appeared 
that the tetO-Dmhsp70 minipromoter was fully or substantially repressed, but a 
secondary promoter acting through a downstream transcriptional start site, was active 
even in the presence of tetracycline. We reasoned that truncating the 5’UTR fragment 
could remove or weaken this putative secondary promoter, and therefore engineer a 
greater extent of repressibility. It would have been possible to characterise the 
transcriptional start site (TSS) or sites of the Ccprot1-FokI effector, but given the 
inconclusive results in identifying the TSS of Ccprot1 and Ccprot2 in a prior study 
(Figure 4.10), and the commercial pressures to rapidly engineer a repressible line, we 
opted to truncate the predicted 5’UTR sequence and attempt removal of these elements. 
7.3.3 Shortening the 5’UTR of Ccprot1 (OX5242), but not Ccprot2 (OX5241), 
engineers penetrant and mostly repressible male sterility  
 The 5’UTR fragments of Ccprot1 (OX5242: Ccprot1-short 5’UTR-FokI) and 
Ccprot2 (OX5241: Ccprot2-short 5’UTR-FokI) were truncated, and each applied to 
regulate a repressible male sterility system, in a conformation that was otherwise 
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identical to that previously described (tetO21-Dmhsp70 minipromoter-Ccprot 5’UTR 
[short]-Ccprot ORF-FokI-Ccprot 3’UTR). A single line, OX5242(1)H1 was assessed 
for the tetO21-Ccprot1-short 5’UTR-FokI system. It demonstrated a penetrant (99%) 
and mostly repressible (81%) phenotype. This was consistent with the presence of a 
putative secondary promoter, which had been mostly attenuated. The exact mechanism 
is uncertain. It could for instance, be mediated by the weakening of the promoter 
element; or an enhancement of its sensitivity to tetracycline repression, by being 
brought closer to the tetO sequences. It remains possible that a fully repressible 
phenotype could be generated, by further shortening of the Ccprot1 5’UTR. This was 
not pursued because the male sterility phenotype appeared to be adequately repressed, 
and the commercial benefits of modifying the system to full repressibility, were 
insufficiently compelling to recommend the investment of further time and resources. If 
the strain is sufficiently repressible to be mass-reared without effects on the fitness of 
the colony, then a greater extent of repressibility is not highly advantageous 
commercially.  
 
 The male sterility effector incorporating a shortened version of Ccprot2 5’UTR 
(OX5241) was extremely penetrant in 3/4 lines (> 99%) but completely non-repressible. 
Therefore, it appears that the 5’UTR fragment was not sufficiently shortened to remove 
all putative elements driving tetracycline-independent expression of the construct. It 
would be interesting to perform 5’RACE on this strain to confirm the presence of 
transcription from an element within the 5’UTR. Alternatively, it would be possible to 
generate an even shorter version (for instance, retaining 70 nt of the 5’UTR), and 
investigate the extent of repressibility. However, this was not necessary commercially, 
because the Ccprot1 short 5’UTR-FokI effector was suitable for commercial 
development. There was therefore no need to develop a redundant system, or 
extensively assess the mechanisms that underpinned the failure of this effector to 
respond to tetracycline. 
 
7.3.4 Expression of Ccprot1-full 5’UTR-FokI (OX5195) in the male germline 
blocks the embryonic development of progeny, but at a later stage than expected  
 We investigated the paternal effect of Ccprot1 full 5’UTR-FokI expression in 
the male germline, by assessing the embryonic development of progeny of OX5195 
(Ccprot1-full 5’UTR-FokI) males (reared off-tet and on-tet) with nuclear staining. We 
assessed embryos at early (0-4 hours) and late (20-24 hours) timepoints; from personal 
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observation, embryos of the Oxitec WT strain typically hatch between 60-72 hours. We 
expected that the majority of embryos from crosses of off-tet reared males of a 
penetrant line (OX5195(2)AU1) would not develop at all, given the minimal hatch rate 
observed (1%). From the early stage (0-4 hours), results were as expected; no embryos 
exhibited nuclear divisions. We were surprised to find that most embryos (62%) of the 
later timepoint (20-24 hours) demonstrated extensive cellular division that proceeded 
past the blastodermal stage, and included early tissue differentiation. In D. 
melanogaster, mutants where the paternal genome is prevented from mediating 
embryonic development have been characterised. This is expected to be similar to the 
phenotypic conditions induced in these embryos, for which the paternal genome has 
been damaged by protamine-FokI expression. In homozygous maternal haploid (mh) 
mutants, the paternal chromatids do not form functional centrosomes and are excluded 
from subsequent divisions. About 22% reach a late stage of embryonic development 
(cuticle deposition) from haploid gynogenetic development, though none hatch (Loppin 
et al., 2001). Mutants of a gene with a similar phenotype, sésame, do not demonstrate 
decondensation of sperm chromatin after embryonic entry. As with mh mutants, the 
paternal DNA is excluded from subsequent divisions. Although hatching is not 
observed, the majority (72%) proceed to late embryonic development and form a 
cuticle; about 7% arrest in early development (Loppin et al., 2000). To compare to the 
phenotype we observed in OX5195(2)AU1 [NT] embryos, early arrest was more 
frequent (38%) and the proportion of embryos demonstrating tissue differentiation was 
similar (62%). This should not be taken to indicate that the mode of arrest is similar, as 
we did not perform an extensive cytogenetic analysis. However, it does indicate that 
even severe disruption of the paternal DNA, to an extent sufficient to induce 
aneuploidy, is not sufficient to block embryonic development in every instance (Loppin 
et al., 2001).  
 
 Therefore, we conclude that the expression of Ccprot1-FokI in spermatids 
induces severe double-stranded breaks and prevents hatching. However, it does not 
prevent partial development of embryos, apparently from the maternal haploid genome 
primarily. Though unexpected, this is not commercially an issue. Hatch rate was 
suppressed to 1%, and we never observed eclosion of adult progeny. Therefore, there 
appears to be no risk of vertical transmission of the transgene in the wild. Furthermore, 
the incidence of crop destruction from larval hatching will be severely reduced in this 
instance, and would be eliminated, if sterility is completely penetrant. A strain with full 
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penetrance in the heterozygous state (OX5257: Dmprot2-chimeric-new-FokI, Figure 
5.15) was subsequently identified. It will be interesting to assess the embryonic arrest 
phenotypes in progeny of OX5242 (Ccprot2-short 5’UTR-FokI) and OX5257 
(Dmprot2-chimeric-new-FokI) males, which demonstrated superior phenotypes for 
commercial development: highly penetrant male sterility that was mostly repressible. 
 
 It should be noted that the assay was developed to a preliminary state, and could 
be substantially improved. The sample size should be increased to at least 100 embryos 
per experimental group at each timepoint, as it was evident that the sample size applied 
was not sufficiently powerful to detect minor effects on viability (no effect on viability 
was detected for a semi-penetrant line, which demonstrated a reduced hatch rate). 
Furthermore, the collection cycles were relatively non-synchronised, spanning four 
hours. This was problematic, as a confounding factor for the early timepoint (0-4 hours) 
was that a minority of eggs may have appeared undeveloped because they were recently 
laid, rather than affected by the expression of protamine-FokI. This effect could be 
abolished by collecting eggs in a 10-30 minute window. Finally, the phenotypic 
categories selected for the 0-4 hour collection (no divisions; divisions visible) and the 
20-24 hour collection (morphologically normal; morphologically aberrant; or no visible 
development) were adequate to highlight severe developmental aberrations. However, 
they were not particularly meaningful from a developmental standpoint, and did not 
accurately account for the intricacies of development that occur in a 24 hour window. 
Therefore, it would be preferable for the experimenter to learn to accurately stage 
embryos using a system similar to the 17-stage model widely used in D. melanogaster 
(Campos-Ortega and Hartenstein, 1997). Finally, it would be interesting to introduce a 
quantitative element to the study to improve statistical analysis, for instance by 
quantifying the paternal and maternal genomic copy numbers with a molecular assay. 
Differentially quantifying the number of paternal and maternal genomes present would 
also provide evidence to confirm or disprove our hypothesis that embryos derived from 
protamine-FokI expressing fathers develop primarily as haploid gynogenetic embryos, 
from the maternal genome alone. Similar qPCR strategies have been applied to quantify 
the number of viral genomes within insect tissue to determine the likelihood of 
infectiousness (Walker et al., 2011), (Bian et al., 2013). Therefore, it seems reasonable 
that such an assay could be adapted to these ends.  
 We noted that the quantity of sperm transferred to WT females after mating, was 
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reduced in OX4718, OX5195(2)AU1, and OX5242(1)H1 males reared off-tet (Figure 
3.8, Figure 5.5, Figure 5.12). That a proportion embryos developed from crosses of 
OX5195(2)AU1[NT] males, but did not hatch, indicated that sterility was mediated by 
paternal effect lethality, in at least some instances. However, it was not possible to 
conclude whether embryos that arrested with zero visible divisions were the result of a 
very early paternal effect lethal phenotype, or were merely unfertilised. As the 
transgenic sperm express a protamine-zsGreen fluorescent sperm marker, it may be 
possible to visualise the paternal haploid genome within the fertilised egg by 
fluorescence microscopy. The visibility of Ccprot1-zsGreen associated with the paternal 
genome could be validated by staining embryonic progeny of males of the Ccprot1-
zsGreen line (OX5122) or Ccprot1-zsGreen; Ccprot1-short 5’UTR-FokI line (OX5242). 
This is certainly worthy of investigation, as it would preclude the necessity for highly 
sensitive PCR techniques, or the development of alternatively marked transgenic 
strains, for instance expressing a fluorescent protein in the sperm tail (Santel et al., 
1997). 
7.3.5 Expression of protamine-FokI reduces the motility and quantity of sperm 
transferred to females after mating 
 Because a previous protamine-FokI effector (OX4718: Dmprot2-mCherry-FokI) 
had demonstrated profound effects on the quantity and quality of sperm transferred to 
females after mating, we next investigated if males of the recently developed systems 
had similar deficits. We first assessed the OX5195 effector (Ccprot1-full 5’UTR-FokI), 
which was not repressible in highly penetrant lines. Marked sperm were visible in the 
most penetrant line (OX5195(2)AU1 [99%]), but at an extremely low quantity. Crosses 
of the second and third-most penetrant lines (OX5195(2)AC2 [97%] and H1 [93%]) 
demonstrated an intermediate phenotype. There were comparatively more sperm present 
relative to OX5195(2)AU1, but fewer relative to the very weakly penetrant lines 
(OX5195(2)AI1 [34%] and BG1 [16%]) and WT. The morphology, however, appeared 
similar to WT. The rate of sperm transfer from males of the weakly penetrant or 
impenetrant lines was similar to WT. Therefore, strongly penetrant male sterility was 
associated with reduced transfer of sperm to mated females, with an approximately 
linear, inverse relationship between penetrance of male sterility and the quantity of 
sperm, at least in OX5195. 
  We performed a similar analysis on OX5242(1)H1 males (tetO21-Ccprot1-short 
5’UTR-FokI), which demonstrated a commercially applicable penetrant and repressible 
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male sterility phenotype. Crosses of off-tet and on-tet reared OX5242(1)H males to WT 
females demonstrated that the rates of sperm transfer were markedly reduced in 
OX5242(1)H1[NT] relative to OX5242(1)H1[T] and WT[NT]. Furthermore, there was 
a reduction in the number of sperm with visible movement, in crosses of 
OX5242(1)H1[NT] males. In some instances, sperm that appeared to have been crushed 
by the cover slip were observed; but these were also present in the WT samples. 
Therefore, at present, we did not detect any effect on the morphology of sperm. 
However, it would be interesting to perform further investigation at a higher 
magnification, and with a haemocytometer or similar device that would not risk 
crushing any cells under investigation; this would allow the unambiguous confirmation 
of an effect on morphology, or lack thereof. Despite a reduction in the quantity of sperm 
transferred upon mating, the transfer of detectably marked sperm in every instance, was 
an improvement on the prior strain characterised (OX4718A-resolved). It is possible 
that the ability of the Ccprot1 5’UTR to mediate translational delay, was responsible for 
this improvement. However, the removal of the Dmhsp70 5’UTR (a gene with early 
translation) from the effector fragment may have been a contributing factor. Because a 
comparison of tetO21-Ccprot1-FokI effectors with and without the Dmhsp70 5’UTR 
were not performed, it is not possible to confirm that its removal had any effect.  
 
  Consistent with the incomplete repression observed in the egg hatch assay, the 
number of sperm transferred to females in OX5242H1[T] crosses appeared to be 
reduced relative to the WT[T] crosses. As previously described, it was difficult to 
perform relative quantification under the experimental conditions applied (squashes of 
spermathecae containing hundreds of overlapping live sperm, directly observed at 10x-
40x magnification). It would be interesting to apply a PCR-based strategy to quantify 
sperm by amplification of transgenic or male-specific sequences; such a technique has 
been developed for A. suspensa, a Tephritid pest (Fritz et al., 2010). The effect of 
protamine-FokI expression was not assessed in OX5241 (Ccprot2-short 5’UTR-FokI), 
because it did not demonstrate a male sterility phenotype suitable for commercial 
development (it was not repressible). Furthermore, it was not possible to assess OX5257 
(Dmprot2-chimeric-new-FokI) lines, due to insufficient time. However, the assessment 
of OX5257 lines will be particularly interesting, as a similar effector (OX4718: 
Dmprot2-chimeric-old-mCherry-FokI) demonstrated deficiencies in sperm transfer and 
morphology. This will provide further evidence regarding whether the effect was 
CONFIDENTIAL       Chapter 7 – Discussion  
 
283 
systematic, or an insertion-specific phenotype in OX4718A-resolved. 
 
 These results provided clear evidence that expression of tetO21-Ccprot1-FokI to 
an extent sufficient to sterilise males, has undesirable effects on the quantity and 
motility of sperm transferred to females upon mating, despite the inclusion of Ccprot1 
5’UTR elements which were previously shown to mediate appropriate translational 
delay in a study of fluorescent reporter localisation (OX5184, Chapter 4). Though 
unexpected, this is not entirely surprising, as the zsGreen reporter (Dmhsp70 promoter-
Ccprot1-zsGreen) was translated in spermatids which were not yet fully elongated. 
Therefore, it could be envisioned that even at this relatively late stage, the translation of 
Ccprot1-FokI was associated with defects in spermatid nuclear shaping, leading to 
failure of spermatid individualisation, and therefore producing sperm with aberrations. 
It should also be noted that the zsGreen reporter was constitutively transcribed from 
Dmhsp70 promoter, rather than from a tetracycline-repressible positive feedback loop. 
Therefore, the levels of tetO21-Ccprot1 short 5’UTR-FokI translation in spermatids 
may have been greater than that of Dmhsp70 promoter-Ccprot1 5’UTR-Ccprot1 ORF-
zsGreen-Ccprot1 3’UTR (OX5184). It would have been highly informative to assess if 
sperm in the male germline are visibly affected, before they are transferred to females 
(by dissection of the male germline). There was insufficient time to perform this 
assessment, but it is recommended for future study. 
 
 In practical terms, it will be interesting to assess if the reduction in the quantity 
of sperm transferred affects the utility of this transgenic system, as a novel means of 
population control. It is expected that females mated to these transgenic strains will be 
relatively more likely to remate, given that re-mating is correlated with the quantity of 
sperm transferred (Mossinson and Yuval, 2003). It will be particularly interesting to 
develop quantitative methods to assess the number of sperm transferred, for instance the 
high-resolution microscopic assessment or qPCR strategies previously described, to 
understand this theoretical effect in detail. It remains possible that a strain with full 
repressibility and minimal or no effects on sperm will be isolated, from the OX5242 and 
OX5257 lines which have not yet been evaluated (three each). A female-specific 
flightless mosquito line developed at Oxitec demonstrated non-repressibility in certain 
lines and full repression in others (Labbé et al., 2012). Therefore, it remains possible 
that a fully repressible OX5242 line may be identified, despite the observation that the 
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repressibility of highly penetrant male sterile lines of a similar construct (OX5195: 
tetO21-Ccprot1 full 5’UTR-FokI) was similar (all were equally insensitive to 
tetracycline). However, the possibility of isolating a highly penetrant OX5242 or 
OX5257 line with minimal or no negative effects on sperm appears low, because 
expression of tetO-Ccprot1-FokI (OX5195 and OX5242) at levels sufficient to mediate 
> 90% penetrance, has been associated with negative effects in four lines. 
Experimentally, it would first be preferable to quantify the extent to which sperm 
transfer is reduced, and thereafter to describe how this translates into a practical effect 
relevant to the population control strategy. For instance, if males remain relatively 
competitive for mating events in the field, and females re-mate only to an extent that 
can be attenuated by release of sterile males at a greater ratio, then there is minimal 
commercial benefit to developing a strain with a superior ability to transfer large 
quantities of sperm. Should the development of such a strain become necessary, it is 
possible that translation could be further delayed by the incorporation of a 5’UTR 
conferring a translational delay at a later stage. However, considering the difficulties 
associated with engineering translational delay with the Ccprot1 5’UTR (non-
repressible sterility resulted in the first instance, and took several months to fix), such 
experiments should only be undertaken if a commercial benefit can be directly 
confirmed. 
 
7.4 Suggestions for future commercial development  
 It is now necessary to generate a double homozygous strain, for the male 
sterility effector and fluorescent sperm marking system (OX5242 or OX5257), and the 
tetracycline-repressible male-selecting system (OX3864). Thereafter, it must be 
confirmed that the male sterility and male-selecting (genetic sexing) phenotypes are 
fully penetrant and sufficiently repressible, when expressed together in a single strain. It 
would also be useful to investigate the expression patterns of the molecular components 
of the male sterility effector and male-selecting elements, to determine if the effectors 
are expressed on-tetracycline or in non-target tissue. This is an important consideration, 
as tetO-protamine-FokI expressing transgenic lines have previously demonstrated 
expression on-tetracycline and in somatic tissue (Jin, 2011), (Asadi, 2013), (Megas et 
al., unpublished data). The leakiness of the tet system is frequently affected by 
positional effect, and therefore it may be necessary to characterise a variety of insertions 
to find a suitable candidate for penetrant and repressible expression of both systems 
with minimal leakiness (Schönig et al., 2011).  
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 The mating competitiveness of the double homozygous strain should first be 
tested in the laboratory, as previously described, to see if there are any evident defects 
in mating competitiveness. Finally, a life history analysis of the double homozygous 
strain will be performed and we will assess the mating competitiveness of the double 
homozygous strain under field-like conditions (greenhouses), to practically validate the 
ability of the strain to reduce populations of Medfly. Greenhouse population trials have 
been conducted for the male-selecting OX3864A-homozygous strain in Austria, Greece, 
Brazil, Morocco, Australia, and the UK; and an open release permit granted in Brazil 
(Leftwich et al., 2014), (Oxitec, 2016). Therefore, following the approval of a licence 
for the novel strain described herein (integrating fluorescent sperm marking, repressible 
male sterility and repressible male-selection), such a strain could be implemented 
alongside the current programmes assessing the efficacy of the OX3864A strain. As 
previously described, this strain is essentially an improvement of the OX3864A male-
selecting system, incorporating two additional effectors for repressible male sterility and 
fluorescent sperm marking. The practical benefits mediated by these additional two 
features is considerable. First, the larval hatch rate is reduced to 0-1%; progeny of the 
OX3864A strain hatch at a similar rate to WT; but female progeny die before pupation 
(Leftwich et al., 2014). Therefore, the novel system would reduce the extent to which 
fruit would be damaged by larval development, hence providing commercial benefits. 
Secondly, the rate of adult eclosion of the most penetrant strain characterised to date 
(OX5257V1) was zero (n=300). Therefore, at present, the risk of vertical propagation of 
the transgenes in the wild appears to be zero for highly penetrant strains. It will 
however, be necessary in future to investigate the rates of larval, pupal and adult 
development in progeny of transgenic males with a larger sample size (n > 10000), to 
confirm that adults never eclose. In practical terms, this is a sufficient improvement on 
the OX3864A system, for which half of progeny of homozygous transgenic males and 
wild females, would be expected to survive to adulthood (all male progeny).  
 Furthermore, a fluorescent marking system in sperm provides a direct method to 
trace the mating competitiveness of sterile males. This would provide evidence that 
sterile males were effective in the field, and from an economic and practical 
perspective, allow the development of models to assess the required scale of release to 
achieve a desired level of suppression. We anticipate that male-selecting and repressibly 
male sterile strains with fluorescently marked sperm, demonstrating adequate 
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competitiveness and acceptance by regulatory bodies, will be an invaluable tool for 
area-wide population control of Medfly and other insects of economic importance.  
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Chapter 8 – Appendix 
 
Appendix 8.1 – Medfly genes homologous to the D. melanogaster meiotic arrest 
genes (tMAC and tTAFs) 
 Protein sequences of tMAC genes (aly, comr, mip40, tomb, topi, Caf1 [180 kDa 
subunit], achi, wuc) and tTAF genes (can, mia, rye, nht, sa) from D. melanogaster were 
searched for homology against the Medfly genomic database with an expect threshold 
of 10 (NCBI, 2016). Matches with a score less than 100 were rejected. The sequences 
were aligned with M-Coffee (Figure 8.1). The D. melanogaster homologues were 
preceded with Dm (eg. Dm-aly) and the Medfly homologues with Cc (eg. Cc-aly). A 
homologous sequence was returned for every gene except wuc (tMAC) and rye (tTAF). 
The tTAF like genes may not be correct in every instance; it is possible that the result is 
the isoform present in the basal version of TAF, rather than the testis-specific version 
(Hiller et al., 2001). Cc-can was annotated as a testis-specific homologue in the NCBI 
database; Cc-mia, Cc-rye and Cc-sa were not. In an attempt to find the basal and testis-
specific versions of these three genes, the Medfly sequences were searched for 
homology against the Medfly genomic database with a lower stringency (expect 
threshold: 100). This failed to identify a testis-specific and basal homologue, for all 
three genes. The Medfly homologues of tMAC and tTAF genes may represent a useful 
source of regulatory sequences for the targeted localisation of transgenic effectors. 
Alternatively, they may provide interesting targets for induced male sterility, for 
instance by RNA interference or synthetic CRISPR repressors. However, it is likely that 
the sterility phenotypes will not be ideal, because mutants of meiotic arrest genes do not 
produce mature spermatozoa, therefore females will not be transferred sperm upon 
mating, and will be likely to remate (Lin et al., 1996), (Mossinson and Yuval, 2003). 
Nonetheless, the genes may represent a wealth of regulatory sequences for the male 
germline; alternatively, it would be interesting to generate mutants or fluorescent 
reporter fusions to characterise their role in male reproductive development.   
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Appendix 8.2 – Primer sequences used in PCR and DNA sequencing, PCR 
amplicons generated in the study, and CRISPR sgRNA target sites 
 
Table 8.1 Sequences of PCR and sequencing primers  
Name Target Sequence (5’-3’)  
Adapter 1 Flanking adapter gtgtagcgtgaagacgacagaa 
Adapter 2 Flanking adapter gacgacagaaagggcgtgtgg 
SS1131 Adh gaaagctgttcgggcttcaggc 
SS1132 Adh cttggaggtgatgtcgaatttggtg 
SS1693 Cc-Rp17S tcgcaagttcgtggtatttctatc 
 
SS1694 Cc-Rp17S caagcaatttcaacatctcctttg 
 
SS1713 
 
sgRNA 
synthesis  
aaaagcaccgactcggtgccactttttcaagttgataacggactagccttattttaacttg
ctatttctagctctaaaac 
SS1714 dsRed2 gaaattaatacgactcactataggccacgagttcgagatcgagttttagagctagaaat
agc 
SS1715 sgRNA 
synthesis 
gaaattaatacgactcactataggtacaccttggagccgtacgttttagagctagaaat
agc 
SS1765 Cas9 agctggtgcagacctacaaccag 
SS1853 Cas9 cggttatccttcaggaacgg 
SS1928 sgRNA 
synthesis 
gaaattaatacgactcactatagggtggcgaccggtttgcgcgttttagagctagaaat
agc 
SS1929 sgRNA 
synthesis 
gaaattaatacgactcactataggcggtacttcatggtcatcgttttagagctagaaata
gc 
SS1930 sgRNA 
synthesis 
gaaattaatacgactcactataggccaaggagatgaccatgagttttagagctagaaa
tagc 
SS1931 sgRNA 
synthesis 
gaaattaatacgactcactataggccggtgatcacgaacttggttttagagctagaaat
agc 
SS1932 sgRNA 
synthesis 
gaaattaatacgactcactatagggaaagataatcatattgtgttttagagctagaaata
gc 
SS1933 sgRNA 
synthesis 
gaaattaatacgactcactataggaaagataatcatattgtggttttagagctagaaata
gc 
SS1934 sgRNA 
synthesis 
gaaattaatacgactcactataggaagataatcatattgtgagttttagagctagaaata
gc 
SS1935 sgRNA 
synthesis 
gaaattaatacgactcactataggttgtgacgtacgttaaaggttttagagctagaaata
gc 
SS1936 sgRNA 
synthesis 
gaaattaatacgactcactataggatatgattatctttctaggttttagagctagaaatag
c 
SS1937 sgRNA 
synthesis 
gaaattaatacgactcactataggacgtacgtcacaatatgagttttagagctagaaat
agc 
SS2045 sgRNA 
synthesis 
gaaattaatacgactcactataggtgatgacgttctcggagggttttagagctagaaat
agc 
SS2047 sgRNA 
synthesis 
gaaattaatacgactcactataggagcgcgtgatgaacttcggttttagagctagaaat
agc 
TD95 dsRed2 cttggccatgtagatggacttgaactcc 
TD96 zsGreen caagcaggccatcaacctgtgc 
TD97  zsGreen gacttggccttgtacacggtgtcg 
TD692 piggyBac 5’ agtcacgtaaaagataatcatgcg 
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TD693 piggyBac 3’ gtgccaaagttgtttctgactgac 
TD775 dsRed2 cacaacgaggactacaccatcg 
TD805 zsGreen acgatgtcctgggggtactc 
TD1018 Scraps intron ccgttcttttctgggttcttcc 
TD1085 dsRed2 acttcatccagcacaagctgacc 
TD1156 pJET atcaactgctttaacacttgtgc 
TD1157 pJET aaagaagaacatcgattttccatg 
TD1167 OX4718 near pB gctccagcttttgttccctttagc 
TD1168 attP220 ggcttcggtgtgtccgtcag 
TD1406 dsRed2 ccatggtcttcttctgcatcac 
TD2121 dsRed2 tgtcattgtatcagtggatcggtg 
TD2908 FokI cggtagccgtacaccttcatg 
TD2955 dsRed2 tgtgtgacgatgaggttgctg 
TD3434 FokI tcgtggataccaaggcctac 
TD3435 FokI ttgcagttggtgatgtggtt 
TD3477 OX4718 3’ flank gagatgatggaccctctctaacca 
TD3478 OX4718 3’ flank 
flanking 
ctcgcactgtcaactgctgatc 
TD3479 OX4718 3’ flank 
flanking 
atgactcccgcattagtattatctgc 
TD3685 OX4718 5’ flank 
flanking 
ggttcaaactttacatgtgagcaatc 
TD3686 OX4718 5’ flank 
flanking 
tctaagcgtcaactgaagatttgg 
TD3687 OX4718 5’ flank 
flanking 
gttagtctaagcgcctcgttaagttc 
TD3883 piggyBac 5’ 
(inverse PCR) 
gacgcatgattatcttttacgtgac 
TD3884 piggyBac 5’ 
(inverse PCR) 
tgacacttaccgcattgaca 
TD3885 piggyBac 5’ 
(inverse PCR) 
gcgatgacgagcttgttggtg 
 
TD3886 piggyBac 5’ 
(inverse PCR) 
tccaagcggcgactgagatg 
TD3887 piggyBac 3’ 
(inverse PCR) 
caacatgactgtttttaaagtacaaa 
TD3888 piggyBac 3’ 
(inverse PCR) 
gtcagaaacaactttggcacatatc 
TD3889 piggyBac 3’ 
(inverse PCR) 
cctcgatatacagaccgataaaac 
TD3890 piggyBac 3’ 
(inverse PCR) 
tgcatttgcctttcgccttat 
TD3938 Ccprot1 cattccttggcaccgcgtcgta 
TD3939 Ccprot1 ataccgctgggacgttgac 
TD3940 Ccprot2 agctttgctccttgtcgcactg 
TD3941 Ccprot2 gccgacagtccacagcatttc 
TD3947 Dmprot1 aatgagtgcaagagcctgtg 
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TD3948 ZsGreen gtcaggtgccacttctggtt 
TD3950 Cc-RpP0 ccgcctggaaagctcaata 
TD3951 Cc-RpP0 gagctggagcgcgtacttt 
UFP1 5’ RACE adapter ctaatacgactcactatagggcaagcagtggtatcaacgcagagt 
UFP2 5’ RACE adapter ctaatacgactcactatagggc 
  
Table 8.2 Amplicons generated by standard, inverse, colony and RACE PCR 
Type Chapter Target Primers Product size 
(bp) 
Notes 
Standard  3 OX4718 (left 
transposon) 
TD693 TD1167 485 Immobilisation of the 
OX4718 transposon 
OX4718 
(central 
element) 
TD1168 TD692 251 
OX4718 
(right 
transposon) 
TD2908 TD775 551 
gDNA 
flanking 
OX4718  
TD3685 TD3477 Varied Large polymorphisms 
were present in the 
flanking sequence of 
certain individuals 
TD3685 TD3478 
TD3685 TD3479 
TD3686 TD3477 
TD3686 TD3478 
TD3686 TD3479 
TD3687 TD3477 
TD3687 TD3478 
TD3687 TD3479 
6 dsRed2 TD2121 TD1085 1438 Identification of 
CRISPR-induced 
mutations 
adh SS1131 SS1132 491 
zsGreen TD1018 TD805 364 
dsRed2 TD2121 TD95 935 
Inverse  piggyBac 5’ TD3883 TD3884 Varied with 
restriction 
digests 
First 5’ reaction 
piggyBac 5’ TD3885 TD3886 Second 5’ reaction 
piggyBac 3’ TD3887 TD3888 First 3’ reaction 
piggyBac 3’ TD3889 TD3890 Second 3’ reaction 
Colony Multiple pJET TD1156 TD1157 > 174 Size varied with the 
insert ligated into pJET 
5’RACE 4 Ccprot1 UFP mix 
(UFP 1 & 
2) 
TD3938 416 First nested PCR 
 TD3939 317 Second nested PCR 
Ccprot2 TD3940 286 First nested PCR 
 TD3941 256 Second nested PCR 
 
 
Table 8.3 Amplicons generated by RT-PCR and qRT-PCR 
Type Chapter Target Primers Product size Notes 
     cDNA gDNA  
RT 4 zsGreen TD3947 
 
TD3948 1200 Dmprot1 promoter functional 
in OX5140 
6 
 
zsGreen TD96 TD97  447 3xp3-zsGreen is transcribed 
in OX5154 but not adequately 
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translated 
Cas9 SS1765 SS1853 751 Cas9 is maternally deposited 
to embryos in OX5173  
4, 6 Cc-RpP0 TD3950 TD3951 315 
 
542 Internal standard 
4 Adh SS1131 SS1132 329 491 Internal standard  
qRT 5 Ccprot1-
FokI 
TD3434 TD3435 232 Tetracycline partially 
represses tetO-Ccprot1-FokI 
in OX5195(2)AU1 
Cc-
Rp17S 
SS1693 SS1694 115 Internal standard  
 
 
Table 8.4 CRISPR sgRNAs used in the study  
Name Target sgRNA sequence (5’-3’)  Activity confirmed? 
SS2045 dsRed2 ggtgatgacgttctcggagg Confirmed in vivo 
SS2047 ggagcgcgtgatgaacttcg 
SS1928 zsGreen gggtggcgaccggtttgcgc None in vivo or in vitro 
SS1929 ggcggtacttcatggtcatc 
SS1930 ggccaaggagatgaccatga 
SS1931 ggccggtgatcacgaacttg Confirmed in vivo and in vitro 
SS1932 pB 3’ gggaaagataatcatattgt Confirmed in vitro but not in vivo 
SS1933 ggaaagataatcatattgtg 
SS1934 ggaagataatcatattgtga 
SS1936 ggatatgattatctttctag 
SS1935 ggttgtgacgtacgttaaag None in vitro 
SS1937 ggacgtacgtcacaatatga 
The two 5’ nucleotides of the sgRNA were always GG (to facilitate efficient transcription from the T7 
promoter); this did not match the genomic target in most instances.  
 
Appendix 8.3 – Transgenic expression constructs investigated in this study and a 
summary of the observed phenotypes after transgenesis 
 
Table 8.5: Summary of all expression constructs tested in this study 
Chapter # Vector 
type 
Function Phenotype observed 
3 OX3671 2-pB Fluorescent sperm marking, validating 
Ccβ2T or Ccβ2T[short]-Cchsp83 as a 
regulator of tTAV 
Sperm marking weak. 
tTAV expressed as 
desired in OX4282  
OX4282 
OX4353 Repressible male sterility Penetrant & 
repressible sterility 
OX4705 Fluorescent sperm marking 
Repressible male sterility 
Sperm marking weak 
Penetrant & 
repressible sterility 
OX4718 4-pB 
OX4801 2-pB Sperm marking weak 
Sterility not fully 
penetrant  
OX5036 Sperm marking weak 
Sterility not fully 
penetrant 
4 OX5122 Fluorescent sperm marking. Sperm marking strong 
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OX5123 
OX5150 
OX5140 Sperm marking absent 
OX5182 Confirm that Dmhsp70 promoter-Ccprot1 
5’UTR mediated transcription of zsGreen in 
with translational delay in spermatids 
Strong reporter 
translation, 
appropriately delayed 
OX5184 
OX5186 
5 OX5195 4-pB Fluorescent sperm marking 
Repressible male sterility 
Sperm marking strong 
Penetrant sterility but 
not repressible 
OX5241 
OX5242 Sperm marking strong 
Penetrant sterility, 
mostly repressible 
OX5257 
6 OX4014 2-pB Marker expressing line used to validate 
CRISPR and TALEN systems for targeted 
mutagenesis 
 
OX5134 Germline expression of nanos-Cas9 No lines isolated 
(3xp3-zsGreen not 
translated)  
OX5154 Two-marker construct to confirm that 3xp3 
promoter does not function in Medfly 
3xp3-zsGreen was not 
visibly translated, 
despite transcription 
OX5173 Germline expression of nanos-Cas9 High efficiency 
targeted CRISPR 
mutagenesis 
 OX3022 pB 
helper 
Plasmid DNA (OX3022) or mRNA 
(OX3081) expression constructs for 
piggyBac transposase. 
 
OX3081 
OX3133 2-pB Germline expression of piggyBac 
transposase (to immobilise four-ended 
piggyBac insertions) 
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Appendix 8.4 – U6 promoter sequences suitable for germline expression of sgRNAs 
and CRISPR sgRNAs active against piggyBac ITRs 
 Materials for these experiments were prepared, but there was insufficient time to 
perform them. It was demonstrated that expression of sgRNAs in the germline (under 
control of the U6 promoter) increased the efficiency of gene editing (Kondo and Ueda, 
2013). Two U6 promoter homologues from Medfly are presented, which could mediate 
the development of this genetic tool. It would have also been interesting to validate the 
CRISPR platform to mediate piggyBac end removal. sgRNAs with validated activity 
against the piggyBac 3’ ITR were characterised. These results are summarised in 
Figure 8.2. 
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Summary 
 Medfly (Ceratitis capitata) is an invasive Tephritid fruit fly that severely 
disrupts global agricultural productivity. Pesticides are the primary control method 
despite genetic resistance, questionable efficacy, and negative effects upon the 
environment. The sterile insect technique (SIT) is an ecofriendly alternative, that 
suppresses the reproduction of wild Medfly by the mass release of sterilised males. 
Currently, males are sterilised by irradiation, which frequently reduces the ability of 
males to court females and thereby suppress reproduction.  
 To address these undesirable effects, we developed a novel sterilisation strategy, 
based on the tetracycline-repressible expression of a nuclease effector in the male 
germline. Strains expressing these effectors were 99-100% sterile in the absence of 
tetracycline, but fertile in the presence of tetracycline. Male mating competitiveness was 
not detectably reduced in one strain expressing the effector, indicating that these 
expression systems are suitable for field use. Subsequently, a fluorescent marking 
system to label sperm was developed, which provided a useful tool to assess the mating 
competitiveness of sterile males: it was possible to accurately differentiate whether 
females had mated wild or transgenic males, under field-simulated conditions.  
  These components may be merged with a tetracycline-repressible genetic switch 
to remove females from the rearing population, to improve the efficacy of the strategy 
by releasing sterile males alone. Thereafter, a full assessment of the life history traits of 
the strain and its mating competitiveness under field-like conditions will be performed, 
to confirm that the release of these sterile males is capable of suppressing wild 
populations of Medfly.  
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